sampleID	_EVENT	_INTEGRATION	_OS	_OS_IND	_PATIENT	_RFS	_RFS_IND	_TIME_TO_EVENT	_anatomical_origin	_cohort	_primary_disease	additional_pharmaceutical_therapy	additional_radiation_therapy	age_at_initial_pathologic_diagnosis	bcr_followup_barcode	biochemical_recurrence	bone_scan_results	clinical_M	clinical_T	days_to_birth	days_to_bone_scan_performed	days_to_collection	days_to_death	days_to_diagnostic_computed_tomography_performed	days_to_diagnostic_mri_performed	days_to_first_biochemical_recurrence	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_after_initial_treatment	days_to_psa	days_to_second_biochemical_recurrence	days_to_third_biochemical_recurrence	diagnostic_ct_abd_pelvis_performed	diagnostic_ct_abd_pelvis_result	diagnostic_mri_performed	diagnostic_mri_result	followup_case_report_form_submission_reason	followup_treatment_success	form_completion_date	gender	gleason_score	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_pathologic_diagnosis_method	initial_weight	intermediate_dimension	is_ffpe	laterality	longest_dimension	lost_follow_up	lymphnodes_examined	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_after_initial_treatment	number_of_lymphnodes_examined	number_of_lymphnodes_positive_by_he	oct_embedded	pathologic_N	pathologic_T	pathology_report_file_name	patient_death_reason	percent_lymphocyte_infiltration_BOTTOM	percent_lymphocyte_infiltration_TOP	percent_monocyte_infiltration_BOTTOM	percent_monocyte_infiltration_TOP	percent_necrosis_BOTTOM	percent_necrosis_TOP	percent_neutrophil_infiltration_BOTTOM	percent_neutrophil_infiltration_TOP	percent_normal_cells_BOTTOM	percent_normal_cells_TOP	percent_stromal_cells_BOTTOM	percent_stromal_cells_TOP	percent_tumor_cells_BOTTOM	percent_tumor_cells_TOP	percent_tumor_nuclei_BOTTOM	percent_tumor_nuclei_TOP	person_neoplasm_cancer_status	primary_pattern	primary_therapy_outcome_success	prior_dx	psa_value	radiation_therapy	residual_tumor	sample_type	sample_type_id	secondary_pattern	shortest_dimension	source_of_patient_death_reason	targeted_molecular_therapy	tertiary_pattern	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_level	tumor_progression_post_ht	tumor_tissue_site	type_ofprogression_of_disease_ht	vial_number	vital_status	year_of_initial_pathologic_diagnosis	zone_of_origin	_GENOMIC_ID_TCGA_PRAD_mutation	_GENOMIC_ID_TCGA_PRAD_mutation_bcm_gene	_GENOMIC_ID_TCGA_PRAD_GSNP6raw	_GENOMIC_ID_TCGA_PRAD_PDMRNAseq	_GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_PRAD_mutation_curated_broad_gene	_GENOMIC_ID_TCGA_PRAD_mutation_broad_gene	_GENOMIC_ID_TCGA_PRAD_gistic2thd	_GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2	_GENOMIC_ID_TCGA_PRAD_gistic2	_GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_PRAD_RPPA	_GENOMIC_ID_TCGA_PRAD_PDMRNAseqCNV	_GENOMIC_ID_TCGA_PRAD_hMethyl450	_GENOMIC_ID_TCGA_PRAD_miRNA_HiSeq	_GENOMIC_ID_TCGA_PRAD_mutation_ucsc_vcf_gene	_GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_PRAD_GSNP6noCNV
TCGA-2A-A8VL-01	0	TCGA-2A-A8VL-01	621	0	TCGA-2A-A8VL	621	0	621	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-18658	21						0	621		585			NO		NO				2014-3-29	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Left			YES				NO	15	0		N0	T2b																			TUMOR FREE	3		No	0.05	NO	R0	Primary Tumor	01	3			NO	4	NO	YES	2A	Middle|Base		Prostate			LIVING	2010	Peripheral Zone			c1624780-5ee0-4c27-be4a-7367f815cc81	TCGA-2A-A8VL-01	e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5		TCGA-2A-A8VL-01A-21D-A377-08	TCGA-2A-A8VL-01A-21D-A376-01	e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5	TCGA-2A-A8VL-01A-21D-A376-01	e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5		TCGA-2A-A8VL-01	TCGA-2A-A8VL-01A-21D-A378-05	TCGA-2A-A8VL-01A-21R-A37H-13		e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5	c1624780-5ee0-4c27-be4a-7367f815cc81
TCGA-2A-A8VO-01	0	TCGA-2A-A8VO-01	1332	0	TCGA-2A-A8VO	1332	0	1332	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20958	22	1290		11	84		0	1332		1332			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-3-30	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral			NO				NO			true		T3a	TCGA-2A-A8VO.B699D2D8-1EB6-4BFE-A468-D1FFA5F32D98.pdf			0		0		0		0		5		10		85		70	TUMOR FREE	3		No	0.05	NO	R1	Primary Tumor	01	3			NO	4	NO	YES	2A	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones			ec1c19d3-4d62-452a-ae7a-37b0411d7045	TCGA-2A-A8VO-01	20a779a3-04ab-4080-b11d-ed7b22fcd2da		TCGA-2A-A8VO-01A-11D-A377-08	TCGA-2A-A8VO-01A-11D-A376-01	20a779a3-04ab-4080-b11d-ed7b22fcd2da	TCGA-2A-A8VO-01A-11D-A376-01	20a779a3-04ab-4080-b11d-ed7b22fcd2da		TCGA-2A-A8VO-01	TCGA-2A-A8VO-01A-11D-A378-05	TCGA-2A-A8VO-01A-11R-A37H-13		20a779a3-04ab-4080-b11d-ed7b22fcd2da	ec1c19d3-4d62-452a-ae7a-37b0411d7045
TCGA-2A-A8VT-01	0	TCGA-2A-A8VT-01	995	0	TCGA-2A-A8VT	995	0	995	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			47		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-17365	4	923		-2	4		0	995		995			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2014-3-29	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral			YES				NO	16	2	true	N1	T4	TCGA-2A-A8VT.9A772AE3-EDB9-4AAB-8883-6BA9CBCA71CD.pdf			0		0		0		0		3		3		94		80	TUMOR FREE	4	Complete Remission/Response	No	0.05	YES	R1	Primary Tumor	01	5			YES		NO	YES	2A	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			3b68b168-ae91-4a75-9e1f-df53e98cf63b	TCGA-2A-A8VT-01	2e80aebe-77b5-496c-bde9-494b9b94ee3f		TCGA-2A-A8VT-01A-11D-A377-08	TCGA-2A-A8VT-01A-11D-A376-01	2e80aebe-77b5-496c-bde9-494b9b94ee3f	TCGA-2A-A8VT-01A-11D-A376-01	2e80aebe-77b5-496c-bde9-494b9b94ee3f		TCGA-2A-A8VT-01	TCGA-2A-A8VT-01A-11D-A378-05	TCGA-2A-A8VT-01A-11R-A37H-13		2e80aebe-77b5-496c-bde9-494b9b94ee3f	3b68b168-ae91-4a75-9e1f-df53e98cf63b
TCGA-2A-A8VV-01	0	TCGA-2A-A8VV-01	671	0	TCGA-2A-A8VV	671	0	671	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			52		NO	Equivocal	M0	T2b	-19065	167	1155		29	204		0	671		560			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2014-3-29	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Right			YES				NO	16	0	true	N0	T2b	TCGA-2A-A8VV.E42BC148-77A7-4FEB-9ACE-8BC2FFD33BF7.pdf			4		1		3		1		7		45		45		80	TUMOR FREE	3		No	0.05	NO	R0	Primary Tumor	01	3			NO	4	NO	YES	2A	Apex|Middle		Prostate		A	LIVING	2010	Peripheral Zone			b069f5b0-78d1-41d0-9ade-207945526272	TCGA-2A-A8VV-01	45eca81f-9ce2-4de6-b970-65959d76398c		TCGA-2A-A8VV-01A-11D-A377-08	TCGA-2A-A8VV-01A-11D-A376-01	45eca81f-9ce2-4de6-b970-65959d76398c	TCGA-2A-A8VV-01A-11D-A376-01	45eca81f-9ce2-4de6-b970-65959d76398c		TCGA-2A-A8VV-01	TCGA-2A-A8VV-01A-11D-A378-05	TCGA-2A-A8VV-01A-11R-A37H-13		45eca81f-9ce2-4de6-b970-65959d76398c	b069f5b0-78d1-41d0-9ade-207945526272
TCGA-2A-A8VX-01	0	TCGA-2A-A8VX-01	1033	0	TCGA-2A-A8VX	1033	0	1033	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-25904	32	922		32	89		0	1033		1033			YES	Extraprostatic Extension  Localized (e.g. seminal vesicles)	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-3-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral			YES				NO	16	0	true	N0	T3b	TCGA-2A-A8VX.418E80EE-4886-43F5-9FB9-2619BC89351E.pdf			4		1		3		1		0		40		57		92	TUMOR FREE	4		No	0.05	NO	R0	Primary Tumor	01	4			NO		NO	YES	2A	Middle		Prostate		A	LIVING	2011	Peripheral Zone			9194d904-9ae2-470b-bfd8-a78934b97a0c	TCGA-2A-A8VX-01	0ff237d2-9283-44c7-bfae-c2020c73b94c		TCGA-2A-A8VX-01A-11D-A377-08	TCGA-2A-A8VX-01A-11D-A376-01	0ff237d2-9283-44c7-bfae-c2020c73b94c	TCGA-2A-A8VX-01A-11D-A376-01	0ff237d2-9283-44c7-bfae-c2020c73b94c		TCGA-2A-A8VX-01	TCGA-2A-A8VX-01A-11D-A378-05	TCGA-2A-A8VX-01A-11R-A37H-13		0ff237d2-9283-44c7-bfae-c2020c73b94c	9194d904-9ae2-470b-bfd8-a78934b97a0c
TCGA-2A-A8W1-01	0	TCGA-2A-A8W1-01	112	0	TCGA-2A-A8W1	112	0	112	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			54		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-19964	27	888					0	112		-122			NO		NO				2014-3-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Left			YES				NO	12	0	true	N0	T3a	TCGA-2A-A8W1.3A4CC21B-D751-49EA-BCFB-785B683423A0.pdf			0		0		0		0		0		20		80		90		4		No	0.05		R1	Primary Tumor	01	3					NO	YES	2A	Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone			6a6e67a8-713b-4956-9b4b-240d7b47fac7	TCGA-2A-A8W1-01	6b22709e-8b89-4a67-9530-3004467b91f6		TCGA-2A-A8W1-01A-11D-A377-08	TCGA-2A-A8W1-01A-11D-A376-01	6b22709e-8b89-4a67-9530-3004467b91f6	TCGA-2A-A8W1-01A-11D-A376-01	6b22709e-8b89-4a67-9530-3004467b91f6		TCGA-2A-A8W1-01	TCGA-2A-A8W1-01A-11D-A378-05	TCGA-2A-A8W1-01A-11R-A37H-13		6b22709e-8b89-4a67-9530-3004467b91f6	6a6e67a8-713b-4956-9b4b-240d7b47fac7
TCGA-2A-A8W3-01	0	TCGA-2A-A8W3-01	771	0	TCGA-2A-A8W3			771	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69		YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-25557	13	882		13	-14	198	0	771		771			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2014-3-29	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	150		NO	Left			YES				YES	3	0	true	N0	T3a	TCGA-2A-A8W3.EC74AC3A-610D-46E0-A4DA-1904E42E1EF8.pdf			0		0		0		0		5		25		70		80	TUMOR FREE	4		No	.36	NO	R0	Primary Tumor	01	5			NO		NO	YES	2A	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone			2e49d5cf-2111-4b73-9a9c-794f2eafe4f4	TCGA-2A-A8W3-01	a6841939-e9fa-43cf-9f64-b1b3c57a2576		TCGA-2A-A8W3-01A-11D-A377-08	TCGA-2A-A8W3-01A-11D-A376-01	a6841939-e9fa-43cf-9f64-b1b3c57a2576	TCGA-2A-A8W3-01A-11D-A376-01	a6841939-e9fa-43cf-9f64-b1b3c57a2576		TCGA-2A-A8W3-01	TCGA-2A-A8W3-01A-11D-A378-05	TCGA-2A-A8W3-01A-11R-A37H-13		a6841939-e9fa-43cf-9f64-b1b3c57a2576	2e49d5cf-2111-4b73-9a9c-794f2eafe4f4
TCGA-2A-AAYF-01	0	TCGA-2A-AAYF-01	972	0	TCGA-2A-AAYF	972	0	972	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57		NO		M0	T1c	-20866					186		0	972		972			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-7-7	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Right			NO				NO					T3a																			TUMOR FREE	3	Complete Remission/Response	No	.05	NO	R0	Primary Tumor	01	4			NO		NO	YES	2A	Apex|Middle|Base		Prostate			LIVING	2011	Overlapping / Multiple Zones			b49720d9-9fe2-4811-8a88-24e5ca4d696f	TCGA-2A-AAYF-01	fe001be4-0c13-4754-8888-3961c98ccfe9			TCGA-2A-AAYF-01A-11D-A41J-01	fe001be4-0c13-4754-8888-3961c98ccfe9	TCGA-2A-AAYF-01A-11D-A41J-01	fe001be4-0c13-4754-8888-3961c98ccfe9		TCGA-2A-AAYF-01	TCGA-2A-AAYF-01A-11D-A41L-05	TCGA-2A-AAYF-01A-11R-A41R-13		fe001be4-0c13-4754-8888-3961c98ccfe9	b49720d9-9fe2-4811-8a88-24e5ca4d696f
TCGA-2A-AAYO-01	0	TCGA-2A-AAYO-01	922	0	TCGA-2A-AAYO	922	0	922	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57		NO		M0	T1c	-21183		854			180		0	922		922			NO		YES	No Evidence of Extraprostatic Extension			2014-7-7	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral			NO				NO			true		T2c	TCGA-2A-AAYO.3889AA76-F350-4DA4-987B-79E8D2349262.pdf			7		0		1		0		2		42		55		90	TUMOR FREE	3	Complete Remission/Response	No	.05	NO	R0	Primary Tumor	01	3			NO		NO	YES	2A	Apex|Middle		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			18ce4a68-d68f-4d24-b4f2-68d421b807e2	TCGA-2A-AAYO-01	024fc1c9-4502-4293-a555-9bb7e5536f45			TCGA-2A-AAYO-01A-11D-A41J-01	024fc1c9-4502-4293-a555-9bb7e5536f45	TCGA-2A-AAYO-01A-11D-A41J-01	024fc1c9-4502-4293-a555-9bb7e5536f45		TCGA-2A-AAYO-01	TCGA-2A-AAYO-01A-11D-A41L-05	TCGA-2A-AAYO-01A-11R-A41R-13		024fc1c9-4502-4293-a555-9bb7e5536f45	18ce4a68-d68f-4d24-b4f2-68d421b807e2
TCGA-2A-AAYU-01	0	TCGA-2A-AAYU-01	615	0	TCGA-2A-AAYU	615	0	615	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56		NO		M0	T1c	-20582		693			52		0	615		269			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-7-7	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Left			YES				NO	28	0	true	N0	T3a	TCGA-2A-AAYU.6CD9378F-F5A6-4214-8685-3D56ED6ADB0B.pdf			40		20		0		20		0		20		80		80	TUMOR FREE	3	Complete Remission/Response	No	.05	NO	R1	Primary Tumor	01	3			NO	4	NO	YES	2A	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			3dec3310-e68b-4651-9fa7-a3682fb9be1f	TCGA-2A-AAYU-01	a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d			TCGA-2A-AAYU-01A-11D-A41J-01	a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d	TCGA-2A-AAYU-01A-11D-A41J-01	a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d		TCGA-2A-AAYU-01	TCGA-2A-AAYU-01A-11D-A41L-05	TCGA-2A-AAYU-01A-11R-A41R-13		a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d	3dec3310-e68b-4651-9fa7-a3682fb9be1f
TCGA-4L-AA1F-01	0	TCGA-4L-AA1F-01	350	0	TCGA-4L-AA1F	350	0	350	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		NO	Abnormal (not related to prostate cancer)	M1a	T2c	-23665	0	64		4	5		0	350		350			YES	Extraprostatic Extension  Localized (e.g. seminal vesicles)	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-11-14	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	380		NO	Bilateral			YES				NO	4	0	false	N0	T3b	TCGA-4L-AA1F.A9DCC04F-A189-408C-9EE0-9F36F388068D.pdf			40		20		0		20		10		30		60		60	TUMOR FREE	4	Complete Remission/Response	No	3.5	NO	R1	Primary Tumor	01	4			YES		YES	NO	4L	Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			9310b32f-d32a-4890-acb8-29a522853615	TCGA-4L-AA1F-01	824f212a-b8a3-429e-a8f1-df83302fa1cf			TCGA-4L-AA1F-01A-11D-A41J-01	824f212a-b8a3-429e-a8f1-df83302fa1cf	TCGA-4L-AA1F-01A-11D-A41J-01	824f212a-b8a3-429e-a8f1-df83302fa1cf		TCGA-4L-AA1F-01	TCGA-4L-AA1F-01A-11D-A41L-05	TCGA-4L-AA1F-01A-11R-A41R-13		824f212a-b8a3-429e-a8f1-df83302fa1cf	9310b32f-d32a-4890-acb8-29a522853615
TCGA-CH-5737-01	0	TCGA-CH-5737-01	91	0	TCGA-CH-5737			91	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			73		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-26753	91			91	91		0	91		88			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.2		YES					8	0		N0	T2c	TCGA-CH-5737.dbf280bb-fb7c-422f-b772-a62381c19afa.pdf		0	0	0	0	0	0	0	0	1	1	7	9	92	90	95	95	TUMOR FREE	4		No	14.69		R0	Primary Tumor	01	3	0.4				YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone	TCGA-CH-5737-01A-11D-1576-08	TCGA-CH-5737-01A-11D-1576-08	ac40626a-d5d8-46eb-9beb-21aa5945919b	TCGA-CH-5737-01	b966ca07-fd34-4428-a460-1ba57a3e519d	TCGA-CH-5737-01A-11D-1576-08	TCGA-CH-5737-01A-11D-1576-08	TCGA-CH-5737-01A-11D-1574-01	b966ca07-fd34-4428-a460-1ba57a3e519d	TCGA-CH-5737-01A-11D-1574-01	b966ca07-fd34-4428-a460-1ba57a3e519d	8F22ABA7-7F51-4F7B-BD3B-E4A9A194A146	TCGA-CH-5737-01	TCGA-CH-5737-01A-11D-1578-05	TCGA-CH-5737-01A-11R-1579-13	TCGA-CH-5737-01A-11D-1576-08	b966ca07-fd34-4428-a460-1ba57a3e519d	ac40626a-d5d8-46eb-9beb-21aa5945919b
TCGA-CH-5738-01	0	TCGA-CH-5738-01	212	0	TCGA-CH-5738	212	0	212	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-CH-5738-F28982	NO		M0		-26329							0	212		195			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.3		NO				NO					T2b	TCGA-CH-5738.3e17e46c-0c96-4930-b8ac-7acee8d40750.pdf		0	2	0	0	0	0	0	0	15	15	25	15	60	70	60	70	TUMOR FREE	3	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	3	0.4		NO	4	YES	NO	CH			Prostate		A	LIVING	2006		TCGA-CH-5738-01A-11D-1576-08	TCGA-CH-5738-01A-11D-1576-08	0fa36fc6-71e1-479b-b882-cfe83d08e1e0	TCGA-CH-5738-01	e5db7986-223c-4ee2-a4c8-c4e8bbb510f3	TCGA-CH-5738-01A-11D-1576-08	TCGA-CH-5738-01A-11D-1576-08	TCGA-CH-5738-01A-11D-1574-01	e5db7986-223c-4ee2-a4c8-c4e8bbb510f3	TCGA-CH-5738-01A-11D-1574-01	e5db7986-223c-4ee2-a4c8-c4e8bbb510f3	65BA7F91-6227-4E96-9C20-EE84A8BFF2A5	TCGA-CH-5738-01	TCGA-CH-5738-01A-11D-1578-05	TCGA-CH-5738-01A-11R-1579-13	TCGA-CH-5738-01A-11D-1576-08	e5db7986-223c-4ee2-a4c8-c4e8bbb510f3	0fa36fc6-71e1-479b-b882-cfe83d08e1e0
TCGA-CH-5739-01	0	TCGA-CH-5739-01	671	0	TCGA-CH-5739	671	0	671	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-CH-5739-F28977	NO		M0		-23953							0	671		586			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Left	0.9		YES				NO	8	0		N0	T3a	TCGA-CH-5739.6db82b14-85e4-40c4-9827-a588c4a25ce8.pdf		0	0	0	0	0	0	0	0	2	20	8	20	90	60	85	70	TUMOR FREE	3	Complete Remission/Response	No	0.02	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2006	Peripheral Zone	TCGA-CH-5739-01A-11D-1576-08	TCGA-CH-5739-01A-11D-1576-08	cf805aa6-fa5d-4054-b4f1-946395c17c28	TCGA-CH-5739-01	26c39f49-cf54-41d6-8c46-c089f4a57002	TCGA-CH-5739-01A-11D-1576-08	TCGA-CH-5739-01A-11D-1576-08	TCGA-CH-5739-01A-11D-1574-01	26c39f49-cf54-41d6-8c46-c089f4a57002	TCGA-CH-5739-01A-11D-1574-01	26c39f49-cf54-41d6-8c46-c089f4a57002	16485141-1F4F-49FC-A8A8-85229B96D859	TCGA-CH-5739-01	TCGA-CH-5739-01A-11D-1578-05	TCGA-CH-5739-01A-11R-1579-13	TCGA-CH-5739-01A-11D-1576-08	26c39f49-cf54-41d6-8c46-c089f4a57002	cf805aa6-fa5d-4054-b4f1-946395c17c28
TCGA-CH-5740-01	0	TCGA-CH-5740-01	31	0	TCGA-CH-5740			31	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20880	31				31		0	31		31			NO		YES	No Evidence of Extraprostatic Extension			2012-3-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1		YES					4	0		N0	T2c	TCGA-CH-5740.25992d81-7441-4d60-a773-457618dcedbc.pdf		3	0	0	0	0	0	0	0	12	5	13	5	75	90	80	90	TUMOR FREE	3		No	1.6		R0	Primary Tumor	01	4	0.3				YES	NO	CH			Prostate		A	LIVING	2009		TCGA-CH-5740-01A-11D-1576-08	TCGA-CH-5740-01A-11D-1576-08	9e7f9683-1645-45b6-87b7-ccf8f65e5786	TCGA-CH-5740-01	59173676-8eca-4a03-b37c-c726208a961a	TCGA-CH-5740-01A-11D-1576-08	TCGA-CH-5740-01A-11D-1576-08	TCGA-CH-5740-01A-11D-1574-01	59173676-8eca-4a03-b37c-c726208a961a	TCGA-CH-5740-01A-11D-1574-01	59173676-8eca-4a03-b37c-c726208a961a	3E98A3E2-8D5D-4383-B8DE-EA3A0DEF3BE4	TCGA-CH-5740-01	TCGA-CH-5740-01A-11D-1578-05	TCGA-CH-5740-01A-11R-1579-13	TCGA-CH-5740-01A-11D-1576-08	59173676-8eca-4a03-b37c-c726208a961a	9e7f9683-1645-45b6-87b7-ccf8f65e5786
TCGA-CH-5741-01	0	TCGA-CH-5741-01	395	0	TCGA-CH-5741	395	0	395	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56	TCGA-CH-5741-F29006	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20759	30			30			0	395		339			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.1		YES				NO	5	1		N1	T3b	TCGA-CH-5741.87c977cc-2a28-49c9-adaf-f67c0bc208c2.pdf		0	0	0	0	0	0	0	0	4	5	6	10	90	85	90	85	TUMOR FREE	4	Complete Remission/Response	No	0.02	YES	R1	Primary Tumor	01	5	0.4		YES		YES	NO	CH			Prostate		A	LIVING	2008	Overlapping / Multiple Zones	TCGA-CH-5741-01A-11D-1576-08	TCGA-CH-5741-01A-11D-1576-08	ef75af78-fb20-408f-a37a-47c7d86660ed	TCGA-CH-5741-01	639c8d3c-8719-49ca-8812-af6480b164ae	TCGA-CH-5741-01A-11D-1576-08	TCGA-CH-5741-01A-11D-1576-08	TCGA-CH-5741-01A-11D-1574-01	639c8d3c-8719-49ca-8812-af6480b164ae	TCGA-CH-5741-01A-11D-1574-01	639c8d3c-8719-49ca-8812-af6480b164ae	F9B2036F-7247-4D9E-8793-3E1418064091	TCGA-CH-5741-01	TCGA-CH-5741-01A-11D-1578-05	TCGA-CH-5741-01A-11R-1579-13	TCGA-CH-5741-01A-11D-1576-08	639c8d3c-8719-49ca-8812-af6480b164ae	ef75af78-fb20-408f-a37a-47c7d86660ed
TCGA-CH-5743-01	0	TCGA-CH-5743-01	425	0	TCGA-CH-5743	425	1	425	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	66	TCGA-CH-5743-F29001	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24321	29			29			0	425	425	394			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.2		YES		New Primary Tumor		YES	1	0		N0	T2c	TCGA-CH-5743.e4f18f30-a6f0-4262-8f34-ce32db5cbe4a.pdf			1		0		0		0		25		25		50		60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	TCGA-CH-5743-01A-21D-1576-08	TCGA-CH-5743-01A-21D-1576-08	3c7e12ba-734b-4fb6-9e78-85dc50ef08a7	TCGA-CH-5743-01	8f097693-4c17-42f4-b319-dd3b4ae93005	TCGA-CH-5743-01A-21D-1576-08	TCGA-CH-5743-01A-21D-1576-08	TCGA-CH-5743-01A-21D-1574-01	8f097693-4c17-42f4-b319-dd3b4ae93005	TCGA-CH-5743-01A-21D-1574-01	8f097693-4c17-42f4-b319-dd3b4ae93005	6C0A6447-8972-4D51-A953-658CF56860E6	TCGA-CH-5743-01	TCGA-CH-5743-01A-21D-1578-05	TCGA-CH-5743-01A-21R-1579-13	TCGA-CH-5743-01A-21D-1576-08	8f097693-4c17-42f4-b319-dd3b4ae93005	3c7e12ba-734b-4fb6-9e78-85dc50ef08a7
TCGA-CH-5744-01	0	TCGA-CH-5744-01	60	0	TCGA-CH-5744			60	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23621	60			60			0	60		48			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.5		YES					3	0		N0	T2c	TCGA-CH-5744.797db4c8-a9d9-4404-a520-9be024ced9d5.pdf		0	0	0	0	0	0	0	0	20	15	20	20	60	65	65	70	TUMOR FREE	4		No	9.63		R0	Primary Tumor	01	3	0.2			5	YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	TCGA-CH-5744-01A-11D-1576-08	TCGA-CH-5744-01A-11D-1576-08	4b2847e2-2626-4648-9e33-d6b9a45383f3	TCGA-CH-5744-01	abf9624e-048a-412b-a0a8-331bb6fc5e16	TCGA-CH-5744-01A-11D-1576-08	TCGA-CH-5744-01A-11D-1576-08	TCGA-CH-5744-01A-11D-1574-01	abf9624e-048a-412b-a0a8-331bb6fc5e16	TCGA-CH-5744-01A-11D-1574-01	abf9624e-048a-412b-a0a8-331bb6fc5e16	6A474A8E-78CD-4DFF-96B2-19A9C3F27541	TCGA-CH-5744-01	TCGA-CH-5744-01A-11D-1578-05	TCGA-CH-5744-01A-11R-1579-13	TCGA-CH-5744-01A-11D-1576-08	abf9624e-048a-412b-a0a8-331bb6fc5e16	4b2847e2-2626-4648-9e33-d6b9a45383f3
TCGA-CH-5745-01	0	TCGA-CH-5745-01	91	0	TCGA-CH-5745			91	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24837	91						0	91		84			NO		NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO		0.8		YES					5	0		N0	T3a	TCGA-CH-5745.43e941e9-cfbd-45bc-91bb-28e5f5d9b767.pdf		0	0	0	0	0	0	0	0	2	2	33	38	65	60	75	70	TUMOR FREE	3		No	4.3		R0	Primary Tumor	01	4	0.4				YES	NO	CH			Prostate		A	LIVING	2008	Overlapping / Multiple Zones	TCGA-CH-5745-01A-11D-1576-08	TCGA-CH-5745-01A-11D-1576-08		TCGA-CH-5745-01	4ca3b9ec-cd21-46fc-9a44-05d5225f0c57	TCGA-CH-5745-01A-11D-1576-08	TCGA-CH-5745-01A-11D-1576-08		4ca3b9ec-cd21-46fc-9a44-05d5225f0c57		4ca3b9ec-cd21-46fc-9a44-05d5225f0c57	0F81C1A9-AF7E-44C9-8E30-F3AB5933967F		TCGA-CH-5745-01A-11D-1578-05	TCGA-CH-5745-01A-11R-1579-13	TCGA-CH-5745-01A-11D-1576-08	4ca3b9ec-cd21-46fc-9a44-05d5225f0c57	
TCGA-CH-5746-01	0	TCGA-CH-5746-01	731	0	TCGA-CH-5746	731	0	731	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-CH-5746-F28996	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20941	59			59			0	731		693			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral			YES				NO	2	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	YES	R1	Primary Tumor	01	4			NO		YES	NO	CH			Prostate			LIVING	2007		TCGA-CH-5746-01A-11D-1576-08	TCGA-CH-5746-01A-11D-1576-08	e1683906-ce4f-44a1-864e-f7e34aa53398	TCGA-CH-5746-01	e129e211-8237-4842-a5f5-c3dc05607527	TCGA-CH-5746-01A-11D-1576-08	TCGA-CH-5746-01A-11D-1576-08	TCGA-CH-5746-01A-11D-1574-01	e129e211-8237-4842-a5f5-c3dc05607527	TCGA-CH-5746-01A-11D-1574-01	e129e211-8237-4842-a5f5-c3dc05607527		TCGA-CH-5746-01	TCGA-CH-5746-01A-11D-1578-05	TCGA-CH-5746-01A-11R-1579-13	TCGA-CH-5746-01A-11D-1576-08	e129e211-8237-4842-a5f5-c3dc05607527	e1683906-ce4f-44a1-864e-f7e34aa53398
TCGA-CH-5748-01	0	TCGA-CH-5748-01	31	0	TCGA-CH-5748			31	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64						-23649							0	31					NO		NO				2012-3-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.3		YES					2	0		N0	T3a	TCGA-CH-5748.7d2d5d7d-481b-445d-8505-42564e11fce4.pdf		0	0	0	0	0	0	0	0	30	10	15	15	55	75	60	80	WITH TUMOR	4		No			R1	Primary Tumor	01	3	0.4				YES	NO	CH			Prostate		A	LIVING	2009		TCGA-CH-5748-01A-11D-1576-08	TCGA-CH-5748-01A-11D-1576-08	03e74232-acb4-4091-a6c6-871373562974	TCGA-CH-5748-01	8d91b55d-0a51-44d3-bcc7-d6d95027683a	TCGA-CH-5748-01A-11D-1576-08	TCGA-CH-5748-01A-11D-1576-08	TCGA-CH-5748-01A-11D-1574-01	8d91b55d-0a51-44d3-bcc7-d6d95027683a	TCGA-CH-5748-01A-11D-1574-01	8d91b55d-0a51-44d3-bcc7-d6d95027683a	F750FE39-81B7-498B-BB7E-651A578395C3	TCGA-CH-5748-01	TCGA-CH-5748-01A-11D-1578-05	TCGA-CH-5748-01A-11R-1579-13	TCGA-CH-5748-01A-11D-1576-08	8d91b55d-0a51-44d3-bcc7-d6d95027683a	03e74232-acb4-4091-a6c6-871373562974
TCGA-CH-5750-01	0	TCGA-CH-5750-01	396	0	TCGA-CH-5750	396	0	396	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-CH-5750-F29002	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-26389	31			31			0	396		337			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.9		YES				NO	7	0		N0	T2c	TCGA-CH-5750.4cbd15a8-2912-4a6d-bdc3-38a4ae4e1381.pdf		0	0	0	0	0	0	0	0	15	15	10	10	75	75	80	80	TUMOR FREE	3	Complete Remission/Response	No	0.02	NO	R0	Primary Tumor	01	4	0.3		NO		YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	TCGA-CH-5750-01A-11D-1576-08	TCGA-CH-5750-01A-11D-1576-08	8c13b109-9fdc-48e7-8577-4e3a26876fbc	TCGA-CH-5750-01	3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f	TCGA-CH-5750-01A-11D-1576-08	TCGA-CH-5750-01A-11D-1576-08	TCGA-CH-5750-01A-11D-1574-01	3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f	TCGA-CH-5750-01A-11D-1574-01	3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f	CD65E017-AF63-4C06-8DCF-A85B8602827E	TCGA-CH-5750-01	TCGA-CH-5750-01A-11D-1578-05	TCGA-CH-5750-01A-11R-1579-13	TCGA-CH-5750-01A-11D-1576-08	3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f	8c13b109-9fdc-48e7-8577-4e3a26876fbc
TCGA-CH-5751-01	0	TCGA-CH-5751-01	1065	0	TCGA-CH-5751	365	1	1065	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	NO	68	TCGA-CH-5751-F28978	NO	Equivocal	M0		-24957	92			92	92		0	1065	365	1004			YES	Equivocal	YES	Equivocal	Scheduled Follow-up Submission	Stable Disease	2012-2-15	MALE	10	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.5		YES	Bone	Distant Metastasis		YES	3	1		N1	T4	TCGA-CH-5751.c4240096-b982-4b8a-b871-677a94cfd6cc.pdf		3	0	0	0	0	0	0	0	0	0	15	15	85	85	95	90	WITH TUMOR	5	Complete Remission/Response	No	0.01	NO	R1	Primary Tumor	01	5	0.5		YES		YES	NO	CH		YES	Prostate	Distant Metastasis	A	LIVING	2006	Overlapping / Multiple Zones	TCGA-CH-5751-01A-11D-1576-08	TCGA-CH-5751-01A-11D-1576-08	06d9436a-ff8b-4c5f-a60c-f434f6d5aaf2	TCGA-CH-5751-01	063f416b-291b-4242-acb4-9587a2dc3244	TCGA-CH-5751-01A-11D-1576-08	TCGA-CH-5751-01A-11D-1576-08	TCGA-CH-5751-01A-11D-1574-01	063f416b-291b-4242-acb4-9587a2dc3244	TCGA-CH-5751-01A-11D-1574-01	063f416b-291b-4242-acb4-9587a2dc3244	05E7E615-27D5-4FAC-AB73-59CE4E5AAC57	TCGA-CH-5751-01	TCGA-CH-5751-01A-11D-1578-05		TCGA-CH-5751-01A-11D-1576-08	063f416b-291b-4242-acb4-9587a2dc3244	06d9436a-ff8b-4c5f-a60c-f434f6d5aaf2
TCGA-CH-5752-01	0	TCGA-CH-5752-01	943	0	TCGA-CH-5752	943	0	943	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-CH-5752-F28987	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24290	30			30			0	943		868			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.9		YES				NO	9	0		N0	T3a	TCGA-CH-5752.d3549715-b952-479c-8edf-86e424811095.pdf		0	2	0	0	2	5	0	0	0	0	43	45	55	50	70	65	TUMOR FREE	4	Complete Remission/Response	No	0.02	YES	R0	Primary Tumor	01	4	0.5		YES		YES	NO	CH			Prostate		A	LIVING	2006	Overlapping / Multiple Zones	TCGA-CH-5752-01A-11D-1576-08	TCGA-CH-5752-01A-11D-1576-08	43bc5e56-b062-4fd3-9523-a3e9c43ff31d	TCGA-CH-5752-01	30861ba6-6539-47a5-82df-5f89d8101d05	TCGA-CH-5752-01A-11D-1576-08	TCGA-CH-5752-01A-11D-1576-08	TCGA-CH-5752-01A-11D-1574-01	30861ba6-6539-47a5-82df-5f89d8101d05	TCGA-CH-5752-01A-11D-1574-01	30861ba6-6539-47a5-82df-5f89d8101d05	F80CE98E-5CF5-4CC1-8AE3-AFCF5CDA4DC2	TCGA-CH-5752-01	TCGA-CH-5752-01A-11D-1578-05	TCGA-CH-5752-01A-11R-1579-13	TCGA-CH-5752-01A-11D-1576-08	30861ba6-6539-47a5-82df-5f89d8101d05	43bc5e56-b062-4fd3-9523-a3e9c43ff31d
TCGA-CH-5753-01	0	TCGA-CH-5753-01	31	0	TCGA-CH-5753			31	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-25780	31			31			0	31		31			YES	No Evidence of Extraprostatic Extension	NO				2012-3-21	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1		YES					10	3		N1	T3b	TCGA-CH-5753.4e86e7fc-a1c5-4d3b-a0b3-23187adfd096.pdf		0	0	0	0	0	0	0	0	20	15	55	15	25	70	30	80	TUMOR FREE	4		Yes	4.53		R0	Primary Tumor	01	5	0.2				YES	NO	CH			Prostate		A	LIVING	2008	Overlapping / Multiple Zones	TCGA-CH-5753-01A-11D-1576-08	TCGA-CH-5753-01A-11D-1576-08	ebf1e8f2-5a63-4dc2-9469-11d3ba3fd19e	TCGA-CH-5753-01	2031e5cb-18c3-421e-b8af-d5dab73e3a89	TCGA-CH-5753-01A-11D-1576-08	TCGA-CH-5753-01A-11D-1576-08	TCGA-CH-5753-01A-11D-1574-01	2031e5cb-18c3-421e-b8af-d5dab73e3a89	TCGA-CH-5753-01A-11D-1574-01	2031e5cb-18c3-421e-b8af-d5dab73e3a89	0F729F85-0E45-4F8B-9E26-7F9589111251	TCGA-CH-5753-01	TCGA-CH-5753-01A-11D-1578-05	TCGA-CH-5753-01A-11R-1579-13	TCGA-CH-5753-01A-11D-1576-08	2031e5cb-18c3-421e-b8af-d5dab73e3a89	ebf1e8f2-5a63-4dc2-9469-11d3ba3fd19e
TCGA-CH-5754-01	0	TCGA-CH-5754-01	62	0	TCGA-CH-5754			62	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23803	62			62			0	62		62			YES	No Evidence of Extraprostatic Extension	NO				2012-3-21	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.2		YES					11	3		N1	T3b	TCGA-CH-5754.6c02cb0e-6826-46f0-8a9f-90f43cc1405c.pdf		3	3	2	2	2	2	0	0	2	0	38	55	58	43	75	60	WITH TUMOR	4		No	37.36		R1	Primary Tumor	01	5	0.2			3	YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	TCGA-CH-5754-01A-11D-1576-08	TCGA-CH-5754-01A-11D-1576-08	8b4570b2-309e-4ddd-b890-ebd96be6cd49	TCGA-CH-5754-01	51cd07b8-f680-4bc2-a207-d0317f5f9358	TCGA-CH-5754-01A-11D-1576-08	TCGA-CH-5754-01A-11D-1576-08	TCGA-CH-5754-01A-11D-1574-01	51cd07b8-f680-4bc2-a207-d0317f5f9358	TCGA-CH-5754-01A-11D-1574-01	51cd07b8-f680-4bc2-a207-d0317f5f9358	8D5A8DE4-0020-4BDC-A119-E1A7698707BF	TCGA-CH-5754-01	TCGA-CH-5754-01A-11D-1578-05	TCGA-CH-5754-01A-11R-1579-13	TCGA-CH-5754-01A-11D-1576-08	51cd07b8-f680-4bc2-a207-d0317f5f9358	8b4570b2-309e-4ddd-b890-ebd96be6cd49
TCGA-CH-5761-01	0	TCGA-CH-5761-01	28	0	TCGA-CH-5761			28	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22433	28			28	28		0	28		39			YES	Equivocal	YES	Equivocal			2012-3-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Left	1		YES					5	0		N0	T3b	TCGA-CH-5761.205f9f59-486c-4211-aa60-0a5b4f746a74.pdf		5	5	3	7	3	10	0	0	2	3	25	47	70	50	80	85	TUMOR FREE	5		No	8.49		R0	Primary Tumor	01	4	0.2			3	YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone	TCGA-CH-5761-01A-11D-1576-08	TCGA-CH-5761-01A-11D-1576-08	111acb48-3962-4e19-88ce-ddbed021777e	TCGA-CH-5761-01	e0f1b805-f155-47d8-a97e-7e611382cb76	TCGA-CH-5761-01A-11D-1576-08	TCGA-CH-5761-01A-11D-1576-08	TCGA-CH-5761-01A-11D-1574-01	e0f1b805-f155-47d8-a97e-7e611382cb76	TCGA-CH-5761-01A-11D-1574-01	e0f1b805-f155-47d8-a97e-7e611382cb76	ADAC7F52-F712-4716-970F-A1A57B09AAC1	TCGA-CH-5761-01	TCGA-CH-5761-01A-11D-1578-05	TCGA-CH-5761-01A-11R-1579-13	TCGA-CH-5761-01A-11D-1576-08	e0f1b805-f155-47d8-a97e-7e611382cb76	111acb48-3962-4e19-88ce-ddbed021777e
TCGA-CH-5761-11	0	TCGA-CH-5761-11	28	0	TCGA-CH-5761			28	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22433	28			28	28		0	28		39			YES	Equivocal	YES	Equivocal			2012-3-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Left	0.8		YES					5	0		N0	T3b																			TUMOR FREE	5		No	8.49		R0	Solid Tissue Normal	11	4	0.2			3	YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone					e3d00d08-5395-48b0-bd95-0c945e2a33fe				e3d00d08-5395-48b0-bd95-0c945e2a33fe		e3d00d08-5395-48b0-bd95-0c945e2a33fe			TCGA-CH-5761-11A-01D-1578-05	TCGA-CH-5761-11A-01R-1579-13		e3d00d08-5395-48b0-bd95-0c945e2a33fe	
TCGA-CH-5762-01	0	TCGA-CH-5762-01	1339	0	TCGA-CH-5762	1339	0	1339	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-CH-5762-F28975	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22068	92			92			0	1339		1313			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-14	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.2		YES				NO	7	0		N0	T3b	TCGA-CH-5762.21608393-74f2-4a7b-aaf4-9b02cb7afc94.pdf		0	0	0	0	0	0	0	0	15	25	15	25	70	50	80	60	WITH TUMOR	4	Complete Remission/Response	No	.01	YES	R1	Primary Tumor	01	3	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2005	Peripheral Zone	TCGA-CH-5762-01A-11D-1576-08	TCGA-CH-5762-01A-11D-1576-08	b5f6e1b9-7de0-464f-8735-542e27a90b71	TCGA-CH-5762-01	bb36bff9-44fd-4f93-a82f-8c23658c335c	TCGA-CH-5762-01A-11D-1576-08	TCGA-CH-5762-01A-11D-1576-08	TCGA-CH-5762-01A-11D-1574-01	bb36bff9-44fd-4f93-a82f-8c23658c335c	TCGA-CH-5762-01A-11D-1574-01	bb36bff9-44fd-4f93-a82f-8c23658c335c	B0A6FB3E-767B-424F-9DE3-51780E3190BD	TCGA-CH-5762-01	TCGA-CH-5762-01A-11D-1578-05	TCGA-CH-5762-01A-11R-1579-13	TCGA-CH-5762-01A-11D-1576-08	bb36bff9-44fd-4f93-a82f-8c23658c335c	b5f6e1b9-7de0-464f-8735-542e27a90b71
TCGA-CH-5762-11	0	TCGA-CH-5762-11	1339	0	TCGA-CH-5762	1339	0	1339	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-CH-5762-F28975	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22068	92			92			0	1339		1313			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-14	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.1		YES				NO	7	0		N0	T3b																			WITH TUMOR	4	Complete Remission/Response	No	.01	YES	R1	Solid Tissue Normal	11	3	0.2		NO		YES	NO	CH			Prostate		A	LIVING	2005	Peripheral Zone														TCGA-CH-5762-11A-01D-1578-05				
TCGA-CH-5763-01	0	TCGA-CH-5763-01	365	0	TCGA-CH-5763	365	0	365	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-CH-5763-F28974	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24380	0			0			0	365		360			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-14	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.5		YES				NO	5	0		N0	T3a	TCGA-CH-5763.8722bfbe-6db5-41ca-9ac4-004b999a772d.pdf		0	0	0	0	0	0	0	0	20	20	15	15	65	65	70	70	TUMOR FREE	3	Complete Remission/Response	Yes	0.1	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	TCGA-CH-5763-01A-11D-1576-08	TCGA-CH-5763-01A-11D-1576-08	07ae234d-5cad-44af-a034-ccc108b7f74d	TCGA-CH-5763-01	40eb0b4a-3863-403f-a90b-919bfa24237e	TCGA-CH-5763-01A-11D-1576-08	TCGA-CH-5763-01A-11D-1576-08	TCGA-CH-5763-01A-11D-1574-01	40eb0b4a-3863-403f-a90b-919bfa24237e	TCGA-CH-5763-01A-11D-1574-01	40eb0b4a-3863-403f-a90b-919bfa24237e	6818B0E0-1156-48C3-9FBE-C38F045E740E	TCGA-CH-5763-01	TCGA-CH-5763-01A-11D-1578-05	TCGA-CH-5763-01A-11R-1579-13	TCGA-CH-5763-01A-11D-1576-08	40eb0b4a-3863-403f-a90b-919bfa24237e	07ae234d-5cad-44af-a034-ccc108b7f74d
TCGA-CH-5763-11	0	TCGA-CH-5763-11	365	0	TCGA-CH-5763	365	0	365	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-CH-5763-F28974	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24380	0			0			0	365		360			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-14	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.6		YES				NO	5	0		N0	T3a																			TUMOR FREE	3	Complete Remission/Response	Yes	0.1	NO	R0	Solid Tissue Normal	11	4	0.1		NO		YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone														TCGA-CH-5763-11A-01D-1578-05				
TCGA-CH-5764-01	0	TCGA-CH-5764-01	31	0	TCGA-CH-5764			31	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24257	31			31			0	31		29			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	1.5		YES					8	0		N0	T3b	TCGA-CH-5764.e7f4fceb-1960-44f0-8e0b-fde2337011ce.pdf			0		0		0		0		10		15		75		75	TUMOR FREE	4		Yes	13.95		R0	Primary Tumor	01	3	0.3				YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	TCGA-CH-5764-01A-21D-1576-08	TCGA-CH-5764-01A-21D-1576-08	705e4aa4-8660-4b86-9d49-13622d25e185	TCGA-CH-5764-01	5bd95b46-d04b-49a9-964a-dd49570f4960	TCGA-CH-5764-01A-21D-1576-08	TCGA-CH-5764-01A-21D-1576-08	TCGA-CH-5764-01A-21D-1574-01	5bd95b46-d04b-49a9-964a-dd49570f4960	TCGA-CH-5764-01A-21D-1574-01	5bd95b46-d04b-49a9-964a-dd49570f4960	84F92AD0-2522-43F9-A6A6-51590A00CABD	TCGA-CH-5764-01	TCGA-CH-5764-01A-21D-1578-05	TCGA-CH-5764-01A-21R-1579-13	TCGA-CH-5764-01A-21D-1576-08	5bd95b46-d04b-49a9-964a-dd49570f4960	705e4aa4-8660-4b86-9d49-13622d25e185
TCGA-CH-5764-11	0	TCGA-CH-5764-11	31	0	TCGA-CH-5764			31	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24257	31			31			0	31		29			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.8		YES					8	0		N0	T3b																			TUMOR FREE	4		Yes	13.95		R0	Solid Tissue Normal	11	3	0.2				YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone														TCGA-CH-5764-11A-01D-1578-05				
TCGA-CH-5765-01	0	TCGA-CH-5765-01	700	0	TCGA-CH-5765	700	0	700	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-CH-5765-F28995	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20364	31			31			0	700		694			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.4		YES				NO	7	0		N0	T3a	TCGA-CH-5765.bf80f60e-d5c8-4a5b-b523-358c51ad7d2c.pdf		2	2	2	2	2	2	0	0	25	18	13	20	60	60	70	75	TUMOR FREE	3	Complete Remission/Response	No	0.02	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2007		TCGA-CH-5765-01A-11D-1576-08	TCGA-CH-5765-01A-11D-1576-08	99fa6301-8724-4942-9b96-95d92453b4de	TCGA-CH-5765-01	b8cc1fb1-5944-431c-aeec-a4301721f667	TCGA-CH-5765-01A-11D-1576-08	TCGA-CH-5765-01A-11D-1576-08	TCGA-CH-5765-01A-11D-1574-01	b8cc1fb1-5944-431c-aeec-a4301721f667	TCGA-CH-5765-01A-11D-1574-01	b8cc1fb1-5944-431c-aeec-a4301721f667	8DBE9F5E-D6A3-4ADC-8FFA-DFCD1A93FBA0	TCGA-CH-5765-01	TCGA-CH-5765-01A-11D-1578-05	TCGA-CH-5765-01A-11R-1579-13	TCGA-CH-5765-01A-11D-1576-08	b8cc1fb1-5944-431c-aeec-a4301721f667	99fa6301-8724-4942-9b96-95d92453b4de
TCGA-CH-5765-11	0	TCGA-CH-5765-11	700	0	TCGA-CH-5765	700	0	700	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-CH-5765-F28995	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20364	31			31			0	700		694			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.1		YES				NO	7	0		N0	T3a																			TUMOR FREE	3	Complete Remission/Response	No	0.02	NO	R0	Solid Tissue Normal	11	4	0.2		NO		YES	NO	CH			Prostate		A	LIVING	2007															TCGA-CH-5765-11A-01D-1578-05				
TCGA-CH-5766-01	0	TCGA-CH-5766-01	31	0	TCGA-CH-5766			31	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20392	31			31			0	31		39			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.8		YES					4	1		N1	T3a	TCGA-CH-5766.f6f3fdff-8296-449a-9a1c-d23803cf078a.pdf		0	0	0	0	0	0	0	0	12	15	8	10	80	75	80	80	TUMOR FREE	4		No	13.9		R0	Primary Tumor	01	3	0.4				YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone	TCGA-CH-5766-01A-11D-1576-08	TCGA-CH-5766-01A-11D-1576-08	293d5955-be52-4566-82cc-cc447f364aee	TCGA-CH-5766-01	f44cdc06-35ed-42dc-b4b2-fdd19399c7d3	TCGA-CH-5766-01A-11D-1576-08	TCGA-CH-5766-01A-11D-1576-08	TCGA-CH-5766-01A-11D-1574-01	f44cdc06-35ed-42dc-b4b2-fdd19399c7d3	TCGA-CH-5766-01A-11D-1574-01	f44cdc06-35ed-42dc-b4b2-fdd19399c7d3	02514EB6-8CF8-4DED-9761-895DA6563B93	TCGA-CH-5766-01	TCGA-CH-5766-01A-11D-1578-05	TCGA-CH-5766-01A-11R-1579-13	TCGA-CH-5766-01A-11D-1576-08	f44cdc06-35ed-42dc-b4b2-fdd19399c7d3	293d5955-be52-4566-82cc-cc447f364aee
TCGA-CH-5766-11	0	TCGA-CH-5766-11	31	0	TCGA-CH-5766			31	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20392	31			31			0	31		39			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1		YES					4	1		N1	T3a																			TUMOR FREE	4		No	13.9		R0	Solid Tissue Normal	11	3	0.2				YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone														TCGA-CH-5766-11A-01D-1578-05				
TCGA-CH-5767-01	0	TCGA-CH-5767-01	458	0	TCGA-CH-5767	458	0	458	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-CH-5767-F28999	NO		M0		-24287							0	458		377			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.3		YES				NO	19	0		N0	T2c	TCGA-CH-5767.237374e0-5b18-407c-ae42-898a95c14fa2.pdf		2	0	0	0	0	0	0	0	20	10	55	10	25	80	40	85	TUMOR FREE	4	Complete Remission/Response	No	0.04	NO	R0	Primary Tumor	01	3	0.2		NO		YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone	TCGA-CH-5767-01A-11D-1786-08	TCGA-CH-5767-01A-11D-1786-08	81320fe9-9dd5-4629-a0db-66607294a19b	TCGA-CH-5767-01	07f49527-0833-481f-b172-cb67601f8b03	TCGA-CH-5767-01A-11D-1786-08	TCGA-CH-5767-01A-11D-1786-08	TCGA-CH-5767-01A-11D-1785-01	07f49527-0833-481f-b172-cb67601f8b03	TCGA-CH-5767-01A-11D-1785-01	07f49527-0833-481f-b172-cb67601f8b03	97F044F9-0CAA-46A2-B22A-97FD42326745	TCGA-CH-5767-01	TCGA-CH-5767-01A-11D-1787-05	TCGA-CH-5767-01A-11R-1788-13	TCGA-CH-5767-01A-11D-1786-08	07f49527-0833-481f-b172-cb67601f8b03	81320fe9-9dd5-4629-a0db-66607294a19b
TCGA-CH-5767-11	0	TCGA-CH-5767-11	458	0	TCGA-CH-5767	458	0	458	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-CH-5767-F28999	NO		M0		-24287							0	458		377			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.2	NO	Bilateral	1.4		YES				NO	19	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	0.04	NO	R0	Solid Tissue Normal	11	3	0.2		NO		YES	NO	CH			Prostate		B	LIVING	2007	Peripheral Zone					6eb0d270-797d-49ab-9bda-a5f0a70a6695				6eb0d270-797d-49ab-9bda-a5f0a70a6695		6eb0d270-797d-49ab-9bda-a5f0a70a6695			TCGA-CH-5767-11B-01D-1787-05	TCGA-CH-5767-11B-01R-1788-13		6eb0d270-797d-49ab-9bda-a5f0a70a6695	
TCGA-CH-5768-01	0	TCGA-CH-5768-01	731	0	TCGA-CH-5768	731	0	731	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-CH-5768-F28998	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-26480	30			30			0	731		634			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.1		YES				NO	16	0		N0	T3a	TCGA-CH-5768.619201a3-bfe0-473c-83f2-76028455fcb5.pdf		0	0	0	0	0	0	0	0	45	20	20	10	35	70	35	75	TUMOR FREE	2	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	CH			Prostate		A	LIVING	2007	Overlapping / Multiple Zones	TCGA-CH-5768-01A-11D-1576-08	TCGA-CH-5768-01A-11D-1576-08	09c6d733-ef8e-465f-bc80-3c648459f93b	TCGA-CH-5768-01	78808f76-820b-439f-8223-38f2899cad5f	TCGA-CH-5768-01A-11D-1576-08	TCGA-CH-5768-01A-11D-1576-08	TCGA-CH-5768-01A-11D-1574-01	78808f76-820b-439f-8223-38f2899cad5f	TCGA-CH-5768-01A-11D-1574-01	78808f76-820b-439f-8223-38f2899cad5f	AB12065D-3680-4DE2-942D-ECCD6C5C5281	TCGA-CH-5768-01	TCGA-CH-5768-01A-11D-1578-05	TCGA-CH-5768-01A-11R-1579-13	TCGA-CH-5768-01A-11D-1576-08	78808f76-820b-439f-8223-38f2899cad5f	09c6d733-ef8e-465f-bc80-3c648459f93b
TCGA-CH-5768-11	0	TCGA-CH-5768-11	731	0	TCGA-CH-5768	731	0	731	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-CH-5768-F28998	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-26480	30			30			0	731		634			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.2		YES				NO	16	0		N0	T3a																			TUMOR FREE	2	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.3		NO	3	YES	NO	CH			Prostate		A	LIVING	2007	Overlapping / Multiple Zones					3c3a7016-6270-4c87-af7d-53b46f7f8fd1				3c3a7016-6270-4c87-af7d-53b46f7f8fd1		3c3a7016-6270-4c87-af7d-53b46f7f8fd1			TCGA-CH-5768-11A-01D-1578-05	TCGA-CH-5768-11A-01R-1579-13		3c3a7016-6270-4c87-af7d-53b46f7f8fd1	
TCGA-CH-5769-01	0	TCGA-CH-5769-01	62	0	TCGA-CH-5769			62	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			48		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-17807	62			62			0	62		60			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1		YES					8	0		N0	T3b	TCGA-CH-5769.7d49b105-6652-41b9-8e3a-e806a14de604.pdf		2	2	3	3	15	15	0	0	25	20	20	10	40	55	50	60	WITH TUMOR	5		No	11.16		R1	Primary Tumor	01	4	0.4				YES	NO	CH			Prostate		A	LIVING	2007		TCGA-CH-5769-01A-11D-1576-08	TCGA-CH-5769-01A-11D-1576-08	2314fd51-f9d0-4e74-b38d-2889b31dbc85	TCGA-CH-5769-01	2d12fd80-ba3f-49c3-aa15-1f67b9bbd443	TCGA-CH-5769-01A-11D-1576-08	TCGA-CH-5769-01A-11D-1576-08	TCGA-CH-5769-01A-11D-1574-01	2d12fd80-ba3f-49c3-aa15-1f67b9bbd443	TCGA-CH-5769-01A-11D-1574-01	2d12fd80-ba3f-49c3-aa15-1f67b9bbd443	545B68DC-C3D2-42E6-8ACC-61E81CEEB8B2	TCGA-CH-5769-01	TCGA-CH-5769-01A-11D-1578-05	TCGA-CH-5769-01A-11R-1579-13	TCGA-CH-5769-01A-11D-1576-08	2d12fd80-ba3f-49c3-aa15-1f67b9bbd443	2314fd51-f9d0-4e74-b38d-2889b31dbc85
TCGA-CH-5769-11	0	TCGA-CH-5769-11	62	0	TCGA-CH-5769			62	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			48		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-17807	62			62			0	62		60			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	80	0.4	NO	Bilateral	1		YES					8	0		N0	T3b																			WITH TUMOR	5		No	11.16		R1	Solid Tissue Normal	11	4	0.2				YES	NO	CH			Prostate		A	LIVING	2007						4e169e09-37da-42c9-bed4-2649212d9c6b				4e169e09-37da-42c9-bed4-2649212d9c6b		4e169e09-37da-42c9-bed4-2649212d9c6b			TCGA-CH-5769-11A-01D-1578-05	TCGA-CH-5769-11A-01R-1579-13		4e169e09-37da-42c9-bed4-2649212d9c6b	
TCGA-CH-5771-01	0	TCGA-CH-5771-01	396	0	TCGA-CH-5771	396	0	396	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-CH-5771-F29003	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23101	31			31			0	396		396			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.3		YES				NO	2	0		N0	T2c	TCGA-CH-5771.7c775a61-67f6-42a1-84e6-5cf8cd66a038.pdf			2		0		0		0		5		15		85		80	TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	3	0.3		NO	5	YES	NO	CH			Prostate		A	LIVING	2008		TCGA-CH-5771-01A-21D-1576-08	TCGA-CH-5771-01A-21D-1576-08	0ddf77d7-a2f7-4784-b327-1242fc43828d	TCGA-CH-5771-01	a771088e-45e1-4e67-8e3e-88c65d0b0618	TCGA-CH-5771-01A-21D-1576-08	TCGA-CH-5771-01A-21D-1576-08	TCGA-CH-5771-01A-21D-1574-01	a771088e-45e1-4e67-8e3e-88c65d0b0618	TCGA-CH-5771-01A-21D-1574-01	a771088e-45e1-4e67-8e3e-88c65d0b0618	AA8280D0-C22E-45CF-B8E1-C2F060CB04FC	TCGA-CH-5771-01	TCGA-CH-5771-01A-21D-1578-05	TCGA-CH-5771-01A-21R-1579-13	TCGA-CH-5771-01A-21D-1576-08	a771088e-45e1-4e67-8e3e-88c65d0b0618	0ddf77d7-a2f7-4784-b327-1242fc43828d
TCGA-CH-5771-11	0	TCGA-CH-5771-11	396	0	TCGA-CH-5771	396	0	396	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-CH-5771-F29003	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23101	31			31			0	396		396			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	1.8		YES				NO	2	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R0	Solid Tissue Normal	11	3	0.2		NO	5	YES	NO	CH			Prostate		A	LIVING	2008															TCGA-CH-5771-11A-01D-1578-05				
TCGA-CH-5772-01	0	TCGA-CH-5772-01	486	0	TCGA-CH-5772	486	0	486	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-CH-5772-F29004	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23194	90			90	90		0	486		424			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.9		YES				NO	6	0		N0	T3a	TCGA-CH-5772.78506402-8bc2-45de-8374-5ddfdc7066eb.pdf		0	0	0	0	0	0	0	0	25	25	15	10	60	65	70	70	TUMOR FREE	4	Complete Remission/Response	Yes	0.03	YES	R1	Primary Tumor	01	5	0.3		NO	3	YES	NO	CH			Prostate		A	LIVING	2008		TCGA-CH-5772-01A-11D-1576-08	TCGA-CH-5772-01A-11D-1576-08	ec9c1dc1-ecb8-4e90-b401-9b4618a05b5f	TCGA-CH-5772-01	77e1b878-fcff-4541-9cb5-85e0dce7b721	TCGA-CH-5772-01A-11D-1576-08	TCGA-CH-5772-01A-11D-1576-08	TCGA-CH-5772-01A-11D-1574-01	77e1b878-fcff-4541-9cb5-85e0dce7b721	TCGA-CH-5772-01A-11D-1574-01	77e1b878-fcff-4541-9cb5-85e0dce7b721	4AD27CF8-24A8-499A-B363-B39DED558CD7	TCGA-CH-5772-01	TCGA-CH-5772-01A-11D-1578-05	TCGA-CH-5772-01A-11R-1579-13	TCGA-CH-5772-01A-11D-1576-08	77e1b878-fcff-4541-9cb5-85e0dce7b721	ec9c1dc1-ecb8-4e90-b401-9b4618a05b5f
TCGA-CH-5772-11	0	TCGA-CH-5772-11	486	0	TCGA-CH-5772	486	0	486	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-CH-5772-F29004	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23194	90			90	90		0	486		424			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.2	NO	Bilateral	1.4		YES				NO	6	0		N0	T3a																			TUMOR FREE	4	Complete Remission/Response	Yes	0.03	YES	R1	Solid Tissue Normal	11	5	0.2		NO	3	YES	NO	CH			Prostate		A	LIVING	2008															TCGA-CH-5772-11A-01D-1578-05				
TCGA-CH-5788-01	0	TCGA-CH-5788-01	821	0	TCGA-CH-5788			821	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69	TCGA-CH-5788-F28991	YES	Normal (no evidence of prostate cancer) [cM0]	M0		-25233	31			31		786	0	821		786			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.8		YES					21	6		N1	T3b	TCGA-CH-5788.41e797ae-db60-4653-9e61-4050ec9c05b2.pdf		3	3	3	3	5	5	0	0	2	0	18	20	75	75	75	80	WITH TUMOR	4	Progressive Disease	No	3.58	NO	R0	Primary Tumor	01	3	0.2		YES	5	YES	NO	CH	Base		Prostate		A	LIVING	2007		TCGA-CH-5788-01A-11D-1576-08	TCGA-CH-5788-01A-11D-1576-08	82404b91-a977-4f15-8bdf-dcd31ec1fa6c	TCGA-CH-5788-01	9caa440e-a8a6-4851-b62e-4ebb09412fad	TCGA-CH-5788-01A-11D-1576-08	TCGA-CH-5788-01A-11D-1576-08	TCGA-CH-5788-01A-11D-1574-01	9caa440e-a8a6-4851-b62e-4ebb09412fad	TCGA-CH-5788-01A-11D-1574-01	9caa440e-a8a6-4851-b62e-4ebb09412fad	4B319620-E1EC-4186-A856-257A95BD5D16	TCGA-CH-5788-01	TCGA-CH-5788-01A-11D-1578-05	TCGA-CH-5788-01A-11R-1579-13		9caa440e-a8a6-4851-b62e-4ebb09412fad	82404b91-a977-4f15-8bdf-dcd31ec1fa6c
TCGA-CH-5789-01	0	TCGA-CH-5789-01	304	0	TCGA-CH-5789	304	0	304	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-CH-5789-F28990	NO		M0		-22494				61			0	304		229			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1						NO	4	0		N0	T3a	TCGA-CH-5789.50e47b92-4c6a-4fca-8d01-0b4abc61bd0e.pdf		0	0	0	0	0	0	0	0	10	20	15	15	75	65	75	70	TUMOR FREE	3	Complete Remission/Response	No	0.02	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2006	Peripheral Zone	TCGA-CH-5789-01A-11D-1576-08	TCGA-CH-5789-01A-11D-1576-08	bd85e2b5-a8e0-449f-8d77-6126f2a1e690	TCGA-CH-5789-01	f659e8f2-3d29-4170-bd40-84e54c70fcd4	TCGA-CH-5789-01A-11D-1576-08	TCGA-CH-5789-01A-11D-1576-08	TCGA-CH-5789-01A-11D-1574-01	f659e8f2-3d29-4170-bd40-84e54c70fcd4	TCGA-CH-5789-01A-11D-1574-01	f659e8f2-3d29-4170-bd40-84e54c70fcd4	12F2FBEB-2CF8-4C5D-90C6-F960AACA4092	TCGA-CH-5789-01	TCGA-CH-5789-01A-11D-1578-05	TCGA-CH-5789-01A-11R-1579-13	TCGA-CH-5789-01A-11D-1576-08	f659e8f2-3d29-4170-bd40-84e54c70fcd4	bd85e2b5-a8e0-449f-8d77-6126f2a1e690
TCGA-CH-5790-01	0	TCGA-CH-5790-01	974	0	TCGA-CH-5790	974	0	974	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-CH-5790-F28986	NO		M0		-23529							0	974		914			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1		YES				NO	5	0		N0	T2c	TCGA-CH-5790.0f2f0a80-6a25-4374-96ad-0dbd6d136906.pdf		0	0	0	0	0	0	0	0	20	5	15	15	65	80	75	85	TUMOR FREE	3	Complete Remission/Response	Yes	0.1	NO	R0	Primary Tumor	01	4	0.3		NO		YES	NO	CH			Prostate		A	LIVING	2006		TCGA-CH-5790-01A-11D-1576-08	TCGA-CH-5790-01A-11D-1576-08	e092ca09-4999-484b-9fb1-f9f30a3b2078	TCGA-CH-5790-01	743ad0e2-903e-4438-a575-1f06c286c079	TCGA-CH-5790-01A-11D-1576-08	TCGA-CH-5790-01A-11D-1576-08	TCGA-CH-5790-01A-11D-1574-01	743ad0e2-903e-4438-a575-1f06c286c079	TCGA-CH-5790-01A-11D-1574-01	743ad0e2-903e-4438-a575-1f06c286c079	0F699258-4F1D-478B-B860-5108C509E56D	TCGA-CH-5790-01	TCGA-CH-5790-01A-11D-1578-05	TCGA-CH-5790-01A-11R-1579-13	TCGA-CH-5790-01A-11D-1576-08	743ad0e2-903e-4438-a575-1f06c286c079	e092ca09-4999-484b-9fb1-f9f30a3b2078
TCGA-CH-5791-01	0	TCGA-CH-5791-01	1004	0	TCGA-CH-5791	396	1	1004	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	72	TCGA-CH-5791-F28985	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-26390	61						0	1004	396	882			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.8		YES		New Primary Tumor		YES	2	0		N0	T3a	TCGA-CH-5791.009bf26f-b3df-4f10-b496-a4304af1e091.pdf		2	0	0	0	0	0	0	0	15	15	30	25	55	60	65	70		3	Complete Remission/Response	Yes	0.18	NO	R1	Primary Tumor	01	4	0.2		NO		YES	NO	CH			Prostate		A	LIVING	2006	Peripheral Zone	TCGA-CH-5791-01A-11D-1576-08	TCGA-CH-5791-01A-11D-1576-08	ca36b1a5-b3af-47f0-aaf6-6e979bf40dd4	TCGA-CH-5791-01	47faa91b-1bfa-4283-bc9d-dfa958252d6f	TCGA-CH-5791-01A-11D-1576-08	TCGA-CH-5791-01A-11D-1576-08	TCGA-CH-5791-01A-11D-1574-01	47faa91b-1bfa-4283-bc9d-dfa958252d6f	TCGA-CH-5791-01A-11D-1574-01	47faa91b-1bfa-4283-bc9d-dfa958252d6f	A78ED02E-3618-49BE-8920-F4BA943CC7A4	TCGA-CH-5791-01	TCGA-CH-5791-01A-11D-1578-05	TCGA-CH-5791-01A-11R-1579-13	TCGA-CH-5791-01A-11D-1576-08	47faa91b-1bfa-4283-bc9d-dfa958252d6f	ca36b1a5-b3af-47f0-aaf6-6e979bf40dd4
TCGA-CH-5792-01	0	TCGA-CH-5792-01	91	0	TCGA-CH-5792			91	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-21002	91						0	91		91			NO		NO				2012-3-21	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.4		YES					6	0		N0	T3a	TCGA-CH-5792.72de5993-cad1-4ba0-9ea5-c545799a2f6e.pdf		4	3	2	2	0	0	0	0	20	20	25	25	55	55	60	60	WITH TUMOR	4		No	11.49		R1	Primary Tumor	01	5	0.4				YES	NO	CH			Prostate		A	LIVING	2009		TCGA-CH-5792-01A-11D-1576-08	TCGA-CH-5792-01A-11D-1576-08	f9cf45fb-7b63-43c4-bd3f-04c2c2559bf6	TCGA-CH-5792-01	4db58676-4bfe-46de-9db9-8270d67b49fe	TCGA-CH-5792-01A-11D-1576-08	TCGA-CH-5792-01A-11D-1576-08	TCGA-CH-5792-01A-11D-1574-01	4db58676-4bfe-46de-9db9-8270d67b49fe	TCGA-CH-5792-01A-11D-1574-01	4db58676-4bfe-46de-9db9-8270d67b49fe	0AC4DEF1-BF7D-4C6C-BFFD-95873ABD655D	TCGA-CH-5792-01	TCGA-CH-5792-01A-11D-1578-05	TCGA-CH-5792-01A-11R-1579-13	TCGA-CH-5792-01A-11D-1576-08	4db58676-4bfe-46de-9db9-8270d67b49fe	f9cf45fb-7b63-43c4-bd3f-04c2c2559bf6
TCGA-CH-5794-01	0	TCGA-CH-5794-01	882	0	TCGA-CH-5794	882	0	882	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-CH-5794-F28994	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23924	62			62			0	882		821			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.1		YES				NO	4	0		N0	T2b	TCGA-CH-5794.2bdbd62b-c2a0-4cdd-8187-6cf1db227e7e.pdf		0	0	0	0	0	0	0	0	10	10	15	10	75	80	75	80	TUMOR FREE	3	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2006	Peripheral Zone	TCGA-CH-5794-01A-11D-1576-08	TCGA-CH-5794-01A-11D-1576-08	2466702a-8539-4ae2-93f6-d7235071c20d	TCGA-CH-5794-01	5c6bca7d-7dcc-4908-add3-c56606b313a7	TCGA-CH-5794-01A-11D-1576-08	TCGA-CH-5794-01A-11D-1576-08	TCGA-CH-5794-01A-11D-1574-01	5c6bca7d-7dcc-4908-add3-c56606b313a7	TCGA-CH-5794-01A-11D-1574-01	5c6bca7d-7dcc-4908-add3-c56606b313a7	538DEA11-0D68-4013-B3EC-BEDAED2F90FA	TCGA-CH-5794-01	TCGA-CH-5794-01A-11D-1578-05	TCGA-CH-5794-01A-11R-1579-13	TCGA-CH-5794-01A-11D-1576-08	5c6bca7d-7dcc-4908-add3-c56606b313a7	2466702a-8539-4ae2-93f6-d7235071c20d
TCGA-EJ-5494-01	0	TCGA-EJ-5494-01	826	0	TCGA-EJ-5494	826	0	826	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			50	TCGA-EJ-5494-F46196	NO		M0	T2a	-18596							0	826		184							Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	17	0		N0	T3a	TCGA-EJ-5494.e52eefbc-e27d-4a5d-a261-d06a2dcf5d53.pdf		0	0	0	0	0	0	0	0	2	2	18	18	80	80	85	85	TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Primary Tumor	01	3	0.3		NO	4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2009		TCGA-EJ-5494-01A-01D-1576-08	TCGA-EJ-5494-01A-01D-1576-08	00814ce1-0bd9-479e-80a7-ff32ac9b3d82	TCGA-EJ-5494-01	fb687a9b-dcb1-46e9-b175-fd28c7242c2b	TCGA-EJ-5494-01A-01D-1576-08	TCGA-EJ-5494-01A-01D-1576-08	TCGA-EJ-5494-01A-01D-1574-01	fb687a9b-dcb1-46e9-b175-fd28c7242c2b	TCGA-EJ-5494-01A-01D-1574-01	fb687a9b-dcb1-46e9-b175-fd28c7242c2b	BA260C91-7D20-4B44-B383-19314D60631D	TCGA-EJ-5494-01	TCGA-EJ-5494-01A-01D-1578-05	TCGA-EJ-5494-01A-01R-1579-13	TCGA-EJ-5494-01A-01D-1576-08	fb687a9b-dcb1-46e9-b175-fd28c7242c2b	00814ce1-0bd9-479e-80a7-ff32ac9b3d82
TCGA-EJ-5495-01	0	TCGA-EJ-5495-01	1007	0	TCGA-EJ-5495	1007	0	1007	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-EJ-5495-F46197	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24904	26						0	1007		606			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.3	NO	YES				NO	18	1		N1	T3b	TCGA-EJ-5495.5c549c39-b223-49eb-aa93-0298cdf33370.pdf		4	3	0	0	0	0	0	0	15	15	20	15	65	70	60	75	TUMOR FREE	5	Complete Remission/Response	No	0.13	NO	R0	Primary Tumor	01	3	0.4		NO	4	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2009		TCGA-EJ-5495-01A-01D-1576-08	TCGA-EJ-5495-01A-01D-1576-08	a6157c95-a103-43a9-9335-b286e4d94876	TCGA-EJ-5495-01	c07b7746-e340-4679-99bb-531c2d93b4e5	TCGA-EJ-5495-01A-01D-1576-08	TCGA-EJ-5495-01A-01D-1576-08	TCGA-EJ-5495-01A-01D-1574-01	c07b7746-e340-4679-99bb-531c2d93b4e5	TCGA-EJ-5495-01A-01D-1574-01	c07b7746-e340-4679-99bb-531c2d93b4e5	E7B35738-2222-4A08-AA6B-8352D26BEC92	TCGA-EJ-5495-01	TCGA-EJ-5495-01A-01D-1578-05	TCGA-EJ-5495-01A-01R-1579-13	TCGA-EJ-5495-01A-01D-1576-08	c07b7746-e340-4679-99bb-531c2d93b4e5	a6157c95-a103-43a9-9335-b286e4d94876
TCGA-EJ-5496-01	0	TCGA-EJ-5496-01	595	0	TCGA-EJ-5496	595	0	595	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-EJ-5496-F46198	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21897	15			15			0	595		595			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	2	NO	YES				NO	26	0		N0	T2c	TCGA-EJ-5496.80e82784-0bca-4657-9c9f-e9b860dc09bc.pdf		4	1	2	0	0	0	0	0	20	10	35	30	45	60	45	70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	4	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones	TCGA-EJ-5496-01A-01D-1576-08	TCGA-EJ-5496-01A-01D-1576-08	bb36767c-9099-438a-9db4-e1d8d0961dd3	TCGA-EJ-5496-01	1059fbc0-46bf-4135-99d0-080ec225391b	TCGA-EJ-5496-01A-01D-1576-08	TCGA-EJ-5496-01A-01D-1576-08	TCGA-EJ-5496-01A-01D-1574-01	1059fbc0-46bf-4135-99d0-080ec225391b	TCGA-EJ-5496-01A-01D-1574-01	1059fbc0-46bf-4135-99d0-080ec225391b	B724F938-FEE2-4AD6-99C3-838742A70AF9	TCGA-EJ-5496-01	TCGA-EJ-5496-01A-01D-1578-05	TCGA-EJ-5496-01A-01R-1579-13	TCGA-EJ-5496-01A-01D-1576-08	1059fbc0-46bf-4135-99d0-080ec225391b	bb36767c-9099-438a-9db4-e1d8d0961dd3
TCGA-EJ-5497-01	0	TCGA-EJ-5497-01	405	0	TCGA-EJ-5497	405	0	405	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			47	TCGA-EJ-5497-F46199	NO		M0	T2c	-17523							0	405		204			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.5	NO	YES				NO	10	0		N0	T2c	TCGA-EJ-5497.4c6ab617-53f7-4556-a1a0-b44df4f67b6b.pdf			1		0		0		0		25		15		60		70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.5		NO	3	YES	NO	EJ	Middle		Prostate		A	LIVING	2009	Overlapping / Multiple Zones	TCGA-EJ-5497-01A-02D-1576-08	TCGA-EJ-5497-01A-02D-1576-08	c3d23009-d760-4ba6-98ec-5d9862114b90	TCGA-EJ-5497-01	86961468-9e93-469a-b812-03ef327bf5fb	TCGA-EJ-5497-01A-02D-1576-08	TCGA-EJ-5497-01A-02D-1576-08	TCGA-EJ-5497-01A-02D-1574-01	86961468-9e93-469a-b812-03ef327bf5fb	TCGA-EJ-5497-01A-02D-1574-01	86961468-9e93-469a-b812-03ef327bf5fb	C7EF553E-B25E-42A5-8C05-6F16BBAFC14B	TCGA-EJ-5497-01	TCGA-EJ-5497-01A-02D-1578-05	TCGA-EJ-5497-01A-02R-1579-13	TCGA-EJ-5497-01A-02D-1576-08	86961468-9e93-469a-b812-03ef327bf5fb	c3d23009-d760-4ba6-98ec-5d9862114b90
TCGA-EJ-5498-01	0	TCGA-EJ-5498-01	906	0	TCGA-EJ-5498	906	0	906	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56	TCGA-EJ-5498-F46200	NO	Normal (no evidence of prostate cancer) [cM0]		T2c	-20472	12			12			0	906		537			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.4	NO	YES				NO	26	0		N0	T2c	TCGA-EJ-5498.53d058fd-5faa-43ab-8a5e-b6f95134970b.pdf		1	0	0	0	0	0	0	0	35	20	50	25	15	55	20	60	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.5		NO	3	YES	NO	EJ	Middle		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	TCGA-EJ-5498-01A-01D-1576-08	TCGA-EJ-5498-01A-01D-1576-08	4829c388-575f-4324-a3ac-c26d167e6e28	TCGA-EJ-5498-01	2bc25263-18b8-4ed5-b986-e9b54f734596	TCGA-EJ-5498-01A-01D-1576-08	TCGA-EJ-5498-01A-01D-1576-08	TCGA-EJ-5498-01A-01D-1574-01	2bc25263-18b8-4ed5-b986-e9b54f734596	TCGA-EJ-5498-01A-01D-1574-01	2bc25263-18b8-4ed5-b986-e9b54f734596	C2B3E926-0662-4245-AFA5-C19AEDF7A673	TCGA-EJ-5498-01	TCGA-EJ-5498-01A-01D-1578-05	TCGA-EJ-5498-01A-01R-1579-13	TCGA-EJ-5498-01A-01D-1576-08	2bc25263-18b8-4ed5-b986-e9b54f734596	4829c388-575f-4324-a3ac-c26d167e6e28
TCGA-EJ-5499-01	0	TCGA-EJ-5499-01	533	0	TCGA-EJ-5499	533	0	533	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-EJ-5499-F46201	NO		M0	T2b	-22286							0	533		533							Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.1	NO	YES				NO	19	0		N0	T3a	TCGA-EJ-5499.f69e29da-24d1-45f2-9b4f-a32f9e5479a4.pdf		1	0	0	0	0	0	0	0	40	20	49	25	1	55	2	60	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.4		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	TCGA-EJ-5499-01A-01D-1576-08	TCGA-EJ-5499-01A-01D-1576-08	03cb6ce8-70a3-4eb2-9caf-a0617fe44842	TCGA-EJ-5499-01	b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df	TCGA-EJ-5499-01A-01D-1576-08	TCGA-EJ-5499-01A-01D-1576-08	TCGA-EJ-5499-01A-01D-1574-01	b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df	TCGA-EJ-5499-01A-01D-1574-01	b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df	C30416C0-12F3-4C0E-BF4C-73F7F7BA4106	TCGA-EJ-5499-01	TCGA-EJ-5499-01A-01D-1578-05	TCGA-EJ-5499-01A-01R-1579-13	TCGA-EJ-5499-01A-01D-1576-08	b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df	03cb6ce8-70a3-4eb2-9caf-a0617fe44842
TCGA-EJ-5501-01	0	TCGA-EJ-5501-01	937	0	TCGA-EJ-5501	937	0	937	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-EJ-5501-F46202	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20409	9			9			0	937		729			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	11	0		N0	T3b	TCGA-EJ-5501.630dee46-15db-4a16-84ee-a9d25fcccb80.pdf		1	1	0	0	0	0	0	0	10	15	25	25	65	60	75	75	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.3		NO	5	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	TCGA-EJ-5501-01A-01D-1576-08	TCGA-EJ-5501-01A-01D-1576-08	fca9ca7e-80ff-4734-bb2a-6cabc1371222	TCGA-EJ-5501-01	b896a143-8a90-424e-9124-45edb6f3f26d	TCGA-EJ-5501-01A-01D-1576-08	TCGA-EJ-5501-01A-01D-1576-08	TCGA-EJ-5501-01A-01D-1574-01	b896a143-8a90-424e-9124-45edb6f3f26d	TCGA-EJ-5501-01A-01D-1574-01	b896a143-8a90-424e-9124-45edb6f3f26d	6979871B-9E73-4200-AED2-92DE897C3053	TCGA-EJ-5501-01	TCGA-EJ-5501-01A-01D-1578-05	TCGA-EJ-5501-01A-01R-1579-13	TCGA-EJ-5501-01A-01D-1576-08	b896a143-8a90-424e-9124-45edb6f3f26d	fca9ca7e-80ff-4734-bb2a-6cabc1371222
TCGA-EJ-5502-01	0	TCGA-EJ-5502-01	800	0	TCGA-EJ-5502	800	0	800	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			50	TCGA-EJ-5502-F46203	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-18447	7			7			0	800		603			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	11	0		N0	T2c	TCGA-EJ-5502.173e45e9-e2ab-4a1d-8bcc-15374f1ae511.pdf		0	0	0	0	0	0	0	0	30	15	30	30	40	55	45	60	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.3		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	TCGA-EJ-5502-01A-01D-1576-08	TCGA-EJ-5502-01A-01D-1576-08	a4cf9c52-7e16-495a-890c-7cade850acc5	TCGA-EJ-5502-01	416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad	TCGA-EJ-5502-01A-01D-1576-08	TCGA-EJ-5502-01A-01D-1576-08	TCGA-EJ-5502-01A-01D-1574-01	416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad	TCGA-EJ-5502-01A-01D-1574-01	416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad	EA44DC8F-0260-437E-BCD3-DC2BD19DD9CE	TCGA-EJ-5502-01	TCGA-EJ-5502-01A-01D-1578-05	TCGA-EJ-5502-01A-01R-1579-13	TCGA-EJ-5502-01A-01D-1576-08	416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad	a4cf9c52-7e16-495a-890c-7cade850acc5
TCGA-EJ-5503-01	0	TCGA-EJ-5503-01	716	0	TCGA-EJ-5503	716	0	716	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			50	TCGA-EJ-5503-F46204	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-18395	31			31			0	716		530			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.3	NO	YES				NO	21	0		N0	T3a	TCGA-EJ-5503.81ca6538-6023-4e21-bd59-0b248e5642ac.pdf		0	0	0	0	0	0	0	0	5	10	10	15	80	75	85	80	TUMOR FREE	5	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.4		NO	4	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	TCGA-EJ-5503-01A-01D-1576-08	TCGA-EJ-5503-01A-01D-1576-08	d0f1fb1c-9c2a-404c-a0f2-d940ad3474ee	TCGA-EJ-5503-01	aa181d66-d198-43ab-920e-a351454194a0	TCGA-EJ-5503-01A-01D-1576-08	TCGA-EJ-5503-01A-01D-1576-08	TCGA-EJ-5503-01A-01D-1574-01	aa181d66-d198-43ab-920e-a351454194a0	TCGA-EJ-5503-01A-01D-1574-01	aa181d66-d198-43ab-920e-a351454194a0	DA70ADB1-141C-472A-BE95-D7B1DD00C689	TCGA-EJ-5503-01	TCGA-EJ-5503-01A-01D-1578-05	TCGA-EJ-5503-01A-01R-1579-13	TCGA-EJ-5503-01A-01D-1576-08	aa181d66-d198-43ab-920e-a351454194a0	d0f1fb1c-9c2a-404c-a0f2-d940ad3474ee
TCGA-EJ-5504-01	0	TCGA-EJ-5504-01	880	0	TCGA-EJ-5504			880	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	65	TCGA-EJ-5504-F46205	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-24072	25			25		82	0	880		385	736		YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Progressive Disease	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	0.9	NO	YES		Biochemical evidence of disease		YES	18	1		N1	T3a	TCGA-EJ-5504.74f98316-075f-45e1-9bca-3d885a070fa8.pdf		0	0	0	0	0	0	0	0	10	10	20	15	70	75	85	90	WITH TUMOR	4	Progressive Disease	No	1.0	NO	R1	Primary Tumor	01	3	0.4		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	TCGA-EJ-5504-01A-01D-1576-08	TCGA-EJ-5504-01A-01D-1576-08	267120ee-7aab-4a7c-9d84-1ce7dfbcdef8	TCGA-EJ-5504-01	70779173-6a72-45e4-bf43-91ee9baba55f	TCGA-EJ-5504-01A-01D-1576-08	TCGA-EJ-5504-01A-01D-1576-08	TCGA-EJ-5504-01A-01D-1574-01	70779173-6a72-45e4-bf43-91ee9baba55f	TCGA-EJ-5504-01A-01D-1574-01	70779173-6a72-45e4-bf43-91ee9baba55f	0D99F039-663F-4BA6-8F9C-DD72439BE2CA	TCGA-EJ-5504-01	TCGA-EJ-5504-01A-01D-1578-05	TCGA-EJ-5504-01A-01R-1579-13	TCGA-EJ-5504-01A-01D-1576-08	70779173-6a72-45e4-bf43-91ee9baba55f	267120ee-7aab-4a7c-9d84-1ce7dfbcdef8
TCGA-EJ-5505-01	0	TCGA-EJ-5505-01	922	0	TCGA-EJ-5505	922	0	922	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-EJ-5505-F46206	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21164	12			12			0	922		448			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	YES				NO	24	0		N0	T2c	TCGA-EJ-5505.b8c31900-c8a8-45a7-a71a-fa356bf78511.pdf		0	0	0	0	0	0	0	0	15	15	15	15	70	70	80	85	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.6		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010		TCGA-EJ-5505-01A-01D-1576-08	TCGA-EJ-5505-01A-01D-1576-08	57ba222c-862d-4f62-845a-ad28c0530bc2	TCGA-EJ-5505-01	b304cf7b-274d-4617-9830-459601eedc10	TCGA-EJ-5505-01A-01D-1576-08	TCGA-EJ-5505-01A-01D-1576-08	TCGA-EJ-5505-01A-01D-1574-01	b304cf7b-274d-4617-9830-459601eedc10	TCGA-EJ-5505-01A-01D-1574-01	b304cf7b-274d-4617-9830-459601eedc10	FB410C59-87B2-422F-9CA2-78D5DCBDCA3C	TCGA-EJ-5505-01	TCGA-EJ-5505-01A-01D-1578-05	TCGA-EJ-5505-01A-01R-1579-13	TCGA-EJ-5505-01A-01D-1576-08	b304cf7b-274d-4617-9830-459601eedc10	57ba222c-862d-4f62-845a-ad28c0530bc2
TCGA-EJ-5506-01	0	TCGA-EJ-5506-01	827	0	TCGA-EJ-5506	827	0	827	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-EJ-5506-F46207	NO		M0	T3b	-24617							0	827		356			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.5	NO	YES				NO	7	1		N1	T3b	TCGA-EJ-5506.4b6b88e5-b9f5-4bed-8320-b227a30bd1a9.pdf		2	2	0	0	0	0	0	0	10	10	25	20	65	70	80	80	TUMOR FREE	5	Complete Remission/Response	No	0.1	NO	RX	Primary Tumor	01	3	0.5		NO	4	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010		TCGA-EJ-5506-01A-01D-1576-08	TCGA-EJ-5506-01A-01D-1576-08	194f9634-e3aa-45b1-98e6-5f12eecf99e4	TCGA-EJ-5506-01	e67b3b01-fdd5-49de-8829-84298c131a5f	TCGA-EJ-5506-01A-01D-1576-08	TCGA-EJ-5506-01A-01D-1576-08	TCGA-EJ-5506-01A-01D-1574-01	e67b3b01-fdd5-49de-8829-84298c131a5f	TCGA-EJ-5506-01A-01D-1574-01	e67b3b01-fdd5-49de-8829-84298c131a5f	B6C93974-DA24-476B-A742-2F25DA08AE0F	TCGA-EJ-5506-01	TCGA-EJ-5506-01A-01D-1578-05	TCGA-EJ-5506-01A-01R-1579-13	TCGA-EJ-5506-01A-01D-1576-08	e67b3b01-fdd5-49de-8829-84298c131a5f	194f9634-e3aa-45b1-98e6-5f12eecf99e4
TCGA-EJ-5507-01	0	TCGA-EJ-5507-01	727	0	TCGA-EJ-5507	727	0	727	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			54	TCGA-EJ-5507-F46208	NO		M0	T2c	-19759							0	727		182			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.4	NO	YES				NO	21	2		N1	T3b	TCGA-EJ-5507.153de441-fbe9-4c8b-9a84-9cdf9c5edcf2.pdf		2	2	3	2	5	5	2	2	20	25	25	20	55	55	60	60	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	5	0.3		NO	4	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010		TCGA-EJ-5507-01A-01D-1576-08	TCGA-EJ-5507-01A-01D-1576-08	9de01a3d-44d6-4ea5-aecf-4273d7691d21	TCGA-EJ-5507-01	487c555b-81bb-4b70-8219-9abac8394b9f	TCGA-EJ-5507-01A-01D-1576-08	TCGA-EJ-5507-01A-01D-1576-08	TCGA-EJ-5507-01A-01D-1574-01	487c555b-81bb-4b70-8219-9abac8394b9f	TCGA-EJ-5507-01A-01D-1574-01	487c555b-81bb-4b70-8219-9abac8394b9f	4E3D63A2-D726-4EBD-B4BA-49DC9D345796	TCGA-EJ-5507-01	TCGA-EJ-5507-01A-01D-1578-05	TCGA-EJ-5507-01A-01R-1579-13	TCGA-EJ-5507-01A-01D-1576-08	487c555b-81bb-4b70-8219-9abac8394b9f	9de01a3d-44d6-4ea5-aecf-4273d7691d21
TCGA-EJ-5508-01	0	TCGA-EJ-5508-01	1184	0	TCGA-EJ-5508	1184	0	1184	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-EJ-5508-F46209	NO		M0	T1c	-23758							0	1184		907			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.7	NO	YES				NO	17	0		N0	T3a	TCGA-EJ-5508.d2590559-0eb6-479e-ba3a-b59c3429ca6d.pdf			2		0		0		0		20		25		55		65	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	4	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2008		TCGA-EJ-5508-01A-02D-1576-08	TCGA-EJ-5508-01A-02D-1576-08	e197b179-8d25-4b4a-833d-8cc2cd02d85f	TCGA-EJ-5508-01	f4463436-536d-412e-824c-0c623a244da5	TCGA-EJ-5508-01A-02D-1576-08	TCGA-EJ-5508-01A-02D-1576-08	TCGA-EJ-5508-01A-02D-1574-01	f4463436-536d-412e-824c-0c623a244da5	TCGA-EJ-5508-01A-02D-1574-01	f4463436-536d-412e-824c-0c623a244da5	64181246-E4A9-4A96-B510-12D30DB1E16C	TCGA-EJ-5508-01	TCGA-EJ-5508-01A-02D-1578-05	TCGA-EJ-5508-01A-02R-1579-13	TCGA-EJ-5508-01A-02D-1576-08	f4463436-536d-412e-824c-0c623a244da5	e197b179-8d25-4b4a-833d-8cc2cd02d85f
TCGA-EJ-5509-01	0	TCGA-EJ-5509-01	1102	0	TCGA-EJ-5509	1102	0	1102	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-EJ-5509-F46210	NO		M0	T2a	-23368							0	1102		1102			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	YES				NO	10	0		N0	T2c	TCGA-EJ-5509.672ff51d-12ba-402a-b6d6-87cc9c91e7ad.pdf		2	2	1	0	1	0	2	0	10	10	19	15	70	75	75	80	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.2		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009		TCGA-EJ-5509-01A-01D-1576-08	TCGA-EJ-5509-01A-01D-1576-08	ee31eb64-26db-496f-b416-fb6a91a55e61	TCGA-EJ-5509-01	1c809dd1-f790-458d-9722-c3262afcd416	TCGA-EJ-5509-01A-01D-1576-08	TCGA-EJ-5509-01A-01D-1576-08	TCGA-EJ-5509-01A-01D-1574-01	1c809dd1-f790-458d-9722-c3262afcd416	TCGA-EJ-5509-01A-01D-1574-01	1c809dd1-f790-458d-9722-c3262afcd416	88604FC1-618E-4581-99DA-AB89129977E3	TCGA-EJ-5509-01	TCGA-EJ-5509-01A-01D-1578-05	TCGA-EJ-5509-01A-01R-1579-13	TCGA-EJ-5509-01A-01D-1576-08	1c809dd1-f790-458d-9722-c3262afcd416	ee31eb64-26db-496f-b416-fb6a91a55e61
TCGA-EJ-5510-01	0	TCGA-EJ-5510-01	1116	0	TCGA-EJ-5510	1116	0	1116	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			48	TCGA-EJ-5510-F46211	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-17895	14			14			0	1116		738			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.3	NO	YES				NO	17	0		N0	T2c	TCGA-EJ-5510.9f549743-cbb3-46bb-9356-40f80e961b4d.pdf		0	0	0	0	0	0	0	0	30	15	20	10	50	75	50	75	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.4		NO	3	YES	NO	EJ			Prostate		A	LIVING	2009		TCGA-EJ-5510-01A-01D-1576-08	TCGA-EJ-5510-01A-01D-1576-08	78c3c78f-0b4c-4c9f-b92b-ef100329d667	TCGA-EJ-5510-01	787d4d9f-1c69-406f-8e1c-2458d77085e7	TCGA-EJ-5510-01A-01D-1576-08	TCGA-EJ-5510-01A-01D-1576-08	TCGA-EJ-5510-01A-01D-1574-01	787d4d9f-1c69-406f-8e1c-2458d77085e7	TCGA-EJ-5510-01A-01D-1574-01	787d4d9f-1c69-406f-8e1c-2458d77085e7	BA5FB8F4-DF35-48CB-888D-0A80C184A03F	TCGA-EJ-5510-01	TCGA-EJ-5510-01A-01D-1578-05	TCGA-EJ-5510-01A-01R-1579-13	TCGA-EJ-5510-01A-01D-1576-08	787d4d9f-1c69-406f-8e1c-2458d77085e7	78c3c78f-0b4c-4c9f-b92b-ef100329d667
TCGA-EJ-5511-01	0	TCGA-EJ-5511-01	974	0	TCGA-EJ-5511	974	0	974	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-EJ-5511-F46212	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20409	18						0	974		788			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	2	NO	YES				NO	15	0		N0	T3a	TCGA-EJ-5511.4e4d79fc-ecc3-4533-ac69-9bdec44a080c.pdf		1	1	0	0	0	0	0	0	15	15	20	15	65	70	70	75	TUMOR FREE	3	Complete Remission/Response	No	0.04	NO	R0	Primary Tumor	01	4	0.3		NO	4	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009		TCGA-EJ-5511-01A-01D-1576-08	TCGA-EJ-5511-01A-01D-1576-08	d6d71030-07f3-4457-b26d-e2309c8eb8a5	TCGA-EJ-5511-01	488dc8bd-9e74-48b2-a407-914f6e0ba0b6	TCGA-EJ-5511-01A-01D-1576-08	TCGA-EJ-5511-01A-01D-1576-08	TCGA-EJ-5511-01A-01D-1574-01	488dc8bd-9e74-48b2-a407-914f6e0ba0b6	TCGA-EJ-5511-01A-01D-1574-01	488dc8bd-9e74-48b2-a407-914f6e0ba0b6	6FC09B2E-53B1-4802-BF39-076F080FCC06	TCGA-EJ-5511-01	TCGA-EJ-5511-01A-01D-1578-05	TCGA-EJ-5511-01A-01R-1579-13	TCGA-EJ-5511-01A-01D-1576-08	488dc8bd-9e74-48b2-a407-914f6e0ba0b6	d6d71030-07f3-4457-b26d-e2309c8eb8a5
TCGA-EJ-5512-01	0	TCGA-EJ-5512-01	1172	0	TCGA-EJ-5512	1172	0	1172	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			46	TCGA-EJ-5512-F46594	NO		M0	T1c	-17127							0	1172		782							Scheduled Follow-up Submission	Complete Remission/Response	2013-8-12	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.1	NO	YES				NO	13	0		N0	T2c	TCGA-EJ-5512.8b273389-2655-4ac1-bcf0-b64505fe7b3d.pdf		1	1	0	0	0	0	0	0	15	20	25	30	60	50	75	65	TUMOR FREE	3	Complete Remission/Response	No	00	NO	R0	Primary Tumor	01	4	0.5		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009		TCGA-EJ-5512-01A-01D-1576-08	TCGA-EJ-5512-01A-01D-1576-08	e95b4a0a-8f83-4e4d-9da8-ada9ca2b7993	TCGA-EJ-5512-01	d0617c13-ba48-44d9-807f-29a9ee7ebf39	TCGA-EJ-5512-01A-01D-1576-08	TCGA-EJ-5512-01A-01D-1576-08	TCGA-EJ-5512-01A-01D-1574-01	d0617c13-ba48-44d9-807f-29a9ee7ebf39	TCGA-EJ-5512-01A-01D-1574-01	d0617c13-ba48-44d9-807f-29a9ee7ebf39	09112836-8FB3-4DCE-B041-DE03ED385768	TCGA-EJ-5512-01	TCGA-EJ-5512-01A-01D-1578-05	TCGA-EJ-5512-01A-01R-1579-13	TCGA-EJ-5512-01A-01D-1576-08	d0617c13-ba48-44d9-807f-29a9ee7ebf39	e95b4a0a-8f83-4e4d-9da8-ada9ca2b7993
TCGA-EJ-5514-01	0	TCGA-EJ-5514-01	1102	0	TCGA-EJ-5514	1102	0	1102	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-EJ-5514-F46598	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24165	7						0	1102		724			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.4	NO	YES				NO	12	0		N0	T2c	TCGA-EJ-5514.5b64ad18-513e-422d-a847-d1862dd0e453.pdf		2	2	2	2	2	2	2	2	10	5	33	28	55	65	65	70	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	5	0.4		NO	4	YES	NO	EJ			Prostate		A	LIVING	2009		TCGA-EJ-5514-01A-01D-1576-08	TCGA-EJ-5514-01A-01D-1576-08	34c59345-7e07-44eb-a1f2-ffb69c3da8cc	TCGA-EJ-5514-01	10892e71-cd86-4bcf-9da9-5faa081d1b0a	TCGA-EJ-5514-01A-01D-1576-08	TCGA-EJ-5514-01A-01D-1576-08	TCGA-EJ-5514-01A-01D-1574-01	10892e71-cd86-4bcf-9da9-5faa081d1b0a	TCGA-EJ-5514-01A-01D-1574-01	10892e71-cd86-4bcf-9da9-5faa081d1b0a	12F1A7B6-283C-4F2B-A3A8-E434E56DEA6F	TCGA-EJ-5514-01	TCGA-EJ-5514-01A-01D-1578-05	TCGA-EJ-5514-01A-01R-1579-13	TCGA-EJ-5514-01A-01D-1576-08	10892e71-cd86-4bcf-9da9-5faa081d1b0a	34c59345-7e07-44eb-a1f2-ffb69c3da8cc
TCGA-EJ-5515-01	0	TCGA-EJ-5515-01	1240	0	TCGA-EJ-5515	1240	0	1240	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-EJ-5515-F46599	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22097	30			30			0	1240		1061			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-12	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Right	2	NO	YES				NO	20	0		N0	T3a	TCGA-EJ-5515.1029ba11-efb4-42b7-871c-c97192a40e12.pdf		2	3	0	0	0	0	0	0	15	15	20	25	65	60	65	65	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	4	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009		TCGA-EJ-5515-01A-01D-1576-08	TCGA-EJ-5515-01A-01D-1576-08	c65b38a5-26d8-4fbc-a257-fe6fce7c54d6	TCGA-EJ-5515-01	7e81cb8c-9d91-4679-8a96-12365c19119b	TCGA-EJ-5515-01A-01D-1576-08	TCGA-EJ-5515-01A-01D-1576-08	TCGA-EJ-5515-01A-01D-1574-01	7e81cb8c-9d91-4679-8a96-12365c19119b	TCGA-EJ-5515-01A-01D-1574-01	7e81cb8c-9d91-4679-8a96-12365c19119b	34C05945-D438-422F-8673-E8BCBCF9E78B	TCGA-EJ-5515-01	TCGA-EJ-5515-01A-01D-1578-05	TCGA-EJ-5515-01A-01R-1579-13	TCGA-EJ-5515-01A-01D-1576-08	7e81cb8c-9d91-4679-8a96-12365c19119b	c65b38a5-26d8-4fbc-a257-fe6fce7c54d6
TCGA-EJ-5516-01	0	TCGA-EJ-5516-01	1416	0	TCGA-EJ-5516	1416	0	1416	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			49	TCGA-EJ-5516-F46600	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-17980	0						0	1416		730			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-12	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.6	NO	YES				NO	6	0		N0	T3a	TCGA-EJ-5516.b15c052e-04f9-49d7-bca9-dddf59a7e9da.pdf		2	3	0	0	0	0	0	0	10	10	20	20	70	70	75	75	TUMOR FREE	3	Complete Remission/Response	No	0.12	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ			Prostate		A	LIVING	2009		TCGA-EJ-5516-01A-01D-1576-08	TCGA-EJ-5516-01A-01D-1576-08	6baab8ff-012e-4e5f-bd38-0c734c14cd51	TCGA-EJ-5516-01	6320daab-3fdb-45d2-bbc8-bbba33e4af37	TCGA-EJ-5516-01A-01D-1576-08	TCGA-EJ-5516-01A-01D-1576-08	TCGA-EJ-5516-01A-01D-1574-01	6320daab-3fdb-45d2-bbc8-bbba33e4af37	TCGA-EJ-5516-01A-01D-1574-01	6320daab-3fdb-45d2-bbc8-bbba33e4af37	480DA000-4D66-4E54-9F00-4ADCB83B6A7E	TCGA-EJ-5516-01	TCGA-EJ-5516-01A-01D-1578-05	TCGA-EJ-5516-01A-01R-1579-13	TCGA-EJ-5516-01A-01D-1576-08	6320daab-3fdb-45d2-bbc8-bbba33e4af37	6baab8ff-012e-4e5f-bd38-0c734c14cd51
TCGA-EJ-5517-01	0	TCGA-EJ-5517-01	1454	0	TCGA-EJ-5517	1454	0	1454	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-EJ-5517-F46601	NO		M0	T1c	-20422							0	1454		187			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-12	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.4	NO	YES				NO	4	0		N0	T2c	TCGA-EJ-5517.67b66178-bd1b-44a8-9a30-762b0fc7c1ba.pdf		5	5	0	0	0	0	0	0	10	5	15	20	75	75	80	75	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.2		NO	2	YES	NO	EJ			Prostate		A	LIVING	2008		TCGA-EJ-5517-01A-01D-1576-08	TCGA-EJ-5517-01A-01D-1576-08	3de898ab-76d0-4a42-a957-cade1356f1a4	TCGA-EJ-5517-01	bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1	TCGA-EJ-5517-01A-01D-1576-08	TCGA-EJ-5517-01A-01D-1576-08	TCGA-EJ-5517-01A-01D-1574-01	bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1	TCGA-EJ-5517-01A-01D-1574-01	bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1	C7B12E0C-ACAF-403B-89AB-4998E1072A96	TCGA-EJ-5517-01	TCGA-EJ-5517-01A-01D-1578-05	TCGA-EJ-5517-01A-01R-1579-13	TCGA-EJ-5517-01A-01D-1576-08	bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1	3de898ab-76d0-4a42-a957-cade1356f1a4
TCGA-EJ-5518-01	0	TCGA-EJ-5518-01	1590	0	TCGA-EJ-5518	1590	0	1590	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-EJ-5518-F46602	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3b	-24313	32						0	1590		1195			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.9	NO	NO				NO	3	0		N0	T4	TCGA-EJ-5518.8299ff67-bed6-462f-87ad-3c8be45e1453.pdf		2	0	0	0	1	0	0	0	15	20	29	30	55	50	60	55	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R1	Primary Tumor	01	5	0.3		NO	4	YES	NO	EJ			Prostate		A	LIVING	2008	Overlapping / Multiple Zones	TCGA-EJ-5518-01A-01D-1576-08	TCGA-EJ-5518-01A-01D-1576-08	a41df7d8-0129-45c2-9d65-8bfdeb365118	TCGA-EJ-5518-01	01d4c289-6d85-4119-86f5-bcf3de30d0f7	TCGA-EJ-5518-01A-01D-1576-08	TCGA-EJ-5518-01A-01D-1576-08	TCGA-EJ-5518-01A-01D-1574-01	01d4c289-6d85-4119-86f5-bcf3de30d0f7	TCGA-EJ-5518-01A-01D-1574-01	01d4c289-6d85-4119-86f5-bcf3de30d0f7	95F2803A-BFFF-43D8-9818-F042F82A052A	TCGA-EJ-5518-01	TCGA-EJ-5518-01A-01D-1578-05	TCGA-EJ-5518-01A-01R-1579-13	TCGA-EJ-5518-01A-01D-1576-08	01d4c289-6d85-4119-86f5-bcf3de30d0f7	a41df7d8-0129-45c2-9d65-8bfdeb365118
TCGA-EJ-5519-01	0	TCGA-EJ-5519-01	1336	0	TCGA-EJ-5519	1336	0	1336	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-EJ-5519-F46603	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-23669	13					84	0	1336		1153			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-12	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	1.2	NO	YES				NO	12	3		N1	T3b	TCGA-EJ-5519.57861c52-0d80-484a-a800-65c3481327db.pdf		3	3	2	1	0	0	0	0	15	15	25	25	60	60	60	65	TUMOR FREE	4	Complete Remission/Response	No	0.2	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones	TCGA-EJ-5519-01A-01D-1576-08	TCGA-EJ-5519-01A-01D-1576-08	2f1dfd6b-9884-4b6d-809f-f1b365bc813f	TCGA-EJ-5519-01	4be2bce2-2032-41a4-af3a-5f01a698e143	TCGA-EJ-5519-01A-01D-1576-08	TCGA-EJ-5519-01A-01D-1576-08	TCGA-EJ-5519-01A-01D-1574-01	4be2bce2-2032-41a4-af3a-5f01a698e143	TCGA-EJ-5519-01A-01D-1574-01	4be2bce2-2032-41a4-af3a-5f01a698e143	A213FE4D-5339-4167-869C-F23252C89EEF	TCGA-EJ-5519-01	TCGA-EJ-5519-01A-01D-1578-05	TCGA-EJ-5519-01A-01R-1579-13	TCGA-EJ-5519-01A-01D-1576-08	4be2bce2-2032-41a4-af3a-5f01a698e143	2f1dfd6b-9884-4b6d-809f-f1b365bc813f
TCGA-EJ-5521-01	0	TCGA-EJ-5521-01	1578	0	TCGA-EJ-5521	1578	0	1578	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-EJ-5521-F46758	NO		M0	T1c	-23304							0	1578		240			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Right	1.2	NO	YES				NO	02	0		N0	T3a	TCGA-EJ-5521.0c816088-3fe4-4646-abaa-94095efd0b26.pdf		4	3	2	0	2	2	0	0	15	20	28	28	55	50	55	60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2008		TCGA-EJ-5521-01A-01D-1576-08	TCGA-EJ-5521-01A-01D-1576-08	60dd97bb-15c2-46da-b316-e1f5ba2098b7	TCGA-EJ-5521-01	f18be8ba-45a0-4db4-90e7-9f0998eb959e	TCGA-EJ-5521-01A-01D-1576-08	TCGA-EJ-5521-01A-01D-1576-08	TCGA-EJ-5521-01A-01D-1574-01	f18be8ba-45a0-4db4-90e7-9f0998eb959e	TCGA-EJ-5521-01A-01D-1574-01	f18be8ba-45a0-4db4-90e7-9f0998eb959e	0B7031DA-2008-4320-9C04-C23D9FA44F24	TCGA-EJ-5521-01	TCGA-EJ-5521-01A-01D-1578-05	TCGA-EJ-5521-01A-01R-1579-13	TCGA-EJ-5521-01A-01D-1576-08	f18be8ba-45a0-4db4-90e7-9f0998eb959e	60dd97bb-15c2-46da-b316-e1f5ba2098b7
TCGA-EJ-5522-01	0	TCGA-EJ-5522-01	1462	0	TCGA-EJ-5522	1462	0	1462	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51	TCGA-EJ-5522-F46759	NO		M0	T2a	-18802							0	1462		1403			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.3	NO	YES				NO	22	0		N0	T2c	TCGA-EJ-5522.756659d2-5e97-40d4-aa4e-c6d777153d0c.pdf		2	2	0	0	0	0	0	0	15	20	20	20	65	60	65	60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones	TCGA-EJ-5522-01A-01D-1576-08	TCGA-EJ-5522-01A-01D-1576-08	bea17ba7-3d7f-4b96-a016-331c6676e773	TCGA-EJ-5522-01	f1441277-65a1-486c-b8e1-2b947734cb17	TCGA-EJ-5522-01A-01D-1576-08	TCGA-EJ-5522-01A-01D-1576-08	TCGA-EJ-5522-01A-01D-1574-01	f1441277-65a1-486c-b8e1-2b947734cb17	TCGA-EJ-5522-01A-01D-1574-01	f1441277-65a1-486c-b8e1-2b947734cb17	F38D9CB6-E73A-4260-8602-22BFA64FD07A	TCGA-EJ-5522-01	TCGA-EJ-5522-01A-01D-1578-05	TCGA-EJ-5522-01A-01R-1579-13	TCGA-EJ-5522-01A-01D-1576-08	f1441277-65a1-486c-b8e1-2b947734cb17	bea17ba7-3d7f-4b96-a016-331c6676e773
TCGA-EJ-5524-01	0	TCGA-EJ-5524-01	1310	0	TCGA-EJ-5524	265	1	1310	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	YES	57	TCGA-EJ-5524-F46760	NO		M0	T2b	-20854						1155	0	1310	265	811			NO		NO		Scheduled Follow-up Submission	Progressive Disease	2013-8-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES		Locoregional Recurrence		YES	17	0		N0	T3a	TCGA-EJ-5524.1f767c93-41f5-45d1-917f-3f1fc5330fb9.pdf		2	2	0	0	0	0	0	0	10	10	20	20	70	70	75	80	WITH TUMOR	4	Progressive Disease	No	0.1	NO	R0	Primary Tumor	01	5	0.2		NO	3	YES	NO	EJ	Base	YES	Prostate	Biochemical Recurrence	A	LIVING	2009		TCGA-EJ-5524-01A-01D-1576-08	TCGA-EJ-5524-01A-01D-1576-08	7090ffdb-b670-4d60-a06f-b3ecc644c84a	TCGA-EJ-5524-01	c88d608d-79c7-41af-a3b3-e27b413cba28	TCGA-EJ-5524-01A-01D-1576-08	TCGA-EJ-5524-01A-01D-1576-08	TCGA-EJ-5524-01A-01D-1574-01	c88d608d-79c7-41af-a3b3-e27b413cba28	TCGA-EJ-5524-01A-01D-1574-01	c88d608d-79c7-41af-a3b3-e27b413cba28	30854379-BFCC-46F4-81B5-8BA4136F47E9	TCGA-EJ-5524-01	TCGA-EJ-5524-01A-01D-1578-05	TCGA-EJ-5524-01A-01R-1579-13	TCGA-EJ-5524-01A-01D-1576-08	c88d608d-79c7-41af-a3b3-e27b413cba28	7090ffdb-b670-4d60-a06f-b3ecc644c84a
TCGA-EJ-5525-01	0	TCGA-EJ-5525-01	1115	0	TCGA-EJ-5525	546	1	1115	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	67	TCGA-EJ-5525-F46762	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-24535	-6			-6		338	0	1115	546	521			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-8-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.6	NO	YES	Bone	Distant Metastasis		YES	8	0		N0	T2c	TCGA-EJ-5525.ab82e8b9-a3ba-48ef-ac3e-fd35c67a13e4.pdf		5	5	5	5	5	5	0	0	10	10	35	30	50	55	55	60	WITH TUMOR	4	Progressive Disease	No	3.0	NO	R0	Primary Tumor	01	5	0.2		NO	3	YES	NO	EJ	Apex|Base		Prostate		A	LIVING	2009		TCGA-EJ-5525-01A-01D-1576-08	TCGA-EJ-5525-01A-01D-1576-08	aa4f47e0-9c04-466a-9402-b972ee88e98e	TCGA-EJ-5525-01	ad22630d-693d-46c9-b785-5343b08679b5	TCGA-EJ-5525-01A-01D-1576-08	TCGA-EJ-5525-01A-01D-1576-08	TCGA-EJ-5525-01A-01D-1574-01	ad22630d-693d-46c9-b785-5343b08679b5	TCGA-EJ-5525-01A-01D-1574-01	ad22630d-693d-46c9-b785-5343b08679b5	D2D649A9-54E5-4091-9C84-6D76D51AD9F1	TCGA-EJ-5525-01	TCGA-EJ-5525-01A-01D-1578-05	TCGA-EJ-5525-01A-01R-1579-13	TCGA-EJ-5525-01A-01D-1576-08	ad22630d-693d-46c9-b785-5343b08679b5	aa4f47e0-9c04-466a-9402-b972ee88e98e
TCGA-EJ-5526-01	0	TCGA-EJ-5526-01	1179	0	TCGA-EJ-5526	537	1	1179	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	56	TCGA-EJ-5526-F46763	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20558	19			19			0	1179	537	175			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-8-16	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.5	NO	YES				YES	27	1		N1	T3a	TCGA-EJ-5526.5afeeeba-2a19-4042-acdc-8dad10ca31f9.pdf		2	2	0	0	0	0	0	0	5	5	15	15	80	80	80	85	WITH TUMOR	4	Progressive Disease	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2009		TCGA-EJ-5526-01A-01D-1576-08	TCGA-EJ-5526-01A-01D-1576-08	0eecf7b2-faae-4da8-b7a2-a4e934bc2b09	TCGA-EJ-5526-01	8536a0fb-4aed-4db0-80b0-994606c87ace	TCGA-EJ-5526-01A-01D-1576-08	TCGA-EJ-5526-01A-01D-1576-08	TCGA-EJ-5526-01A-01D-1574-01	8536a0fb-4aed-4db0-80b0-994606c87ace	TCGA-EJ-5526-01A-01D-1574-01	8536a0fb-4aed-4db0-80b0-994606c87ace	B6A40EC1-49E5-46DC-B8C1-FE2489A3640D	TCGA-EJ-5526-01	TCGA-EJ-5526-01A-01D-1578-05	TCGA-EJ-5526-01A-01R-1579-13	TCGA-EJ-5526-01A-01D-1576-08	8536a0fb-4aed-4db0-80b0-994606c87ace	0eecf7b2-faae-4da8-b7a2-a4e934bc2b09
TCGA-EJ-5527-01	0	TCGA-EJ-5527-01	1209	0	TCGA-EJ-5527	1209	0	1209	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69	TCGA-EJ-5527-F46764	NO		M0	T2a	-25234							0	1209		217			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.5	NO	YES				NO	9	0		N0	T3a	TCGA-EJ-5527.b4c74b9e-b639-4488-aef1-8bf008324f73.pdf		0	0	0	0	0	0	0	0	10	10	20	20	70	70	75	75	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.3		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2009		TCGA-EJ-5527-01A-01D-1576-08	TCGA-EJ-5527-01A-01D-1576-08	eb00507c-a2a3-4aeb-be36-92abdabd48b4	TCGA-EJ-5527-01	2bd35c12-2701-45c4-a6ea-981667028597	TCGA-EJ-5527-01A-01D-1576-08	TCGA-EJ-5527-01A-01D-1576-08	TCGA-EJ-5527-01A-01D-1574-01	2bd35c12-2701-45c4-a6ea-981667028597	TCGA-EJ-5527-01A-01D-1574-01	2bd35c12-2701-45c4-a6ea-981667028597	8134B0C5-9EDD-4E20-8CE5-E07292233534	TCGA-EJ-5527-01	TCGA-EJ-5527-01A-01D-1578-05	TCGA-EJ-5527-01A-01R-1579-13	TCGA-EJ-5527-01A-01D-1576-08	2bd35c12-2701-45c4-a6ea-981667028597	eb00507c-a2a3-4aeb-be36-92abdabd48b4
TCGA-EJ-5530-01	0	TCGA-EJ-5530-01	1832	0	TCGA-EJ-5530	1832	0	1832	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-EJ-5530-F46774	NO		M0	T2c	-22316							0	1832		586			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.8	NO	Bilateral	2	NO	YES				NO	6	0		N0	T2c	TCGA-EJ-5530.03cb0863-99db-411a-a347-a8675a65cb5a.pdf		2	3	0	0	0	0	0	0	10	10	20	20	70	70	70	70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2008		TCGA-EJ-5530-01A-01D-1576-08	TCGA-EJ-5530-01A-01D-1576-08	d108a249-8b0f-4205-90b5-0cb6b1b63844	TCGA-EJ-5530-01	314e8006-a060-4b71-a51e-ba450bbbb86c	TCGA-EJ-5530-01A-01D-1576-08	TCGA-EJ-5530-01A-01D-1576-08	TCGA-EJ-5530-01A-01D-1574-01	314e8006-a060-4b71-a51e-ba450bbbb86c	TCGA-EJ-5530-01A-01D-1574-01	314e8006-a060-4b71-a51e-ba450bbbb86c	FA2D5EAA-F949-4055-96A2-AA66B1BD92A4	TCGA-EJ-5530-01	TCGA-EJ-5530-01A-01D-1578-05	TCGA-EJ-5530-01A-01R-1579-13	TCGA-EJ-5530-01A-01D-1576-08	314e8006-a060-4b71-a51e-ba450bbbb86c	d108a249-8b0f-4205-90b5-0cb6b1b63844
TCGA-EJ-5531-01	0	TCGA-EJ-5531-01	921	0	TCGA-EJ-5531	921	0	921	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-EJ-5531-F46781	NO		M0	T2b	-22760							0	921		724			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	35	0		N0	T3a	TCGA-EJ-5531.0f235aad-3f99-4ac4-919e-0a4290c02075.pdf		3	4	2	2	0	0	0	0	10	15	30	30	70	65	75	70	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.8		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009		TCGA-EJ-5531-01A-01D-1576-08	TCGA-EJ-5531-01A-01D-1576-08	fb189fe4-223b-4cca-969a-edf60a08f816	TCGA-EJ-5531-01	49dda006-76b0-4088-8221-2bbfb1ac22f7	TCGA-EJ-5531-01A-01D-1576-08	TCGA-EJ-5531-01A-01D-1576-08	TCGA-EJ-5531-01A-01D-1574-01	49dda006-76b0-4088-8221-2bbfb1ac22f7	TCGA-EJ-5531-01A-01D-1574-01	49dda006-76b0-4088-8221-2bbfb1ac22f7	FA6526B7-E5CE-4F77-93F2-19EB45C6D0EC	TCGA-EJ-5531-01	TCGA-EJ-5531-01A-01D-1578-05	TCGA-EJ-5531-01A-01R-1579-13	TCGA-EJ-5531-01A-01D-1576-08	49dda006-76b0-4088-8221-2bbfb1ac22f7	fb189fe4-223b-4cca-969a-edf60a08f816
TCGA-EJ-5532-01	0	TCGA-EJ-5532-01	1456	0	TCGA-EJ-5532	1456	0	1456	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	57	TCGA-EJ-5532-F48003	NO		M0	T1c	-21110							0	1456		926			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	8	0		N0	T3a	TCGA-EJ-5532.11afaa3c-a99c-4e43-b4cb-eb139c9b1dab.pdf		3	3	0	0	0	0	0	0	10	10	20	15	70	75	70	80	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2009		TCGA-EJ-5532-01A-01D-1576-08	TCGA-EJ-5532-01A-01D-1576-08	9b2cd068-7b26-478f-a14d-cc13c82da34f	TCGA-EJ-5532-01	51d276c8-e669-48c9-92d8-676a348249d5	TCGA-EJ-5532-01A-01D-1576-08	TCGA-EJ-5532-01A-01D-1576-08	TCGA-EJ-5532-01A-01D-1574-01	51d276c8-e669-48c9-92d8-676a348249d5	TCGA-EJ-5532-01A-01D-1574-01	51d276c8-e669-48c9-92d8-676a348249d5	4B1CD569-388D-42B3-B26B-F71A360AB2D2	TCGA-EJ-5532-01	TCGA-EJ-5532-01A-01D-1578-05	TCGA-EJ-5532-01A-01R-1579-13	TCGA-EJ-5532-01A-01D-1576-08	51d276c8-e669-48c9-92d8-676a348249d5	9b2cd068-7b26-478f-a14d-cc13c82da34f
TCGA-EJ-5542-01	0	TCGA-EJ-5542-01	884	0	TCGA-EJ-5542	884	0	884	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-EJ-5542-F48838	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-21942	8			9	-21		0	884		519			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2013-9-23	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.7	NO	YES				NO	17	0		N0	T3a	TCGA-EJ-5542.d6fe7cc6-45e5-4b6c-b1f4-1dd7fd3c27be.pdf		2	2	0	0	0	0	0	0	15	20	15	10	70	70	80	85	TUMOR FREE	3	Complete Remission/Response	Yes	0.1	NO	R0	Primary Tumor	01	4	0.4		YES	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010		TCGA-EJ-5542-01A-01D-1576-08	TCGA-EJ-5542-01A-01D-1576-08	71ee4dd1-5aae-42d3-803e-b3159840797f	TCGA-EJ-5542-01	71b37147-df4c-40ef-b57a-57c2f692de06	TCGA-EJ-5542-01A-01D-1576-08	TCGA-EJ-5542-01A-01D-1576-08	TCGA-EJ-5542-01A-01D-1574-01	71b37147-df4c-40ef-b57a-57c2f692de06	TCGA-EJ-5542-01A-01D-1574-01	71b37147-df4c-40ef-b57a-57c2f692de06	C8C9F531-0F7E-437F-A593-39612548858E	TCGA-EJ-5542-01	TCGA-EJ-5542-01A-01D-1578-05	TCGA-EJ-5542-01A-01R-1579-13	TCGA-EJ-5542-01A-01D-1576-08	71b37147-df4c-40ef-b57a-57c2f692de06	71ee4dd1-5aae-42d3-803e-b3159840797f
TCGA-EJ-7115-01	0	TCGA-EJ-7115-01	2687	0	TCGA-EJ-7115	2687	0	2687	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-EJ-7115-F64799	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23986	10			10			0	2687		204			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.1	NO	YES				NO	21	0		N0	T3a	TCGA-EJ-7115.1638ac15-f8d6-4c88-b91e-e21033ae09db.pdf							0				5		5		90		90	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.4		NO	2	YES	NO	EJ			Prostate		A	LIVING	2006			TCGA-EJ-7115-01A-11D-2114-08	c338847c-e006-46bf-ba8d-d7ffac0b5961	TCGA-EJ-7115-01	c5dbae69-fb0e-458b-81ce-1f64c391cfe1	TCGA-EJ-7115-01A-11D-2114-08	TCGA-EJ-7115-01A-11D-2114-08	TCGA-EJ-7115-01A-11D-2112-01	c5dbae69-fb0e-458b-81ce-1f64c391cfe1	TCGA-EJ-7115-01A-11D-2112-01	c5dbae69-fb0e-458b-81ce-1f64c391cfe1	C57E396B-8F17-4ACF-A298-9CEE180D644C	TCGA-EJ-7115-01	TCGA-EJ-7115-01A-11D-2116-05	TCGA-EJ-7115-01A-11R-2117-13	TCGA-EJ-7115-01A-11D-2114-08	c5dbae69-fb0e-458b-81ce-1f64c391cfe1	c338847c-e006-46bf-ba8d-d7ffac0b5961
TCGA-EJ-7115-11	0	TCGA-EJ-7115-11	2687	0	TCGA-EJ-7115	2687	0	2687	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-EJ-7115-F64799	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23986	10			10			0	2687		204			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1	NO	YES				NO	21	0		N0	T3a																			TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	3	0.5		NO	2	YES	NO	EJ			Prostate		A	LIVING	2006						b2b21d28-08c6-43e3-8b64-e9cdc913b15e				b2b21d28-08c6-43e3-8b64-e9cdc913b15e		b2b21d28-08c6-43e3-8b64-e9cdc913b15e				TCGA-EJ-7115-11A-01R-2117-13		b2b21d28-08c6-43e3-8b64-e9cdc913b15e	
TCGA-EJ-7123-01	0	TCGA-EJ-7123-01	2254	0	TCGA-EJ-7123	2254	0	2254	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-EJ-7123-F64800	NO		M0	T1c	-21741							0	2254		1491			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.7	NO	YES				NO	22	0		N0	T2c	TCGA-EJ-7123.1ba8d08d-0be5-46a6-9540-8f6d028e0dea.pdf							0				1		29		70		70	TUMOR FREE	3	Complete Remission/Response	Yes	0.1	NO	R0	Primary Tumor	01	4	0.1		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2007			TCGA-EJ-7123-01A-11D-1961-08	49059dbb-d999-481a-9f82-a6e0650ca2a6	TCGA-EJ-7123-01	12e19460-da9a-4ff4-8664-801e7f8829b7	TCGA-EJ-7123-01A-11D-1961-08	TCGA-EJ-7123-01A-11D-1961-08	TCGA-EJ-7123-01A-11D-1959-01	12e19460-da9a-4ff4-8664-801e7f8829b7	TCGA-EJ-7123-01A-11D-1959-01	12e19460-da9a-4ff4-8664-801e7f8829b7		TCGA-EJ-7123-01	TCGA-EJ-7123-01A-11D-1963-05	TCGA-EJ-7123-01A-11R-1964-13	TCGA-EJ-7123-01A-11D-1961-08	12e19460-da9a-4ff4-8664-801e7f8829b7	49059dbb-d999-481a-9f82-a6e0650ca2a6
TCGA-EJ-7123-11	0	TCGA-EJ-7123-11	2254	0	TCGA-EJ-7123	2254	0	2254	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-EJ-7123-F64800	NO		M0	T1c	-21741							0	2254		1491			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	2	NO	YES				NO	22	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	Yes	0.1	NO	R0	Solid Tissue Normal	11	4	0.4		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2007						8dfd97d6-25a9-4579-80a7-b3bb0ef53074				8dfd97d6-25a9-4579-80a7-b3bb0ef53074		8dfd97d6-25a9-4579-80a7-b3bb0ef53074			TCGA-EJ-7123-11A-01D-1963-05	TCGA-EJ-7123-11A-01R-1964-13		8dfd97d6-25a9-4579-80a7-b3bb0ef53074	
TCGA-EJ-7125-01	0	TCGA-EJ-7125-01	2850	0	TCGA-EJ-7125	2850	0	2850	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			44	TCGA-EJ-7125-F64801	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-16425	12						0	2850		1860			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	13	0		N0	T2c	TCGA-EJ-7125.3565cc83-8305-490f-a47a-dc71b36a9044.pdf						0	0			5	5	25	25	70	70	70	70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2005			TCGA-EJ-7125-01A-11D-1961-08	81f37e35-00d2-4622-837c-4ce8c19aa102	TCGA-EJ-7125-01	a15d99f4-2e43-4fb8-93d5-6cc582b12237	TCGA-EJ-7125-01A-11D-1961-08	TCGA-EJ-7125-01A-11D-1961-08	TCGA-EJ-7125-01A-11D-1959-01	a15d99f4-2e43-4fb8-93d5-6cc582b12237	TCGA-EJ-7125-01A-11D-1959-01	a15d99f4-2e43-4fb8-93d5-6cc582b12237	A83D9347-6980-4561-BEAE-55A44B4D254A	TCGA-EJ-7125-01	TCGA-EJ-7125-01A-11D-1963-05	TCGA-EJ-7125-01A-11R-1964-13	TCGA-EJ-7125-01A-11D-1961-08	a15d99f4-2e43-4fb8-93d5-6cc582b12237	81f37e35-00d2-4622-837c-4ce8c19aa102
TCGA-EJ-7125-11	0	TCGA-EJ-7125-11	2850	0	TCGA-EJ-7125	2850	0	2850	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			44	TCGA-EJ-7125-F64801	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-16425	12						0	2850		1860			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.8	NO	YES				NO	13	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.1		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2005						ab016062-694f-4925-934e-0ea8b62bc2a9				ab016062-694f-4925-934e-0ea8b62bc2a9		ab016062-694f-4925-934e-0ea8b62bc2a9			TCGA-EJ-7125-11A-01D-1963-05	TCGA-EJ-7125-11A-01R-1964-13		ab016062-694f-4925-934e-0ea8b62bc2a9	
TCGA-EJ-7218-01	0	TCGA-EJ-7218-01	2542	0	TCGA-EJ-7218	2542	0	2542	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71	TCGA-EJ-7218-F64802	NO		M0	T2a	-26181		2397					0	2542		1473							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	850		NO	Bilateral		NO	YES				NO	3	0	true	N0	T2c				0		0		0		0		0		20		80		90	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		B	LIVING	2006				ad0b4a31-fbfc-4766-86c7-9f9110efbb64	TCGA-EJ-7218-01	0502e061-ae1d-4384-b2a5-24091a92eeab		TCGA-EJ-7218-01B-11D-A32B-08	TCGA-EJ-7218-01B-11D-A32A-01	0502e061-ae1d-4384-b2a5-24091a92eeab	TCGA-EJ-7218-01B-11D-A32A-01	0502e061-ae1d-4384-b2a5-24091a92eeab		TCGA-EJ-7218-01	TCGA-EJ-7218-01B-11D-A32C-05	TCGA-EJ-7218-01B-11R-A32J-13		0502e061-ae1d-4384-b2a5-24091a92eeab	ad0b4a31-fbfc-4766-86c7-9f9110efbb64
TCGA-EJ-7312-01	0	TCGA-EJ-7312-01	1099	0	TCGA-EJ-7312	1099	0	1099	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-EJ-7312-F64805	NO		M0	T3b	-21292		832					0	1099		376							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	320		NO	Bilateral		NO	YES				NO	3	0	true	N0	T3b				0		0		0		0		0		20		80		90	TUMOR FREE	4	Complete Remission/Response	Yes, History of Prior Malignancy	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		B	LIVING	2011				159aaf7d-d6d1-405a-b154-5168216d1f0a	TCGA-EJ-7312-01	43077b04-13be-4fc0-a691-9cb49bdd50d5		TCGA-EJ-7312-01B-21D-A32B-08	TCGA-EJ-7312-01B-21D-A32A-01	43077b04-13be-4fc0-a691-9cb49bdd50d5	TCGA-EJ-7312-01B-21D-A32A-01	43077b04-13be-4fc0-a691-9cb49bdd50d5		TCGA-EJ-7312-01	TCGA-EJ-7312-01B-21D-A32C-05	TCGA-EJ-7312-01B-21R-A32J-13		43077b04-13be-4fc0-a691-9cb49bdd50d5	159aaf7d-d6d1-405a-b154-5168216d1f0a
TCGA-EJ-7314-01	0	TCGA-EJ-7314-01	1150	0	TCGA-EJ-7314	1150	0	1150	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-EJ-7314-F64807	NO		M0	T2c	-22766				14			0	1150		295			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.5	NO	YES				NO	14	0		N0	T3b	TCGA-EJ-7314.bbd6fa31-f4d4-4c06-aa64-1e263ccd8844.pdf							0				10		25		65		65	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.3		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-EJ-7314-01A-31D-2114-08	dd9ca28f-b76f-435c-8ca7-8de256d3035a	TCGA-EJ-7314-01	cd77237d-0598-41cd-b12c-eea4b9c06e6d	TCGA-EJ-7314-01A-31D-2114-08	TCGA-EJ-7314-01A-31D-2114-08	TCGA-EJ-7314-01A-31D-2112-01	cd77237d-0598-41cd-b12c-eea4b9c06e6d	TCGA-EJ-7314-01A-31D-2112-01	cd77237d-0598-41cd-b12c-eea4b9c06e6d	DC6ADA36-C498-434F-8E25-D17A78ED67F1	TCGA-EJ-7314-01	TCGA-EJ-7314-01A-31D-2116-05	TCGA-EJ-7314-01A-31R-2117-13	TCGA-EJ-7314-01A-31D-2114-08	cd77237d-0598-41cd-b12c-eea4b9c06e6d	dd9ca28f-b76f-435c-8ca7-8de256d3035a
TCGA-EJ-7314-11	0	TCGA-EJ-7314-11	1150	0	TCGA-EJ-7314	1150	0	1150	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-EJ-7314-F64807	NO		M0	T2c	-22766				14			0	1150		295			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.1	NO	YES				NO	14	0		N0	T3b																			TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	3	0.3		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011						cc827a61-5c7d-41a0-a677-35a52e5eb471				cc827a61-5c7d-41a0-a677-35a52e5eb471		cc827a61-5c7d-41a0-a677-35a52e5eb471				TCGA-EJ-7314-11A-01R-2117-13		cc827a61-5c7d-41a0-a677-35a52e5eb471	
TCGA-EJ-7315-01	0	TCGA-EJ-7315-01	1008	0	TCGA-EJ-7315	1008	0	1008	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-EJ-7315-F64804	NO		M0	T2a	-25154							0	1008		289			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	2.5	NO	YES				NO	7	0		N0	T3a	TCGA-EJ-7315.6afa83ac-9060-4b49-90a3-dc19824822e3.pdf							0										75	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.5		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-EJ-7315-01A-31D-2114-08	1bf34c76-8e94-4e2d-b4f7-9587b87187ea	TCGA-EJ-7315-01	5e185249-6ea1-460b-b841-f40e94ea1ccd	TCGA-EJ-7315-01A-31D-2114-08	TCGA-EJ-7315-01A-31D-2114-08	TCGA-EJ-7315-01A-31D-2112-01	5e185249-6ea1-460b-b841-f40e94ea1ccd	TCGA-EJ-7315-01A-31D-2112-01	5e185249-6ea1-460b-b841-f40e94ea1ccd	952C4870-B6EB-4BE0-8769-AEE172D193F8	TCGA-EJ-7315-01	TCGA-EJ-7315-01A-31D-2116-05	TCGA-EJ-7315-01A-31R-2117-13	TCGA-EJ-7315-01A-31D-2114-08	5e185249-6ea1-460b-b841-f40e94ea1ccd	1bf34c76-8e94-4e2d-b4f7-9587b87187ea
TCGA-EJ-7315-11	0	TCGA-EJ-7315-11	1008	0	TCGA-EJ-7315	1008	0	1008	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-EJ-7315-F64804	NO		M0	T2a	-25154							0	1008		289			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.8	NO	Bilateral	2.2	NO	YES				NO	7	0		N0	T3a																			TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	3	0.4		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011						85e48131-0ef8-4b94-986a-3829ccad6d25				85e48131-0ef8-4b94-986a-3829ccad6d25		85e48131-0ef8-4b94-986a-3829ccad6d25				TCGA-EJ-7315-11A-01R-2117-13		85e48131-0ef8-4b94-986a-3829ccad6d25	
TCGA-EJ-7317-01	0	TCGA-EJ-7317-01	771	0	TCGA-EJ-7317	771	0	771	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71	TCGA-EJ-7317-F64809	NO		M0	T1c	-26064							0	771		285							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.2	NO	YES				NO	40	0		N0	T2c	TCGA-EJ-7317.f1531404-e42a-47a0-bbd7-6b0bd5ebf56b.pdf							0				10		20		70		70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011			TCGA-EJ-7317-01A-31D-2114-08	a3e55616-a9d7-4b38-ab7e-86ca6ed3dc20	TCGA-EJ-7317-01	64f48f1f-3d80-43fa-bd06-3a5881291ee3	TCGA-EJ-7317-01A-31D-2114-08	TCGA-EJ-7317-01A-31D-2114-08	TCGA-EJ-7317-01A-31D-2112-01	64f48f1f-3d80-43fa-bd06-3a5881291ee3	TCGA-EJ-7317-01A-31D-2112-01	64f48f1f-3d80-43fa-bd06-3a5881291ee3	0D44E764-75EA-4F90-961A-15B05A137AAD	TCGA-EJ-7317-01	TCGA-EJ-7317-01A-31D-2116-05	TCGA-EJ-7317-01A-31R-2117-13	TCGA-EJ-7317-01A-31D-2114-08	64f48f1f-3d80-43fa-bd06-3a5881291ee3	a3e55616-a9d7-4b38-ab7e-86ca6ed3dc20
TCGA-EJ-7317-11	0	TCGA-EJ-7317-11	771	0	TCGA-EJ-7317	771	0	771	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71	TCGA-EJ-7317-F64809	NO		M0	T1c	-26064							0	771		285							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	40	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.5		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011						7e9f1df1-e76f-45a0-9f1b-9a0cbd626430				7e9f1df1-e76f-45a0-9f1b-9a0cbd626430		7e9f1df1-e76f-45a0-9f1b-9a0cbd626430			TCGA-EJ-7317-11A-01D-2116-05	TCGA-EJ-7317-11A-01R-2117-13		7e9f1df1-e76f-45a0-9f1b-9a0cbd626430	
TCGA-EJ-7318-01	0	TCGA-EJ-7318-01	1029	0	TCGA-EJ-7318	1029	0	1029	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51	TCGA-EJ-7318-F64810	YES		M0	T3a	-18686		757				189	0	1029		189							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	650		NO	Bilateral		NO	NO				NO			true		T3a				0		0		0		0		20		40		40		60	TUMOR FREE	4	Partial Remission/Response	No	.08	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		B	LIVING	2011				8d2719a3-300b-4643-a131-81db17b35b05	TCGA-EJ-7318-01	0b50b27b-e429-41b1-8324-c9e03b6bbaaf		TCGA-EJ-7318-01B-11D-A32B-08	TCGA-EJ-7318-01B-11D-A32A-01	0b50b27b-e429-41b1-8324-c9e03b6bbaaf	TCGA-EJ-7318-01B-11D-A32A-01	0b50b27b-e429-41b1-8324-c9e03b6bbaaf		TCGA-EJ-7318-01	TCGA-EJ-7318-01B-11D-A32C-05	TCGA-EJ-7318-01B-11R-A32J-13		0b50b27b-e429-41b1-8324-c9e03b6bbaaf	8d2719a3-300b-4643-a131-81db17b35b05
TCGA-EJ-7321-01	0	TCGA-EJ-7321-01	824	0	TCGA-EJ-7321	824	0	824	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-EJ-7321-F64812	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21108	10						0	824		128			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.4	NO	YES				NO	25	0		N0	T3a	TCGA-EJ-7321.9d0d3184-b73a-4f24-919d-0ba7d5d32ff2.pdf							0										85	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.4		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-7321-01A-31D-2260-08	d4e45638-6a32-4342-a942-21937718fec5	TCGA-EJ-7321-01	951adcbd-7d7a-466c-bbac-7c7afb8b9df6	TCGA-EJ-7321-01A-31D-2260-08	TCGA-EJ-7321-01A-31D-2260-08	TCGA-EJ-7321-01A-31D-2259-01	951adcbd-7d7a-466c-bbac-7c7afb8b9df6	TCGA-EJ-7321-01A-31D-2259-01	951adcbd-7d7a-466c-bbac-7c7afb8b9df6	C3ADD46F-DA97-482C-AFE3-7CB575D960B9	TCGA-EJ-7321-01	TCGA-EJ-7321-01A-31D-2261-05	TCGA-EJ-7321-01A-31R-2262-13	TCGA-EJ-7321-01A-31D-2260-08	951adcbd-7d7a-466c-bbac-7c7afb8b9df6	d4e45638-6a32-4342-a942-21937718fec5
TCGA-EJ-7321-11	0	TCGA-EJ-7321-11	824	0	TCGA-EJ-7321	824	0	824	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-EJ-7321-F64812	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21108	10						0	824		128			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.1	NO	Bilateral	2	NO	YES				NO	25	0		N0	T3a																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	3	0.5		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011						fff1f232-8978-406d-a6fc-61df98382b86				fff1f232-8978-406d-a6fc-61df98382b86		fff1f232-8978-406d-a6fc-61df98382b86				TCGA-EJ-7321-11A-01R-2262-13		fff1f232-8978-406d-a6fc-61df98382b86	
TCGA-EJ-7325-01	0	TCGA-EJ-7325-01	1070	0	TCGA-EJ-7325	1070	0	1070	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-EJ-7325-F64803	NO		M0	T3b	-23029		855					0	1070		507							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	480		NO	Bilateral		NO	YES				NO	9	0	true	N0	T3b				0		0		0		0		0		40		60		80	TUMOR FREE	3	Complete Remission/Response	Yes, History of Prior Malignancy	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		B	LIVING	2011				bda57a4b-ab3b-44ab-9fc6-ff539f56a098	TCGA-EJ-7325-01	3c6d1cda-258e-42f4-ad31-16069e437ac3		TCGA-EJ-7325-01B-11D-A32B-08	TCGA-EJ-7325-01B-11D-A32A-01	3c6d1cda-258e-42f4-ad31-16069e437ac3	TCGA-EJ-7325-01B-11D-A32A-01	3c6d1cda-258e-42f4-ad31-16069e437ac3		TCGA-EJ-7325-01	TCGA-EJ-7325-01B-11D-A32C-05	TCGA-EJ-7325-01B-11R-A32J-13		3c6d1cda-258e-42f4-ad31-16069e437ac3	bda57a4b-ab3b-44ab-9fc6-ff539f56a098
TCGA-EJ-7327-01	0	TCGA-EJ-7327-01	923	0	TCGA-EJ-7327	923	0	923	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-EJ-7327-F64808	NO		M0	T2a	-22475							0	923		175			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.6	NO	Bilateral	1.7	NO	YES				NO	17	0		N0	T3b				4		0		0		0		20		15		65		65	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.2		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-EJ-7327-01A-11D-2114-08	4a93f4bf-ae72-40d1-a70c-ac30eff5e875	TCGA-EJ-7327-01	bc6a091a-720d-4a70-b3de-66db6b240669	TCGA-EJ-7327-01A-11D-2114-08	TCGA-EJ-7327-01A-11D-2114-08	TCGA-EJ-7327-01A-11D-2112-01	bc6a091a-720d-4a70-b3de-66db6b240669	TCGA-EJ-7327-01A-11D-2112-01	bc6a091a-720d-4a70-b3de-66db6b240669		TCGA-EJ-7327-01	TCGA-EJ-7327-01A-11D-2116-05	TCGA-EJ-7327-01A-11R-2117-13	TCGA-EJ-7327-01A-11D-2114-08	bc6a091a-720d-4a70-b3de-66db6b240669	4a93f4bf-ae72-40d1-a70c-ac30eff5e875
TCGA-EJ-7327-11	0	TCGA-EJ-7327-11	923	0	TCGA-EJ-7327	923	0	923	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-EJ-7327-F64808	NO		M0	T2a	-22475							0	923		175			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	1.9	NO	YES				NO	17	0		N0	T3b																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.7		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011						63cd2e90-2a03-406a-a094-b855c02b0c04				63cd2e90-2a03-406a-a094-b855c02b0c04		63cd2e90-2a03-406a-a094-b855c02b0c04			TCGA-EJ-7327-11A-01D-2116-05	TCGA-EJ-7327-11A-01R-2117-13		63cd2e90-2a03-406a-a094-b855c02b0c04	
TCGA-EJ-7328-01	0	TCGA-EJ-7328-01	842	0	TCGA-EJ-7328	842	0	842	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-EJ-7328-F64806			M0	T1c	-25756							0	842					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.8	NO	YES				NO	9	0		N0	T3a	TCGA-EJ-7328.30c9c833-ae7e-46de-951c-a488df1d723a.pdf							0										70	TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Primary Tumor	01	3	0.5		NO	5	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2011			TCGA-EJ-7328-01A-31D-2114-08	370a1c0f-78d2-4330-a6fb-f644064b8ed7	TCGA-EJ-7328-01	bd8a26e3-ddaf-405d-9b32-bd6adb09024f	TCGA-EJ-7328-01A-31D-2114-08	TCGA-EJ-7328-01A-31D-2114-08	TCGA-EJ-7328-01A-31D-2112-01	bd8a26e3-ddaf-405d-9b32-bd6adb09024f	TCGA-EJ-7328-01A-31D-2112-01	bd8a26e3-ddaf-405d-9b32-bd6adb09024f	7E4BA80A-1D78-491D-BFB2-F624B8B4F89E	TCGA-EJ-7328-01	TCGA-EJ-7328-01A-31D-2116-05	TCGA-EJ-7328-01A-31R-2117-13	TCGA-EJ-7328-01A-31D-2114-08	bd8a26e3-ddaf-405d-9b32-bd6adb09024f	370a1c0f-78d2-4330-a6fb-f644064b8ed7
TCGA-EJ-7328-11	0	TCGA-EJ-7328-11	842	0	TCGA-EJ-7328	842	0	842	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-EJ-7328-F64806			M0	T1c	-25756							0	842					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	2	NO	YES				NO	9	0		N0	T3a																			TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Solid Tissue Normal	11	3	0.3		NO	5	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2011						cbc2c758-bf49-4165-bbb1-30c046caf99c				cbc2c758-bf49-4165-bbb1-30c046caf99c		cbc2c758-bf49-4165-bbb1-30c046caf99c			TCGA-EJ-7328-11A-01D-2116-05	TCGA-EJ-7328-11A-01R-2117-13		cbc2c758-bf49-4165-bbb1-30c046caf99c	
TCGA-EJ-7330-01	0	TCGA-EJ-7330-01	191	0	TCGA-EJ-7330			191	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68		NO		M0	T1c	-25050							0	191		191			NO		NO				2012-4-5	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	1.5		YES					18	0		N0	T3a	TCGA-EJ-7330.d910cd86-89be-4fc9-8f9d-497692a6face.pdf		3	2	0	0	0	0	0	0	25	20	15	15	60	65	55	60	TUMOR FREE	4		No	0.1		R0	Primary Tumor	01	3	0.4			5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-EJ-7330-01A-11D-2114-08	0879d43a-3b2d-46a7-9faa-3dd9136be5c7	TCGA-EJ-7330-01	07b4fdf4-19af-42f6-8c17-520047dce246	TCGA-EJ-7330-01A-11D-2114-08	TCGA-EJ-7330-01A-11D-2114-08	TCGA-EJ-7330-01A-11D-2112-01	07b4fdf4-19af-42f6-8c17-520047dce246	TCGA-EJ-7330-01A-11D-2112-01	07b4fdf4-19af-42f6-8c17-520047dce246	3BD9A152-B0AC-440D-B2B3-E465FF1BD0E1	TCGA-EJ-7330-01	TCGA-EJ-7330-01A-11D-2116-05	TCGA-EJ-7330-01A-11R-2117-13	TCGA-EJ-7330-01A-11D-2114-08	07b4fdf4-19af-42f6-8c17-520047dce246	0879d43a-3b2d-46a7-9faa-3dd9136be5c7
TCGA-EJ-7330-11	0	TCGA-EJ-7330-11	191	0	TCGA-EJ-7330			191	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68		NO		M0	T1c	-25050							0	191		191			NO		NO				2012-4-5	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	2.3		YES					18	0		N0	T3a																			TUMOR FREE	4		No	0.1		R0	Solid Tissue Normal	11	3	0.4			5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011						15602b9c-e496-4b8b-a416-82db780d8f28				15602b9c-e496-4b8b-a416-82db780d8f28		15602b9c-e496-4b8b-a416-82db780d8f28				TCGA-EJ-7330-11A-01R-2117-13		15602b9c-e496-4b8b-a416-82db780d8f28	
TCGA-EJ-7331-01	0	TCGA-EJ-7331-01	742	0	TCGA-EJ-7331	742	0	742	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-EJ-7331-F64813	YES		M0	T1c	-23458						189	0	742		189			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.4	NO	Bilateral	1.9	NO	YES				NO	7	0		N0	T2c	TCGA-EJ-7331.84790d75-bbef-49b0-9486-94e049c13ddd.pdf		2	2	0	0	0	0	0	0	15	10	20	10	65	80	60	75	TUMOR FREE	3	Complete Remission/Response	No	0.8	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011			TCGA-EJ-7331-01A-11D-2114-08	71243c04-cab3-4235-85e6-48daf5fe828e	TCGA-EJ-7331-01	0c4495e4-b826-45ee-9ad3-873266b4585b	TCGA-EJ-7331-01A-11D-2114-08	TCGA-EJ-7331-01A-11D-2114-08	TCGA-EJ-7331-01A-11D-2112-01	0c4495e4-b826-45ee-9ad3-873266b4585b	TCGA-EJ-7331-01A-11D-2112-01	0c4495e4-b826-45ee-9ad3-873266b4585b	29032C53-2573-4E12-BD74-01229692E6B8	TCGA-EJ-7331-01	TCGA-EJ-7331-01A-11D-2116-05	TCGA-EJ-7331-01A-11R-2117-13	TCGA-EJ-7331-01A-11D-2114-08	0c4495e4-b826-45ee-9ad3-873266b4585b	71243c04-cab3-4235-85e6-48daf5fe828e
TCGA-EJ-7331-11	0	TCGA-EJ-7331-11	742	0	TCGA-EJ-7331	742	0	742	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-EJ-7331-F64813	YES		M0	T1c	-23458						189	0	742		189			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.4	NO	Bilateral	2.5	NO	YES				NO	7	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.8	NO	R0	Solid Tissue Normal	11	4	0.3		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011						9356c4e0-eb35-4e70-85da-10ad2ae535a6				9356c4e0-eb35-4e70-85da-10ad2ae535a6		9356c4e0-eb35-4e70-85da-10ad2ae535a6			TCGA-EJ-7331-11A-01D-2116-05	TCGA-EJ-7331-11A-01R-2117-13		9356c4e0-eb35-4e70-85da-10ad2ae535a6	
TCGA-EJ-7781-01	0	TCGA-EJ-7781-01	356	0	TCGA-EJ-7781	356	0	356	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-EJ-7781-F48880	NO		M0	T1c	-23937							0	356		169			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	2	NO	YES				NO	17	0		N0	T2c	TCGA-EJ-7781.3582ff42-09f7-4ffb-9421-60f3cba1ff28.pdf		0	0	0	0	0	0	0	0	30	20	30	30	40	50	60	70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	5	YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-7781-01A-11D-2114-08	72b08c45-fc17-4dbe-a06a-eb032cd2d266	TCGA-EJ-7781-01	26cd2872-7067-4cd7-bf85-4f028d9a819d	TCGA-EJ-7781-01A-11D-2114-08	TCGA-EJ-7781-01A-11D-2114-08	TCGA-EJ-7781-01A-11D-2112-01	26cd2872-7067-4cd7-bf85-4f028d9a819d	TCGA-EJ-7781-01A-11D-2112-01	26cd2872-7067-4cd7-bf85-4f028d9a819d	1F6DDC7F-411E-4B6C-8EA5-A3B79D27E921	TCGA-EJ-7781-01	TCGA-EJ-7781-01A-11D-2116-05	TCGA-EJ-7781-01A-11R-2117-13	TCGA-EJ-7781-01A-11D-2114-08	26cd2872-7067-4cd7-bf85-4f028d9a819d	72b08c45-fc17-4dbe-a06a-eb032cd2d266
TCGA-EJ-7781-11	0	TCGA-EJ-7781-11	356	0	TCGA-EJ-7781	356	0	356	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-EJ-7781-F48880	NO		M0	T1c	-23937							0	356		169			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	2	NO	YES				NO	17	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.4		NO	5	YES	NO	EJ			Prostate		A	LIVING	2011						d75a22a0-a230-4ac8-a3db-96ea29ca95b9				d75a22a0-a230-4ac8-a3db-96ea29ca95b9		d75a22a0-a230-4ac8-a3db-96ea29ca95b9			TCGA-EJ-7781-11A-01D-2116-05	TCGA-EJ-7781-11A-01R-2117-13		d75a22a0-a230-4ac8-a3db-96ea29ca95b9	
TCGA-EJ-7782-01	0	TCGA-EJ-7782-01	642	0	TCGA-EJ-7782	642	0	642	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71	TCGA-EJ-7782-F48882	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-25965	49						0	642		350			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	1.5	NO	YES				NO	17	0		N0	T2c	TCGA-EJ-7782.d8500e84-1aa4-4a3b-874c-563d520dec03.pdf		2	1	0	0	1	1	0	0	10	10	29	19	60	70	70	80	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.5		NO	4	YES	NO	EJ			Prostate		A	LIVING	2010			TCGA-EJ-7782-01A-11D-2114-08	9a9209d3-0ff1-47a5-a3d4-caad8ba732c3	TCGA-EJ-7782-01	0d9fb905-5374-4054-b799-9c4c4efd36d6	TCGA-EJ-7782-01A-11D-2114-08	TCGA-EJ-7782-01A-11D-2114-08	TCGA-EJ-7782-01A-11D-2112-01	0d9fb905-5374-4054-b799-9c4c4efd36d6	TCGA-EJ-7782-01A-11D-2112-01	0d9fb905-5374-4054-b799-9c4c4efd36d6	875D4449-957F-414F-8835-C9C0E35BA249	TCGA-EJ-7782-01	TCGA-EJ-7782-01A-11D-2116-05	TCGA-EJ-7782-01A-11R-2117-13	TCGA-EJ-7782-01A-11D-2114-08	0d9fb905-5374-4054-b799-9c4c4efd36d6	9a9209d3-0ff1-47a5-a3d4-caad8ba732c3
TCGA-EJ-7782-11	0	TCGA-EJ-7782-11	642	0	TCGA-EJ-7782	642	0	642	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71	TCGA-EJ-7782-F48882	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-25965	49						0	642		350			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.8	NO	YES				NO	17	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.5		NO	4	YES	NO	EJ			Prostate		A	LIVING	2010						e74de9a3-6dd4-42b7-b92c-eba3e3827bed				e74de9a3-6dd4-42b7-b92c-eba3e3827bed		e74de9a3-6dd4-42b7-b92c-eba3e3827bed			TCGA-EJ-7782-11A-01D-2116-05	TCGA-EJ-7782-11A-01R-2117-13		e74de9a3-6dd4-42b7-b92c-eba3e3827bed	
TCGA-EJ-7783-01	0	TCGA-EJ-7783-01	425	0	TCGA-EJ-7783	425	0	425	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-EJ-7783-F48948	YES		M0	T2c	-25600						81	0	425		172			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	1.4	NO	YES				NO	17	0		N0	T3a	TCGA-EJ-7783.8c4eab7f-e0e2-4cad-b06c-ae2d3ed11052.pdf		0	0	0	0	0	0	0	0	50	30	25	30	25	40	25	60	TUMOR FREE	4	Complete Remission/Response	No	0.7	NO	R0	Primary Tumor	01	3	0.3		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-7783-01A-11D-2114-08	d43df529-d00f-463e-968e-7b10ccb74727	TCGA-EJ-7783-01	e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf	TCGA-EJ-7783-01A-11D-2114-08	TCGA-EJ-7783-01A-11D-2114-08	TCGA-EJ-7783-01A-11D-2112-01	e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf	TCGA-EJ-7783-01A-11D-2112-01	e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf	1CECAFF4-5B92-46E3-990E-A69030E24E21	TCGA-EJ-7783-01	TCGA-EJ-7783-01A-11D-2116-05	TCGA-EJ-7783-01A-11R-2117-13	TCGA-EJ-7783-01A-11D-2114-08	e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf	d43df529-d00f-463e-968e-7b10ccb74727
TCGA-EJ-7783-11	0	TCGA-EJ-7783-11	425	0	TCGA-EJ-7783	425	0	425	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-EJ-7783-F48948	YES		M0	T2c	-25600						81	0	425		172			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	1.4	NO	YES				NO	17	0		N0	T3a																			TUMOR FREE	4	Complete Remission/Response	No	0.7	NO	R0	Solid Tissue Normal	11	3	0.4		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011						7afedcd4-d921-4996-9587-a8faa03dcea0				7afedcd4-d921-4996-9587-a8faa03dcea0		7afedcd4-d921-4996-9587-a8faa03dcea0				TCGA-EJ-7783-11A-01R-2117-13		7afedcd4-d921-4996-9587-a8faa03dcea0	
TCGA-EJ-7784-01	0	TCGA-EJ-7784-01	396	0	TCGA-EJ-7784	396	0	396	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-EJ-7784-F48949	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-23183	0			0			0	396		167			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.1	NO	YES				NO	13	0		N0	T2c	TCGA-EJ-7784.d140c74d-8e74-43da-a181-63a7bbe718af.pdf		0	0	0	0	0	0	0	0	2	3	8	7	90	90	95	95	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.3		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-7784-01A-11D-2114-08	fd5998ec-9011-42b6-9d31-37df1ef49374	TCGA-EJ-7784-01	731721fa-4ced-445d-855f-e4ded85f9726	TCGA-EJ-7784-01A-11D-2114-08	TCGA-EJ-7784-01A-11D-2114-08	TCGA-EJ-7784-01A-11D-2112-01	731721fa-4ced-445d-855f-e4ded85f9726	TCGA-EJ-7784-01A-11D-2112-01	731721fa-4ced-445d-855f-e4ded85f9726	CC78BF20-57A1-4F83-B519-6672553F20DD	TCGA-EJ-7784-01	TCGA-EJ-7784-01A-11D-2116-05	TCGA-EJ-7784-01A-11R-2117-13	TCGA-EJ-7784-01A-11D-2114-08	731721fa-4ced-445d-855f-e4ded85f9726	fd5998ec-9011-42b6-9d31-37df1ef49374
TCGA-EJ-7784-11	0	TCGA-EJ-7784-11	396	0	TCGA-EJ-7784	396	0	396	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-EJ-7784-F48949	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-23183	0			0			0	396		167			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.5	NO	YES				NO	13	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	3	0.7		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011						bb77b27a-0450-4874-b46f-ab9505681648				bb77b27a-0450-4874-b46f-ab9505681648		bb77b27a-0450-4874-b46f-ab9505681648			TCGA-EJ-7784-11A-01D-2116-05	TCGA-EJ-7784-11A-01R-2117-13		bb77b27a-0450-4874-b46f-ab9505681648	
TCGA-EJ-7785-01	0	TCGA-EJ-7785-01	625	0	TCGA-EJ-7785	625	0	625	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			54	TCGA-EJ-7785-F48956	NO		M0	T2b	-19939							0	625		259			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	7	0		N0	T3a	TCGA-EJ-7785.01ed5c8e-64f0-4e58-bd52-92a0d4f4af2b.pdf		0	0	0	0	0	0	0	0	10	10	50	30	40	60	50	60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2011			TCGA-EJ-7785-01A-11D-2114-08	10d0e0ff-6e69-4e3d-aa7f-bc5718502c5f	TCGA-EJ-7785-01	0cc5f629-5046-4d05-8a5f-923ce5c04b9e	TCGA-EJ-7785-01A-11D-2114-08	TCGA-EJ-7785-01A-11D-2114-08	TCGA-EJ-7785-01A-11D-2112-01	0cc5f629-5046-4d05-8a5f-923ce5c04b9e	TCGA-EJ-7785-01A-11D-2112-01	0cc5f629-5046-4d05-8a5f-923ce5c04b9e	25F1DC25-C819-4C02-8394-8226BDE2896D	TCGA-EJ-7785-01	TCGA-EJ-7785-01A-11D-2116-05	TCGA-EJ-7785-01A-11R-2117-13	TCGA-EJ-7785-01A-11D-2114-08	0cc5f629-5046-4d05-8a5f-923ce5c04b9e	10d0e0ff-6e69-4e3d-aa7f-bc5718502c5f
TCGA-EJ-7785-11	0	TCGA-EJ-7785-11	625	0	TCGA-EJ-7785	625	0	625	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			54	TCGA-EJ-7785-F48956	NO		M0	T2b	-19939							0	625		259			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	2.2	NO	YES				NO	7	0		N0	T3a																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.4		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2011						2d8faa2d-336f-46e9-992d-4a5a5dbc4ece				2d8faa2d-336f-46e9-992d-4a5a5dbc4ece		2d8faa2d-336f-46e9-992d-4a5a5dbc4ece			TCGA-EJ-7785-11A-01D-2116-05	TCGA-EJ-7785-11A-01R-2117-13		2d8faa2d-336f-46e9-992d-4a5a5dbc4ece	
TCGA-EJ-7786-01	0	TCGA-EJ-7786-01	442	0	TCGA-EJ-7786	442	0	442	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-EJ-7786-F48958	NO		M0	T1c	-22793							0	442		79			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	0.9	NO	YES				NO	5	0		N0	T2c	TCGA-EJ-7786.3b3ac042-2bb6-445b-a82b-eea969f0bd33.pdf		0	0	0	0	0	0	0	0	5	5	25	35	70	60	80	70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.6		NO	3	YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-7786-01A-11D-2114-08	953058e5-c2f2-4b7f-b46c-ba211876b110	TCGA-EJ-7786-01	d444c3d1-235a-413c-8e5c-4f4465b378e1	TCGA-EJ-7786-01A-11D-2114-08	TCGA-EJ-7786-01A-11D-2114-08	TCGA-EJ-7786-01A-11D-2112-01	d444c3d1-235a-413c-8e5c-4f4465b378e1	TCGA-EJ-7786-01A-11D-2112-01	d444c3d1-235a-413c-8e5c-4f4465b378e1	CB2FF7FE-0571-494A-A39B-3CF58DDCA502	TCGA-EJ-7786-01	TCGA-EJ-7786-01A-11D-2116-05	TCGA-EJ-7786-01A-11R-2117-13	TCGA-EJ-7786-01A-11D-2114-08	d444c3d1-235a-413c-8e5c-4f4465b378e1	953058e5-c2f2-4b7f-b46c-ba211876b110
TCGA-EJ-7786-11	0	TCGA-EJ-7786-11	442	0	TCGA-EJ-7786	442	0	442	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-EJ-7786-F48958	NO		M0	T1c	-22793							0	442		79			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	1.5	NO	YES				NO	5	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.4		NO	3	YES	NO	EJ			Prostate		A	LIVING	2011						c4aa58a3-f1ef-489f-be76-ce0f20a5446f				c4aa58a3-f1ef-489f-be76-ce0f20a5446f		c4aa58a3-f1ef-489f-be76-ce0f20a5446f			TCGA-EJ-7786-11A-01D-2116-05	TCGA-EJ-7786-11A-01R-2117-13		c4aa58a3-f1ef-489f-be76-ce0f20a5446f	
TCGA-EJ-7788-01	0	TCGA-EJ-7788-01	248	0	TCGA-EJ-7788	248	0	248	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-EJ-7788-F48959	NO		M0	T3b	-19623							0	248		52			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	2	NO	YES				NO	6	0		N0	T3b	TCGA-EJ-7788.b66a0868-e91c-4ebf-be9c-ba55e94552fd.pdf		2	2	0	0	0	0	0	0	2	2	8	8	90	90	95	95	TUMOR FREE	3	Complete Remission/Response	No	0.2	NO	R0	Primary Tumor	01	4	0.4		NO	5	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2011			TCGA-EJ-7788-01A-11D-2114-08	172408e8-59f2-4915-af53-1b0e2b5aa4d8	TCGA-EJ-7788-01	83fedf64-9e72-4f9c-ab33-166dc0202cc9	TCGA-EJ-7788-01A-11D-2114-08	TCGA-EJ-7788-01A-11D-2114-08	TCGA-EJ-7788-01A-11D-2112-01	83fedf64-9e72-4f9c-ab33-166dc0202cc9	TCGA-EJ-7788-01A-11D-2112-01	83fedf64-9e72-4f9c-ab33-166dc0202cc9	429F179D-1B60-4097-ADCC-C126936A19D6	TCGA-EJ-7788-01	TCGA-EJ-7788-01A-11D-2116-05	TCGA-EJ-7788-01A-11R-2117-13	TCGA-EJ-7788-01A-11D-2114-08	83fedf64-9e72-4f9c-ab33-166dc0202cc9	172408e8-59f2-4915-af53-1b0e2b5aa4d8
TCGA-EJ-7789-01	0	TCGA-EJ-7789-01	552	0	TCGA-EJ-7789	552	0	552	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-EJ-7789-F48961			M0	T1c	-24107							0	552					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	1.8	NO	YES				NO	14	0		N0	T3a	TCGA-EJ-7789.7483212d-f96c-4afd-b817-74517b54de53.pdf		0	0	0	0	0	0	0	0	5	3	15	7	80	90	90	95	TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Primary Tumor	01	3	0.3		NO	5	YES	NO	EJ	Base		Prostate		A	LIVING	2011			TCGA-EJ-7789-01A-11D-2114-08	14c664ab-ffc0-44c5-8b63-0ff7ae320e19	TCGA-EJ-7789-01	784cb488-904d-49e4-b63e-bb0e5bacb6e3	TCGA-EJ-7789-01A-11D-2114-08	TCGA-EJ-7789-01A-11D-2114-08	TCGA-EJ-7789-01A-11D-2112-01	784cb488-904d-49e4-b63e-bb0e5bacb6e3	TCGA-EJ-7789-01A-11D-2112-01	784cb488-904d-49e4-b63e-bb0e5bacb6e3	18796055-6F9D-478E-89FB-3FDC019C8119	TCGA-EJ-7789-01	TCGA-EJ-7789-01A-11D-2116-05	TCGA-EJ-7789-01A-11R-2117-13	TCGA-EJ-7789-01A-11D-2114-08	784cb488-904d-49e4-b63e-bb0e5bacb6e3	14c664ab-ffc0-44c5-8b63-0ff7ae320e19
TCGA-EJ-7789-11	0	TCGA-EJ-7789-11	552	0	TCGA-EJ-7789	552	0	552	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-EJ-7789-F48961			M0	T1c	-24107							0	552					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.8	NO	YES				NO	14	0		N0	T3a																			TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Solid Tissue Normal	11	3	0.5		NO	5	YES	NO	EJ	Base		Prostate		A	LIVING	2011						8666da07-07d0-417e-954b-c18e107bdeb1				8666da07-07d0-417e-954b-c18e107bdeb1		8666da07-07d0-417e-954b-c18e107bdeb1			TCGA-EJ-7789-11A-01D-2116-05	TCGA-EJ-7789-11A-01R-2117-13		8666da07-07d0-417e-954b-c18e107bdeb1	
TCGA-EJ-7791-01	0	TCGA-EJ-7791-01	596	0	TCGA-EJ-7791	596	0	596	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-EJ-7791-F48843	NO		M0	T1c	-24621							0	596		217			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-23	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	2	NO	YES				NO	18	0		N0	T2c	TCGA-EJ-7791.001c43cb-3e9b-43db-b6d0-61e67d058c9f.pdf		0	0	0	0	0	0	0	0	5	5	15	15	80	80	90	90	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011			TCGA-EJ-7791-01A-11D-2114-08	f4436b7e-4ac4-4a7a-8943-142014b6b76f	TCGA-EJ-7791-01	14830a14-5495-4425-b6ef-78ccffafe03c	TCGA-EJ-7791-01A-11D-2114-08	TCGA-EJ-7791-01A-11D-2114-08	TCGA-EJ-7791-01A-11D-2112-01	14830a14-5495-4425-b6ef-78ccffafe03c	TCGA-EJ-7791-01A-11D-2112-01	14830a14-5495-4425-b6ef-78ccffafe03c	74CA9A60-9C42-4A7C-9407-DBAF152289EB	TCGA-EJ-7791-01	TCGA-EJ-7791-01A-11D-2116-05	TCGA-EJ-7791-01A-11R-2117-13	TCGA-EJ-7791-01A-11D-2114-08	14830a14-5495-4425-b6ef-78ccffafe03c	f4436b7e-4ac4-4a7a-8943-142014b6b76f
TCGA-EJ-7792-01	0	TCGA-EJ-7792-01	526	0	TCGA-EJ-7792			526	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53		NO		M0	T1c	-19454							0	526		526			NO		NO				2012-4-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	1.4		YES					35	0		N0	T2c	TCGA-EJ-7792.607fd612-7ab9-475b-8c22-fd7cdbaccb37.pdf		1	2	0	0	0	0	0	1	10	10	40	30	50	60	70	80	TUMOR FREE	3		No	0.13		R0	Primary Tumor	01	4	0.3			4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2010			TCGA-EJ-7792-01A-11D-2114-08	a3891202-4a6c-4bcf-837b-c71961ef60f3	TCGA-EJ-7792-01	310d0da6-5694-4dc0-82f7-3fe0f6699271	TCGA-EJ-7792-01A-11D-2114-08	TCGA-EJ-7792-01A-11D-2114-08	TCGA-EJ-7792-01A-11D-2112-01	310d0da6-5694-4dc0-82f7-3fe0f6699271	TCGA-EJ-7792-01A-11D-2112-01	310d0da6-5694-4dc0-82f7-3fe0f6699271	A8CB42CF-915F-4CC4-80CE-337A822EC406	TCGA-EJ-7792-01	TCGA-EJ-7792-01A-11D-2116-05	TCGA-EJ-7792-01A-11R-2117-13	TCGA-EJ-7792-01A-11D-2114-08	310d0da6-5694-4dc0-82f7-3fe0f6699271	a3891202-4a6c-4bcf-837b-c71961ef60f3
TCGA-EJ-7792-11	0	TCGA-EJ-7792-11	526	0	TCGA-EJ-7792			526	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53		NO		M0	T1c	-19454							0	526		526			NO		NO				2012-4-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.7		YES					35	0		N0	T2c																			TUMOR FREE	3		No	0.13		R0	Solid Tissue Normal	11	4	0.3			4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2010						3f8c4a26-6796-4070-aea8-a7507103cfc7				3f8c4a26-6796-4070-aea8-a7507103cfc7		3f8c4a26-6796-4070-aea8-a7507103cfc7			TCGA-EJ-7792-11A-01D-2116-05	TCGA-EJ-7792-11A-01R-2117-13		3f8c4a26-6796-4070-aea8-a7507103cfc7	
TCGA-EJ-7793-01	0	TCGA-EJ-7793-01	114	0	TCGA-EJ-7793	114	0	114	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			49	TCGA-EJ-7793-F48840	NO		M0	T2c	-17982							0	114		114			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-23	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	1.7	YES	NO				NO					T2c	TCGA-EJ-7793.c9d3d69c-f362-454f-a8ff-cbda4d713c41.pdf							0				5		10		85		85	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011			TCGA-EJ-7793-01A-31D-2260-08	fbb5f412-b807-4a40-a5de-95a9c121e0d9	TCGA-EJ-7793-01	8a63eeeb-2e0d-466f-a446-ac6649cba90c	TCGA-EJ-7793-01A-31D-2260-08	TCGA-EJ-7793-01A-31D-2260-08	TCGA-EJ-7793-01A-31D-2259-01	8a63eeeb-2e0d-466f-a446-ac6649cba90c	TCGA-EJ-7793-01A-31D-2259-01	8a63eeeb-2e0d-466f-a446-ac6649cba90c	97BBA440-7AFC-4EF1-B98D-EC635488B1D0	TCGA-EJ-7793-01	TCGA-EJ-7793-01A-31D-2261-05	TCGA-EJ-7793-01A-31R-2262-13	TCGA-EJ-7793-01A-31D-2260-08	8a63eeeb-2e0d-466f-a446-ac6649cba90c	fbb5f412-b807-4a40-a5de-95a9c121e0d9
TCGA-EJ-7793-11	0	TCGA-EJ-7793-11	114	0	TCGA-EJ-7793	114	0	114	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			49	TCGA-EJ-7793-F48840	NO		M0	T2c	-17982							0	114		114			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-23	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	2	YES	NO				NO					T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.5		NO	4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011						5b2c7f9e-d8f2-44db-8981-5acefbfd38c8				5b2c7f9e-d8f2-44db-8981-5acefbfd38c8		5b2c7f9e-d8f2-44db-8981-5acefbfd38c8				TCGA-EJ-7793-11A-01R-2262-13		5b2c7f9e-d8f2-44db-8981-5acefbfd38c8	
TCGA-EJ-7794-01	0	TCGA-EJ-7794-01	701	0	TCGA-EJ-7794	701	0	701	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-EJ-7794-F48876	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-24478	35			35			0	701		285			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.4	NO	YES				NO	11	0		N0	T2c	TCGA-EJ-7794.73164d62-bc3a-4dd3-8201-86c5f35ef168.pdf		0	1	0	0	0	0	0	0	30	25	50	50	20	25	40	60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ			Prostate		A	LIVING	2010			TCGA-EJ-7794-01A-11D-2114-08	cda5c305-a85e-4da1-9b00-e7803bca2053	TCGA-EJ-7794-01	cecb86b2-f20c-4fde-b9b6-c87e95f2e390	TCGA-EJ-7794-01A-11D-2114-08	TCGA-EJ-7794-01A-11D-2114-08	TCGA-EJ-7794-01A-11D-2112-01	cecb86b2-f20c-4fde-b9b6-c87e95f2e390	TCGA-EJ-7794-01A-11D-2112-01	cecb86b2-f20c-4fde-b9b6-c87e95f2e390	28E1D66C-1D4C-48FB-9583-1896B7759EFB	TCGA-EJ-7794-01	TCGA-EJ-7794-01A-11D-2116-05	TCGA-EJ-7794-01A-11R-2117-13	TCGA-EJ-7794-01A-11D-2114-08	cecb86b2-f20c-4fde-b9b6-c87e95f2e390	cda5c305-a85e-4da1-9b00-e7803bca2053
TCGA-EJ-7794-11	0	TCGA-EJ-7794-11	701	0	TCGA-EJ-7794	701	0	701	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-EJ-7794-F48876	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-24478	35			35			0	701		285			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.5	NO	YES				NO	11	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.4		NO	3	YES	NO	EJ			Prostate		A	LIVING	2010						6970283b-3673-49bc-9b2b-bd268140327f				6970283b-3673-49bc-9b2b-bd268140327f		6970283b-3673-49bc-9b2b-bd268140327f			TCGA-EJ-7794-11A-01D-2116-05	TCGA-EJ-7794-11A-01R-2117-13		6970283b-3673-49bc-9b2b-bd268140327f	
TCGA-EJ-7797-01	0	TCGA-EJ-7797-01	369	0	TCGA-EJ-7797	369	0	369	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-EJ-7797-F48954	NO		M0	T1c	-19616							0	369		187			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	YES				NO	14	0		N0	T2c	TCGA-EJ-7797.d9d6f871-c436-469e-9d7f-9684c379a320.pdf							0				8		2		90		90	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-7797-01A-11D-2260-08	6f24610e-5482-421b-b733-ee38d0a9312b	TCGA-EJ-7797-01	960c1e43-d2be-41f0-9f3a-8234cddb84be	TCGA-EJ-7797-01A-11D-2260-08	TCGA-EJ-7797-01A-11D-2260-08	TCGA-EJ-7797-01A-11D-2259-01	960c1e43-d2be-41f0-9f3a-8234cddb84be	TCGA-EJ-7797-01A-11D-2259-01	960c1e43-d2be-41f0-9f3a-8234cddb84be	B43E0A20-FE97-46E4-A509-CD8497EC0A2B	TCGA-EJ-7797-01	TCGA-EJ-7797-01A-11D-2261-05	TCGA-EJ-7797-01A-11R-2262-13	TCGA-EJ-7797-01A-11D-2260-08	960c1e43-d2be-41f0-9f3a-8234cddb84be	6f24610e-5482-421b-b733-ee38d0a9312b
TCGA-EJ-7797-11	0	TCGA-EJ-7797-11	369	0	TCGA-EJ-7797	369	0	369	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-EJ-7797-F48954	NO		M0	T1c	-19616							0	369		187			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	1.6	NO	YES				NO	14	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.3		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011						a461340b-d5cd-4600-9046-f3942bec1c19				a461340b-d5cd-4600-9046-f3942bec1c19		a461340b-d5cd-4600-9046-f3942bec1c19				TCGA-EJ-7797-11A-01R-2262-13		a461340b-d5cd-4600-9046-f3942bec1c19	
TCGA-EJ-8468-01	0	TCGA-EJ-8468-01	2347	0	TCGA-EJ-8468	2347	0	2347	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-EJ-8468-F64614	NO	Normal (no evidence of prostate cancer) [cM0]		T3a	-23371	23			23			0	2347		1961			YES				Scheduled Follow-up Submission	Complete Remission/Response	2014-9-5	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Left	1.9	NO	YES				NO	7	0		N0	T3a								0				25		10		65		65	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ			Prostate		A	LIVING	2007			TCGA-EJ-8468-01A-21D-2395-08	22183fae-e6bd-4d2d-9e64-0ceee5806cc7	TCGA-EJ-8468-01	2c178e64-b87b-4887-b599-cc928e45db86	TCGA-EJ-8468-01A-21D-2395-08	TCGA-EJ-8468-01A-21D-2395-08	TCGA-EJ-8468-01A-21D-2391-01	2c178e64-b87b-4887-b599-cc928e45db86	TCGA-EJ-8468-01A-21D-2391-01	2c178e64-b87b-4887-b599-cc928e45db86	67EC88F5-6AA2-403F-A61C-68BA66BAA9BC	TCGA-EJ-8468-01	TCGA-EJ-8468-01A-21D-2399-05	TCGA-EJ-8468-01A-21R-2401-13	TCGA-EJ-8468-01A-21D-2395-08	2c178e64-b87b-4887-b599-cc928e45db86	22183fae-e6bd-4d2d-9e64-0ceee5806cc7
TCGA-EJ-8469-01	0	TCGA-EJ-8469-01	2324	0	TCGA-EJ-8469	1925	1	2324	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	46	TCGA-EJ-8469-F64636	YES		M0	T3a	-17014				30		1925	0	2324	1925	1925			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Partial Remission/Response	2014-9-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	2.3	NO	YES		Locoregional Recurrence		YES	57	0		N0	T3a							0	0			10	5	15	20	75	75	75	75	WITH TUMOR	4	Partial Remission/Response	No	3.1	NO	RX	Primary Tumor	01	5	0.5		NO	3	YES	NO	EJ			Prostate		A	LIVING	2007			TCGA-EJ-8469-01A-11D-2395-08	6de87bdd-b51f-4955-95e3-f136349df59a	TCGA-EJ-8469-01	6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe	TCGA-EJ-8469-01A-11D-2395-08	TCGA-EJ-8469-01A-11D-2395-08	TCGA-EJ-8469-01A-11D-2391-01	6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe	TCGA-EJ-8469-01A-11D-2391-01	6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe	D7E8BC9A-83B5-47EE-A1C9-CA1D8689DB42	TCGA-EJ-8469-01	TCGA-EJ-8469-01A-11D-2399-05	TCGA-EJ-8469-01A-11R-2401-13	TCGA-EJ-8469-01A-11D-2395-08	6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe	6de87bdd-b51f-4955-95e3-f136349df59a
TCGA-EJ-8470-01	0	TCGA-EJ-8470-01	1159	0	TCGA-EJ-8470	1159	0	1159	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-EJ-8470-F64637			M0	T2c	-21209							0	1159									Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.6	NO	Bilateral	1.9	NO	YES				NO	21	0		N0	T2c								0				15		10		75		75	TUMOR FREE	4	Complete Remission/Response	No		NO		Primary Tumor	01	3	0.4		NO		YES	NO	EJ			Prostate		A	LIVING	2010			TCGA-EJ-8470-01A-11D-2395-08	5ac39210-a0ab-40c3-b0bf-e4bbd47abaee	TCGA-EJ-8470-01	33f711ae-41c4-415e-8faf-3d7984c4b5cb	TCGA-EJ-8470-01A-11D-2395-08	TCGA-EJ-8470-01A-11D-2395-08	TCGA-EJ-8470-01A-11D-2391-01	33f711ae-41c4-415e-8faf-3d7984c4b5cb	TCGA-EJ-8470-01A-11D-2391-01	33f711ae-41c4-415e-8faf-3d7984c4b5cb	07951FC5-7A6B-4735-B060-3FE8AA58B959	TCGA-EJ-8470-01	TCGA-EJ-8470-01A-11D-2399-05	TCGA-EJ-8470-01A-11R-2401-13	TCGA-EJ-8470-01A-11D-2395-08	33f711ae-41c4-415e-8faf-3d7984c4b5cb	5ac39210-a0ab-40c3-b0bf-e4bbd47abaee
TCGA-EJ-8472-01	0	TCGA-EJ-8472-01	756	0	TCGA-EJ-8472	756	0	756	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-EJ-8472-F64638	YES		M0	T3a	-23104						196	0	756		196							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO		0.8	NO	YES				NO	12	0		N0	T3a				1		0		2		0		10		18		70		90	TUMOR FREE	4	Partial Remission/Response	No	0.4	NO	R0	Primary Tumor	01	4	0.2		NO	3	YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-8472-01A-11D-2395-08	0085255e-1e3c-48b2-9e53-bfc5aa5bf7c6	TCGA-EJ-8472-01	139abcca-ef3c-4520-9829-ebf4915d6b92	TCGA-EJ-8472-01A-11D-2395-08	TCGA-EJ-8472-01A-11D-2395-08	TCGA-EJ-8472-01A-11D-2391-01	139abcca-ef3c-4520-9829-ebf4915d6b92	TCGA-EJ-8472-01A-11D-2391-01	139abcca-ef3c-4520-9829-ebf4915d6b92		TCGA-EJ-8472-01	TCGA-EJ-8472-01A-11D-2399-05	TCGA-EJ-8472-01A-11R-2401-13	TCGA-EJ-8472-01A-11D-2395-08	139abcca-ef3c-4520-9829-ebf4915d6b92	0085255e-1e3c-48b2-9e53-bfc5aa5bf7c6
TCGA-EJ-8474-01	0	TCGA-EJ-8474-01	766	0	TCGA-EJ-8474	766	0	766	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69	TCGA-EJ-8474-F64640	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-25561	51			7			0	766		766			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.9	NO	YES				NO	15	0		N0	T3a							0	0			15	7	25	8	60	85	60	85	TUMOR FREE	4	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	4	0.3		NO		YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-8474-01A-11D-2395-08	ae2ccf56-92e7-4db8-a589-8ad336ff4555	TCGA-EJ-8474-01	1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a	TCGA-EJ-8474-01A-11D-2395-08	TCGA-EJ-8474-01A-11D-2395-08	TCGA-EJ-8474-01A-11D-2391-01	1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a	TCGA-EJ-8474-01A-11D-2391-01	1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a	2E549886-7E39-4F40-AE00-325886B78B9E	TCGA-EJ-8474-01	TCGA-EJ-8474-01A-11D-2399-05	TCGA-EJ-8474-01A-11R-2401-13	TCGA-EJ-8474-01A-11D-2395-08	1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a	ae2ccf56-92e7-4db8-a589-8ad336ff4555
TCGA-EJ-A46B-01	0	TCGA-EJ-A46B-01	657	0	TCGA-EJ-A46B	657	0	657	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-EJ-A46B-F64641	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24305	10	114		10			0	657		157			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	420		NO	Bilateral		NO	YES				NO	10	0	true	N0	T3a	TCGA-EJ-A46B.4B418B68-7866-45C1-8728-9D61BF5A9273.pdf			1		0		0		0		0		40		60		100	TUMOR FREE	4	Complete Remission/Response	Yes, History of Prior Malignancy	0.1	NO	R0	Primary Tumor	01	4			NO	3	YES	NO	EJ			Prostate		A	LIVING	2012			TCGA-EJ-A46B-01A-31D-A257-08	e4729318-facc-4ed6-9a29-d656847bae65	TCGA-EJ-A46B-01	112e7329-5135-4307-bda5-d041bc04f0ea	TCGA-EJ-A46B-01A-31D-A257-08	TCGA-EJ-A46B-01A-31D-A257-08	TCGA-EJ-A46B-01A-31D-A256-01	112e7329-5135-4307-bda5-d041bc04f0ea	TCGA-EJ-A46B-01A-31D-A256-01	112e7329-5135-4307-bda5-d041bc04f0ea	1BE1E342-BF2D-44B3-9A06-831B4561FA70	TCGA-EJ-A46B-01	TCGA-EJ-A46B-01A-31D-A258-05	TCGA-EJ-A46B-01A-31R-A25C-13	TCGA-EJ-A46B-01A-31D-A257-08	112e7329-5135-4307-bda5-d041bc04f0ea	e4729318-facc-4ed6-9a29-d656847bae65
TCGA-EJ-A46D-01	0	TCGA-EJ-A46D-01	626	0	TCGA-EJ-A46D	626	0	626	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-EJ-A46D-F64643	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-19466	42	181					0	626		122							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	940		NO	Bilateral		NO	YES				NO	6	0	true	N0	T2c	TCGA-EJ-A46D.A0EF60EA-85C2-40AA-9162-E8C96748F94D.pdf			0		0		0		0		20		30		50		70	TUMOR FREE	3	Complete Remission/Response	No	.03	NO		Primary Tumor	01	5			NO	4	YES	NO	EJ			Prostate		A	LIVING	2012			TCGA-EJ-A46D-01A-21D-A257-08	44aecbcc-21e4-4cc8-96b6-2fe8e2e21192	TCGA-EJ-A46D-01	dbde3775-bbbc-4492-8449-6f04c4edc65d	TCGA-EJ-A46D-01A-21D-A257-08	TCGA-EJ-A46D-01A-21D-A257-08	TCGA-EJ-A46D-01A-21D-A256-01	dbde3775-bbbc-4492-8449-6f04c4edc65d	TCGA-EJ-A46D-01A-21D-A256-01	dbde3775-bbbc-4492-8449-6f04c4edc65d	15A79981-3C10-431E-94BB-2F6F357BEEFF	TCGA-EJ-A46D-01	TCGA-EJ-A46D-01A-21D-A258-05	TCGA-EJ-A46D-01A-21R-A25C-13	TCGA-EJ-A46D-01A-21D-A257-08	dbde3775-bbbc-4492-8449-6f04c4edc65d	44aecbcc-21e4-4cc8-96b6-2fe8e2e21192
TCGA-EJ-A46E-01	0	TCGA-EJ-A46E-01	524	0	TCGA-EJ-A46E	524	0	524	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-EJ-A46E-F64644	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21054		489					0	524		503			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	760		NO	Bilateral		YES	YES				NO	9	0	true	N0		TCGA-EJ-A46E.F2A59B31-7CFE-4DA8-A7B7-229021357746.pdf			1		0		0		0		0		50		50		100	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-A46E-01A-31D-A257-08	24aac24d-653f-4cca-81e2-4cbfd3094f09	TCGA-EJ-A46E-01	369853c1-dc8d-45cc-8131-7ce625ac3020	TCGA-EJ-A46E-01A-31D-A257-08	TCGA-EJ-A46E-01A-31D-A257-08	TCGA-EJ-A46E-01A-31D-A256-01	369853c1-dc8d-45cc-8131-7ce625ac3020	TCGA-EJ-A46E-01A-31D-A256-01	369853c1-dc8d-45cc-8131-7ce625ac3020	85F7E0C3-9BA7-4C02-953E-D3AB67D54648	TCGA-EJ-A46E-01	TCGA-EJ-A46E-01A-31D-A258-05	TCGA-EJ-A46E-01A-31R-A25C-13	TCGA-EJ-A46E-01A-31D-A257-08	369853c1-dc8d-45cc-8131-7ce625ac3020	24aac24d-653f-4cca-81e2-4cbfd3094f09
TCGA-EJ-A46F-01	0	TCGA-EJ-A46F-01	783	0	TCGA-EJ-A46F	783	0	783	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-EJ-A46F-F64645	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-21160	166	286		166		215	0	783		215			YES				Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	580		NO	Bilateral		NO	YES				NO	23	1	true	N1	T3b	TCGA-EJ-A46F.E424A7C8-4DDD-4ECC-A0B4-DF22A9996D01.pdf			2		0		0		0		0		40		60		100	TUMOR FREE	4	Partial Remission/Response	No	19.8	NO	R0	Primary Tumor	01	4			NO	3	YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-A46F-01A-31D-A257-08	67c3246d-52b2-48d2-b490-89b6506328ab	TCGA-EJ-A46F-01	a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78	TCGA-EJ-A46F-01A-31D-A257-08	TCGA-EJ-A46F-01A-31D-A257-08	TCGA-EJ-A46F-01A-31D-A256-01	a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78	TCGA-EJ-A46F-01A-31D-A256-01	a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78	BF4BE828-8FC8-42E3-A77C-706D6AA1B3F8	TCGA-EJ-A46F-01	TCGA-EJ-A46F-01A-31D-A258-05	TCGA-EJ-A46F-01A-31R-A25C-13	TCGA-EJ-A46F-01A-31D-A257-08	a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78	67c3246d-52b2-48d2-b490-89b6506328ab
TCGA-EJ-A46G-01	0	TCGA-EJ-A46G-01	93	0	TCGA-EJ-A46G	93	0	93	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-26219	28	219					0	93		93									2013-1-24	MALE	8	Prostate Adenocarcinoma  Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	430		NO	Bilateral			YES				NO	17	0	true	N0	T3a	TCGA-EJ-A46G.ACBA1CE1-E248-47D3-B03D-BE0C1B4A6F21.pdf			1		0		0		0		0		35		65		100	TUMOR FREE	4		Yes, History of Prior Malignancy	0.1		R0	Primary Tumor	01	4				5	YES	NO	EJ			Prostate		A	LIVING	2012			TCGA-EJ-A46G-01A-31D-A26M-08	e96bec69-b10d-49e8-b180-6f1d782a2671	TCGA-EJ-A46G-01	db968587-1271-4b4a-8195-f17a06085ae5	TCGA-EJ-A46G-01A-31D-A26M-08	TCGA-EJ-A46G-01A-31D-A26M-08	TCGA-EJ-A46G-01A-31D-A26L-01	db968587-1271-4b4a-8195-f17a06085ae5	TCGA-EJ-A46G-01A-31D-A26L-01	db968587-1271-4b4a-8195-f17a06085ae5	DE0677A3-E5C4-42C4-8A19-C69F4269939D	TCGA-EJ-A46G-01	TCGA-EJ-A46G-01A-31D-A26N-05	TCGA-EJ-A46G-01A-31R-A26Y-13	TCGA-EJ-A46G-01A-31D-A26M-08	db968587-1271-4b4a-8195-f17a06085ae5	e96bec69-b10d-49e8-b180-6f1d782a2671
TCGA-EJ-A46H-01	0	TCGA-EJ-A46H-01	724	0	TCGA-EJ-A46H	724	0	724	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-EJ-A46H-F64713	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22059	-6						0	724		131							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	6			N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate			LIVING	2012			TCGA-EJ-A46H-01A-31D-A26M-08	fa766da3-1bb8-4d68-b30a-1e326d3d560a	TCGA-EJ-A46H-01	da936a2e-af10-4496-8fa7-00742c30c766	TCGA-EJ-A46H-01A-31D-A26M-08	TCGA-EJ-A46H-01A-31D-A26M-08	TCGA-EJ-A46H-01A-31D-A26L-01	da936a2e-af10-4496-8fa7-00742c30c766	TCGA-EJ-A46H-01A-31D-A26L-01	da936a2e-af10-4496-8fa7-00742c30c766		TCGA-EJ-A46H-01	TCGA-EJ-A46H-01A-31D-A26N-05	TCGA-EJ-A46H-01A-31R-A26Y-13	TCGA-EJ-A46H-01A-31D-A26M-08	da936a2e-af10-4496-8fa7-00742c30c766	fa766da3-1bb8-4d68-b30a-1e326d3d560a
TCGA-EJ-A46I-01	0	TCGA-EJ-A46I-01	668	0	TCGA-EJ-A46I	668	0	668	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-EJ-A46I-F64714	NO		M0	T1c	-21046		520					0	668		484							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES		150		NO	Bilateral		NO					NO			true	N0	T3a	TCGA-EJ-A46I.741CC282-0593-45E4-BEEB-343339F891AA.pdf			0		0		0		0		20		30		50		60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2011			TCGA-EJ-A46I-01A-12D-A26M-08	5a9d4210-b61e-4b6d-becd-73a00c1b4886	TCGA-EJ-A46I-01	7c901d39-8b22-4fc7-8995-2511507b741e	TCGA-EJ-A46I-01A-12D-A26M-08	TCGA-EJ-A46I-01A-12D-A26M-08	TCGA-EJ-A46I-01A-12D-A26L-01	7c901d39-8b22-4fc7-8995-2511507b741e	TCGA-EJ-A46I-01A-12D-A26L-01	7c901d39-8b22-4fc7-8995-2511507b741e		TCGA-EJ-A46I-01	TCGA-EJ-A46I-01A-12D-A26N-05	TCGA-EJ-A46I-01A-12R-A26Y-13	TCGA-EJ-A46I-01A-12D-A26M-08	7c901d39-8b22-4fc7-8995-2511507b741e	5a9d4210-b61e-4b6d-becd-73a00c1b4886
TCGA-EJ-A65B-01	0	TCGA-EJ-A65B-01	710	0	TCGA-EJ-A65B	710	0	710	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-EJ-A65B-F64715	NO		M0	T3b	-20204		359					0	710		536							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	9	Prostate Adenocarcinoma  Other Subtype	No	C61	8255/3	C61.9	YES	Core needle biopsy	300		NO			NO	YES				NO	13	0	true	N0	T3b	TCGA-EJ-A65B.007E056B-1675-4639-9978-05C7EDEA1D74.pdf			2		1		0		0		15		40		45		85	TUMOR FREE	4	Complete Remission/Response	No	.01	NO	R1	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate		A	LIVING	2012			TCGA-EJ-A65B-01A-12D-A30E-08	de779a56-cb13-4592-a380-ac110c1b159f	TCGA-EJ-A65B-01	55753ec3-4f9f-439b-908f-43e4053ca8cb	TCGA-EJ-A65B-01A-12D-A30E-08	TCGA-EJ-A65B-01A-12D-A30E-08	TCGA-EJ-A65B-01A-12D-A30D-01	55753ec3-4f9f-439b-908f-43e4053ca8cb	TCGA-EJ-A65B-01A-12D-A30D-01	55753ec3-4f9f-439b-908f-43e4053ca8cb		TCGA-EJ-A65B-01	TCGA-EJ-A65B-01A-12D-A30F-05	TCGA-EJ-A65B-01A-12R-A30I-13	TCGA-EJ-A65B-01A-12D-A30E-08	55753ec3-4f9f-439b-908f-43e4053ca8cb	de779a56-cb13-4592-a380-ac110c1b159f
TCGA-EJ-A65D-01	0	TCGA-EJ-A65D-01	393	0	TCGA-EJ-A65D	393	0	393	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-EJ-A65D-F64716	NO		M0	T3a	-24297		240					0	393		393							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	8	Prostate Adenocarcinoma  Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	270		NO	Bilateral		NO	YES				NO	34	0	true	N0	T3a	TCGA-EJ-A65D.AD3DEFE9-4977-4334-A197-159F043C92A6.pdf			2		3		0		0		0		15		85		95	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2012			TCGA-EJ-A65D-01A-11D-A30E-08	55a5ef61-a6bf-4685-85bb-1eec1cbf676e	TCGA-EJ-A65D-01	6f5b0c12-0853-49c8-8421-58faa14b3955	TCGA-EJ-A65D-01A-11D-A30E-08	TCGA-EJ-A65D-01A-11D-A30E-08	TCGA-EJ-A65D-01A-11D-A30D-01	6f5b0c12-0853-49c8-8421-58faa14b3955	TCGA-EJ-A65D-01A-11D-A30D-01	6f5b0c12-0853-49c8-8421-58faa14b3955		TCGA-EJ-A65D-01	TCGA-EJ-A65D-01A-11D-A30F-05	TCGA-EJ-A65D-01A-11R-A30I-13	TCGA-EJ-A65D-01A-11D-A30E-08	6f5b0c12-0853-49c8-8421-58faa14b3955	55a5ef61-a6bf-4685-85bb-1eec1cbf676e
TCGA-EJ-A65E-01	0	TCGA-EJ-A65E-01	417	0	TCGA-EJ-A65E	417	0	417	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-EJ-A65E-F64717	NO		M0	T3b	-24558		289					0	417		254							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma  Other Subtype	No	C61	8255/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral		NO	YES				NO	23	0	true	N0	T3b	TCGA-EJ-A65E.4B502278-393D-4B65-A424-B795547938ED.pdf			1		1		0		0		25		15		60		80	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2012			TCGA-EJ-A65E-01A-11D-A29Q-08	784e11f7-e861-4df6-9257-feea3450b8f3	TCGA-EJ-A65E-01	d28ba0e6-a04b-4341-95c2-f03b6d894a5e	TCGA-EJ-A65E-01A-11D-A29Q-08	TCGA-EJ-A65E-01A-11D-A29Q-08	TCGA-EJ-A65E-01A-11D-A323-01	d28ba0e6-a04b-4341-95c2-f03b6d894a5e	TCGA-EJ-A65E-01A-11D-A323-01	d28ba0e6-a04b-4341-95c2-f03b6d894a5e	A9C1464F-B927-426E-A862-EDCEC264C79E	TCGA-EJ-A65E-01	TCGA-EJ-A65E-01A-11D-A29T-05	TCGA-EJ-A65E-01A-11R-A29V-13	TCGA-EJ-A65E-01A-11D-A29Q-08	d28ba0e6-a04b-4341-95c2-f03b6d894a5e	784e11f7-e861-4df6-9257-feea3450b8f3
TCGA-EJ-A65F-01	0	TCGA-EJ-A65F-01	560	0	TCGA-EJ-A65F			560	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59		YES		M0	T3b	-21681		293				75	0	560		75									2014-3-4	MALE	9	Prostate Adenocarcinoma  Other Subtype	No	C61	8255/3	C61.9	YES	Core needle biopsy	360		NO	Bilateral			YES				YES	4	0	true	N0	T3b	TCGA-EJ-A65F.635A6F68-B3A7-4856-BE21-C2DC0AADAA59.pdf			40		20		0		20		20		20		60		60	WITH TUMOR	4	Progressive Disease	No	0.8	NO	R0	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate		A	LIVING	2012			TCGA-EJ-A65F-01A-21D-A30X-08	3b85eb5e-f92a-42fd-b8d0-be3823c2ce88	TCGA-EJ-A65F-01	3479eef9-e120-4723-b333-cd4623de6499	TCGA-EJ-A65F-01A-21D-A30X-08	TCGA-EJ-A65F-01A-21D-A30X-08	TCGA-EJ-A65F-01A-21D-A30W-01	3479eef9-e120-4723-b333-cd4623de6499	TCGA-EJ-A65F-01A-21D-A30W-01	3479eef9-e120-4723-b333-cd4623de6499		TCGA-EJ-A65F-01	TCGA-EJ-A65F-01A-21D-A30Z-05	TCGA-EJ-A65F-01A-21R-A310-13	TCGA-EJ-A65F-01A-21D-A30X-08	3479eef9-e120-4723-b333-cd4623de6499	3b85eb5e-f92a-42fd-b8d0-be3823c2ce88
TCGA-EJ-A65G-01	0	TCGA-EJ-A65G-01	666	0	TCGA-EJ-A65G	666	0	666	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-EJ-A65G-F64719	NO		M0	T2c	-20821		299					0	666		152							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Transurethral resection (TURBT)	140		NO	Bilateral		NO	YES				NO	24	0	true	N0	T2c	TCGA-EJ-A65G.A04673B5-5B72-4D0F-B12A-BC2663A2855B.pdf			1		1		0		0		0		25		75		95	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate		A	LIVING	2012			TCGA-EJ-A65G-01A-21D-A29Q-08	27a66d97-ee5a-40de-8fc3-ea27bd53f1d5	TCGA-EJ-A65G-01	32e41154-dbcb-474c-8605-67c0ae0ed85e	TCGA-EJ-A65G-01A-21D-A29Q-08	TCGA-EJ-A65G-01A-21D-A29Q-08	TCGA-EJ-A65G-01A-21D-A323-01	32e41154-dbcb-474c-8605-67c0ae0ed85e	TCGA-EJ-A65G-01A-21D-A323-01	32e41154-dbcb-474c-8605-67c0ae0ed85e		TCGA-EJ-A65G-01	TCGA-EJ-A65G-01A-21D-A29T-05	TCGA-EJ-A65G-01A-21R-A29V-13	TCGA-EJ-A65G-01A-21D-A29Q-08	32e41154-dbcb-474c-8605-67c0ae0ed85e	27a66d97-ee5a-40de-8fc3-ea27bd53f1d5
TCGA-EJ-A65J-01	0	TCGA-EJ-A65J-01	451	0	TCGA-EJ-A65J	451	0	451	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-EJ-A65J-F64720	NO		M0	T3a	-22904		218					0	451		91							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	970		NO	Bilateral		NO	YES				NO	11	0	true	N0	T3a	TCGA-EJ-A65J.DBB16691-F1A8-40B8-99E7-FB206B3B680C.pdf			40		20		10		20		0		10		80		80	TUMOR FREE	4	Complete Remission/Response	Yes, History of Prior Malignancy	0.1	NO	R0	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate		A	LIVING	2012			TCGA-EJ-A65J-01A-11D-A30X-08	f2da47c9-4500-4867-98db-8068831247d0	TCGA-EJ-A65J-01	3be6c54c-f606-4eba-8242-8dff705fa2d0	TCGA-EJ-A65J-01A-11D-A30X-08	TCGA-EJ-A65J-01A-11D-A30X-08	TCGA-EJ-A65J-01A-11D-A30W-01	3be6c54c-f606-4eba-8242-8dff705fa2d0	TCGA-EJ-A65J-01A-11D-A30W-01	3be6c54c-f606-4eba-8242-8dff705fa2d0		TCGA-EJ-A65J-01	TCGA-EJ-A65J-01A-11D-A30Z-05	TCGA-EJ-A65J-01A-11R-A310-13	TCGA-EJ-A65J-01A-11D-A30X-08	3be6c54c-f606-4eba-8242-8dff705fa2d0	f2da47c9-4500-4867-98db-8068831247d0
TCGA-EJ-A65M-01	0	TCGA-EJ-A65M-01	230	0	TCGA-EJ-A65M	230	0	230	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-EJ-A65M-F64721	NO		M0	T2c	-23767		69					0	230		230							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Transurethral resection (TURBT)	340		NO	Bilateral		NO	YES				NO	30	0	true	N0	T2c	TCGA-EJ-A65M.E0FB271C-8BC6-43FB-BE90-85A28009D962.pdf			0		0		0		0		35		0		65		65	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO		Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013			TCGA-EJ-A65M-01A-11D-A29Q-08	25f72629-b734-4736-b869-a60832b88cb3	TCGA-EJ-A65M-01	9d16eccb-44fa-4188-9ad2-3a17ed821247	TCGA-EJ-A65M-01A-11D-A29Q-08	TCGA-EJ-A65M-01A-11D-A29Q-08	TCGA-EJ-A65M-01A-11D-A323-01	9d16eccb-44fa-4188-9ad2-3a17ed821247	TCGA-EJ-A65M-01A-11D-A323-01	9d16eccb-44fa-4188-9ad2-3a17ed821247	7F4408EE-6B45-4B45-95B9-887D81BE65ED	TCGA-EJ-A65M-01	TCGA-EJ-A65M-01A-11D-A29T-05	TCGA-EJ-A65M-01A-11R-A29V-13	TCGA-EJ-A65M-01A-11D-A29Q-08	9d16eccb-44fa-4188-9ad2-3a17ed821247	25f72629-b734-4736-b869-a60832b88cb3
TCGA-EJ-A6RA-01	0	TCGA-EJ-A6RA-01	353	0	TCGA-EJ-A6RA	353	0	353	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-EJ-A6RA-F64722	YES		M0	T3b	-25679						353	0	353		353							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	18	1		N1	T3b																			TUMOR FREE	4	Complete Remission/Response	No	0.652	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate			LIVING	2012				d4d22f9f-9939-4174-a744-9731f443c150	TCGA-EJ-A6RA-01	ae29efe9-4446-4f0a-b765-f04e3935d7a8		TCGA-EJ-A6RA-01A-11D-A33T-08	TCGA-EJ-A6RA-01A-11D-A33S-01	ae29efe9-4446-4f0a-b765-f04e3935d7a8	TCGA-EJ-A6RA-01A-11D-A33S-01	ae29efe9-4446-4f0a-b765-f04e3935d7a8		TCGA-EJ-A6RA-01	TCGA-EJ-A6RA-01A-11D-A33U-05	TCGA-EJ-A6RA-01A-11R-A343-13		ae29efe9-4446-4f0a-b765-f04e3935d7a8	d4d22f9f-9939-4174-a744-9731f443c150
TCGA-EJ-A6RC-01	0	TCGA-EJ-A6RC-01	873	0	TCGA-EJ-A6RC	873	0	873	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	64	TCGA-EJ-A6RC-F64723	NO		M0	T1c	-23598		631					0	873		693							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Transurethral resection (TURBT)	450		NO	Bilateral		NO	YES				NO	38	0	true	N0		TCGA-EJ-A6RC.3DB930C6-0B64-4FBF-8BB8-5FA4EBC122CA.pdf			0		0		0		0		40		10		50		60	TUMOR FREE	4	Complete Remission/Response	Yes, History of Prior Malignancy	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2011				9a239c56-501b-487d-9bd5-26f21d203a57	TCGA-EJ-A6RC-01	ea34e227-a427-42a6-9f42-80069e972764		TCGA-EJ-A6RC-01A-11D-A32B-08	TCGA-EJ-A6RC-01A-11D-A32A-01	ea34e227-a427-42a6-9f42-80069e972764	TCGA-EJ-A6RC-01A-11D-A32A-01	ea34e227-a427-42a6-9f42-80069e972764		TCGA-EJ-A6RC-01	TCGA-EJ-A6RC-01A-11D-A32C-05	TCGA-EJ-A6RC-01A-11R-A360-13		ea34e227-a427-42a6-9f42-80069e972764	9a239c56-501b-487d-9bd5-26f21d203a57
TCGA-EJ-A7NF-01	0	TCGA-EJ-A7NF-01	250	0	TCGA-EJ-A7NF	250	0	250	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56	TCGA-EJ-A7NF-F64724	NO		M0	T2c	-20587							0	250		117							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Transurethral resection (TURBT)				Bilateral		NO	YES				NO	29	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate			LIVING	2013				b969df13-e108-4fe8-9d5e-8c11a0b90be2	TCGA-EJ-A7NF-01	d94972a7-535d-4bb8-b221-d3c22a120d01		TCGA-EJ-A7NF-01A-11D-A33T-08	TCGA-EJ-A7NF-01A-11D-A33S-01	d94972a7-535d-4bb8-b221-d3c22a120d01	TCGA-EJ-A7NF-01A-11D-A33S-01	d94972a7-535d-4bb8-b221-d3c22a120d01		TCGA-EJ-A7NF-01	TCGA-EJ-A7NF-01A-11D-A33U-05	TCGA-EJ-A7NF-01A-11R-A343-13		d94972a7-535d-4bb8-b221-d3c22a120d01	b969df13-e108-4fe8-9d5e-8c11a0b90be2
TCGA-EJ-A7NG-01	0	TCGA-EJ-A7NG-01	432	0	TCGA-EJ-A7NG	432	0	432	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-EJ-A7NG-F64725	NO		M0	T3a	-23458		209					0	432		264							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	300		NO	Bilateral		NO	YES				NO	6	0	true	N0	T3a	TCGA-EJ-A7NG.05993405-656B-4DB6-98BC-8359E16AC6AB.pdf			0		0		0		0		15		35		50		65	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2013				56ae3a14-f536-4008-96b5-41de4c3095d4	TCGA-EJ-A7NG-01	06c95ac2-2f97-4200-9a29-a3ff8cce8697		TCGA-EJ-A7NG-01A-31D-A33T-08	TCGA-EJ-A7NG-01A-31D-A33S-01	06c95ac2-2f97-4200-9a29-a3ff8cce8697	TCGA-EJ-A7NG-01A-31D-A33S-01	06c95ac2-2f97-4200-9a29-a3ff8cce8697		TCGA-EJ-A7NG-01	TCGA-EJ-A7NG-01A-31D-A33U-05	TCGA-EJ-A7NG-01A-31R-A343-13		06c95ac2-2f97-4200-9a29-a3ff8cce8697	56ae3a14-f536-4008-96b5-41de4c3095d4
TCGA-EJ-A7NH-01	0	TCGA-EJ-A7NH-01	474	0	TCGA-EJ-A7NH	474	0	474	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56	TCGA-EJ-A7NH-F64726	NO		M0	T2c	-20734							0	474		105							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	4			N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate			LIVING	2013				b1e88923-eb62-4e9e-88ab-7a8296a144fc	TCGA-EJ-A7NH-01	a4e4f617-d329-4c8f-8cbd-f6111c427f71		TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-01A-12D-A33S-01	a4e4f617-d329-4c8f-8cbd-f6111c427f71	TCGA-EJ-A7NH-01A-12D-A33S-01	a4e4f617-d329-4c8f-8cbd-f6111c427f71		TCGA-EJ-A7NH-01	TCGA-EJ-A7NH-01A-12D-A33U-05	TCGA-EJ-A7NH-01A-12R-A343-13		a4e4f617-d329-4c8f-8cbd-f6111c427f71	b1e88923-eb62-4e9e-88ab-7a8296a144fc
TCGA-EJ-A7NJ-01	0	TCGA-EJ-A7NJ-01	197	0	TCGA-EJ-A7NJ	197	0	197	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-EJ-A7NJ-F64727	NO		M0	T2c	-21748		211					0	197		92							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	250		NO	Bilateral		NO	YES				NO	16	0	true	N0	T2c	TCGA-EJ-A7NJ.B6D55BEF-A9C3-4092-AE17-FB6790EC65AD.pdf			20		0		2		0		20		35		43		60	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2013				c0f13f25-6bf7-4e95-b344-fd23fb4603e1	TCGA-EJ-A7NJ-01	1f891baf-2b98-4c2f-8f5f-799018220513		TCGA-EJ-A7NJ-01A-22D-A34U-08	TCGA-EJ-A7NJ-01A-22D-A34T-01	1f891baf-2b98-4c2f-8f5f-799018220513	TCGA-EJ-A7NJ-01A-22D-A34T-01	1f891baf-2b98-4c2f-8f5f-799018220513		TCGA-EJ-A7NJ-01	TCGA-EJ-A7NJ-01A-22D-A34V-05	TCGA-EJ-A7NJ-01A-22R-A358-13		1f891baf-2b98-4c2f-8f5f-799018220513	c0f13f25-6bf7-4e95-b344-fd23fb4603e1
TCGA-EJ-A7NK-01	0	TCGA-EJ-A7NK-01	476	0	TCGA-EJ-A7NK	476	0	476	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-EJ-A7NK-F64761	NO		M0	T3a	-21530		254					0	476		295							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Transurethral resection (TURBT)	140		NO	Bilateral		NO	YES				NO	48	0	true	N0	T3a	TCGA-EJ-A7NK.E1362D2A-6ED3-4BA3-A92D-63C5024946A6.pdf			40		20		0		20		0		30		70		70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2012				f7afcba3-497d-4679-a1ac-6a41ffe34b58	TCGA-EJ-A7NK-01	107d849f-0497-4daa-bd4e-d82570909838		TCGA-EJ-A7NK-01A-12D-A34U-08	TCGA-EJ-A7NK-01A-12D-A34T-01	107d849f-0497-4daa-bd4e-d82570909838	TCGA-EJ-A7NK-01A-12D-A34T-01	107d849f-0497-4daa-bd4e-d82570909838		TCGA-EJ-A7NK-01	TCGA-EJ-A7NK-01A-12D-A34V-05	TCGA-EJ-A7NK-01A-12R-A358-13		107d849f-0497-4daa-bd4e-d82570909838	f7afcba3-497d-4679-a1ac-6a41ffe34b58
TCGA-EJ-A7NM-01	0	TCGA-EJ-A7NM-01	128	0	TCGA-EJ-A7NM	128	0	128	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-EJ-A7NM-F64762	NO		M0	T3b	-23603		115					0	128		128							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	9	Prostate Adenocarcinoma  Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	410		NO	Bilateral		NO	YES				NO	29	3	true	N1	T3b	TCGA-EJ-A7NM.D7D49539-80E3-4A37-BEEB-FA75951947F8.pdf			40		20		0		20		0		20		80		80	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate		A	LIVING	2013				59b61027-f89a-468d-a6f0-992331581ca1	TCGA-EJ-A7NM-01	e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9		TCGA-EJ-A7NM-01A-21D-A33T-08	TCGA-EJ-A7NM-01A-21D-A33S-01	e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9	TCGA-EJ-A7NM-01A-21D-A33S-01	e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9		TCGA-EJ-A7NM-01	TCGA-EJ-A7NM-01A-21D-A33U-05	TCGA-EJ-A7NM-01A-21R-A343-13		e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9	59b61027-f89a-468d-a6f0-992331581ca1
TCGA-EJ-A7NN-01	0	TCGA-EJ-A7NN-01	197	0	TCGA-EJ-A7NN	197	0	197	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-EJ-A7NN-F64763	YES		M0	T3b	-22499						197	0	197		197							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	25	3		N1	T3b																			TUMOR FREE	4	Complete Remission/Response	No	0.3	NO	R1	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate			LIVING	2013					TCGA-EJ-A7NN-01	f46d3930-be89-420e-b0b7-ffad2c8149e7		TCGA-EJ-A7NN-01A-11D-A33T-08		f46d3930-be89-420e-b0b7-ffad2c8149e7		f46d3930-be89-420e-b0b7-ffad2c8149e7			TCGA-EJ-A7NN-01A-11D-A33U-05	TCGA-EJ-A7NN-01A-11R-A343-13		f46d3930-be89-420e-b0b7-ffad2c8149e7	
TCGA-EJ-A8FN-01	0	TCGA-EJ-A8FN-01	329	0	TCGA-EJ-A8FN	329	0	329	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-EJ-A8FN-F64780	NO		M0	T2c	-21506		203					0	329		203							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	330		NO	Bilateral		NO	YES				NO	25	0	true	N0	T2c	TCGA-EJ-A8FN.FCAC56D3-5775-4A05-A739-108C8FBC9FD8.pdf			0		0		0		0		50		0		50		60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2013				b0c2a29e-984b-483b-8a2a-ca1de742aded	TCGA-EJ-A8FN-01	0984a482-7559-48b4-a09d-d95f78816f23		TCGA-EJ-A8FN-01A-11D-A34U-08	TCGA-EJ-A8FN-01A-11D-A34T-01	0984a482-7559-48b4-a09d-d95f78816f23	TCGA-EJ-A8FN-01A-11D-A34T-01	0984a482-7559-48b4-a09d-d95f78816f23		TCGA-EJ-A8FN-01	TCGA-EJ-A8FN-01A-11D-A34V-05	TCGA-EJ-A8FN-01A-11R-A358-13		0984a482-7559-48b4-a09d-d95f78816f23	b0c2a29e-984b-483b-8a2a-ca1de742aded
TCGA-EJ-A8FO-01	0	TCGA-EJ-A8FO-01	282	0	TCGA-EJ-A8FO	282	0	282	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51	TCGA-EJ-A8FO-F64781	NO		M0	T3a	-18875		177					0	282		156							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma  Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral		NO	YES				NO	37	0	true	N0	T3a	TCGA-EJ-A8FO.72728A33-3CFC-43B5-B88C-B2DC34C83207.pdf			0		0		0		0		5		35		60		70	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013				d63f9cfe-146e-401b-a672-7832324e75e2	TCGA-EJ-A8FO-01	56336ee0-a1f8-4426-adec-b1c92d96891f		TCGA-EJ-A8FO-01A-21D-A364-08	TCGA-EJ-A8FO-01A-21D-A363-01	56336ee0-a1f8-4426-adec-b1c92d96891f	TCGA-EJ-A8FO-01A-21D-A363-01	56336ee0-a1f8-4426-adec-b1c92d96891f		TCGA-EJ-A8FO-01	TCGA-EJ-A8FO-01A-21D-A365-05	TCGA-EJ-A8FO-01A-21R-A36B-13		56336ee0-a1f8-4426-adec-b1c92d96891f	d63f9cfe-146e-401b-a672-7832324e75e2
TCGA-EJ-A8FO-11	0	TCGA-EJ-A8FO-11	282	0	TCGA-EJ-A8FO	282	0	282	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51	TCGA-EJ-A8FO-F64781	NO		M0	T3a	-18875		177					0	282		156							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma  Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	500		NO	Bilateral		NO	YES				NO	37	0	true	N0	T3a				0		0		0		0		25		75		0		0	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013						edeacf74-688e-4996-868e-e78277d17415				edeacf74-688e-4996-868e-e78277d17415		edeacf74-688e-4996-868e-e78277d17415				TCGA-EJ-A8FO-11A-11R-A36B-13		edeacf74-688e-4996-868e-e78277d17415	
TCGA-EJ-A8FP-01	0	TCGA-EJ-A8FP-01	299	0	TCGA-EJ-A8FP	299	0	299	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	59	TCGA-EJ-A8FP-F64784	YES		M0	T2c	-21769						117	0	299		117							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	8	Prostate Adenocarcinoma  Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	40	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.2	NO	R0	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate			LIVING	2013				ff5aaab8-c118-4cdf-a6d6-cf095fab162b	TCGA-EJ-A8FP-01	b9ec6c3f-9801-4c81-9c80-fabc85306c31		TCGA-EJ-A8FP-01A-21D-A364-08	TCGA-EJ-A8FP-01A-21D-A363-01	b9ec6c3f-9801-4c81-9c80-fabc85306c31	TCGA-EJ-A8FP-01A-21D-A363-01	b9ec6c3f-9801-4c81-9c80-fabc85306c31		TCGA-EJ-A8FP-01	TCGA-EJ-A8FP-01A-21D-A365-05	TCGA-EJ-A8FP-01A-21R-A36B-13		b9ec6c3f-9801-4c81-9c80-fabc85306c31	ff5aaab8-c118-4cdf-a6d6-cf095fab162b
TCGA-EJ-A8FS-01	0	TCGA-EJ-A8FS-01	266	0	TCGA-EJ-A8FS	266	0	266	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-EJ-A8FS-F64787	YES		M0	T3a	-24380		126				216	0	266		216							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Transurethral resection (TURBT)	130		NO	Bilateral		NO	YES				NO	69	0	true	N0	T3a	TCGA-EJ-A8FS.18FF4FBA-0D6B-44D5-B5B5-68CD8DADF716.pdf			0		0		0		0		50		0		50		60	TUMOR FREE	3	Complete Remission/Response	No	0.3	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2013				23ba5dc4-65ab-49bd-bd71-deb63b208437	TCGA-EJ-A8FS-01	b31f1e9a-cc4d-4e17-ab88-d88e234df83d		TCGA-EJ-A8FS-01A-11D-A34U-08	TCGA-EJ-A8FS-01A-11D-A34T-01	b31f1e9a-cc4d-4e17-ab88-d88e234df83d	TCGA-EJ-A8FS-01A-11D-A34T-01	b31f1e9a-cc4d-4e17-ab88-d88e234df83d		TCGA-EJ-A8FS-01	TCGA-EJ-A8FS-01A-11D-A34V-05	TCGA-EJ-A8FS-01A-11R-A358-13		b31f1e9a-cc4d-4e17-ab88-d88e234df83d	23ba5dc4-65ab-49bd-bd71-deb63b208437
TCGA-EJ-A8FU-01	0	TCGA-EJ-A8FU-01	138	0	TCGA-EJ-A8FU	138	0	138	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-EJ-A8FU-F64788			M0	T3a	-23472		89					0	138									Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	29	0	true	N0	T3a	TCGA-EJ-A8FU.613A9A17-E6E6-4A15-A06A-FB3D91D7459A.pdf			6		0		1		1		3		77		19		60	TUMOR FREE	5	Complete Remission/Response	No		NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013				5586ad35-94b7-459e-8982-8e7fb25697a1	TCGA-EJ-A8FU-01	7adcdf73-3ad3-4da7-ab27-2888f1d4f53a		TCGA-EJ-A8FU-01A-11D-A364-08	TCGA-EJ-A8FU-01A-11D-A363-01	7adcdf73-3ad3-4da7-ab27-2888f1d4f53a	TCGA-EJ-A8FU-01A-11D-A363-01	7adcdf73-3ad3-4da7-ab27-2888f1d4f53a		TCGA-EJ-A8FU-01	TCGA-EJ-A8FU-01A-11D-A365-05	TCGA-EJ-A8FU-01A-11R-A36B-13		7adcdf73-3ad3-4da7-ab27-2888f1d4f53a	5586ad35-94b7-459e-8982-8e7fb25697a1
TCGA-EJ-AB20-01	0	TCGA-EJ-AB20-01	131	0	TCGA-EJ-AB20	131	0	131	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-EJ-AB20-F64790	NO		M0	T2c	-22626		136					0	131		131							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	180		NO	Bilateral		NO	YES				NO	18	0	true	N0	T2c	TCGA-EJ-AB20.C1D97704-7C64-4C39-8812-BD8B95C2299F.pdf			3		1		0		2		5		25		70		70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013				28f34dfd-5b42-46d6-8b67-479c3852f997	TCGA-EJ-AB20-01	4e640b86-66f7-458c-af5c-b195778aa295			TCGA-EJ-AB20-01A-12D-A41J-01	4e640b86-66f7-458c-af5c-b195778aa295	TCGA-EJ-AB20-01A-12D-A41J-01	4e640b86-66f7-458c-af5c-b195778aa295		TCGA-EJ-AB20-01	TCGA-EJ-AB20-01A-12D-A41L-05	TCGA-EJ-AB20-01A-12R-A41R-13		4e640b86-66f7-458c-af5c-b195778aa295	28f34dfd-5b42-46d6-8b67-479c3852f997
TCGA-EJ-AB27-01	0	TCGA-EJ-AB27-01	145	0	TCGA-EJ-AB27	145	0	145	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51	TCGA-EJ-AB27-F64798	NO		M0	T1c	-18648		130					0	145		145							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	490		NO	Bilateral		NO	YES				NO	15	0	true	N0	T2c	TCGA-EJ-AB27.83FBE69E-525B-4833-BD10-AE4360BFF925.pdf			4		0		2		0		2		38		58		90	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013				d72c08d9-1f90-4098-9172-a81d4cd752c0	TCGA-EJ-AB27-01	7ea62df0-1cc5-4bd9-ad9e-3d68aa965731			TCGA-EJ-AB27-01A-11D-A41J-01	7ea62df0-1cc5-4bd9-ad9e-3d68aa965731	TCGA-EJ-AB27-01A-11D-A41J-01	7ea62df0-1cc5-4bd9-ad9e-3d68aa965731		TCGA-EJ-AB27-01	TCGA-EJ-AB27-01A-11D-A41L-05	TCGA-EJ-AB27-01A-11R-A41R-13		7ea62df0-1cc5-4bd9-ad9e-3d68aa965731	d72c08d9-1f90-4098-9172-a81d4cd752c0
TCGA-FC-7708-01	0	TCGA-FC-7708-01	864	0	TCGA-FC-7708	864	0	864	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			52	TCGA-FC-7708-F55508	NO		M0	T1c	-19144							0	864					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-1-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.3	YES	YES				NO	4	0		N0	T3a	TCGA-FC-7708.da17eddc-be95-4387-9c6a-fa647f33ceb7.pdf						0	0			25	25	15	15	60	60	60	60	TUMOR FREE	4	Complete Remission/Response	No		NO	RX	Primary Tumor	01	3	0.2		NO		YES	NO	FC	Apex|Middle		Prostate		A	LIVING	2011	Overlapping / Multiple Zones		TCGA-FC-7708-01A-11D-2114-08	4b22cb7e-77f0-44d0-a12a-4e4c9e592718	TCGA-FC-7708-01	39239ac6-7757-43ca-928a-4885260ecbc7	TCGA-FC-7708-01A-11D-2114-08	TCGA-FC-7708-01A-11D-2114-08	TCGA-FC-7708-01A-11D-2112-01	39239ac6-7757-43ca-928a-4885260ecbc7	TCGA-FC-7708-01A-11D-2112-01	39239ac6-7757-43ca-928a-4885260ecbc7	AD6852A9-511A-4380-80DD-ACEC1139B9E9	TCGA-FC-7708-01	TCGA-FC-7708-01A-11D-2116-05	TCGA-FC-7708-01A-11R-2117-13	TCGA-FC-7708-01A-11D-2114-08	39239ac6-7757-43ca-928a-4885260ecbc7	4b22cb7e-77f0-44d0-a12a-4e4c9e592718
TCGA-FC-7961-01	0	TCGA-FC-7961-01	469	0	TCGA-FC-7961	469	0	469	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-FC-7961-F33190			M0	T1c	-22888				65			0	469					YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2012-6-22	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.9	YES	YES				NO	3	0		N0	T3a								0				3		10		87		85	TUMOR FREE	4	Complete Remission/Response	No		NO		Primary Tumor	01	5	0.3		NO		YES	NO	FC	Apex		Prostate		A	LIVING	2011	Peripheral Zone		TCGA-FC-7961-01A-11D-A29Q-08	77c144d6-76b1-408e-bf59-ebcf1b17eae4	TCGA-FC-7961-01	038600cd-c0ca-4de4-9539-570f7b960793	TCGA-FC-7961-01A-11D-A29Q-08	TCGA-FC-7961-01A-11D-A29Q-08	TCGA-FC-7961-01A-11D-A323-01	038600cd-c0ca-4de4-9539-570f7b960793	TCGA-FC-7961-01A-11D-A323-01	038600cd-c0ca-4de4-9539-570f7b960793	3B491827-1556-45E0-B647-AB15B3716C84	TCGA-FC-7961-01	TCGA-FC-7961-01A-11D-A29T-05	TCGA-FC-7961-01A-11R-A29V-13	TCGA-FC-7961-01A-11D-A29Q-08	038600cd-c0ca-4de4-9539-570f7b960793	77c144d6-76b1-408e-bf59-ebcf1b17eae4
TCGA-FC-A4JI-01	0	TCGA-FC-A4JI-01	409	0	TCGA-FC-A4JI	409	0	409	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-FC-A4JI-F46430		Normal (no evidence of prostate cancer) [cM0]		T4	-25931	12	101		16			0	409					YES	Extraprostatic Extension  Localized (e.g. seminal vesicles)	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-7	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	630		NO	Bilateral		NO	NO				NO			true		T3a	TCGA-FC-A4JI.BEFDDE59-6838-433A-BAFC-82B4D3802349.pdf			0		0		3		0		0		7		90		90	TUMOR FREE	5	Complete Remission/Response	No		YES	R0	Primary Tumor	01	3			YES		YES	NO	FC	Apex|Middle|Base		Prostate		A	LIVING	2012	Central Zone		TCGA-FC-A4JI-01A-11D-A257-08	40bfa491-7667-4b80-935b-dd0ce559e001	TCGA-FC-A4JI-01	4351923f-0818-42f3-9869-6963bcd2e98d	TCGA-FC-A4JI-01A-11D-A257-08	TCGA-FC-A4JI-01A-11D-A257-08	TCGA-FC-A4JI-01A-11D-A256-01	4351923f-0818-42f3-9869-6963bcd2e98d	TCGA-FC-A4JI-01A-11D-A256-01	4351923f-0818-42f3-9869-6963bcd2e98d	9ECD6E03-86DE-4395-9BCF-34A4AD7369C8	TCGA-FC-A4JI-01	TCGA-FC-A4JI-01A-11D-A258-05	TCGA-FC-A4JI-01A-11R-A25C-13	TCGA-FC-A4JI-01A-11D-A257-08	4351923f-0818-42f3-9869-6963bcd2e98d	40bfa491-7667-4b80-935b-dd0ce559e001
TCGA-FC-A5OB-01	0	TCGA-FC-A5OB-01	680	0	TCGA-FC-A5OB	680	0	680	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-FC-A5OB-F61434	NO	Abnormal (not related to prostate cancer)	M0	T3a	-19413	9	162		9			0	680		110			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-6-30	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	9	0	true	N0	T3b	TCGA-FC-A5OB.E54208A5-C6DA-450A-AA5D-9A8FE5F6ECD6.pdf			0		0		0		0		2		13		85		90	WITH TUMOR	4		No	5.22	YES	R1	Primary Tumor	01	5			YES		YES	NO	FC	Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones		TCGA-FC-A5OB-01A-11D-A29Q-08	c8377fd0-a9e1-4985-ad6a-ddda9dba7d32	TCGA-FC-A5OB-01	131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d	TCGA-FC-A5OB-01A-11D-A29Q-08	TCGA-FC-A5OB-01A-11D-A29Q-08	TCGA-FC-A5OB-01A-11D-A323-01	131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d	TCGA-FC-A5OB-01A-11D-A323-01	131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d	D10ACA59-D338-42DF-98CF-3700E1685EE7	TCGA-FC-A5OB-01	TCGA-FC-A5OB-01A-11D-A29T-05	TCGA-FC-A5OB-01A-11R-A29V-13	TCGA-FC-A5OB-01A-11D-A29Q-08	131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d	c8377fd0-a9e1-4985-ad6a-ddda9dba7d32
TCGA-FC-A66V-01	0	TCGA-FC-A66V-01	524	0	TCGA-FC-A66V	524	0	524	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			74	TCGA-FC-A66V-F52816	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3b	-27282	28	287		27			0	524		-164			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-12-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	180		NO	Bilateral		YES	YES				NO	2	0	true	N0	T3b	TCGA-FC-A66V.3C1BD6CD-0915-4DEA-A013-F2DE554C267F.pdf			1		0		0		0		30		0		70		70	TUMOR FREE	4	Complete Remission/Response	No	10.8	NO	R0	Primary Tumor	01	3			NO		YES	NO	FC	Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			e9ad93d6-d9e2-4b01-87e4-9dc8041178fb	TCGA-FC-A66V-01	60448472-d440-4608-8fca-b54c41c5cde1	TCGA-FC-A66V-01A-21D-A30E-08	TCGA-FC-A66V-01A-21D-A30E-08	TCGA-FC-A66V-01A-21D-A30D-01	60448472-d440-4608-8fca-b54c41c5cde1	TCGA-FC-A66V-01A-21D-A30D-01	60448472-d440-4608-8fca-b54c41c5cde1		TCGA-FC-A66V-01	TCGA-FC-A66V-01A-21D-A30F-05	TCGA-FC-A66V-01A-21R-A30I-13	TCGA-FC-A66V-01A-21D-A30E-08	60448472-d440-4608-8fca-b54c41c5cde1	e9ad93d6-d9e2-4b01-87e4-9dc8041178fb
TCGA-FC-A6HD-01	0	TCGA-FC-A6HD-01	494	0	TCGA-FC-A6HD	494	0	494	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			77	TCGA-FC-A6HD-F59729	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-28197	33	140		33			0	494		-5			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-5-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	10	0	true	N0	T3a	TCGA-FC-A6HD.7452FEB1-FFB9-4DD2-8CD7-5BEB2B108208.pdf			0		0		0		0		30		0		70		85	TUMOR FREE	4	Complete Remission/Response	No	19.08	NO	R0	Primary Tumor	01	3			NO		YES	NO	FC	Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones		TCGA-FC-A6HD-01A-11D-A31L-08	64923179-e258-493b-aee7-4810190b4aaa	TCGA-FC-A6HD-01	6b96fce2-199f-463c-982e-4ed8179ddd90	TCGA-FC-A6HD-01A-11D-A31L-08	TCGA-FC-A6HD-01A-11D-A31L-08	TCGA-FC-A6HD-01A-11D-A31K-01	6b96fce2-199f-463c-982e-4ed8179ddd90	TCGA-FC-A6HD-01A-11D-A31K-01	6b96fce2-199f-463c-982e-4ed8179ddd90		TCGA-FC-A6HD-01	TCGA-FC-A6HD-01A-11D-A31M-05	TCGA-FC-A6HD-01A-11R-A31R-13	TCGA-FC-A6HD-01A-11D-A31L-08	6b96fce2-199f-463c-982e-4ed8179ddd90	64923179-e258-493b-aee7-4810190b4aaa
TCGA-FC-A8O0-01	0	TCGA-FC-A8O0-01	54	0	TCGA-FC-A8O0	54	0	54	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68		NO		M0	T2c	-25115		168		10	-8		0	54		18			YES	Extraprostatic Extension  Localized (e.g. seminal vesicles)	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1]			2014-2-27	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	430		NO	Bilateral			YES				NO	12	0	true	N0	T3a	TCGA-FC-A8O0.4DC18F34-9319-45E5-8ECA-D86E9CD81EE6.pdf			0		0		0		0		0		30		70		90	TUMOR FREE	3	Complete Remission/Response	No	7.82		R0	Primary Tumor	01	3				4	YES	NO	FC	Base		Prostate		A	LIVING	2013	Peripheral Zone			430a76ec-07bd-4b82-89ad-c0d79f35b48d	TCGA-FC-A8O0-01	e5b8a092-0e86-4003-9ba6-112006161e93		TCGA-FC-A8O0-01A-41D-A377-08	TCGA-FC-A8O0-01A-41D-A376-01	e5b8a092-0e86-4003-9ba6-112006161e93	TCGA-FC-A8O0-01A-41D-A376-01	e5b8a092-0e86-4003-9ba6-112006161e93		TCGA-FC-A8O0-01	TCGA-FC-A8O0-01A-41D-A378-05	TCGA-FC-A8O0-01A-41R-A37H-13		e5b8a092-0e86-4003-9ba6-112006161e93	430a76ec-07bd-4b82-89ad-c0d79f35b48d
TCGA-G9-6329-01	0	TCGA-G9-6329-01	1266	0	TCGA-G9-6329	1266	0	1266	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-G9-6329-F40680	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24797	10			10			0	1266		923			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.3	NO	NO				NO					T2c	TCGA-G9-6329.fd7b8f28-b1ee-428e-859c-c888c459a3b0.pdf		0	1		0		1	0	0	70	10	0	15	30	75	0	78	TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	4	0.2		NO		NO	YES	G9			Prostate		A	LIVING	2009			TCGA-G9-6329-01A-13D-1961-08	f4128d22-86fd-4c8f-8624-9088fdbf25b8	TCGA-G9-6329-01	3b6f54f6-1812-474f-aced-f6790e59611c	TCGA-G9-6329-01A-13D-1961-08	TCGA-G9-6329-01A-13D-1961-08	TCGA-G9-6329-01A-13D-1959-01	3b6f54f6-1812-474f-aced-f6790e59611c	TCGA-G9-6329-01A-13D-1959-01	3b6f54f6-1812-474f-aced-f6790e59611c	41AF7C4D-6EF8-49D7-9F6A-2A84A4BB23BB	TCGA-G9-6329-01	TCGA-G9-6329-01A-13D-1963-05	TCGA-G9-6329-01A-13R-1964-13	TCGA-G9-6329-01A-13D-1961-08	3b6f54f6-1812-474f-aced-f6790e59611c	f4128d22-86fd-4c8f-8624-9088fdbf25b8
TCGA-G9-6332-01	0	TCGA-G9-6332-01	2657	0	TCGA-G9-6332	1180	1	2657	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	55	TCGA-G9-6332-F40974		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20166	11			11		1180	0	2657	1180	2090			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.2	NO	Bilateral	0.4	NO	YES		Biochemical evidence of disease		YES	7	0		N0	T3a	TCGA-G9-6332.18b9fda1-2d69-4c5e-94ba-bfbbcd742bdd.pdf			1		0		0		0		15		10		70		75	WITH TUMOR	4	Complete Remission/Response	No	0.73	NO	R0	Primary Tumor	01	3	0.1		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2005		TCGA-G9-6332-01A-11D-1786-08	TCGA-G9-6332-01A-11D-1786-08	583b8007-12cc-4c42-a6d8-2ef36cdbadbc	TCGA-G9-6332-01	22ec0a34-74ad-48d6-80f4-b88ef082101d	TCGA-G9-6332-01A-11D-1786-08	TCGA-G9-6332-01A-11D-1786-08	TCGA-G9-6332-01A-11D-1785-01	22ec0a34-74ad-48d6-80f4-b88ef082101d	TCGA-G9-6332-01A-11D-1785-01	22ec0a34-74ad-48d6-80f4-b88ef082101d		TCGA-G9-6332-01	TCGA-G9-6332-01A-11D-1787-05	TCGA-G9-6332-01A-11R-1788-13	TCGA-G9-6332-01A-11D-1786-08	22ec0a34-74ad-48d6-80f4-b88ef082101d	583b8007-12cc-4c42-a6d8-2ef36cdbadbc
TCGA-G9-6332-11	0	TCGA-G9-6332-11	2657	0	TCGA-G9-6332	1180	1	2657	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	55	TCGA-G9-6332-F40974		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20166	11			11		1180	0	2657	1180	2090			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1	NO	YES		Biochemical evidence of disease		YES	7	0		N0	T3a																			WITH TUMOR	4	Complete Remission/Response	No	0.73	NO	R0	Solid Tissue Normal	11	3	0.5		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2005															TCGA-G9-6332-11A-01D-1787-05				
TCGA-G9-6333-01	0	TCGA-G9-6333-01	1925	0	TCGA-G9-6333	1925	0	1925	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-G9-6333-F40652	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24249	1102			1102			0	1925		1920			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	YES				NO	13	0		N0	T2c	TCGA-G9-6333.df50612f-a299-468b-b6bf-226366f4cf42.pdf			1		0		0		0		10		15		75		80	TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	3	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2006			TCGA-G9-6333-01A-12D-1961-08	42cd79b7-b298-459f-9186-2df6077c99a8	TCGA-G9-6333-01	644e2830-703e-4a1f-86e3-f9cea798c1eb	TCGA-G9-6333-01A-12D-1961-08	TCGA-G9-6333-01A-12D-1961-08	TCGA-G9-6333-01A-12D-1959-01	644e2830-703e-4a1f-86e3-f9cea798c1eb	TCGA-G9-6333-01A-12D-1959-01	644e2830-703e-4a1f-86e3-f9cea798c1eb		TCGA-G9-6333-01	TCGA-G9-6333-01A-12D-1963-05	TCGA-G9-6333-01A-12R-1964-13	TCGA-G9-6333-01A-12D-1961-08	644e2830-703e-4a1f-86e3-f9cea798c1eb	42cd79b7-b298-459f-9186-2df6077c99a8
TCGA-G9-6333-11	0	TCGA-G9-6333-11	1925	0	TCGA-G9-6333	1925	0	1925	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-G9-6333-F40652	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24249	1102			1102			0	1925		1920			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.4	NO	YES				NO	13	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R0	Solid Tissue Normal	11	3	0.4		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2006						7e787a16-e77d-46eb-8666-7489349b5c82				7e787a16-e77d-46eb-8666-7489349b5c82		7e787a16-e77d-46eb-8666-7489349b5c82			TCGA-G9-6333-11A-01D-1963-05	TCGA-G9-6333-11A-01R-1964-13		7e787a16-e77d-46eb-8666-7489349b5c82	
TCGA-G9-6336-01	0	TCGA-G9-6336-01	2068	0	TCGA-G9-6336	2068	0	2068	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-G9-6336-F40679	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-20851	98			104			0	2068		1669			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.4	NO	YES				NO	5	0		N0		TCGA-G9-6336.ceda2ffb-b844-4f89-baba-82a66e6f3f0e.pdf			2		0		20		2		15		20		65		70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R1	Primary Tumor	01	4	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2007		TCGA-G9-6336-01A-11D-1786-08	TCGA-G9-6336-01A-11D-1786-08	e597dc1b-39be-4280-99d0-b9f2ff614a6a	TCGA-G9-6336-01	9cbe4eef-89aa-453e-b22b-1c1256bf3c51	TCGA-G9-6336-01A-11D-1786-08	TCGA-G9-6336-01A-11D-1786-08	TCGA-G9-6336-01A-11D-1785-01	9cbe4eef-89aa-453e-b22b-1c1256bf3c51	TCGA-G9-6336-01A-11D-1785-01	9cbe4eef-89aa-453e-b22b-1c1256bf3c51		TCGA-G9-6336-01	TCGA-G9-6336-01A-11D-1787-05	TCGA-G9-6336-01A-11R-1788-13		9cbe4eef-89aa-453e-b22b-1c1256bf3c51	e597dc1b-39be-4280-99d0-b9f2ff614a6a
TCGA-G9-6338-01	0	TCGA-G9-6338-01	1831	0	TCGA-G9-6338	1831	0	1831	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-G9-6338-F40677		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22360	13			82			0	1831		1634			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	2	0		N0	T3a	TCGA-G9-6338.d3962697-f160-4a76-bfbe-81c06c89d5c3.pdf		2	2	0	0	0	0	0	0	15	10	20	15	65	75	65	75	TUMOR FREE	4	Complete Remission/Response	No	0.05	NO	R1	Primary Tumor	01	3	0.2		NO		NO	YES	G9	Apex		Prostate		A	LIVING	2007			TCGA-G9-6338-01A-12D-1961-08	13e0c2e6-d855-48e4-9e33-5bdcfc4d0ea9	TCGA-G9-6338-01	3790dc43-aa3d-4d1b-aa7a-340675c98bd4	TCGA-G9-6338-01A-12D-1961-08	TCGA-G9-6338-01A-12D-1961-08	TCGA-G9-6338-01A-12D-1959-01	3790dc43-aa3d-4d1b-aa7a-340675c98bd4	TCGA-G9-6338-01A-12D-1959-01	3790dc43-aa3d-4d1b-aa7a-340675c98bd4	186A0C7B-C4BC-47F6-A2B3-43D06A5E72A1	TCGA-G9-6338-01	TCGA-G9-6338-01A-12D-1963-05	TCGA-G9-6338-01A-12R-1964-13	TCGA-G9-6338-01A-12D-1961-08	3790dc43-aa3d-4d1b-aa7a-340675c98bd4	13e0c2e6-d855-48e4-9e33-5bdcfc4d0ea9
TCGA-G9-6339-01	0	TCGA-G9-6339-01	2362	0	TCGA-G9-6339	2362	0	2362	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-G9-6339-F65344	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3b	-21305	4					1634	0	2362		2110			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.3	NO	YES				NO	6	0		N0	T3b				0		0		0		0		15		45		40		60	TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	4	0.3		NO		NO	YES	G9	Apex|Middle|Base		Prostate		A	LIVING	2007			TCGA-G9-6339-01A-12D-A30X-08	f47c9e33-d7cc-4ecb-a650-730b2ec7a9b3	TCGA-G9-6339-01	18c4e2fd-5696-4577-bd9d-019a402f7c81	TCGA-G9-6339-01A-12D-A30X-08	TCGA-G9-6339-01A-12D-A30X-08	TCGA-G9-6339-01A-12D-A30W-01	18c4e2fd-5696-4577-bd9d-019a402f7c81	TCGA-G9-6339-01A-12D-A30W-01	18c4e2fd-5696-4577-bd9d-019a402f7c81		TCGA-G9-6339-01	TCGA-G9-6339-01A-12D-A30Z-05	TCGA-G9-6339-01A-12R-A310-13	TCGA-G9-6339-01A-12D-A30X-08	18c4e2fd-5696-4577-bd9d-019a402f7c81	f47c9e33-d7cc-4ecb-a650-730b2ec7a9b3
TCGA-G9-6342-01	0	TCGA-G9-6342-01	1696	0	TCGA-G9-6342	1696	0	1696	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-G9-6342-F40650	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-22472	32			36			0	1696		1338			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.8	NO	NO				NO					T3a	TCGA-G9-6342.80379cb8-9fb7-4e01-9e4a-2bf7813dc839.pdf		15	3	0	2	0	5	0	0	20	20	15	10	65	65	75	75	TUMOR FREE	3	Complete Remission/Response	No	0.05	NO	R0	Primary Tumor	01	3	0.3		NO	4	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008			TCGA-G9-6342-01A-11D-1961-08	5f3e122f-bef3-496d-9345-c25e659277ed	TCGA-G9-6342-01	07384291-d5cc-44d8-a025-f10636c91691	TCGA-G9-6342-01A-11D-1961-08	TCGA-G9-6342-01A-11D-1961-08	TCGA-G9-6342-01A-11D-1959-01	07384291-d5cc-44d8-a025-f10636c91691	TCGA-G9-6342-01A-11D-1959-01	07384291-d5cc-44d8-a025-f10636c91691	78676530-C980-4B09-984C-A54A0B59899D	TCGA-G9-6342-01	TCGA-G9-6342-01A-11D-1963-05	TCGA-G9-6342-01A-11R-1964-13	TCGA-G9-6342-01A-11D-1961-08	07384291-d5cc-44d8-a025-f10636c91691	5f3e122f-bef3-496d-9345-c25e659277ed
TCGA-G9-6342-11	0	TCGA-G9-6342-11	1696	0	TCGA-G9-6342	1696	0	1696	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-G9-6342-F40650	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-22472	32			36			0	1696		1338			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.2	NO	NO				NO					T3a																			TUMOR FREE	3	Complete Remission/Response	No	0.05	NO	R0	Solid Tissue Normal	11	3	0.5		NO	4	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008						35c918eb-2a20-4e32-93d4-ae2c80d6cee7				35c918eb-2a20-4e32-93d4-ae2c80d6cee7		35c918eb-2a20-4e32-93d4-ae2c80d6cee7			TCGA-G9-6342-11A-02D-1963-05	TCGA-G9-6342-11A-02R-1964-13		35c918eb-2a20-4e32-93d4-ae2c80d6cee7	
TCGA-G9-6343-01	0	TCGA-G9-6343-01	554	0	TCGA-G9-6343			554	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-G9-6343-F40964	NO		M0	T2a	-22843							0	554		554			NO		NO		Scheduled Follow-up Submission		2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.5	YES	NO									T2c	TCGA-G9-6343.3d7d837b-a09e-4281-93af-a789123a9356.pdf			1		0		5		0		15		10		70		75	TUMOR FREE	4		No	0.03		R0	Primary Tumor	01	3	0.2				NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008			TCGA-G9-6343-01A-21D-1961-08	77cc98e1-333a-4e28-b53c-f96483486c76	TCGA-G9-6343-01	938046b4-330f-49e1-99b3-4cc4a1a1e48d	TCGA-G9-6343-01A-21D-1961-08	TCGA-G9-6343-01A-21D-1961-08	TCGA-G9-6343-01A-21D-1959-01	938046b4-330f-49e1-99b3-4cc4a1a1e48d	TCGA-G9-6343-01A-21D-1959-01	938046b4-330f-49e1-99b3-4cc4a1a1e48d	16D4166B-4EF0-476D-AD9A-7A2D8CD0E180	TCGA-G9-6343-01	TCGA-G9-6343-01A-21D-1963-05	TCGA-G9-6343-01A-21R-1964-13	TCGA-G9-6343-01A-21D-1961-08	938046b4-330f-49e1-99b3-4cc4a1a1e48d	77cc98e1-333a-4e28-b53c-f96483486c76
TCGA-G9-6347-01	0	TCGA-G9-6347-01	2089	0	TCGA-G9-6347	2089	0	2089	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-G9-6347-F61289	NO		M0	T1c	-21721							0	2089		1718			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-26	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1	NO	NO				NO					T2c				0		0		0		0		30		0		70		60	TUMOR FREE	3	Complete Remission/Response	No	00.03	NO	R0	Primary Tumor	01	3	0.1		NO		NO	YES	G9	Apex|Middle		Prostate		A	LIVING	2008	Peripheral Zone		TCGA-G9-6347-01A-11D-A31L-08	c994720a-b3b4-47b1-9dc8-e21bba25c04e	TCGA-G9-6347-01	817b51f3-fa06-4c82-956e-220b4396d30b	TCGA-G9-6347-01A-11D-A31L-08	TCGA-G9-6347-01A-11D-A31L-08	TCGA-G9-6347-01A-11D-A31K-01	817b51f3-fa06-4c82-956e-220b4396d30b	TCGA-G9-6347-01A-11D-A31K-01	817b51f3-fa06-4c82-956e-220b4396d30b		TCGA-G9-6347-01	TCGA-G9-6347-01A-11D-A31M-05	TCGA-G9-6347-01A-11R-A31R-13	TCGA-G9-6347-01A-11D-A31L-08	817b51f3-fa06-4c82-956e-220b4396d30b	c994720a-b3b4-47b1-9dc8-e21bba25c04e
TCGA-G9-6348-01	0	TCGA-G9-6348-01	1515	0	TCGA-G9-6348	1515	0	1515	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-G9-6348-F40648	NO	Abnormal (not related to prostate cancer)	M0	T3a	-24936	31			31			0	1515		1136			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO	15	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.02	NO	R0	Primary Tumor	01	4			NO		NO	YES	G9	Apex|Base		Prostate			LIVING	2008		TCGA-G9-6348-01A-11D-1786-08	TCGA-G9-6348-01A-11D-1786-08	c04f4a37-36f0-4a8a-9b36-48be41c3bd68	TCGA-G9-6348-01	f1647dd0-3eda-473f-9902-12d0817ee165	TCGA-G9-6348-01A-11D-1786-08	TCGA-G9-6348-01A-11D-1786-08	TCGA-G9-6348-01A-11D-1785-01	f1647dd0-3eda-473f-9902-12d0817ee165	TCGA-G9-6348-01A-11D-1785-01	f1647dd0-3eda-473f-9902-12d0817ee165		TCGA-G9-6348-01	TCGA-G9-6348-01A-11D-1787-05	TCGA-G9-6348-01A-11R-1788-13	TCGA-G9-6348-01A-11D-1786-08	f1647dd0-3eda-473f-9902-12d0817ee165	c04f4a37-36f0-4a8a-9b36-48be41c3bd68
TCGA-G9-6348-11	0	TCGA-G9-6348-11	1515	0	TCGA-G9-6348	1515	0	1515	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-G9-6348-F40648	NO	Abnormal (not related to prostate cancer)	M0	T3a	-24936	31			31			0	1515		1136			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.1	NO	NO				NO	15	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.02	NO	R0	Solid Tissue Normal	11	4	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008						f2ad4c22-c476-44af-a8ca-dffcae313ae2				f2ad4c22-c476-44af-a8ca-dffcae313ae2		f2ad4c22-c476-44af-a8ca-dffcae313ae2			TCGA-G9-6348-11A-01D-1787-05	TCGA-G9-6348-11A-01R-1788-13		f2ad4c22-c476-44af-a8ca-dffcae313ae2	
TCGA-G9-6351-01	0	TCGA-G9-6351-01	1404	0	TCGA-G9-6351	1404	0	1404	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51	TCGA-G9-6351-F40969	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-18723	8			11			0	1404		1215			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.6	NO	NO				NO					T2c	TCGA-G9-6351.7942304b-0a3d-492c-bbb2-65695f1958e4.pdf			2		0		0		0		25		13		60		60	TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R1	Primary Tumor	01	4	0.3		NO		NO	YES	G9	Apex		Prostate		A	LIVING	2008			TCGA-G9-6351-01A-21D-1961-08	4b5ae95f-b79a-4aeb-a46c-612e089b64f6	TCGA-G9-6351-01	5b656979-9a9f-4ef2-8948-2979d1db0c68	TCGA-G9-6351-01A-21D-1961-08	TCGA-G9-6351-01A-21D-1961-08	TCGA-G9-6351-01A-21D-1959-01	5b656979-9a9f-4ef2-8948-2979d1db0c68	TCGA-G9-6351-01A-21D-1959-01	5b656979-9a9f-4ef2-8948-2979d1db0c68	0CC4613B-D3AE-44E1-86B8-BF52A68C44CD	TCGA-G9-6351-01	TCGA-G9-6351-01A-21D-1963-05	TCGA-G9-6351-01A-21R-1964-13	TCGA-G9-6351-01A-21D-1961-08	5b656979-9a9f-4ef2-8948-2979d1db0c68	4b5ae95f-b79a-4aeb-a46c-612e089b64f6
TCGA-G9-6351-11	0	TCGA-G9-6351-11	1404	0	TCGA-G9-6351	1404	0	1404	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51	TCGA-G9-6351-F40969	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-18723	8			11			0	1404		1215			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	120	1	NO	Bilateral	1.4	NO	NO				NO					T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R1	Solid Tissue Normal	11	4	0.3		NO		NO	YES	G9	Apex		Prostate		A	LIVING	2008						6b264e41-b852-4221-8e09-692a6a639ccf				6b264e41-b852-4221-8e09-692a6a639ccf		6b264e41-b852-4221-8e09-692a6a639ccf			TCGA-G9-6351-11A-01D-1963-05	TCGA-G9-6351-11A-01R-1964-13		6b264e41-b852-4221-8e09-692a6a639ccf	
TCGA-G9-6353-01	0	TCGA-G9-6353-01	1542	0	TCGA-G9-6353	1542	0	1542	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-G9-6353-F42753	NO		M0	T1c	-21221							0	1542		590			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	NO				NO					T3a	TCGA-G9-6353.72b2694f-8b37-402a-a75a-2a50372a789e.pdf		0	2	0	0	0	0	0	0	15	20	25	20	60	60	65	65	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R1	Primary Tumor	01	4	0.5		NO		NO	YES	G9	Apex|Middle		Prostate		A	LIVING	2009	Peripheral Zone		TCGA-G9-6353-01A-11D-1961-08	eee644bd-aedd-45b8-b158-5d7782f43aca	TCGA-G9-6353-01	f8cdc431-ee4c-4337-975f-eb380faebb8c	TCGA-G9-6353-01A-11D-1961-08	TCGA-G9-6353-01A-11D-1961-08	TCGA-G9-6353-01A-11D-1959-01	f8cdc431-ee4c-4337-975f-eb380faebb8c	TCGA-G9-6353-01A-11D-1959-01	f8cdc431-ee4c-4337-975f-eb380faebb8c	0B613135-6859-4DD9-9090-C52376CEA024	TCGA-G9-6353-01	TCGA-G9-6353-01A-11D-1963-05	TCGA-G9-6353-01A-11R-1964-13	TCGA-G9-6353-01A-11D-1961-08	f8cdc431-ee4c-4337-975f-eb380faebb8c	eee644bd-aedd-45b8-b158-5d7782f43aca
TCGA-G9-6353-11	0	TCGA-G9-6353-11	1542	0	TCGA-G9-6353	1542	0	1542	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-G9-6353-F42753	NO		M0	T1c	-21221							0	1542		590			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.1	NO	NO				NO					T3a																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R1	Solid Tissue Normal	11	4	0.6		NO		NO	YES	G9	Apex|Middle		Prostate		A	LIVING	2009	Peripheral Zone														TCGA-G9-6353-11A-02D-1963-05				
TCGA-G9-6354-01	0	TCGA-G9-6354-01	1501	0	TCGA-G9-6354	1501	0	1501	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-G9-6354-F65349	NO		M0	T1c	-20403							0	1501		525			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.1	NO	Right	0.6	NO	NO				NO					T2b				0		0		0		0		5		25		70		80	TUMOR FREE	3	Complete Remission/Response	No	00.03	NO	R0	Primary Tumor	01	4	0.1		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009			TCGA-G9-6354-01A-11D-A30X-08	877823a0-3984-4a46-9418-8efeffc9a88b	TCGA-G9-6354-01	99b27a89-5e60-4b2f-8d54-2bea08ac897c	TCGA-G9-6354-01A-11D-A30X-08	TCGA-G9-6354-01A-11D-A30X-08	TCGA-G9-6354-01A-11D-A30W-01	99b27a89-5e60-4b2f-8d54-2bea08ac897c	TCGA-G9-6354-01A-11D-A30W-01	99b27a89-5e60-4b2f-8d54-2bea08ac897c		TCGA-G9-6354-01	TCGA-G9-6354-01A-11D-A30Z-05	TCGA-G9-6354-01A-11R-A310-13	TCGA-G9-6354-01A-11D-A30X-08	99b27a89-5e60-4b2f-8d54-2bea08ac897c	877823a0-3984-4a46-9418-8efeffc9a88b
TCGA-G9-6356-01	0	TCGA-G9-6356-01	1434	0	TCGA-G9-6356	1434	0	1434	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-G9-6356-F40973	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22010	24			21			0	1434		986			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.3	NO	YES				NO	5	0		N0	T3b	TCGA-G9-6356.818a2716-ca81-4534-ba13-a0fe3a18b2e9.pdf		1	2	0	0	0	0	0	0	20	30	20	15	60	55	60	60	TUMOR FREE	4	Complete Remission/Response	No	0.13	NO	R1	Primary Tumor	01	5	0.6		NO	3	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		TCGA-G9-6356-01A-11D-1786-08	TCGA-G9-6356-01A-11D-1786-08	bab0286f-5437-4add-a929-f6d48bd21ae0	TCGA-G9-6356-01	9584ae14-c30b-421b-8975-b5b1bb94a465	TCGA-G9-6356-01A-11D-1786-08	TCGA-G9-6356-01A-11D-1786-08	TCGA-G9-6356-01A-11D-1785-01	9584ae14-c30b-421b-8975-b5b1bb94a465	TCGA-G9-6356-01A-11D-1785-01	9584ae14-c30b-421b-8975-b5b1bb94a465	64132E9C-00E9-4F9B-8DBB-63B39E1CFFC9	TCGA-G9-6356-01	TCGA-G9-6356-01A-11D-1787-05	TCGA-G9-6356-01A-11R-1788-13	TCGA-G9-6356-01A-11D-1786-08	9584ae14-c30b-421b-8975-b5b1bb94a465	bab0286f-5437-4add-a929-f6d48bd21ae0
TCGA-G9-6356-11	0	TCGA-G9-6356-11	1434	0	TCGA-G9-6356	1434	0	1434	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-G9-6356-F40973	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22010	24			21			0	1434		986			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1	NO	YES				NO	5	0		N0	T3b																			TUMOR FREE	4	Complete Remission/Response	No	0.13	NO	R1	Solid Tissue Normal	11	5	0.2		NO	3	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009						aabc18c1-ba2e-40a8-b564-eb97b2a188f8				aabc18c1-ba2e-40a8-b564-eb97b2a188f8		aabc18c1-ba2e-40a8-b564-eb97b2a188f8			TCGA-G9-6356-11A-01D-1787-05	TCGA-G9-6356-11A-01R-1788-13		aabc18c1-ba2e-40a8-b564-eb97b2a188f8	
TCGA-G9-6361-01	0	TCGA-G9-6361-01	1415	0	TCGA-G9-6361	1415	0	1415	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-G9-6361-F42767	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-22565	38			31			0	1415		1002			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.3	NO	YES				NO	12	0		N0	T3a	TCGA-G9-6361.49fe865a-79e8-4ff3-a52e-9888c4514cf2.pdf			2		0		0		0		10		20		70		70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R1	Primary Tumor	01	4	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009			TCGA-G9-6361-01A-21D-1961-08	acf7afe9-a0fb-477c-a19f-d69d37362258	TCGA-G9-6361-01	011453b6-9736-4ea4-8845-bbe4416783d3	TCGA-G9-6361-01A-21D-1961-08	TCGA-G9-6361-01A-21D-1961-08	TCGA-G9-6361-01A-21D-1959-01	011453b6-9736-4ea4-8845-bbe4416783d3	TCGA-G9-6361-01A-21D-1959-01	011453b6-9736-4ea4-8845-bbe4416783d3	E7B28BAE-ED87-4EF9-A0C9-A32D513CE718	TCGA-G9-6361-01	TCGA-G9-6361-01A-21D-1963-05	TCGA-G9-6361-01A-21R-1964-13	TCGA-G9-6361-01A-21D-1961-08	011453b6-9736-4ea4-8845-bbe4416783d3	acf7afe9-a0fb-477c-a19f-d69d37362258
TCGA-G9-6362-01	0	TCGA-G9-6362-01	1101	0	TCGA-G9-6362	1101	0	1101	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-G9-6362-F41012	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21149	8						0	1101		815			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.2	NO	YES				NO	2	0		N0	T3a	TCGA-G9-6362.fc8bac85-e3c5-47c1-b4c1-9b8834e01780.pdf		5	5	0	0	0	0	0	0	5	5	20	15	75	80	75	80	TUMOR FREE	4	Progressive Disease	No	0.07	NO	R1	Primary Tumor	01	3	0.2		NO	5	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		TCGA-G9-6362-01A-11D-1786-08	TCGA-G9-6362-01A-11D-1786-08	afd886a8-f121-452a-b810-85fa6c3dcd42	TCGA-G9-6362-01	986964bc-b680-4fc1-8f93-20772f0a8949	TCGA-G9-6362-01A-11D-1786-08	TCGA-G9-6362-01A-11D-1786-08	TCGA-G9-6362-01A-11D-1785-01	986964bc-b680-4fc1-8f93-20772f0a8949	TCGA-G9-6362-01A-11D-1785-01	986964bc-b680-4fc1-8f93-20772f0a8949	3840697C-A557-4C88-BE3D-8FE326DE6C5E	TCGA-G9-6362-01	TCGA-G9-6362-01A-11D-1787-05	TCGA-G9-6362-01A-11R-1788-13	TCGA-G9-6362-01A-11D-1786-08	986964bc-b680-4fc1-8f93-20772f0a8949	afd886a8-f121-452a-b810-85fa6c3dcd42
TCGA-G9-6362-11	0	TCGA-G9-6362-11	1101	0	TCGA-G9-6362	1101	0	1101	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-G9-6362-F41012	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21149	8						0	1101		815			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	250	0.8	NO	Bilateral	2	NO	YES				NO	2	0		N0	T3a																			TUMOR FREE	4	Progressive Disease	No	0.07	NO	R1	Solid Tissue Normal	11	3	0.4		NO	5	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009						d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642				d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642		d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642			TCGA-G9-6362-11A-01D-1787-05	TCGA-G9-6362-11A-01R-1788-13		d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642	
TCGA-G9-6363-01	0	TCGA-G9-6363-01	1175	0	TCGA-G9-6363	1175	0	1175	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-G9-6363-F40645	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-23480	58			23			0	1175		993			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.2	NO	YES				NO	6	0		N0	T4	TCGA-G9-6363.bd52ccc2-462d-41df-a5a4-dc45bd78aea4.pdf			5		2		0		0		10		25		65		70	TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	3	0.3		NO		NO	YES	G9	Base		Prostate		A	LIVING	2009		TCGA-G9-6363-01A-21D-1786-08	TCGA-G9-6363-01A-21D-1786-08	5f1c8721-1abd-437c-8143-8a095ea02097	TCGA-G9-6363-01	766eb893-3bc9-4a17-9b66-7eed2b1c01c3	TCGA-G9-6363-01A-21D-1786-08	TCGA-G9-6363-01A-21D-1786-08	TCGA-G9-6363-01A-21D-1785-01	766eb893-3bc9-4a17-9b66-7eed2b1c01c3	TCGA-G9-6363-01A-21D-1785-01	766eb893-3bc9-4a17-9b66-7eed2b1c01c3	6E48E2C0-5361-44BC-B94A-EC324A89657D	TCGA-G9-6363-01	TCGA-G9-6363-01A-21D-1787-05	TCGA-G9-6363-01A-21R-1788-13	TCGA-G9-6363-01A-21D-1786-08	766eb893-3bc9-4a17-9b66-7eed2b1c01c3	5f1c8721-1abd-437c-8143-8a095ea02097
TCGA-G9-6363-11	0	TCGA-G9-6363-11	1175	0	TCGA-G9-6363	1175	0	1175	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-G9-6363-F40645	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-23480	58			23			0	1175		993			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	100	0.7	NO	Bilateral	1.8	NO	YES				NO	6	0		N0	T4																			TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R0	Solid Tissue Normal	11	3	0.4		NO		NO	YES	G9	Base		Prostate		A	LIVING	2009						1eda4d9f-e9a1-4ee7-8c71-559c8940b751				1eda4d9f-e9a1-4ee7-8c71-559c8940b751		1eda4d9f-e9a1-4ee7-8c71-559c8940b751			TCGA-G9-6363-11A-01D-1787-05	TCGA-G9-6363-11A-01R-1788-13		1eda4d9f-e9a1-4ee7-8c71-559c8940b751	
TCGA-G9-6364-01	0	TCGA-G9-6364-01	1198	0	TCGA-G9-6364	1198	0	1198	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-G9-6364-F40643	NO		M0		-26603							0	1198		841			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)		0.8	NO	Bilateral	1.7	NO	YES				NO	25	0		N0	T3a	TCGA-G9-6364.81deb5a1-4d5d-490a-a956-a64a4e6763f8.pdf			2		0		0		0		15		10		75		75	TUMOR FREE	3	Complete Remission/Response	Yes	0.03	NO	R0	Primary Tumor	01	4	0.4		NO		NO	YES	G9			Prostate		A	LIVING	2009		TCGA-G9-6364-01A-21D-1786-08	TCGA-G9-6364-01A-21D-1786-08	60173bb8-3c68-4231-a3df-905221e80180	TCGA-G9-6364-01	e9de50a5-d753-40f8-bb1f-3602ad9627ca	TCGA-G9-6364-01A-21D-1786-08	TCGA-G9-6364-01A-21D-1786-08	TCGA-G9-6364-01A-21D-1785-01	e9de50a5-d753-40f8-bb1f-3602ad9627ca	TCGA-G9-6364-01A-21D-1785-01	e9de50a5-d753-40f8-bb1f-3602ad9627ca	9813C17B-FBC4-4064-AA64-7F4C4AAEDD00	TCGA-G9-6364-01	TCGA-G9-6364-01A-21D-1787-05	TCGA-G9-6364-01A-21R-1788-13	TCGA-G9-6364-01A-21D-1786-08	e9de50a5-d753-40f8-bb1f-3602ad9627ca	60173bb8-3c68-4231-a3df-905221e80180
TCGA-G9-6364-11	0	TCGA-G9-6364-11	1198	0	TCGA-G9-6364	1198	0	1198	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-G9-6364-F40643	NO		M0		-26603							0	1198		841			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)		1	NO	Bilateral	2	NO	YES				NO	25	0		N0	T3a																			TUMOR FREE	3	Complete Remission/Response	Yes	0.03	NO	R0	Solid Tissue Normal	11	4	0.3		NO		NO	YES	G9			Prostate		A	LIVING	2009															TCGA-G9-6364-11A-01D-1787-05				
TCGA-G9-6365-01	0	TCGA-G9-6365-01	1363	0	TCGA-G9-6365	1363	0	1363	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71	TCGA-G9-6365-F42754	NO			T2a	-26207							0	1363		804			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	2	NO	YES				NO	13	0		N0	T4	TCGA-G9-6365.0f1f5e1b-4086-4a77-96ba-2108abdde80f.pdf		2	2	0	0	0	0	0	0	25	10	30	15	45	75	45	80	TUMOR FREE	3	Complete Remission/Response	No	0.01	NO	R1	Primary Tumor	01	4	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		TCGA-G9-6365-01A-11D-1786-08	TCGA-G9-6365-01A-11D-1786-08	d2216f15-250a-4f64-8517-0d72a53dbcff	TCGA-G9-6365-01	67816085-c038-4c4f-86f0-b03e6da18aee	TCGA-G9-6365-01A-11D-1786-08	TCGA-G9-6365-01A-11D-1786-08	TCGA-G9-6365-01A-11D-1785-01	67816085-c038-4c4f-86f0-b03e6da18aee	TCGA-G9-6365-01A-11D-1785-01	67816085-c038-4c4f-86f0-b03e6da18aee	2FD641B9-006D-40FE-8E01-678EEC130C6E	TCGA-G9-6365-01	TCGA-G9-6365-01A-11D-1787-05	TCGA-G9-6365-01A-11R-1788-13		67816085-c038-4c4f-86f0-b03e6da18aee	d2216f15-250a-4f64-8517-0d72a53dbcff
TCGA-G9-6365-11	0	TCGA-G9-6365-11	1363	0	TCGA-G9-6365	1363	0	1363	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71	TCGA-G9-6365-F42754	NO			T2a	-26207							0	1363		804			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	2.2	NO	YES				NO	13	0		N0	T4																			TUMOR FREE	3	Complete Remission/Response	No	0.01	NO	R1	Solid Tissue Normal	11	4	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009						40c411e7-c0cb-4aff-8418-fd7400562bad				40c411e7-c0cb-4aff-8418-fd7400562bad		40c411e7-c0cb-4aff-8418-fd7400562bad			TCGA-G9-6365-11A-01D-1787-05	TCGA-G9-6365-11A-01R-1788-13		40c411e7-c0cb-4aff-8418-fd7400562bad	
TCGA-G9-6366-01	0	TCGA-G9-6366-01	101	0	TCGA-G9-6366			101	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-G9-6366-F40971	NO			T1c	-22428							0	101		101			NO		NO		Scheduled Follow-up Submission		2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Left	1.8	YES	NO									T3b	TCGA-G9-6366.6ef07861-a4db-4aa2-ba73-4cd43e10d72f.pdf		2	2	0	0	0	0	0	0	12	15	13	10	75	75	80	80		4		No	0.1		R0	Primary Tumor	01	3	0.2				NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009			TCGA-G9-6366-01A-11D-2114-08	26fd13a5-03ff-44c1-8497-6a950f01e0f1	TCGA-G9-6366-01	27357b4d-5d44-4c5e-bb80-0d5f68c3db8e	TCGA-G9-6366-01A-11D-2114-08	TCGA-G9-6366-01A-11D-2114-08	TCGA-G9-6366-01A-11D-2112-01	27357b4d-5d44-4c5e-bb80-0d5f68c3db8e	TCGA-G9-6366-01A-11D-2112-01	27357b4d-5d44-4c5e-bb80-0d5f68c3db8e	5675FF17-E0DA-44EC-81FE-892D96FF7ECA	TCGA-G9-6366-01	TCGA-G9-6366-01A-11D-2116-05	TCGA-G9-6366-01A-11R-2117-13	TCGA-G9-6366-01A-11D-2114-08	27357b4d-5d44-4c5e-bb80-0d5f68c3db8e	26fd13a5-03ff-44c1-8497-6a950f01e0f1
TCGA-G9-6367-01	0	TCGA-G9-6367-01	1222	0	TCGA-G9-6367	1222	0	1222	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-G9-6367-F40631		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-22176	30			30			0	1222		836			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.6	NO	YES				NO	5	0		N0	T3a	TCGA-G9-6367.1306f52c-6633-4ca8-8998-c5306e0c34be.pdf		2	5	0	0	0	0	0	0	50	25	40	15	10	60	10	65	WITH TUMOR	4	Progressive Disease	No	0.42	NO	R1	Primary Tumor	01	5	0.4		NO	3	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		TCGA-G9-6367-01A-11D-1786-08	TCGA-G9-6367-01A-11D-1786-08	566e5390-feaf-438b-9d9c-57ff0274a9a2	TCGA-G9-6367-01	e0881b2c-c095-4742-ba07-71286ed84d93	TCGA-G9-6367-01A-11D-1786-08	TCGA-G9-6367-01A-11D-1786-08	TCGA-G9-6367-01A-11D-1785-01	e0881b2c-c095-4742-ba07-71286ed84d93	TCGA-G9-6367-01A-11D-1785-01	e0881b2c-c095-4742-ba07-71286ed84d93	236D0F90-0152-4454-ACC2-D0F5316627CE	TCGA-G9-6367-01	TCGA-G9-6367-01A-11D-1787-05	TCGA-G9-6367-01A-11R-1788-13		e0881b2c-c095-4742-ba07-71286ed84d93	566e5390-feaf-438b-9d9c-57ff0274a9a2
TCGA-G9-6367-11	0	TCGA-G9-6367-11	1222	0	TCGA-G9-6367	1222	0	1222	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-G9-6367-F40631		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-22176	30			30			0	1222		836			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.5	NO	YES				NO	5	0		N0	T3a																			WITH TUMOR	4	Progressive Disease	No	0.42	NO	R1	Solid Tissue Normal	11	5	0.4		NO	3	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009															TCGA-G9-6367-11A-01D-1787-05				
TCGA-G9-6369-01	0	TCGA-G9-6369-01	1215	0	TCGA-G9-6369	1215	0	1215	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-G9-6369-F40640	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20238	35			23			0	1215		851			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1	NO	YES				NO	21	0		N0	T2c	TCGA-G9-6369.8da381e8-6bab-4b75-9ae3-d7b76f90f044.pdf			0		0		0		0		10		10		80		80	TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	3	0.2		NO		NO	YES	G9	Base		Prostate		A	LIVING	2009			TCGA-G9-6369-01A-21D-1961-08	acc3f89c-41d3-45b9-ac9e-41fecfb0d3b5	TCGA-G9-6369-01	3d626bcf-fa11-443c-ac02-b2a099494189	TCGA-G9-6369-01A-21D-1961-08	TCGA-G9-6369-01A-21D-1961-08	TCGA-G9-6369-01A-21D-1959-01	3d626bcf-fa11-443c-ac02-b2a099494189	TCGA-G9-6369-01A-21D-1959-01	3d626bcf-fa11-443c-ac02-b2a099494189		TCGA-G9-6369-01	TCGA-G9-6369-01A-21D-1963-05	TCGA-G9-6369-01A-21R-1964-13	TCGA-G9-6369-01A-21D-1961-08	3d626bcf-fa11-443c-ac02-b2a099494189	acc3f89c-41d3-45b9-ac9e-41fecfb0d3b5
TCGA-G9-6370-01	0	TCGA-G9-6370-01	1156	0	TCGA-G9-6370	1156	0	1156	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			52	TCGA-G9-6370-F40638	NO		M0	T1c	-19149							0	1156		806			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.2	NO	YES				NO	1	0		N0	T3b	TCGA-G9-6370.fa0332e6-d535-45c0-8ed9-9b36816f1350.pdf		3	2	3	0	0	0	0	0	25	15	72	15	3	70	3	75	TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	4	0.4		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		TCGA-G9-6370-01A-11D-1786-08	TCGA-G9-6370-01A-11D-1786-08	5caae40b-d90e-42d8-a3a4-12b2b192460d	TCGA-G9-6370-01	d964a3c5-aa6c-431c-b179-7e0b70e26e2d	TCGA-G9-6370-01A-11D-1786-08	TCGA-G9-6370-01A-11D-1786-08	TCGA-G9-6370-01A-11D-1785-01	d964a3c5-aa6c-431c-b179-7e0b70e26e2d	TCGA-G9-6370-01A-11D-1785-01	d964a3c5-aa6c-431c-b179-7e0b70e26e2d	661EDA4E-9E63-4FDD-BDB4-9010BA2B499A	TCGA-G9-6370-01	TCGA-G9-6370-01A-11D-1787-05	TCGA-G9-6370-01A-11R-1788-13		d964a3c5-aa6c-431c-b179-7e0b70e26e2d	5caae40b-d90e-42d8-a3a4-12b2b192460d
TCGA-G9-6371-01	0	TCGA-G9-6371-01	1226	0	TCGA-G9-6371	1226	0	1226	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-G9-6371-F40637	NO		M0	T1c	-21365							0	1226		846			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	NO				NO					T2c	TCGA-G9-6371.26034718-f43a-491d-99fb-934d99ba4a6a.pdf		2	2	0	0	0	0	0	0	30	20	35	20	35	60	35	60	TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R1	Primary Tumor	01	3	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		TCGA-G9-6371-01A-11D-1786-08	TCGA-G9-6371-01A-11D-1786-08	ad5bcdea-8640-4aba-8af1-96db5510204d	TCGA-G9-6371-01	f1503f33-421a-4d7b-8e87-d73f5cbcc760	TCGA-G9-6371-01A-11D-1786-08	TCGA-G9-6371-01A-11D-1786-08	TCGA-G9-6371-01A-11D-1785-01	f1503f33-421a-4d7b-8e87-d73f5cbcc760	TCGA-G9-6371-01A-11D-1785-01	f1503f33-421a-4d7b-8e87-d73f5cbcc760	837A890A-ED54-4C9F-8A65-A3A1E2391267	TCGA-G9-6371-01	TCGA-G9-6371-01A-11D-1787-05	TCGA-G9-6371-01A-11R-1788-13	TCGA-G9-6371-01A-11D-1786-08	f1503f33-421a-4d7b-8e87-d73f5cbcc760	ad5bcdea-8640-4aba-8af1-96db5510204d
TCGA-G9-6373-01	0	TCGA-G9-6373-01	811	0	TCGA-G9-6373	811	0	811	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-G9-6373-F40635		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-24887	29						0	811					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1	NO	NO				NO					T3a	TCGA-G9-6373.ed631fb0-95e4-4b30-963f-1ff4cb4f0ece.pdf		4	3	0	0	0	0	0	0	20	20	20	20	60	60	60	60	TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Primary Tumor	01	3	0.1		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		TCGA-G9-6373-01A-11D-1786-08	TCGA-G9-6373-01A-11D-1786-08	1dd6d739-bdc3-440a-8304-a79f672209ca	TCGA-G9-6373-01	5ed0de42-f949-4046-895b-f97853201a8d	TCGA-G9-6373-01A-11D-1786-08	TCGA-G9-6373-01A-11D-1786-08	TCGA-G9-6373-01A-11D-1785-01	5ed0de42-f949-4046-895b-f97853201a8d	TCGA-G9-6373-01A-11D-1785-01	5ed0de42-f949-4046-895b-f97853201a8d	E22A00A4-A324-478F-BCBD-623FED9198EA	TCGA-G9-6373-01	TCGA-G9-6373-01A-11D-1787-05	TCGA-G9-6373-01A-11R-1788-13	TCGA-G9-6373-01A-11D-1786-08	5ed0de42-f949-4046-895b-f97853201a8d	1dd6d739-bdc3-440a-8304-a79f672209ca
TCGA-G9-6373-11	0	TCGA-G9-6373-11	811	0	TCGA-G9-6373	811	0	811	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-G9-6373-F40635		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-24887	29						0	811					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	2.5	NO	NO				NO					T3a																			TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Solid Tissue Normal	11	3	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009															TCGA-G9-6373-11A-01D-1787-05				
TCGA-G9-6377-01	0	TCGA-G9-6377-01	958	0	TCGA-G9-6377	958	0	958	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-G9-6377-F40633	NO	Abnormal (not related to prostate cancer)	M0	T2b	-22419	36			11			0	958		518			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.4	NO	YES				NO	6	0		N0	T2c	TCGA-G9-6377.520abbf9-817a-45db-aecc-22c4fc80ddae.pdf		0	2	0	0	0	0	0	0	5	3	15	12	80	85	80	90	TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	4	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009			TCGA-G9-6377-01A-11D-1961-08	da86abc9-27b6-4bd9-80f7-f7f63ac53381	TCGA-G9-6377-01	47d13480-7771-450a-ab70-07c8ca2eb14f	TCGA-G9-6377-01A-11D-1961-08	TCGA-G9-6377-01A-11D-1961-08	TCGA-G9-6377-01A-11D-1959-01	47d13480-7771-450a-ab70-07c8ca2eb14f	TCGA-G9-6377-01A-11D-1959-01	47d13480-7771-450a-ab70-07c8ca2eb14f	6BA4F223-DC52-474F-87C0-A362EA498FB0	TCGA-G9-6377-01	TCGA-G9-6377-01A-11D-1963-05	TCGA-G9-6377-01A-11R-1964-13	TCGA-G9-6377-01A-11D-1961-08	47d13480-7771-450a-ab70-07c8ca2eb14f	da86abc9-27b6-4bd9-80f7-f7f63ac53381
TCGA-G9-6378-01	0	TCGA-G9-6378-01	1155	0	TCGA-G9-6378	1155	0	1155	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			54	TCGA-G9-6378-F40630	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-19879	-176			100			0	1155		223			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.2	NO	NO				NO					T2c	TCGA-G9-6378.425008c5-919c-45b3-beb7-2392d6866ffb.pdf		2	2	0	0	0	0	0	0	15	13	10	12	75	75	75	75	TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R1	Primary Tumor	01	4	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		TCGA-G9-6378-01A-11D-1786-08	TCGA-G9-6378-01A-11D-1786-08	29f2a9fd-37da-4454-a84a-14d8ae0bce2e	TCGA-G9-6378-01	02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c	TCGA-G9-6378-01A-11D-1786-08	TCGA-G9-6378-01A-11D-1786-08	TCGA-G9-6378-01A-11D-1785-01	02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c	TCGA-G9-6378-01A-11D-1785-01	02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c	9EE8BD41-956E-4AB2-B578-5C05E9E08578	TCGA-G9-6378-01	TCGA-G9-6378-01A-11D-1787-05	TCGA-G9-6378-01A-11R-1788-13	TCGA-G9-6378-01A-11D-1786-08	02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c	29f2a9fd-37da-4454-a84a-14d8ae0bce2e
TCGA-G9-6379-01	0	TCGA-G9-6379-01	1575	0	TCGA-G9-6379	1575	0	1575	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-G9-6379-F65354	NO		M0	T1b	-25126							0	1575		1393			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.5	NO	YES				NO	6	0		N0	T3b				1		1		0		0		30		20		50		70	TUMOR FREE	4	Complete Remission/Response	No	00.03	NO	R1	Primary Tumor	01	3	0.4		NO	5	NO	YES	G9	Apex		Prostate		A	LIVING	2009			TCGA-G9-6379-01A-11D-A31L-08	14d4fb7a-df0f-4c5e-83ab-e12b6ad49de4	TCGA-G9-6379-01	edc61caa-7008-45ba-b69b-8998ad510549	TCGA-G9-6379-01A-11D-A31L-08	TCGA-G9-6379-01A-11D-A31L-08	TCGA-G9-6379-01A-11D-A31K-01	edc61caa-7008-45ba-b69b-8998ad510549	TCGA-G9-6379-01A-11D-A31K-01	edc61caa-7008-45ba-b69b-8998ad510549		TCGA-G9-6379-01	TCGA-G9-6379-01A-11D-A31M-05	TCGA-G9-6379-01A-11R-A31R-13	TCGA-G9-6379-01A-11D-A31L-08	edc61caa-7008-45ba-b69b-8998ad510549	14d4fb7a-df0f-4c5e-83ab-e12b6ad49de4
TCGA-G9-6384-01	0	TCGA-G9-6384-01	765	0	TCGA-G9-6384	765	0	765	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-G9-6384-F40625	NO		M0	T1c	-19620							0	765		390			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.2	NO	YES				NO	14	0		N0	T3a	TCGA-G9-6384.6987c1c1-6e23-44f0-bba8-6bba4a288025.pdf		1	3	0	0	0	0	0	0	15	12	10	13	75	75	80	80	TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	4	0.6		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2010		TCGA-G9-6384-01A-11D-1786-08	TCGA-G9-6384-01A-11D-1786-08	a6a12836-cd07-450a-b281-2e35ea17333e	TCGA-G9-6384-01	30e19950-9bbe-4952-8308-41689e57430c	TCGA-G9-6384-01A-11D-1786-08	TCGA-G9-6384-01A-11D-1786-08	TCGA-G9-6384-01A-11D-1785-01	30e19950-9bbe-4952-8308-41689e57430c	TCGA-G9-6384-01A-11D-1785-01	30e19950-9bbe-4952-8308-41689e57430c	7AEAE7AC-64AC-472B-B93E-362036E8C058	TCGA-G9-6384-01	TCGA-G9-6384-01A-11D-1787-05	TCGA-G9-6384-01A-11R-1788-13	TCGA-G9-6384-01A-11D-1786-08	30e19950-9bbe-4952-8308-41689e57430c	a6a12836-cd07-450a-b281-2e35ea17333e
TCGA-G9-6384-11	0	TCGA-G9-6384-11	765	0	TCGA-G9-6384	765	0	765	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-G9-6384-F40625	NO		M0	T1c	-19620							0	765		390			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1	NO	YES				NO	14	0		N0	T3a																			TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R0	Solid Tissue Normal	11	4	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2010						36973833-7245-444f-94e9-062e6b83df14				36973833-7245-444f-94e9-062e6b83df14		36973833-7245-444f-94e9-062e6b83df14			TCGA-G9-6384-11A-01D-1787-05	TCGA-G9-6384-11A-01R-2186-13		36973833-7245-444f-94e9-062e6b83df14	
TCGA-G9-6385-01	0	TCGA-G9-6385-01	830	0	TCGA-G9-6385	830	0	830	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-G9-6385-F40620	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24399	12						0	830		336			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1	NO	NO				NO					T2c	TCGA-G9-6385.3027c5cd-f972-469c-a9f2-9a72b83a86c8.pdf			2		0		0		0		20		20		60		60	TUMOR FREE	3	Complete Remission/Response	No	0.064	NO	R0	Primary Tumor	01	4	0.3		NO		NO	YES	G9	Base		Prostate		A	LIVING	2010		TCGA-G9-6385-01A-11D-1786-08	TCGA-G9-6385-01A-11D-1786-08	67c29243-0296-4d33-8510-19e42dd02b43	TCGA-G9-6385-01	c72a1f85-6eb7-45ef-ac30-f695d87226ed	TCGA-G9-6385-01A-11D-1786-08	TCGA-G9-6385-01A-11D-1786-08	TCGA-G9-6385-01A-11D-1785-01	c72a1f85-6eb7-45ef-ac30-f695d87226ed	TCGA-G9-6385-01A-11D-1785-01	c72a1f85-6eb7-45ef-ac30-f695d87226ed		TCGA-G9-6385-01	TCGA-G9-6385-01A-11D-1787-05	TCGA-G9-6385-01A-11R-1788-13	TCGA-G9-6385-01A-11D-1786-08	c72a1f85-6eb7-45ef-ac30-f695d87226ed	67c29243-0296-4d33-8510-19e42dd02b43
TCGA-G9-6385-11	0	TCGA-G9-6385-11	830	0	TCGA-G9-6385	830	0	830	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-G9-6385-F40620	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24399	12						0	830		336			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.3	NO	NO				NO					T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.064	NO	R0	Solid Tissue Normal	11	4	0.3		NO		NO	YES	G9	Base		Prostate		A	LIVING	2010															TCGA-G9-6385-11A-01D-1787-05				
TCGA-G9-6494-01	0	TCGA-G9-6494-01	1771	0	TCGA-G9-6494	1771	0	1771	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-G9-6494-F41058		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24381	-13			-13			0	1771		1423			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	2	0		N0	T4	TCGA-G9-6494.9aad0222-0731-498b-a9c2-400ce0ccfa0d.pdf		5	5	0	0	0	0	0	0	20	10	25	20	55	70	55	70	WITH TUMOR	4	Progressive Disease	No	1.13	NO	R1	Primary Tumor	01	3	0.4		NO		NO	YES	G9	Base		Prostate		A	LIVING	2008		TCGA-G9-6494-01A-11D-1786-08	TCGA-G9-6494-01A-11D-1786-08	7a898096-893c-4eec-8cd0-b18c685cdfed	TCGA-G9-6494-01	8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3	TCGA-G9-6494-01A-11D-1786-08	TCGA-G9-6494-01A-11D-1786-08	TCGA-G9-6494-01A-11D-1785-01	8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3	TCGA-G9-6494-01A-11D-1785-01	8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3	F22871CE-C484-455D-8446-DBE2A62AE7C4	TCGA-G9-6494-01	TCGA-G9-6494-01A-11D-1787-05	TCGA-G9-6494-01A-11R-1788-13	TCGA-G9-6494-01A-11D-1786-08	8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3	7a898096-893c-4eec-8cd0-b18c685cdfed
TCGA-G9-6494-11	0	TCGA-G9-6494-11	1771	0	TCGA-G9-6494	1771	0	1771	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-G9-6494-F41058		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24381	-13			-13			0	1771		1423			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.5	NO	YES				NO	2	0		N0	T4																			WITH TUMOR	4	Progressive Disease	No	1.13	NO	R1	Solid Tissue Normal	11	3	0.5		NO		NO	YES	G9	Base		Prostate		A	LIVING	2008															TCGA-G9-6494-11A-01D-1787-05				
TCGA-G9-6496-01	0	TCGA-G9-6496-01	1726	0	TCGA-G9-6496	1726	0	1726	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-G9-6496-F41001	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22602	19			20			0	1726		703			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.2	NO	YES				NO	15	0		N0	T2c	TCGA-G9-6496.193cca51-2d1f-49aa-afdb-63a55d689c86.pdf		2	2	0	0	0	0	0	0	5	5	20	15	75	80	70	80	TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	3	0.5		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008		TCGA-G9-6496-01A-11D-1786-08	TCGA-G9-6496-01A-11D-1786-08	bcbd830a-af25-4ec2-8797-767a2b4148e4	TCGA-G9-6496-01	6a2c4d22-f7b6-4e0a-bd71-a669786da5b1	TCGA-G9-6496-01A-11D-1786-08	TCGA-G9-6496-01A-11D-1786-08	TCGA-G9-6496-01A-11D-1785-01	6a2c4d22-f7b6-4e0a-bd71-a669786da5b1	TCGA-G9-6496-01A-11D-1785-01	6a2c4d22-f7b6-4e0a-bd71-a669786da5b1	E5EBFB91-E2C6-47C1-8719-F596466B36A7	TCGA-G9-6496-01	TCGA-G9-6496-01A-11D-1787-05	TCGA-G9-6496-01A-11R-1788-13	TCGA-G9-6496-01A-11D-1786-08	6a2c4d22-f7b6-4e0a-bd71-a669786da5b1	bcbd830a-af25-4ec2-8797-767a2b4148e4
TCGA-G9-6496-11	0	TCGA-G9-6496-11	1726	0	TCGA-G9-6496	1726	0	1726	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-G9-6496-F41001	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22602	19			20			0	1726		703			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	1.7	NO	YES				NO	15	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R0	Solid Tissue Normal	11	3	0.5		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008						7aa49ecf-9e25-4166-9ed2-487c41f1066c				7aa49ecf-9e25-4166-9ed2-487c41f1066c		7aa49ecf-9e25-4166-9ed2-487c41f1066c			TCGA-G9-6496-11A-01D-1787-05	TCGA-G9-6496-11A-01R-1788-13		7aa49ecf-9e25-4166-9ed2-487c41f1066c	
TCGA-G9-6498-01	0	TCGA-G9-6498-01	1952	0	TCGA-G9-6498	1952	0	1952	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-G9-6498-F65343	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-19568	47					1342	0	1952		1608			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.3	NO	NO				NO					T3a				0		0		0		0		5		20		75		90	TUMOR FREE	3	Complete Remission/Response	No	00.03	NO	R1	Primary Tumor	01	4	0.4		NO		NO	YES	G9	Apex		Prostate		A	LIVING	2008			TCGA-G9-6498-01A-12D-A30X-08	a6607330-9f21-4054-8687-2eb8fa53b79e	TCGA-G9-6498-01	1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83	TCGA-G9-6498-01A-12D-A30X-08	TCGA-G9-6498-01A-12D-A30X-08	TCGA-G9-6498-01A-12D-A30W-01	1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83	TCGA-G9-6498-01A-12D-A30W-01	1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83		TCGA-G9-6498-01	TCGA-G9-6498-01A-12D-A30Z-05	TCGA-G9-6498-01A-12R-A310-13	TCGA-G9-6498-01A-12D-A30X-08	1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83	a6607330-9f21-4054-8687-2eb8fa53b79e
TCGA-G9-6499-01	0	TCGA-G9-6499-01	1543	0	TCGA-G9-6499	1543	0	1543	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-G9-6499-F41000	NO	Equivocal	M0	T3a	-24388	56			421			0	1543		1109			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.4	NO	YES				NO	13	0		N0	T3a	TCGA-G9-6499.8e1d4212-b252-4019-b188-3cdd60be733d.pdf		5	3	0	0	0	0	0	0	15	15	40	25	45	60	45	60	TUMOR FREE	4	Complete Remission/Response	No	0.11	NO	R0	Primary Tumor	01	5	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008			TCGA-G9-6499-01A-12D-1961-08	3b297aee-e2c6-4764-a084-64372c4b05ee	TCGA-G9-6499-01	a597168e-2c74-4e79-b863-45c94ac8efa1	TCGA-G9-6499-01A-12D-1961-08	TCGA-G9-6499-01A-12D-1961-08	TCGA-G9-6499-01A-12D-1959-01	a597168e-2c74-4e79-b863-45c94ac8efa1	TCGA-G9-6499-01A-12D-1959-01	a597168e-2c74-4e79-b863-45c94ac8efa1	8452B7C0-AB4D-402F-A9FF-513FABC3E7ED	TCGA-G9-6499-01	TCGA-G9-6499-01A-12D-1963-05	TCGA-G9-6499-01A-12R-1964-13	TCGA-G9-6499-01A-12D-1961-08	a597168e-2c74-4e79-b863-45c94ac8efa1	3b297aee-e2c6-4764-a084-64372c4b05ee
TCGA-G9-6499-11	0	TCGA-G9-6499-11	1543	0	TCGA-G9-6499	1543	0	1543	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-G9-6499-F41000	NO	Equivocal	M0	T3a	-24388	56			421			0	1543		1109			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	60	1	NO	Bilateral	1.5	NO	YES				NO	13	0		N0	T3a																			TUMOR FREE	4	Complete Remission/Response	No	0.11	NO	R0	Solid Tissue Normal	11	5	0.5		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008						0cb961d7-87be-40c2-b703-3e424b8c8e78				0cb961d7-87be-40c2-b703-3e424b8c8e78		0cb961d7-87be-40c2-b703-3e424b8c8e78			TCGA-G9-6499-11A-02D-1963-05	TCGA-G9-6499-11A-02R-1964-13		0cb961d7-87be-40c2-b703-3e424b8c8e78	
TCGA-G9-7509-01	0	TCGA-G9-7509-01	1610	0	TCGA-G9-7509	1610	0	1610	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			48	TCGA-G9-7509-F65350	NO		M0	T1c	-17538							0	1610		352			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-22	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.3	NO	NO				NO					T2c				0		0		0		0		15		35		50		60	TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	3	0.4		NO	4	NO	YES	G9	Apex|Middle|Base		Prostate		A	LIVING	2009				304636a5-a0c2-4ee5-9e65-fec31f017d39	TCGA-G9-7509-01	b5d317d7-382e-4695-9f30-bb6664b3189f			TCGA-G9-7509-01A-11D-A41J-01	b5d317d7-382e-4695-9f30-bb6664b3189f	TCGA-G9-7509-01A-11D-A41J-01	b5d317d7-382e-4695-9f30-bb6664b3189f		TCGA-G9-7509-01	TCGA-G9-7509-01A-11D-A41L-05	TCGA-G9-7509-01A-11R-A41R-13		b5d317d7-382e-4695-9f30-bb6664b3189f	304636a5-a0c2-4ee5-9e65-fec31f017d39
TCGA-G9-7510-01	0	TCGA-G9-7510-01	1185	0	TCGA-G9-7510	1185	0	1185	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-G9-7510-F48752	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24187	22			22			0	1185		674			YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.6	NO	YES				NO	10	0		N0	T3a	TCGA-G9-7510.11c8711a-57c0-41fe-82fa-2e9592fef570.pdf						0	0			25	15	20	15	55	70	55	70	TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R1	Primary Tumor	01	4	0.5		NO	5	NO	YES	G9	Apex		Prostate		A	LIVING	2010			TCGA-G9-7510-01A-11D-2260-08	52228b98-8bab-454b-8b5b-c6310b55aa82	TCGA-G9-7510-01	c969c5c7-c72e-4e8f-9213-8ab2f192c845	TCGA-G9-7510-01A-11D-2260-08	TCGA-G9-7510-01A-11D-2260-08	TCGA-G9-7510-01A-11D-2259-01	c969c5c7-c72e-4e8f-9213-8ab2f192c845	TCGA-G9-7510-01A-11D-2259-01	c969c5c7-c72e-4e8f-9213-8ab2f192c845	075BD106-9C0B-424C-90D1-BDECE264407C	TCGA-G9-7510-01	TCGA-G9-7510-01A-11D-2261-05	TCGA-G9-7510-01A-11R-2262-13	TCGA-G9-7510-01A-11D-2260-08	c969c5c7-c72e-4e8f-9213-8ab2f192c845	52228b98-8bab-454b-8b5b-c6310b55aa82
TCGA-G9-7519-01	0	TCGA-G9-7519-01	849	0	TCGA-G9-7519	849	0	849	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-G9-7519-F48751	NO	Abnormal (not related to prostate cancer)	M0	T1c	-21276	7			7			0	849		457			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.1	NO	NO				NO					T2c	TCGA-G9-7519.07227b7d-9285-4d1b-9484-ccdb20841905.pdf							0				3		17		80		80	TUMOR FREE	3	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	4	0.7		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2010			TCGA-G9-7519-01A-11D-2260-08	95bf40c2-314d-4304-87bf-057dccacfbaf	TCGA-G9-7519-01	104e14d3-f1d5-443f-88fd-6d67c98b1eff	TCGA-G9-7519-01A-11D-2260-08	TCGA-G9-7519-01A-11D-2260-08	TCGA-G9-7519-01A-11D-2259-01	104e14d3-f1d5-443f-88fd-6d67c98b1eff	TCGA-G9-7519-01A-11D-2259-01	104e14d3-f1d5-443f-88fd-6d67c98b1eff		TCGA-G9-7519-01	TCGA-G9-7519-01A-11D-2261-05	TCGA-G9-7519-01A-11R-2262-13	TCGA-G9-7519-01A-11D-2260-08	104e14d3-f1d5-443f-88fd-6d67c98b1eff	95bf40c2-314d-4304-87bf-057dccacfbaf
TCGA-G9-7521-01	0	TCGA-G9-7521-01	942	0	TCGA-G9-7521	942	0	942	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			52	TCGA-G9-7521-F48747	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-19216	13			12	45		0	942		487			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Progressive Disease	2013-9-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	0.9	NO	YES				NO	9	1		N1	T3a	TCGA-G9-7521.b0a188e3-c084-4e2d-93dd-31de3a3f47e6.pdf						0	0			5	5	15	15	80	80	80	80	TUMOR FREE	4	Progressive Disease	No	0.06	NO	R0	Primary Tumor	01	4	0.2		YES	5	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2010			TCGA-G9-7521-01A-11D-2260-08	158a4a47-b1c7-4907-8eaf-eb09bca2c6ca	TCGA-G9-7521-01	c3841b03-197a-4cd1-9331-02fde85bcb55	TCGA-G9-7521-01A-11D-2260-08	TCGA-G9-7521-01A-11D-2260-08	TCGA-G9-7521-01A-11D-2259-01	c3841b03-197a-4cd1-9331-02fde85bcb55	TCGA-G9-7521-01A-11D-2259-01	c3841b03-197a-4cd1-9331-02fde85bcb55	28F62670-5FB9-4BCC-9E9F-AF8119B2A924	TCGA-G9-7521-01	TCGA-G9-7521-01A-11D-2261-05	TCGA-G9-7521-01A-11R-2262-13	TCGA-G9-7521-01A-11D-2260-08	c3841b03-197a-4cd1-9331-02fde85bcb55	158a4a47-b1c7-4907-8eaf-eb09bca2c6ca
TCGA-G9-7522-01	0	TCGA-G9-7522-01	1075	0	TCGA-G9-7522	1075	0	1075	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			49	TCGA-G9-7522-F48746	NO		M0	T1c	-18033							0	1075		452			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.1	NO	YES				NO	9	0		N0	T2c	TCGA-G9-7522.8d3c4720-f528-4a73-b2f0-95b2aac093f2.pdf						0	0			30	20	20	10	50	70	50	70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.4		NO		NO	YES	G9	Apex		Prostate		A	LIVING	2011			TCGA-G9-7522-01A-11D-2260-08	03615f93-a516-4e87-a900-ff455eae68ae	TCGA-G9-7522-01	79ff57d5-3224-4195-aa64-32ccd6d23e27	TCGA-G9-7522-01A-11D-2260-08	TCGA-G9-7522-01A-11D-2260-08	TCGA-G9-7522-01A-11D-2259-01	79ff57d5-3224-4195-aa64-32ccd6d23e27	TCGA-G9-7522-01A-11D-2259-01	79ff57d5-3224-4195-aa64-32ccd6d23e27	D7FFB71D-C1DE-4BE4-8BDC-68CF02134A65	TCGA-G9-7522-01	TCGA-G9-7522-01A-11D-2261-05	TCGA-G9-7522-01A-11R-2262-13		79ff57d5-3224-4195-aa64-32ccd6d23e27	03615f93-a516-4e87-a900-ff455eae68ae
TCGA-G9-7523-01	0	TCGA-G9-7523-01	857	0	TCGA-G9-7523	857	0	857	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			44	TCGA-G9-7523-F48753	NO	Abnormal (not related to prostate cancer)	M0	T1c	-16269	20			20			0	857		324			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	10	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.4	NO	YES				NO	10	0		N0	T3a	TCGA-G9-7523.8a16d779-bcf3-4371-87ec-3cd68330b1d6.pdf						0	0			20	15	25	20	55	65	55	65	TUMOR FREE	5	Complete Remission/Response	No	0.03	NO	R1	Primary Tumor	01	5	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2011			TCGA-G9-7523-01A-11D-2260-08	f247eee6-6938-4437-b30b-b2cf5532bcaa	TCGA-G9-7523-01	5f4f5adc-cebd-473a-94c7-b93426be2b95	TCGA-G9-7523-01A-11D-2260-08	TCGA-G9-7523-01A-11D-2260-08	TCGA-G9-7523-01A-11D-2259-01	5f4f5adc-cebd-473a-94c7-b93426be2b95	TCGA-G9-7523-01A-11D-2259-01	5f4f5adc-cebd-473a-94c7-b93426be2b95	75D8D91C-63A8-46D0-A807-6E9866561892	TCGA-G9-7523-01	TCGA-G9-7523-01A-11D-2261-05	TCGA-G9-7523-01A-11R-2262-13	TCGA-G9-7523-01A-11D-2260-08	5f4f5adc-cebd-473a-94c7-b93426be2b95	f247eee6-6938-4437-b30b-b2cf5532bcaa
TCGA-G9-7525-01	0	TCGA-G9-7525-01	994	0	TCGA-G9-7525	994	0	994	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-G9-7525-F48745	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23481	12			12			0	994		512			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.8	NO	YES				NO	6	0		N0	T2c	TCGA-G9-7525.837a5284-61ec-4a13-9743-010fc6a8df6a.pdf							0										70	TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R0	Primary Tumor	01	3	0.4		NO		NO	YES	G9	Base		Prostate		A	LIVING	2010			TCGA-G9-7525-01A-31D-2260-08	7911ee48-8329-48eb-a936-41d988690ef4	TCGA-G9-7525-01	e0888e7a-a0d3-4016-8ed2-8818c332aeea	TCGA-G9-7525-01A-31D-2260-08	TCGA-G9-7525-01A-31D-2260-08	TCGA-G9-7525-01A-31D-2259-01	e0888e7a-a0d3-4016-8ed2-8818c332aeea	TCGA-G9-7525-01A-31D-2259-01	e0888e7a-a0d3-4016-8ed2-8818c332aeea	05FBCA7E-B3A1-4E9D-8B97-9B99184A6FE9	TCGA-G9-7525-01	TCGA-G9-7525-01A-31D-2261-05	TCGA-G9-7525-01A-31R-2262-13	TCGA-G9-7525-01A-31D-2260-08	e0888e7a-a0d3-4016-8ed2-8818c332aeea	7911ee48-8329-48eb-a936-41d988690ef4
TCGA-G9-A9S0-01	1	TCGA-G9-A9S0-01	791	1	TCGA-G9-A9S0	650	1	791	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	53	TCGA-G9-A9S0-F60806	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-19530	73	840	791	73		429	0		650	759			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Progressive Disease	2014-6-17	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Transurethral resection (TURBT)	130		NO	Bilateral		NO	YES	Other, specify	Distant Metastasis	Lung and Liver	YES	13	5	true	N1	T3b	TCGA-G9-A9S0.2E6B54C4-BC0A-46E3-A3F9-B55CEB1B1ECD.pdf	Prostate Cancer		3		1		0		2		5		20		75		75	WITH TUMOR	4	Complete Remission/Response	No	10.87	YES	R1	Primary Tumor	01	4		Medical Record	YES	5	NO	YES	G9	Apex|Middle|Base	YES	Prostate	Distant Metastasis	A	DECEASED	2011	Overlapping / Multiple Zones			d1ceef18-b780-4a26-84cf-76aa4c93d039	TCGA-G9-A9S0-01	22cc7838-fc6a-431b-b25a-07ca943a6f48			TCGA-G9-A9S0-01A-11D-A41J-01	22cc7838-fc6a-431b-b25a-07ca943a6f48	TCGA-G9-A9S0-01A-11D-A41J-01	22cc7838-fc6a-431b-b25a-07ca943a6f48		TCGA-G9-A9S0-01	TCGA-G9-A9S0-01A-11D-A41L-05	TCGA-G9-A9S0-01A-11R-A41R-13		22cc7838-fc6a-431b-b25a-07ca943a6f48	d1ceef18-b780-4a26-84cf-76aa4c93d039
TCGA-G9-A9S4-01	0	TCGA-G9-A9S4-01	906	0	TCGA-G9-A9S4	906	0	906	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-G9-A9S4-F66995	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-22684	14			14			0	906		753			YES	Extraprostatic Extension  Localized (e.g. seminal vesicles)	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	10	4		N1	T3b																			TUMOR FREE	4	Complete Remission/Response	No	0.03	NO	R1	Primary Tumor	01	4			YES	5	NO	YES	G9	Apex|Middle|Base		Prostate			LIVING	2012	Overlapping / Multiple Zones				TCGA-G9-A9S4-01	e41ecd5a-af8e-4852-991a-026efa65e442				e41ecd5a-af8e-4852-991a-026efa65e442		e41ecd5a-af8e-4852-991a-026efa65e442			TCGA-G9-A9S4-01A-11D-A41L-05	TCGA-G9-A9S4-01A-11R-A41R-13		e41ecd5a-af8e-4852-991a-026efa65e442	
TCGA-G9-A9S7-01	0	TCGA-G9-A9S7-01	728	0	TCGA-G9-A9S7	728	0	728	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-G9-A9S7-F66989	NO	Abnormal (not related to prostate cancer)	M0	T2a	-20213	32			32			0	728		643			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Partial Remission/Response	2014-10-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	8	0		N0	T3a																			WITH TUMOR	4	Partial Remission/Response	No	0.13	YES	R0	Primary Tumor	01	4			NO		NO	YES	G9	Apex|Middle		Prostate			LIVING	2012	Overlapping / Multiple Zones			b3df239e-0ec6-4566-bfa5-542092a73d36	TCGA-G9-A9S7-01	d04b0992-91fb-4af2-92cd-dbb361a1b83f			TCGA-G9-A9S7-01A-11D-A41J-01	d04b0992-91fb-4af2-92cd-dbb361a1b83f	TCGA-G9-A9S7-01A-11D-A41J-01	d04b0992-91fb-4af2-92cd-dbb361a1b83f		TCGA-G9-A9S7-01	TCGA-G9-A9S7-01A-11D-A41L-05	TCGA-G9-A9S7-01A-11R-A41R-13		d04b0992-91fb-4af2-92cd-dbb361a1b83f	b3df239e-0ec6-4566-bfa5-542092a73d36
TCGA-H9-7775-01	0	TCGA-H9-7775-01	185	0	TCGA-H9-7775	185	0	185	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-H9-7775-F37932	NO				-24898							0	185		73							Scheduled Follow-up Submission	Complete Remission/Response	2012-12-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Right	1	YES	NO				NO					T2c	TCGA-H9-7775.2a752788-15f1-4879-96a7-eaf5dfa6921d.pdf						0	0			10	10	15	15	75	75	75	75	TUMOR FREE	3	Complete Remission/Response	No	0.04	NO		Primary Tumor	01	4	0.4		NO	0	YES	NO	H9			Prostate		A	LIVING	2011			TCGA-H9-7775-01A-11D-2114-08	c165b6f3-2297-4df3-a467-ec84daf5b82e	TCGA-H9-7775-01	8c9b95d4-ee46-4312-ba8c-8000c9988ee8	TCGA-H9-7775-01A-11D-2114-08	TCGA-H9-7775-01A-11D-2114-08	TCGA-H9-7775-01A-11D-2112-01	8c9b95d4-ee46-4312-ba8c-8000c9988ee8	TCGA-H9-7775-01A-11D-2112-01	8c9b95d4-ee46-4312-ba8c-8000c9988ee8	49F8D1FD-0D46-4BCD-9EDA-5B65E8D44702	TCGA-H9-7775-01	TCGA-H9-7775-01A-11D-2116-05	TCGA-H9-7775-01A-11R-2117-13	TCGA-H9-7775-01A-11D-2114-08	8c9b95d4-ee46-4312-ba8c-8000c9988ee8	c165b6f3-2297-4df3-a467-ec84daf5b82e
TCGA-H9-A6BX-01	0	TCGA-H9-A6BX-01	941	0	TCGA-H9-A6BX	941	0	941	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-H9-A6BX-F63936	NO				-22039		479					0	941		570			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES		190		NO	Bilateral		NO	NO				NO			false		T2c	TCGA-H9-A6BX.5AEA61BF-A79E-4A8A-B3F1-45982DAF288E.pdf			8		0		2		1		3		75		20		60	TUMOR FREE	3	Complete Remission/Response	No	0.04	NO	R0	Primary Tumor	01	3			NO		YES	NO	H9			Prostate		A	LIVING	2012			TCGA-H9-A6BX-01A-31D-A30X-08	39208fa2-d459-46d0-84e2-9b3c4051805b	TCGA-H9-A6BX-01	ba7eb097-85ab-40fd-86dc-1e5aeb388843	TCGA-H9-A6BX-01A-31D-A30X-08	TCGA-H9-A6BX-01A-31D-A30X-08	TCGA-H9-A6BX-01A-31D-A30W-01	ba7eb097-85ab-40fd-86dc-1e5aeb388843	TCGA-H9-A6BX-01A-31D-A30W-01	ba7eb097-85ab-40fd-86dc-1e5aeb388843		TCGA-H9-A6BX-01	TCGA-H9-A6BX-01A-31D-A30Z-05	TCGA-H9-A6BX-01A-31R-A310-13	TCGA-H9-A6BX-01A-31D-A30X-08	ba7eb097-85ab-40fd-86dc-1e5aeb388843	39208fa2-d459-46d0-84e2-9b3c4051805b
TCGA-H9-A6BY-01	0	TCGA-H9-A6BY-01	112	0	TCGA-H9-A6BY	112	0	112	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63					T1c	-23297							0	112											2013-12-2	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES				NO	19	0		N0	T3a																				3		No			RX	Primary Tumor	01	4					YES	NO	H9			Prostate			LIVING	2012	Overlapping / Multiple Zones		TCGA-H9-A6BY-01A-11D-A30E-08	b452ef07-5e07-43dd-ab42-faa95e20b3ff	TCGA-H9-A6BY-01	d6c9e56e-c040-40ff-a71b-74bd4a2d431c	TCGA-H9-A6BY-01A-11D-A30E-08	TCGA-H9-A6BY-01A-11D-A30E-08	TCGA-H9-A6BY-01A-11D-A30D-01	d6c9e56e-c040-40ff-a71b-74bd4a2d431c	TCGA-H9-A6BY-01A-11D-A30D-01	d6c9e56e-c040-40ff-a71b-74bd4a2d431c		TCGA-H9-A6BY-01	TCGA-H9-A6BY-01A-11D-A30F-05	TCGA-H9-A6BY-01A-11R-A30I-13	TCGA-H9-A6BY-01A-11D-A30E-08	d6c9e56e-c040-40ff-a71b-74bd4a2d431c	b452ef07-5e07-43dd-ab42-faa95e20b3ff
TCGA-HC-7075-01	0	TCGA-HC-7075-01	601	0	TCGA-HC-7075	601	0	601	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-HC-7075-F45566			M0	T1c								0	601		96							Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Right	0.7	NO	NO				NO					T2a	TCGA-HC-7075.72e3166c-bbd4-4bc1-931c-5fda225b3cf9.pdf							0				1		9		90		85	TUMOR FREE	3	Complete Remission/Response	No	.01	NO	R0	Primary Tumor	01	3	0.2		NO		NO	YES	HC			Prostate		A	LIVING	2010			TCGA-HC-7075-01A-11D-1961-08	75ba9456-2e87-4332-886b-84210e5e66d4	TCGA-HC-7075-01	ee8dbce4-8e78-42dd-b090-8de64629f92f	TCGA-HC-7075-01A-11D-1961-08	TCGA-HC-7075-01A-11D-1961-08	TCGA-HC-7075-01A-11D-1959-01	ee8dbce4-8e78-42dd-b090-8de64629f92f	TCGA-HC-7075-01A-11D-1959-01	ee8dbce4-8e78-42dd-b090-8de64629f92f		TCGA-HC-7075-01	TCGA-HC-7075-01A-11D-1963-05	TCGA-HC-7075-01A-11R-1964-13		ee8dbce4-8e78-42dd-b090-8de64629f92f	75ba9456-2e87-4332-886b-84210e5e66d4
TCGA-HC-7077-01		TCGA-HC-7077-01			TCGA-HC-7077				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64			Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23713	-91						0	0		1672			NO		NO				2012-4-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)		0.5	NO	Bilateral	1.1		NO									T3a	TCGA-HC-7077.67940700-dcd0-4e3c-9cca-4f6daeacf34c.pdf						0	0			10	5	10	10	80	85	80	85	TUMOR FREE	3		No	.83		R0	Primary Tumor	01	3	0.1				NO	YES	HC			Prostate		A	LIVING	2007			TCGA-HC-7077-01A-11D-1961-08	d54ee333-584f-4ac4-be01-7a8595777678	TCGA-HC-7077-01	5330437a-0b3d-4249-9c70-a5f967f989de	TCGA-HC-7077-01A-11D-1961-08	TCGA-HC-7077-01A-11D-1961-08	TCGA-HC-7077-01A-11D-1959-01	5330437a-0b3d-4249-9c70-a5f967f989de	TCGA-HC-7077-01A-11D-1959-01	5330437a-0b3d-4249-9c70-a5f967f989de	9DBBA55C-BD0C-47E4-A1DF-E4F80130BF60	TCGA-HC-7077-01	TCGA-HC-7077-01A-11D-1963-05	TCGA-HC-7077-01A-11R-1964-13	TCGA-HC-7077-01A-11D-1961-08	5330437a-0b3d-4249-9c70-a5f967f989de	d54ee333-584f-4ac4-be01-7a8595777678
TCGA-HC-7078-01	0	TCGA-HC-7078-01	1985	0	TCGA-HC-7078	1985	0	1985	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69	TCGA-HC-7078-F47785		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25402							0	1985		1409			NO	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	3	0		N0	T3a																			TUMOR FREE	3	Complete Remission/Response	No	.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	HC			Prostate			LIVING	2007			TCGA-HC-7078-01A-11D-2114-08	efb3ddd1-3168-4db1-acb1-6a33b398d449	TCGA-HC-7078-01	c1188eb0-1e8b-4451-b9bc-312f33bb9fd3	TCGA-HC-7078-01A-11D-2114-08	TCGA-HC-7078-01A-11D-2114-08	TCGA-HC-7078-01A-11D-2112-01	c1188eb0-1e8b-4451-b9bc-312f33bb9fd3	TCGA-HC-7078-01A-11D-2112-01	c1188eb0-1e8b-4451-b9bc-312f33bb9fd3		TCGA-HC-7078-01	TCGA-HC-7078-01A-11D-2116-05	TCGA-HC-7078-01A-11R-2117-13	TCGA-HC-7078-01A-11D-2114-08	c1188eb0-1e8b-4451-b9bc-312f33bb9fd3	efb3ddd1-3168-4db1-acb1-6a33b398d449
TCGA-HC-7079-01	0	TCGA-HC-7079-01	89	0	TCGA-HC-7079			89	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51				M0	T3a	-18734							0	89		126			NO		NO				2012-4-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.9		YES					4	0		N0	T3a	TCGA-HC-7079.8e42fce1-33e7-45e1-b8e9-2faf5a02766d.pdf						0	0			5	0	45	10	50	90	50	90	TUMOR FREE	3		No	0.1		R0	Primary Tumor	01	4	0.3				NO	YES	HC	Apex|Middle|Base		Prostate		A	LIVING	2010			TCGA-HC-7079-01A-11D-1961-08	980a405f-db0d-4338-ae81-98b3842885cb	TCGA-HC-7079-01	0a67e3de-1840-44f1-ae19-14f3c2df230c	TCGA-HC-7079-01A-11D-1961-08	TCGA-HC-7079-01A-11D-1961-08	TCGA-HC-7079-01A-11D-1959-01	0a67e3de-1840-44f1-ae19-14f3c2df230c	TCGA-HC-7079-01A-11D-1959-01	0a67e3de-1840-44f1-ae19-14f3c2df230c	7E67A6D7-6D0A-44A0-BCB0-0EDF56685FD2	TCGA-HC-7079-01	TCGA-HC-7079-01A-11D-1963-05	TCGA-HC-7079-01A-11R-1964-13		0a67e3de-1840-44f1-ae19-14f3c2df230c	980a405f-db0d-4338-ae81-98b3842885cb
TCGA-HC-7080-01	0	TCGA-HC-7080-01	1106	0	TCGA-HC-7080	894	1	1106	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	66	TCGA-HC-7080-F64334	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-24243	19			19			0	1106	894	104			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-8-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Right	0.5	NO	YES		New Primary Tumor		YES	2	0		N0	T2a	TCGA-HC-7080.f2bf590a-9473-47fe-89a9-69c480b6c42b.pdf							0				10		20		70		70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.2		NO		NO	YES	HC	Apex|Middle		Prostate		A	LIVING	2010			TCGA-HC-7080-01A-11D-1961-08	ef1a4c09-1c57-49c8-831e-5ef2281211bb	TCGA-HC-7080-01	8d250084-d374-4ec4-994b-6c5f9c0f1a14	TCGA-HC-7080-01A-11D-1961-08	TCGA-HC-7080-01A-11D-1961-08	TCGA-HC-7080-01A-11D-1959-01	8d250084-d374-4ec4-994b-6c5f9c0f1a14	TCGA-HC-7080-01A-11D-1959-01	8d250084-d374-4ec4-994b-6c5f9c0f1a14		TCGA-HC-7080-01	TCGA-HC-7080-01A-11D-1963-05	TCGA-HC-7080-01A-11R-1964-13	TCGA-HC-7080-01A-11D-1961-08	8d250084-d374-4ec4-994b-6c5f9c0f1a14	ef1a4c09-1c57-49c8-831e-5ef2281211bb
TCGA-HC-7081-01	0	TCGA-HC-7081-01	1136	0	TCGA-HC-7081	1136	0	1136	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-HC-7081-F64330												0	1136									Scheduled Follow-up Submission	Stable Disease	2014-8-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	0.8	NO	NO				NO					T3b	TCGA-HC-7081.75d1573a-cbf6-4b3c-93c4-2d410586884c.pdf						0	0			5	10	45	20	50	70	50	70	WITH TUMOR	4	Partial Remission/Response	No		YES	R2	Primary Tumor	01	5	0.3		NO		YES	NO	HC			Prostate		A	LIVING	2010			TCGA-HC-7081-01A-11D-1961-08	19c8abf2-af56-4abe-a85b-de13f4c10eee	TCGA-HC-7081-01	9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90	TCGA-HC-7081-01A-11D-1961-08	TCGA-HC-7081-01A-11D-1961-08	TCGA-HC-7081-01A-11D-1959-01	9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90	TCGA-HC-7081-01A-11D-1959-01	9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90	C39E6101-EF90-4969-9F01-AA137D5370D2	TCGA-HC-7081-01	TCGA-HC-7081-01A-11D-1963-05	TCGA-HC-7081-01A-11R-1964-13	TCGA-HC-7081-01A-11D-1961-08	9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90	19c8abf2-af56-4abe-a85b-de13f4c10eee
TCGA-HC-7209-01	0	TCGA-HC-7209-01	440	0	TCGA-HC-7209	440	0	440	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-HC-7209-F66045				T2b	-22129							0	440		108							Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.6	YES	YES				NO	2	0		N0	T2c	TCGA-HC-7209.87f8ff1b-d58b-470e-9156-144cbe34b71c.pdf							0				2		8		90		90	TUMOR FREE	3	Complete Remission/Response	No	0.05	NO	R0	Primary Tumor	01	3	0.1		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-HC-7209-01A-11D-2114-08	f9574351-9ea9-4bca-8913-f200ccf16bdd	TCGA-HC-7209-01	9675123f-6606-4e75-be55-3ef938c72178	TCGA-HC-7209-01A-11D-2114-08	TCGA-HC-7209-01A-11D-2114-08	TCGA-HC-7209-01A-11D-2112-01	9675123f-6606-4e75-be55-3ef938c72178	TCGA-HC-7209-01A-11D-2112-01	9675123f-6606-4e75-be55-3ef938c72178		TCGA-HC-7209-01	TCGA-HC-7209-01A-11D-2116-05	TCGA-HC-7209-01A-11R-2117-13	TCGA-HC-7209-01A-11D-2114-08	9675123f-6606-4e75-be55-3ef938c72178	f9574351-9ea9-4bca-8913-f200ccf16bdd
TCGA-HC-7210-01	0	TCGA-HC-7210-01	868	0	TCGA-HC-7210	868	0	868	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			74	TCGA-HC-7210-F64378					-27343							0	868		149							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Right	1.1	NO	YES				NO	7	0		N0	T2a	TCGA-HC-7210.8398444a-bfad-41d6-94a6-ab85ddf159aa.pdf							0										60	TUMOR FREE	3	Complete Remission/Response	No	.1	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-7210-01A-11D-2114-08	f82d6ce4-2dd9-4d54-8dd1-5ace4da8541a	TCGA-HC-7210-01	a83b2830-20b3-4773-b929-733f772252ec	TCGA-HC-7210-01A-11D-2114-08	TCGA-HC-7210-01A-11D-2114-08	TCGA-HC-7210-01A-11D-2112-01	a83b2830-20b3-4773-b929-733f772252ec	TCGA-HC-7210-01A-11D-2112-01	a83b2830-20b3-4773-b929-733f772252ec	B7EB854F-8169-4DD4-86E5-139AE6F39CB2	TCGA-HC-7210-01	TCGA-HC-7210-01A-11D-2116-05	TCGA-HC-7210-01A-11R-2117-13	TCGA-HC-7210-01A-11D-2114-08	a83b2830-20b3-4773-b929-733f772252ec	f82d6ce4-2dd9-4d54-8dd1-5ace4da8541a
TCGA-HC-7211-01	0	TCGA-HC-7211-01	24	0	TCGA-HC-7211			24	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62			Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-22768	14			14			0	24		-17			YES	No Evidence of Extraprostatic Extension	NO				2012-4-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.7		YES					10	0		N0	T2c	TCGA-HC-7211.47e4122a-96e7-43d6-9242-ad7bff977ba8.pdf							0				0		5		95		95		3		No	10.9		R0	Primary Tumor	01	4	0.4				NO	YES	HC	Apex|Middle|Base		Prostate		A	LIVING	2010			TCGA-HC-7211-01A-11D-2114-08	0a2f665e-c127-4af4-8a0d-751b62189fb9	TCGA-HC-7211-01	3b524c3b-40b6-43bd-8108-5243463ce4a0	TCGA-HC-7211-01A-11D-2114-08	TCGA-HC-7211-01A-11D-2114-08	TCGA-HC-7211-01A-11D-2112-01	3b524c3b-40b6-43bd-8108-5243463ce4a0	TCGA-HC-7211-01A-11D-2112-01	3b524c3b-40b6-43bd-8108-5243463ce4a0	071088A3-B9EB-44CF-A3DB-ED777A2263C4	TCGA-HC-7211-01	TCGA-HC-7211-01A-11D-2116-05	TCGA-HC-7211-01A-11R-2117-13	TCGA-HC-7211-01A-11D-2114-08	3b524c3b-40b6-43bd-8108-5243463ce4a0	0a2f665e-c127-4af4-8a0d-751b62189fb9
TCGA-HC-7211-11	0	TCGA-HC-7211-11	24	0	TCGA-HC-7211			24	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62			Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-22768	14			14			0	24		-17			YES	No Evidence of Extraprostatic Extension	NO				2012-4-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.5		YES					10	0		N0	T2c																				3		No	10.9		R0	Solid Tissue Normal	11	4	0.4				NO	YES	HC	Apex|Middle|Base		Prostate		A	LIVING	2010						7dc99228-873b-44e1-a2cb-9bd2fe9d217f				7dc99228-873b-44e1-a2cb-9bd2fe9d217f		7dc99228-873b-44e1-a2cb-9bd2fe9d217f			TCGA-HC-7211-11A-01D-2116-05	TCGA-HC-7211-11A-01R-2117-13		7dc99228-873b-44e1-a2cb-9bd2fe9d217f	
TCGA-HC-7212-01	0	TCGA-HC-7212-01	870	0	TCGA-HC-7212			870	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56	TCGA-HC-7212-F45569			M0		-20576						396	0	870		424							Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Right	1	NO	YES		Biochemical evidence of disease		YES	4	0		N0	T2a	TCGA-HC-7212.b401d78b-78c2-4e6e-86db-c93997da85a4.pdf							2				5		18		75		75	TUMOR FREE	3	Complete Remission/Response	No	.28			Primary Tumor	01	4	0.3				YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-7212-01A-11D-2114-08	4c93da8b-74f2-4285-a792-a1d6843bb591	TCGA-HC-7212-01	23e9edc6-a5ab-4dca-9243-a40e69d65615	TCGA-HC-7212-01A-11D-2114-08	TCGA-HC-7212-01A-11D-2114-08	TCGA-HC-7212-01A-11D-2112-01	23e9edc6-a5ab-4dca-9243-a40e69d65615	TCGA-HC-7212-01A-11D-2112-01	23e9edc6-a5ab-4dca-9243-a40e69d65615	56489764-D94A-4346-B9E1-5BBD98590625	TCGA-HC-7212-01	TCGA-HC-7212-01A-11D-2116-05	TCGA-HC-7212-01A-11R-2117-13	TCGA-HC-7212-01A-11D-2114-08	23e9edc6-a5ab-4dca-9243-a40e69d65615	4c93da8b-74f2-4285-a792-a1d6843bb591
TCGA-HC-7213-01	0	TCGA-HC-7213-01	1219	0	TCGA-HC-7213	170	1	1219	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	YES	53	TCGA-HC-7213-F66041	YES		M0	T3b	-19699				22	34	170	0	1219	170	170			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.1	NO	YES		Biochemical evidence of disease		YES	4	0		N0	T3b	TCGA-HC-7213.8b2f0b23-7a12-432a-b209-37e57a2f112b.pdf							2				0		8		90		90	TUMOR FREE	4	Partial Remission/Response	No	4.09	NO	R0	Primary Tumor	01	5	0.3		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2010			TCGA-HC-7213-01A-11D-2114-08	a28c6103-309e-47df-b3b1-25a732a31b6b	TCGA-HC-7213-01	cf7a71f6-8d7d-4833-b9b2-c40abc1654e6	TCGA-HC-7213-01A-11D-2114-08	TCGA-HC-7213-01A-11D-2114-08	TCGA-HC-7213-01A-11D-2112-01	cf7a71f6-8d7d-4833-b9b2-c40abc1654e6	TCGA-HC-7213-01A-11D-2112-01	cf7a71f6-8d7d-4833-b9b2-c40abc1654e6	423C67EC-ACA2-4723-8E0C-689CBD6709DA	TCGA-HC-7213-01	TCGA-HC-7213-01A-11D-2116-05	TCGA-HC-7213-01A-11R-2117-13	TCGA-HC-7213-01A-11D-2114-08	cf7a71f6-8d7d-4833-b9b2-c40abc1654e6	a28c6103-309e-47df-b3b1-25a732a31b6b
TCGA-HC-7230-01	0	TCGA-HC-7230-01	51	0	TCGA-HC-7230			51	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			50						-18577							0	51											2011-10-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO		0.5		YES					3	0		N0	T2c	TCGA-HC-7230.0c078733-c8ed-4d5c-9da0-979f4af4fc4f.pdf							0				0		15		85		85		3		No	3		R0	Primary Tumor	01	4	0.1				YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-7230-01A-11D-2114-08	6738bbf5-45cc-4eb0-bf85-c94c58c96fc0	TCGA-HC-7230-01	2ff3af27-d43b-4707-a337-0ff988ac2763	TCGA-HC-7230-01A-11D-2114-08	TCGA-HC-7230-01A-11D-2114-08	TCGA-HC-7230-01A-11D-2112-01	2ff3af27-d43b-4707-a337-0ff988ac2763	TCGA-HC-7230-01A-11D-2112-01	2ff3af27-d43b-4707-a337-0ff988ac2763		TCGA-HC-7230-01	TCGA-HC-7230-01A-11D-2116-05	TCGA-HC-7230-01A-11R-2117-13	TCGA-HC-7230-01A-11D-2114-08	2ff3af27-d43b-4707-a337-0ff988ac2763	6738bbf5-45cc-4eb0-bf85-c94c58c96fc0
TCGA-HC-7231-01	0	TCGA-HC-7231-01	72	0	TCGA-HC-7231			72	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66				M0	T1c	-24278							0	72											2011-10-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.2	NO	Bilateral	0.3		NO									T2c	TCGA-HC-7231.4a904b18-b8cf-4666-a384-2b3ce33f7891.pdf							0				0		15		85		85		3		No			R0	Primary Tumor	01	4	0.1				YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-7231-01A-11D-2114-08	246799a5-9027-4e87-85c9-9b60b3dd69fa	TCGA-HC-7231-01	f7d253d6-fce6-42d3-8926-563e8e7eff7f	TCGA-HC-7231-01A-11D-2114-08	TCGA-HC-7231-01A-11D-2114-08	TCGA-HC-7231-01A-11D-2112-01	f7d253d6-fce6-42d3-8926-563e8e7eff7f	TCGA-HC-7231-01A-11D-2112-01	f7d253d6-fce6-42d3-8926-563e8e7eff7f		TCGA-HC-7231-01	TCGA-HC-7231-01A-11D-2116-05	TCGA-HC-7231-01A-11R-2117-13	TCGA-HC-7231-01A-11D-2114-08	f7d253d6-fce6-42d3-8926-563e8e7eff7f	246799a5-9027-4e87-85c9-9b60b3dd69fa
TCGA-HC-7232-01	0	TCGA-HC-7232-01	1161	0	TCGA-HC-7232	766	1	1161	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	YES	66	TCGA-HC-7232-F64391					-24324						766	0	1161	766								Scheduled Follow-up Submission	Stable Disease	2014-8-29	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	NO		Biochemical evidence of disease		YES					T3b	TCGA-HC-7232.d5b6e727-43d6-4d27-a7ae-d89c046ef4eb.pdf							0										65	[Discrepancy]	4	Complete Remission/Response	No		NO	R0	Primary Tumor	01	5	0.4		NO		YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-7232-01A-11D-2114-08	579d62a4-c425-40cd-9f4c-28f79639e92d	TCGA-HC-7232-01	499d25b2-e516-4aea-b732-5c8096dc968a	TCGA-HC-7232-01A-11D-2114-08	TCGA-HC-7232-01A-11D-2114-08	TCGA-HC-7232-01A-11D-2112-01	499d25b2-e516-4aea-b732-5c8096dc968a	TCGA-HC-7232-01A-11D-2112-01	499d25b2-e516-4aea-b732-5c8096dc968a	7B5B1C42-36DB-4D44-96DD-6E8769289C80	TCGA-HC-7232-01	TCGA-HC-7232-01A-11D-2116-05	TCGA-HC-7232-01A-11R-2117-13	TCGA-HC-7232-01A-11D-2114-08	499d25b2-e516-4aea-b732-5c8096dc968a	579d62a4-c425-40cd-9f4c-28f79639e92d
TCGA-HC-7233-01	0	TCGA-HC-7233-01	1355	0	TCGA-HC-7233	1355	0	1355	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			73	TCGA-HC-7233-F63155												0	1355									Scheduled Follow-up Submission	Complete Remission/Response	2014-7-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Left	1	NO	YES				NO	2	0		N0	T2a	TCGA-HC-7233.3531e095-4042-4fc8-aa69-522b16e4e1fc.pdf							0										80	TUMOR FREE	4	Complete Remission/Response	Yes		NO	R1	Primary Tumor	01	3	0.6		NO		NO	YES	HC	Apex		Prostate		A	LIVING	2010			TCGA-HC-7233-01A-11D-2114-08	64d868e9-c6ef-435c-b16b-e985a9bb12e1	TCGA-HC-7233-01	81388e39-1fc8-47bd-b49b-946bc979996d	TCGA-HC-7233-01A-11D-2114-08	TCGA-HC-7233-01A-11D-2114-08	TCGA-HC-7233-01A-11D-2112-01	81388e39-1fc8-47bd-b49b-946bc979996d	TCGA-HC-7233-01A-11D-2112-01	81388e39-1fc8-47bd-b49b-946bc979996d	A195D5BC-E277-436D-B0F6-1BF27D835B89	TCGA-HC-7233-01	TCGA-HC-7233-01A-11D-2116-05	TCGA-HC-7233-01A-11R-2117-13		81388e39-1fc8-47bd-b49b-946bc979996d	64d868e9-c6ef-435c-b16b-e985a9bb12e1
TCGA-HC-7736-01	0	TCGA-HC-7736-01	22	0	TCGA-HC-7736			22	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59				M0	T2b	-21703				-21			0	22		102			YES	No Evidence of Extraprostatic Extension					2012-4-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1		YES					13	0		N0	T2c	TCGA-HC-7736.d5cb57cb-ff9a-4c83-b019-7b5ed2cd7494.pdf							0										65		3		No	.02			Primary Tumor	01	4	0.4				NO	YES	HC	Middle|Base		Prostate		A	LIVING	2010			TCGA-HC-7736-01A-11D-2114-08	33cdfda5-62b4-4f2a-a8dc-4c46e3f8cc44	TCGA-HC-7736-01	28ebf50e-d63f-439e-8e16-4a815eccb465	TCGA-HC-7736-01A-11D-2114-08	TCGA-HC-7736-01A-11D-2114-08	TCGA-HC-7736-01A-11D-2112-01	28ebf50e-d63f-439e-8e16-4a815eccb465	TCGA-HC-7736-01A-11D-2112-01	28ebf50e-d63f-439e-8e16-4a815eccb465	11886AD8-EAB8-4749-A880-4AF10F7EDFC1	TCGA-HC-7736-01	TCGA-HC-7736-01A-11D-2116-05	TCGA-HC-7736-01A-11R-2117-13	TCGA-HC-7736-01A-11D-2114-08	28ebf50e-d63f-439e-8e16-4a815eccb465	33cdfda5-62b4-4f2a-a8dc-4c46e3f8cc44
TCGA-HC-7737-01	0	TCGA-HC-7737-01	64	0	TCGA-HC-7737			64	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55			Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20122	9			9			0	64		147			YES	No Evidence of Extraprostatic Extension	NO				2012-4-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1		YES					8	1		N1	T2c	TCGA-HC-7737.deaefdb1-471e-43e7-a9b9-a2264cba6a53.pdf							0										80		3		No	0.1		R0	Primary Tumor	01	4	0.1				NO	YES	HC			Prostate		A	LIVING	2010			TCGA-HC-7737-01A-11D-2114-08	4f1dfa12-98af-4da2-91a1-4fcf1d58f36d	TCGA-HC-7737-01	bdb4a761-71cf-4465-a48f-4f938493ffcb	TCGA-HC-7737-01A-11D-2114-08	TCGA-HC-7737-01A-11D-2114-08	TCGA-HC-7737-01A-11D-2112-01	bdb4a761-71cf-4465-a48f-4f938493ffcb	TCGA-HC-7737-01A-11D-2112-01	bdb4a761-71cf-4465-a48f-4f938493ffcb		TCGA-HC-7737-01	TCGA-HC-7737-01A-11D-2116-05	TCGA-HC-7737-01A-11R-2117-13		bdb4a761-71cf-4465-a48f-4f938493ffcb	4f1dfa12-98af-4da2-91a1-4fcf1d58f36d
TCGA-HC-7737-11	0	TCGA-HC-7737-11	64	0	TCGA-HC-7737			64	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55			Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20122	9			9			0	64		147			YES	No Evidence of Extraprostatic Extension	NO				2012-4-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	0.8		YES					8	1		N1	T2c																				3		No	0.1		R0	Solid Tissue Normal	11	4	0.4				NO	YES	HC			Prostate		A	LIVING	2010						801b06ab-6ef3-46ba-af12-3b2230aabf51				801b06ab-6ef3-46ba-af12-3b2230aabf51		801b06ab-6ef3-46ba-af12-3b2230aabf51			TCGA-HC-7737-11A-02D-2116-05	TCGA-HC-7737-11A-02R-2117-13		801b06ab-6ef3-46ba-af12-3b2230aabf51	
TCGA-HC-7738-01	0	TCGA-HC-7738-01	964	0	TCGA-HC-7738	420	1	964	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	58	TCGA-HC-7738-F63151			M0		-21195						420	0	964	420								Scheduled Follow-up Submission	Stable Disease	2014-7-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.6	NO	NO	Other, specify	Biochemical evidence of disease	biochemical recurrence only	YES					T2c	TCGA-HC-7738.374827be-3cc2-4da8-a815-40539e441ccd.pdf							0				15		15		75		75	WITH TUMOR	3	Partial Remission/Response	No		NO	R0	Primary Tumor	01	4	0.1		NO		YES	NO	HC	Apex	NO	Prostate		A	LIVING	2011			TCGA-HC-7738-01A-11D-2114-08	341fc6ff-110a-4b58-bed2-56d1b7c651eb	TCGA-HC-7738-01	b02ac966-c160-4310-a80d-98fdc6134074	TCGA-HC-7738-01A-11D-2114-08	TCGA-HC-7738-01A-11D-2114-08	TCGA-HC-7738-01A-11D-2112-01	b02ac966-c160-4310-a80d-98fdc6134074	TCGA-HC-7738-01A-11D-2112-01	b02ac966-c160-4310-a80d-98fdc6134074		TCGA-HC-7738-01	TCGA-HC-7738-01A-11D-2116-05	TCGA-HC-7738-01A-11R-2117-13	TCGA-HC-7738-01A-11D-2114-08	b02ac966-c160-4310-a80d-98fdc6134074	341fc6ff-110a-4b58-bed2-56d1b7c651eb
TCGA-HC-7738-11	0	TCGA-HC-7738-11	964	0	TCGA-HC-7738	420	1	964	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	58	TCGA-HC-7738-F63151			M0		-21195						420	0	964	420								Scheduled Follow-up Submission	Stable Disease	2014-7-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.1	NO	NO	Other, specify	Biochemical evidence of disease	biochemical recurrence only	YES					T2c																			WITH TUMOR	3	Partial Remission/Response	No		NO	R0	Solid Tissue Normal	11	4	0.5		NO		YES	NO	HC	Apex	NO	Prostate		A	LIVING	2011						65592ca4-9afc-462c-86ee-a5f352aeb1f0				65592ca4-9afc-462c-86ee-a5f352aeb1f0		65592ca4-9afc-462c-86ee-a5f352aeb1f0				TCGA-HC-7738-11A-01R-2117-13		65592ca4-9afc-462c-86ee-a5f352aeb1f0	
TCGA-HC-7740-01	0	TCGA-HC-7740-01	717	0	TCGA-HC-7740	717	0	717	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-HC-7740-F48772			M0	T2a	-21883							0	717		154							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.2	NO	YES				NO	4	0		N0	T2c	TCGA-HC-7740.d2b80346-3a50-4fc3-99c2-0e15225cc433.pdf							0										65	TUMOR FREE	3	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	4	0.3		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-HC-7740-01A-11D-2114-08,TCGA-HC-7740-01B-04D-2298-08	6b555c8b-828c-497f-b018-b44d18baa407,ead38efb-2670-4586-84b8-db0a488b52ed	TCGA-HC-7740-01	095f3c80-890e-4529-816c-306daf614ec2	TCGA-HC-7740-01A-11D-2114-08	TCGA-HC-7740-01A-11D-2114-08	TCGA-HC-7740-01A-11D-2112-01	095f3c80-890e-4529-816c-306daf614ec2	TCGA-HC-7740-01A-11D-2112-01	095f3c80-890e-4529-816c-306daf614ec2	23F340A8-0AC4-4218-A18E-4CFDED8782FA	TCGA-HC-7740-01	TCGA-HC-7740-01B-04D-2299-05,TCGA-HC-7740-01A-11D-2116-05	TCGA-HC-7740-01B-04R-2303-13,TCGA-HC-7740-01A-11R-2117-13	TCGA-HC-7740-01B-04D-2298-08	095f3c80-890e-4529-816c-306daf614ec2	6b555c8b-828c-497f-b018-b44d18baa407,ead38efb-2670-4586-84b8-db0a488b52ed
TCGA-HC-7740-11	0	TCGA-HC-7740-11	717	0	TCGA-HC-7740	717	0	717	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-HC-7740-F48772			M0	T2a	-21883							0	717		154							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.6	NO	YES				NO	4	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0	NO	R0	Solid Tissue Normal	11	4	0.4		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011						0120b5b1-d204-429a-aa21-704fd98624ea				0120b5b1-d204-429a-aa21-704fd98624ea		0120b5b1-d204-429a-aa21-704fd98624ea				TCGA-HC-7740-11A-01R-2117-13		0120b5b1-d204-429a-aa21-704fd98624ea	
TCGA-HC-7741-01	0	TCGA-HC-7741-01	2725	0	TCGA-HC-7741			2725	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	YES	67	TCGA-HC-7741-F66040	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24608	9			9		1969	0	2725		146			YES				Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy			YES	Bilateral		NO	YES		Biochemical evidence of disease		YES	2	0		N0	T3b																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	HC	Apex|Middle|Base		Prostate		C	LIVING	2006				228b11d3-2780-4cac-b7ed-c0d0d8835fa5															228b11d3-2780-4cac-b7ed-c0d0d8835fa5
TCGA-HC-7742-01	0	TCGA-HC-7742-01	45	0	TCGA-HC-7742			45	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58						-21323							0	45											2012-4-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy							YES					2	0		N0	T3a																			TUMOR FREE	3		No			R0	Primary Tumor	01	4					YES	NO	HC			Prostate			LIVING	2011			TCGA-HC-7742-01A-11D-2114-08	e0ee4d13-21e3-4fbb-bf62-625c15d6ac09	TCGA-HC-7742-01	d8765abc-befa-49b5-893e-04de2ddb2ee1	TCGA-HC-7742-01A-11D-2114-08	TCGA-HC-7742-01A-11D-2114-08	TCGA-HC-7742-01A-11D-2112-01	d8765abc-befa-49b5-893e-04de2ddb2ee1	TCGA-HC-7742-01A-11D-2112-01	d8765abc-befa-49b5-893e-04de2ddb2ee1		TCGA-HC-7742-01	TCGA-HC-7742-01A-11D-2116-05	TCGA-HC-7742-01A-11R-2117-13	TCGA-HC-7742-01A-11D-2114-08	d8765abc-befa-49b5-893e-04de2ddb2ee1	e0ee4d13-21e3-4fbb-bf62-625c15d6ac09
TCGA-HC-7742-11	0	TCGA-HC-7742-11	45	0	TCGA-HC-7742			45	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58						-21323							0	45											2012-4-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy		0.6	NO		0.7		YES					2	0		N0	T3a																			TUMOR FREE	3		No			R0	Solid Tissue Normal	11	4	0.3				YES	NO	HC			Prostate		A	LIVING	2011						12358445-06b8-4055-8454-69b8544774fc				12358445-06b8-4055-8454-69b8544774fc		12358445-06b8-4055-8454-69b8544774fc			TCGA-HC-7742-11A-01D-2116-05	TCGA-HC-7742-11A-01R-2117-13		12358445-06b8-4055-8454-69b8544774fc	
TCGA-HC-7744-01	0	TCGA-HC-7744-01	51	0	TCGA-HC-7744			51	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			46		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-17065	10			40	42		0	51		282			YES		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2012-4-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1		YES					8	0		N0	T3b	TCGA-HC-7744.01b8c2af-bdf8-4627-bf6e-c7a41d929b94.pdf							0										60	TUMOR FREE	4		No	0.04		R1	Primary Tumor	01	3	0.3				YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-HC-7744-01A-11D-2114-08	05b4d21f-ac5c-4b7c-8cdc-9aad09365368	TCGA-HC-7744-01	82b1d50a-9ed4-4d42-80d4-59d06b43df3e	TCGA-HC-7744-01A-11D-2114-08	TCGA-HC-7744-01A-11D-2114-08	TCGA-HC-7744-01A-11D-2112-01	82b1d50a-9ed4-4d42-80d4-59d06b43df3e	TCGA-HC-7744-01A-11D-2112-01	82b1d50a-9ed4-4d42-80d4-59d06b43df3e	607F5599-9CEB-49A9-8D9D-8EAA0C9ED792	TCGA-HC-7744-01	TCGA-HC-7744-01A-11D-2116-05	TCGA-HC-7744-01A-11R-2117-13		82b1d50a-9ed4-4d42-80d4-59d06b43df3e	05b4d21f-ac5c-4b7c-8cdc-9aad09365368
TCGA-HC-7745-01	0	TCGA-HC-7745-01	721	0	TCGA-HC-7745	721	0	721	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-HC-7745-F66044					-24078							0	721					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.7	NO	YES				NO	3	0		N0	T3b	TCGA-HC-7745.4a65a2d9-6007-4ff2-9711-46351f540367.pdf							0				15		15		70		70	TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Primary Tumor	01	3	0.2		YES		YES	NO	HC	Middle		Prostate		A	LIVING	2011			TCGA-HC-7745-01A-11D-2114-08	4e61e622-4c90-4f9c-a7c1-f1b37f1c32a8	TCGA-HC-7745-01	d26a0c98-2768-48df-ab84-dcce5e18537a	TCGA-HC-7745-01A-11D-2114-08	TCGA-HC-7745-01A-11D-2114-08	TCGA-HC-7745-01A-11D-2112-01	d26a0c98-2768-48df-ab84-dcce5e18537a	TCGA-HC-7745-01A-11D-2112-01	d26a0c98-2768-48df-ab84-dcce5e18537a		TCGA-HC-7745-01	TCGA-HC-7745-01A-11D-2116-05	TCGA-HC-7745-01A-11R-2117-13	TCGA-HC-7745-01A-11D-2114-08	d26a0c98-2768-48df-ab84-dcce5e18537a	4e61e622-4c90-4f9c-a7c1-f1b37f1c32a8
TCGA-HC-7745-11	0	TCGA-HC-7745-11	721	0	TCGA-HC-7745	721	0	721	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-HC-7745-F66044					-24078							0	721					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.1	NO	YES				NO	3	0		N0	T3b																			TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Solid Tissue Normal	11	3	0.3		YES		YES	NO	HC	Middle		Prostate		A	LIVING	2011						3e2b99bc-6a05-4de8-b135-923d443cd4fa				3e2b99bc-6a05-4de8-b135-923d443cd4fa		3e2b99bc-6a05-4de8-b135-923d443cd4fa			TCGA-HC-7745-11A-01D-2116-05	TCGA-HC-7745-11A-01R-2117-13		3e2b99bc-6a05-4de8-b135-923d443cd4fa	
TCGA-HC-7747-01	0	TCGA-HC-7747-01	748	0	TCGA-HC-7747	748	0	748	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			52	TCGA-HC-7747-F60208	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-19188	25			25			0	748		392			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-5-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.5	NO	YES				NO	4	0		N0	T2c	TCGA-HC-7747.cd814697-95e2-46d6-8f80-4467d7bedf01.pdf							0				10		25		65		65	TUMOR FREE	3	Complete Remission/Response	No	0.19	YES		Primary Tumor	01	4	0.2		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-HC-7747-01A-11D-2114-08	2184f5d4-22e9-4ae5-a4a7-6b31798a7d3b	TCGA-HC-7747-01	a88b498e-6e56-4d49-b11d-827ad2b29b5d	TCGA-HC-7747-01A-11D-2114-08	TCGA-HC-7747-01A-11D-2114-08	TCGA-HC-7747-01A-11D-2112-01	a88b498e-6e56-4d49-b11d-827ad2b29b5d	TCGA-HC-7747-01A-11D-2112-01	a88b498e-6e56-4d49-b11d-827ad2b29b5d		TCGA-HC-7747-01	TCGA-HC-7747-01A-11D-2116-05	TCGA-HC-7747-01A-11R-2117-13	TCGA-HC-7747-01A-11D-2114-08	a88b498e-6e56-4d49-b11d-827ad2b29b5d	2184f5d4-22e9-4ae5-a4a7-6b31798a7d3b
TCGA-HC-7747-11	0	TCGA-HC-7747-11	748	0	TCGA-HC-7747	748	0	748	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			52	TCGA-HC-7747-F60208	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-19188	25			25			0	748		392			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-5-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.1	NO	YES				NO	4	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.19	YES		Solid Tissue Normal	11	4	0.4		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011						8f9b3818-5334-4aa0-9ad1-22bca0afb925				8f9b3818-5334-4aa0-9ad1-22bca0afb925		8f9b3818-5334-4aa0-9ad1-22bca0afb925				TCGA-HC-7747-11A-01R-2117-13		8f9b3818-5334-4aa0-9ad1-22bca0afb925	
TCGA-HC-7748-01	0	TCGA-HC-7748-01	792	0	TCGA-HC-7748	792	0	792	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-HC-7748-F48774					-22072							0	792		99							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Right	0.8	NO	YES				NO	10	0		N0	T2a	TCGA-HC-7748.6516e000-dc8c-4715-a561-ee47a114ad23.pdf							0										70	TUMOR FREE	3	Complete Remission/Response	Yes	0.1	NO	R0	Primary Tumor	01	3	0.4		NO		YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-7748-01A-11D-2114-08	b0b9c638-e19e-4c95-9a57-ded341742dce	TCGA-HC-7748-01	eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b	TCGA-HC-7748-01A-11D-2114-08	TCGA-HC-7748-01A-11D-2114-08	TCGA-HC-7748-01A-11D-2112-01	eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b	TCGA-HC-7748-01A-11D-2112-01	eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b	09D67575-C709-4A9C-BB42-85F697F4ECAC	TCGA-HC-7748-01	TCGA-HC-7748-01A-11D-2116-05	TCGA-HC-7748-01A-11R-2117-13	TCGA-HC-7748-01A-11D-2114-08	eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b	b0b9c638-e19e-4c95-9a57-ded341742dce
TCGA-HC-7749-01	0	TCGA-HC-7749-01	60	0	TCGA-HC-7749			60	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70				M0		-25688							0	60		102									2012-4-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Right	0.3		YES					10	0		N0	T3a	TCGA-HC-7749.35e33cb7-77a7-4d02-b4ec-9374423027c0.pdf							0										70		4		No	0.1		R0	Primary Tumor	01	3	0.2			5	YES	NO	HC	Middle|Base		Prostate		A	LIVING	2011			TCGA-HC-7749-01A-11D-2114-08	4013662a-fc6d-4814-b807-3fe516f9b303	TCGA-HC-7749-01	6551bbb1-297f-41db-969b-17bb3c432426	TCGA-HC-7749-01A-11D-2114-08	TCGA-HC-7749-01A-11D-2114-08	TCGA-HC-7749-01A-11D-2112-01	6551bbb1-297f-41db-969b-17bb3c432426	TCGA-HC-7749-01A-11D-2112-01	6551bbb1-297f-41db-969b-17bb3c432426		TCGA-HC-7749-01	TCGA-HC-7749-01A-11D-2116-05	TCGA-HC-7749-01A-11R-2117-13	TCGA-HC-7749-01A-11D-2114-08	6551bbb1-297f-41db-969b-17bb3c432426	4013662a-fc6d-4814-b807-3fe516f9b303
TCGA-HC-7750-01	0	TCGA-HC-7750-01	522	0	TCGA-HC-7750	522	0	522	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			50	TCGA-HC-7750-F46692			M0	T2b	-18580							0	522		83							Scheduled Follow-up Submission	Complete Remission/Response	2013-8-13	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Left	0.4	NO	NO				NO					T2c	TCGA-HC-7750.f05d95fd-391d-49ab-8a2f-039110a654bd.pdf							0				10		20		70		70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.2		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-HC-7750-01A-11D-2114-08	234f489c-8bc6-448d-81d2-8b06729445e7	TCGA-HC-7750-01	54ad372c-0c62-42b9-86c4-91cd0e148af2	TCGA-HC-7750-01A-11D-2114-08	TCGA-HC-7750-01A-11D-2114-08	TCGA-HC-7750-01A-11D-2112-01	54ad372c-0c62-42b9-86c4-91cd0e148af2	TCGA-HC-7750-01A-11D-2112-01	54ad372c-0c62-42b9-86c4-91cd0e148af2		TCGA-HC-7750-01	TCGA-HC-7750-01A-11D-2116-05	TCGA-HC-7750-01A-11R-2117-13	TCGA-HC-7750-01A-11D-2114-08	54ad372c-0c62-42b9-86c4-91cd0e148af2	234f489c-8bc6-448d-81d2-8b06729445e7
TCGA-HC-7752-01	0	TCGA-HC-7752-01	782	0	TCGA-HC-7752	782	0	782	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-HC-7752-F64386			M0		-22366							0	782		138							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	6	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	HC	Base		Prostate			LIVING	2011			TCGA-HC-7752-01A-11D-2114-08	a83cf9c6-f66a-4b37-a36f-bba5140512cd	TCGA-HC-7752-01	f57a7df0-0aaf-4181-b8c1-f50133964823	TCGA-HC-7752-01A-11D-2114-08	TCGA-HC-7752-01A-11D-2114-08	TCGA-HC-7752-01A-11D-2112-01	f57a7df0-0aaf-4181-b8c1-f50133964823	TCGA-HC-7752-01A-11D-2112-01	f57a7df0-0aaf-4181-b8c1-f50133964823		TCGA-HC-7752-01	TCGA-HC-7752-01A-11D-2116-05	TCGA-HC-7752-01A-11R-2117-13	TCGA-HC-7752-01A-11D-2114-08	f57a7df0-0aaf-4181-b8c1-f50133964823	a83cf9c6-f66a-4b37-a36f-bba5140512cd
TCGA-HC-7752-11	0	TCGA-HC-7752-11	782	0	TCGA-HC-7752	782	0	782	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-HC-7752-F64386			M0		-22366							0	782		138							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.2	NO	YES				NO	6	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.3		NO		YES	NO	HC	Base		Prostate		A	LIVING	2011						c08293b3-507d-4c7c-8b14-9a328e1d15fe				c08293b3-507d-4c7c-8b14-9a328e1d15fe		c08293b3-507d-4c7c-8b14-9a328e1d15fe			TCGA-HC-7752-11A-01D-2116-05	TCGA-HC-7752-11A-01R-2117-13		c08293b3-507d-4c7c-8b14-9a328e1d15fe	
TCGA-HC-7817-01	0	TCGA-HC-7817-01	928	0	TCGA-HC-7817	928	0	928	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			52	TCGA-HC-7817-F60204	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-19207							0	928		171			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-5-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.1	NO	NO				NO					T3b								0				15		15		70		70	TUMOR FREE	4	Complete Remission/Response	No	0.1	YES		Primary Tumor	01	3	0.5		NO		YES	NO	HC	Apex|Middle|Base		Prostate		B	LIVING	2011			TCGA-HC-7817-01B-11D-A29Q-08	44820343-75e0-477e-99a5-ea0fa62adae9	TCGA-HC-7817-01	c995e591-f2b7-4c3e-ae81-9e72b9548b57	TCGA-HC-7817-01B-11D-A29Q-08	TCGA-HC-7817-01B-11D-A29Q-08	TCGA-HC-7817-01B-11D-A323-01	c995e591-f2b7-4c3e-ae81-9e72b9548b57	TCGA-HC-7817-01B-11D-A323-01	c995e591-f2b7-4c3e-ae81-9e72b9548b57	1B96882F-EE27-453F-84A4-83C09511A492	TCGA-HC-7817-01	TCGA-HC-7817-01B-11D-A29T-05	TCGA-HC-7817-01B-11R-A29V-13	TCGA-HC-7817-01B-11D-A29Q-08	c995e591-f2b7-4c3e-ae81-9e72b9548b57	44820343-75e0-477e-99a5-ea0fa62adae9
TCGA-HC-7818-01	0	TCGA-HC-7818-01	938	0	TCGA-HC-7818	938	0	938	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-HC-7818-F64380			M0	T2b	-24391							0	938		99							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.2	NO	Bilateral	0.4	NO	YES				NO	6	0		N0	T2c	TCGA-HC-7818.e6f3745f-31bf-4475-85f8-956811ce6cb6.pdf							0				20		10		70		70	TUMOR FREE	3	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	4	0.2		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-HC-7818-01A-11D-2114-08	3183a603-4043-4256-b9fd-d03afccd1310	TCGA-HC-7818-01	776e6a2e-e939-4c92-b8dc-000c91bf5f64	TCGA-HC-7818-01A-11D-2114-08	TCGA-HC-7818-01A-11D-2114-08	TCGA-HC-7818-01A-11D-2112-01	776e6a2e-e939-4c92-b8dc-000c91bf5f64	TCGA-HC-7818-01A-11D-2112-01	776e6a2e-e939-4c92-b8dc-000c91bf5f64		TCGA-HC-7818-01	TCGA-HC-7818-01A-11D-2116-05	TCGA-HC-7818-01A-11R-2117-13	TCGA-HC-7818-01A-11D-2114-08	776e6a2e-e939-4c92-b8dc-000c91bf5f64	3183a603-4043-4256-b9fd-d03afccd1310
TCGA-HC-7819-01	0	TCGA-HC-7819-01	543	0	TCGA-HC-7819	543	0	543	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-HC-7819-F56150			M0	T2c	-19663					-73		0	543		172			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.3	NO	YES				NO	3	0		N0	T2c	TCGA-HC-7819.ab62f75e-d1f0-47f7-8a78-4151af81d409.pdf							0				5		10		85		85	TUMOR FREE	4	Complete Remission/Response	No	.01	NO	R2	Primary Tumor	01	4	0.3		NO	4	YES	NO	HC			Prostate		A	LIVING	2011	Central Zone		TCGA-HC-7819-01A-11D-2114-08	3edbb14f-435b-41fe-99b6-a0a732330aff	TCGA-HC-7819-01	285a1a43-5494-49f4-95bb-671ebc1a953a	TCGA-HC-7819-01A-11D-2114-08	TCGA-HC-7819-01A-11D-2114-08	TCGA-HC-7819-01A-11D-2112-01	285a1a43-5494-49f4-95bb-671ebc1a953a	TCGA-HC-7819-01A-11D-2112-01	285a1a43-5494-49f4-95bb-671ebc1a953a		TCGA-HC-7819-01	TCGA-HC-7819-01A-11D-2116-05	TCGA-HC-7819-01A-11R-2117-13	TCGA-HC-7819-01A-11D-2114-08	285a1a43-5494-49f4-95bb-671ebc1a953a	3edbb14f-435b-41fe-99b6-a0a732330aff
TCGA-HC-7819-11	0	TCGA-HC-7819-11	543	0	TCGA-HC-7819	543	0	543	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-HC-7819-F56150			M0	T2c	-19663					-73		0	543		172			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.6	NO	YES				NO	3	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	.01	NO	R2	Solid Tissue Normal	11	4	0.3		NO	4	YES	NO	HC			Prostate		A	LIVING	2011	Central Zone					e95f79a8-15ea-4b95-9f8e-b63ada04c51e				e95f79a8-15ea-4b95-9f8e-b63ada04c51e		e95f79a8-15ea-4b95-9f8e-b63ada04c51e			TCGA-HC-7819-11A-01D-2116-05	TCGA-HC-7819-11A-01R-2117-13		e95f79a8-15ea-4b95-9f8e-b63ada04c51e	
TCGA-HC-7820-01	0	TCGA-HC-7820-01	747	0	TCGA-HC-7820	747	0	747	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-HC-7820-F57012					-26576							0	747									Scheduled Follow-up Submission	Complete Remission/Response	2014-2-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.4	NO	NO				NO					T2c	TCGA-HC-7820.750c91eb-1732-4ca3-8c71-f1309a90e4f5.pdf							0				10		10		80		80	TUMOR FREE	3	Complete Remission/Response	No		NO	R0	Primary Tumor	01	4	0.1		NO		YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-7820-01A-11D-2114-08	74867a42-5f50-412d-9df0-b6c40d017a49	TCGA-HC-7820-01	297e88ae-4a8d-4021-825a-8a7d7e2f71d1	TCGA-HC-7820-01A-11D-2114-08	TCGA-HC-7820-01A-11D-2114-08	TCGA-HC-7820-01A-11D-2112-01	297e88ae-4a8d-4021-825a-8a7d7e2f71d1	TCGA-HC-7820-01A-11D-2112-01	297e88ae-4a8d-4021-825a-8a7d7e2f71d1		TCGA-HC-7820-01	TCGA-HC-7820-01A-11D-2116-05	TCGA-HC-7820-01A-11R-2117-13	TCGA-HC-7820-01A-11D-2114-08	297e88ae-4a8d-4021-825a-8a7d7e2f71d1	74867a42-5f50-412d-9df0-b6c40d017a49
TCGA-HC-7820-11	0	TCGA-HC-7820-11	747	0	TCGA-HC-7820	747	0	747	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-HC-7820-F57012					-26576							0	747									Scheduled Follow-up Submission	Complete Remission/Response	2014-2-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.9	NO	NO				NO					T2c																			TUMOR FREE	3	Complete Remission/Response	No		NO	R0	Solid Tissue Normal	11	4	0.4		NO		YES	NO	HC			Prostate		A	LIVING	2011															TCGA-HC-7820-11A-01D-2116-05				
TCGA-HC-7821-01	0	TCGA-HC-7821-01	956	0	TCGA-HC-7821			956	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	54	TCGA-HC-7821-F66038	NO		M0		-19894						950	0	956		236							Scheduled Follow-up Submission	Progressive Disease	2014-10-1	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES		Biochemical evidence of disease		YES	7	2		N1	T3b																			WITH TUMOR	4	Complete Remission/Response	Yes	0.01	YES		Primary Tumor	01	4			YES		YES	NO	HC	Apex|Middle|Base		Prostate			LIVING	2011			TCGA-HC-7821-01A-12D-2114-08	bd4ca136-1ccc-44fb-954e-68a4a5f6c86f	TCGA-HC-7821-01	df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7	TCGA-HC-7821-01A-12D-2114-08	TCGA-HC-7821-01A-12D-2114-08	TCGA-HC-7821-01A-12D-2112-01	df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7	TCGA-HC-7821-01A-12D-2112-01	df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7		TCGA-HC-7821-01	TCGA-HC-7821-01A-12D-2116-05	TCGA-HC-7821-01A-12R-2117-13	TCGA-HC-7821-01A-12D-2114-08	df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7	bd4ca136-1ccc-44fb-954e-68a4a5f6c86f
TCGA-HC-8212-01	0	TCGA-HC-8212-01	2179	0	TCGA-HC-8212			2179	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	YES	53	TCGA-HC-8212-F66042					-19539							0	2179		640							Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy			YES	Bilateral		NO	YES		Biochemical evidence of disease		YES	3	0		N0	T3a																			TUMOR FREE	3	Complete Remission/Response	No	3.27	NO	R0	Primary Tumor	01	4			NO		NO	YES	HC			Prostate		B	LIVING	2007				e8f75aa5-d3a7-45ab-8f3e-bba9bb58cfe1															e8f75aa5-d3a7-45ab-8f3e-bba9bb58cfe1
TCGA-HC-8213-01	0	TCGA-HC-8213-01	589	0	TCGA-HC-8213	589	0	589	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			48	TCGA-HC-8213-F45567					-17673							0	589									Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES			0.5	NO	Bilateral	0.7	NO	NO				NO					T2c								0				10		5		85		65	TUMOR FREE	3	Complete Remission/Response	No		NO	R0	Primary Tumor	01	3	0.3		NO		YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-8213-01A-11D-A29Q-08	f33cabe6-f026-4d8e-83fc-f995d1e4c4ed	TCGA-HC-8213-01	61843a22-9a35-4370-a301-881d5c967d29	TCGA-HC-8213-01A-11D-A29Q-08	TCGA-HC-8213-01A-11D-A29Q-08	TCGA-HC-8213-01A-11D-A323-01	61843a22-9a35-4370-a301-881d5c967d29	TCGA-HC-8213-01A-11D-A323-01	61843a22-9a35-4370-a301-881d5c967d29		TCGA-HC-8213-01	TCGA-HC-8213-01A-11D-A29T-05	TCGA-HC-8213-01A-11R-A29V-13	TCGA-HC-8213-01A-11D-A29Q-08	61843a22-9a35-4370-a301-881d5c967d29	f33cabe6-f026-4d8e-83fc-f995d1e4c4ed
TCGA-HC-8216-01	0	TCGA-HC-8216-01	682	0	TCGA-HC-8216	682	0	682	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-HC-8216-F48769		Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-21428	10			10			0	682		137			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Right	0.4	NO	YES				NO	3	0		N0	T3a								0				5		10		85		85	TUMOR FREE	4	Complete Remission/Response	No	.19	NO	R0	Primary Tumor	01	3	0.3		NO	5	YES	NO	HC	Middle|Base		Prostate		A	LIVING	2011			TCGA-HC-8216-01A-11D-A29Q-08	526b4593-0f3c-4d7a-abe4-32321926eae0	TCGA-HC-8216-01	98021887-fb82-4cb4-a5f4-c4316901da21	TCGA-HC-8216-01A-11D-A29Q-08	TCGA-HC-8216-01A-11D-A29Q-08	TCGA-HC-8216-01A-11D-A323-01	98021887-fb82-4cb4-a5f4-c4316901da21	TCGA-HC-8216-01A-11D-A323-01	98021887-fb82-4cb4-a5f4-c4316901da21		TCGA-HC-8216-01	TCGA-HC-8216-01A-11D-A29T-05	TCGA-HC-8216-01A-11R-A29V-13	TCGA-HC-8216-01A-11D-A29Q-08	98021887-fb82-4cb4-a5f4-c4316901da21	526b4593-0f3c-4d7a-abe4-32321926eae0
TCGA-HC-8256-01	0	TCGA-HC-8256-01	860	0	TCGA-HC-8256	860	0	860	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-HC-8256-F64369			M0		-19598							0	860									Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.4	YES	NO				NO					T2c	TCGA-HC-8256.2ec7732c-f24c-41eb-ba84-39bfc1c0c5b3.pdf							0				10		5		85		85	TUMOR FREE	3	Complete Remission/Response	No		NO	R0	Primary Tumor	01	4	0.1		NO		YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-8256-01A-11D-2260-08	3f251fc1-31d7-4c8f-8331-2f3a49fd8fc0	TCGA-HC-8256-01	c7ab83e0-85c1-4224-8f47-746221f66d1e	TCGA-HC-8256-01A-11D-2260-08	TCGA-HC-8256-01A-11D-2260-08	TCGA-HC-8256-01A-11D-2259-01	c7ab83e0-85c1-4224-8f47-746221f66d1e	TCGA-HC-8256-01A-11D-2259-01	c7ab83e0-85c1-4224-8f47-746221f66d1e		TCGA-HC-8256-01	TCGA-HC-8256-01A-11D-2261-05	TCGA-HC-8256-01A-11R-2262-13	TCGA-HC-8256-01A-11D-2260-08	c7ab83e0-85c1-4224-8f47-746221f66d1e	3f251fc1-31d7-4c8f-8331-2f3a49fd8fc0
TCGA-HC-8257-01	0	TCGA-HC-8257-01	726	0	TCGA-HC-8257	726	0	726	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-HC-8257-F57852	NO				-25629							0	726		726							Scheduled Follow-up Submission	Complete Remission/Response	2014-3-27	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES			0.3	NO	Bilateral	1.1	NO	YES				NO	8	1		N1	T3b	TCGA-HC-8257.ff35baf5-f38f-4458-8c20-c61d61c61c19.pdf							0				0		0		0		80	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R1	Primary Tumor	01	4	0.1		YES		YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-8257-01A-11D-2260-08	cead766d-7f61-46a8-bda2-b1cddf5489c5	TCGA-HC-8257-01	940cfbb0-1808-41e0-8b13-4447b0d3c8cc	TCGA-HC-8257-01A-11D-2260-08	TCGA-HC-8257-01A-11D-2260-08	TCGA-HC-8257-01A-11D-2259-01	940cfbb0-1808-41e0-8b13-4447b0d3c8cc	TCGA-HC-8257-01A-11D-2259-01	940cfbb0-1808-41e0-8b13-4447b0d3c8cc		TCGA-HC-8257-01	TCGA-HC-8257-01A-11D-2261-05	TCGA-HC-8257-01A-11R-2262-13	TCGA-HC-8257-01A-11D-2260-08	940cfbb0-1808-41e0-8b13-4447b0d3c8cc	cead766d-7f61-46a8-bda2-b1cddf5489c5
TCGA-HC-8258-01	0	TCGA-HC-8258-01	66	0	TCGA-HC-8258	66	0	66	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56		NO				-20703							0	66		162									2012-6-20	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.6		YES				NO	2	0		N0	T2c	TCGA-HC-8258.fffd3795-6c0c-43a0-afe4-30e759e5f20a.pdf							0				5		5		90		90	TUMOR FREE	3		No	.01			Primary Tumor	01	3	0.2				YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-8258-01B-05D-2298-08,TCGA-HC-8258-01A-11D-2260-08	8ce90327-6a5c-442f-be2e-2fb684c72603,fc97d832-3e85-45fa-b5a2-c1a7d2ab32fd	TCGA-HC-8258-01	b353ec8f-70d1-40a6-bf94-12662bd11146	TCGA-HC-8258-01A-11D-2260-08	TCGA-HC-8258-01A-11D-2260-08	TCGA-HC-8258-01A-11D-2259-01	b353ec8f-70d1-40a6-bf94-12662bd11146	TCGA-HC-8258-01A-11D-2259-01	b353ec8f-70d1-40a6-bf94-12662bd11146		TCGA-HC-8258-01	TCGA-HC-8258-01B-05D-2299-05,TCGA-HC-8258-01A-11D-2261-05	TCGA-HC-8258-01A-11R-2262-13,TCGA-HC-8258-01B-05R-2303-13		b353ec8f-70d1-40a6-bf94-12662bd11146	8ce90327-6a5c-442f-be2e-2fb684c72603,fc97d832-3e85-45fa-b5a2-c1a7d2ab32fd
TCGA-HC-8258-11	0	TCGA-HC-8258-11	66	0	TCGA-HC-8258	66	0	66	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56		NO				-20703							0	66		162									2012-6-20	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.6		YES				NO	2	0		N0	T2c																			TUMOR FREE	3		No	.01			Solid Tissue Normal	11	3	0.3				YES	NO	HC			Prostate		A	LIVING	2011						575740a1-6467-4f58-b462-6fd1a4f63c51				575740a1-6467-4f58-b462-6fd1a4f63c51		575740a1-6467-4f58-b462-6fd1a4f63c51				TCGA-HC-8258-11A-01R-2262-13		575740a1-6467-4f58-b462-6fd1a4f63c51	
TCGA-HC-8259-01	0	TCGA-HC-8259-01	69	0	TCGA-HC-8259	69	0	69	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			50		NO				-18309							0	69		123									2012-6-20	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Left	0.5		NO				NO					T2a	TCGA-HC-8259.e53c1322-0854-4ae8-b087-3ddd3712df56.pdf							0				5		5		90		90	TUMOR FREE	3		No	0.01		R0	Primary Tumor	01	3	0.2				YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-8259-01A-11D-2260-08	481deefc-88c1-4697-a1a5-51778ceace83	TCGA-HC-8259-01	add784d0-7733-448c-a8b9-53442128d8ac	TCGA-HC-8259-01A-11D-2260-08	TCGA-HC-8259-01A-11D-2260-08	TCGA-HC-8259-01A-11D-2259-01	add784d0-7733-448c-a8b9-53442128d8ac	TCGA-HC-8259-01A-11D-2259-01	add784d0-7733-448c-a8b9-53442128d8ac		TCGA-HC-8259-01	TCGA-HC-8259-01A-11D-2261-05	TCGA-HC-8259-01A-11R-2262-13	TCGA-HC-8259-01A-11D-2260-08	add784d0-7733-448c-a8b9-53442128d8ac	481deefc-88c1-4697-a1a5-51778ceace83
TCGA-HC-8259-11	0	TCGA-HC-8259-11	69	0	TCGA-HC-8259	69	0	69	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			50		NO				-18309							0	69		123									2012-6-20	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Left	0.7		NO				NO					T2a																			TUMOR FREE	3		No	0.01		R0	Solid Tissue Normal	11	3	0.3				YES	NO	HC			Prostate		A	LIVING	2011						b805e5e4-4d99-46c8-b308-11cac572ac42				b805e5e4-4d99-46c8-b308-11cac572ac42		b805e5e4-4d99-46c8-b308-11cac572ac42				TCGA-HC-8259-11A-01R-2262-13		b805e5e4-4d99-46c8-b308-11cac572ac42	
TCGA-HC-8260-01	0	TCGA-HC-8260-01	686	0	TCGA-HC-8260	686	0	686	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			43	TCGA-HC-8260-F64387	NO				-15884							0	686		106							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1	NO	YES				NO	9	0		N0	T2c	TCGA-HC-8260.12d41624-f0a9-4ba1-aa55-18fea0b733af.pdf							0				0		0		0		65	[Discrepancy]	3	Complete Remission/Response	No	0.01	NO	R1	Primary Tumor	01	4	0.1		NO		YES	NO	HC	Apex		Prostate		A	LIVING	2011	Peripheral Zone		TCGA-HC-8260-01A-11D-2260-08	84483dbf-542b-4ae7-b20c-8d56229cfd01	TCGA-HC-8260-01	59a3d245-6921-4799-9eb7-1bff6021680f	TCGA-HC-8260-01A-11D-2260-08	TCGA-HC-8260-01A-11D-2260-08	TCGA-HC-8260-01A-11D-2259-01	59a3d245-6921-4799-9eb7-1bff6021680f	TCGA-HC-8260-01A-11D-2259-01	59a3d245-6921-4799-9eb7-1bff6021680f		TCGA-HC-8260-01	TCGA-HC-8260-01A-11D-2261-05	TCGA-HC-8260-01A-11R-2262-13	TCGA-HC-8260-01A-11D-2260-08	59a3d245-6921-4799-9eb7-1bff6021680f	84483dbf-542b-4ae7-b20c-8d56229cfd01
TCGA-HC-8260-11	0	TCGA-HC-8260-11	686	0	TCGA-HC-8260	686	0	686	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			43	TCGA-HC-8260-F64387	NO				-15884							0	686		106							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.9	NO	YES				NO	9	0		N0	T2c																			[Discrepancy]	3	Complete Remission/Response	No	0.01	NO	R1	Solid Tissue Normal	11	4	0.3		NO		YES	NO	HC	Apex		Prostate		A	LIVING	2011	Peripheral Zone					094a8a62-d69a-4054-a9d8-120cf7920c39				094a8a62-d69a-4054-a9d8-120cf7920c39		094a8a62-d69a-4054-a9d8-120cf7920c39				TCGA-HC-8260-11A-01R-2262-13		094a8a62-d69a-4054-a9d8-120cf7920c39	
TCGA-HC-8261-01	0	TCGA-HC-8261-01	546	0	TCGA-HC-8261	546	0	546	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			48	TCGA-HC-8261-F57017					-17874							0	546									Scheduled Follow-up Submission	Complete Remission/Response	2014-2-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy			YES	Bilateral		NO	NO				NO					T2c																			TUMOR FREE	3	Complete Remission/Response	No		NO	R0	Primary Tumor	01	4			NO		YES	NO	HC			Prostate		B	LIVING	2011			TCGA-HC-8261-01A-11D-2260-08,TCGA-HC-8261-01B-05D-2298-08	05a21de2-ea0f-47d0-b712-2f9e9741db60,c3212c6b-5f59-49f1-a7e6-091f2d3ea8ff	TCGA-HC-8261-01	4a54f172-9435-4e46-8396-405634425db2	TCGA-HC-8261-01A-11D-2260-08	TCGA-HC-8261-01A-11D-2260-08	TCGA-HC-8261-01A-11D-2259-01	4a54f172-9435-4e46-8396-405634425db2	TCGA-HC-8261-01A-11D-2259-01	4a54f172-9435-4e46-8396-405634425db2		TCGA-HC-8261-01	TCGA-HC-8261-01A-11D-2261-05,TCGA-HC-8261-01B-05D-2299-05	TCGA-HC-8261-01B-05R-2303-13,TCGA-HC-8261-01A-11R-2262-13	TCGA-HC-8261-01B-05D-2298-08,TCGA-HC-8261-01A-11D-2260-08	4a54f172-9435-4e46-8396-405634425db2	05a21de2-ea0f-47d0-b712-2f9e9741db60,c3212c6b-5f59-49f1-a7e6-091f2d3ea8ff
TCGA-HC-8262-01	0	TCGA-HC-8262-01	679	0	TCGA-HC-8262	679	0	679	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-HC-8262-F48770	NO				-20946							0	679		112							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.2	NO	Bilateral	0.3	NO	YES				NO	8	0		N0	T2c	TCGA-HC-8262.b2b40b37-fcee-4ad0-ae88-0ca54e39cf7c.pdf							0				20		10		70		70	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.1		NO		YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-8262-01A-11D-2260-08	25ca9770-6372-4c2d-87d0-0122998dca1f	TCGA-HC-8262-01	b081b1a5-2ab9-401b-a892-83e1d51ade54	TCGA-HC-8262-01A-11D-2260-08	TCGA-HC-8262-01A-11D-2260-08	TCGA-HC-8262-01A-11D-2259-01	b081b1a5-2ab9-401b-a892-83e1d51ade54	TCGA-HC-8262-01A-11D-2259-01	b081b1a5-2ab9-401b-a892-83e1d51ade54		TCGA-HC-8262-01	TCGA-HC-8262-01A-11D-2261-05	TCGA-HC-8262-01A-11R-2262-13	TCGA-HC-8262-01A-11D-2260-08	b081b1a5-2ab9-401b-a892-83e1d51ade54	25ca9770-6372-4c2d-87d0-0122998dca1f
TCGA-HC-8262-11	0	TCGA-HC-8262-11	679	0	TCGA-HC-8262	679	0	679	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-HC-8262-F48770	NO				-20946							0	679		112							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.7	NO	YES				NO	8	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Solid Tissue Normal	11	4	0.3		NO		YES	NO	HC			Prostate		A	LIVING	2011						4979a47e-0078-40c7-abad-849dfd54263c				4979a47e-0078-40c7-abad-849dfd54263c		4979a47e-0078-40c7-abad-849dfd54263c				TCGA-HC-8262-11A-01R-2262-13		4979a47e-0078-40c7-abad-849dfd54263c	
TCGA-HC-8264-01	0	TCGA-HC-8264-01	48	0	TCGA-HC-8264	48	0	48	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60						-22177							0	48											2013-1-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.2		YES				NO	2	1		N1	T3b								0										85	WITH TUMOR	4		No			R1	Primary Tumor	01	5	0.5				YES	NO	HC			Prostate		B	LIVING	2011			TCGA-HC-8264-01B-11D-2395-08	45a0f345-3bc2-45a4-a315-8dc79eb98b11	TCGA-HC-8264-01	9adad1de-52dd-48a2-b025-bc9081af4ac9	TCGA-HC-8264-01B-11D-2395-08	TCGA-HC-8264-01B-11D-2395-08	TCGA-HC-8264-01B-11D-2391-01	9adad1de-52dd-48a2-b025-bc9081af4ac9	TCGA-HC-8264-01B-11D-2391-01	9adad1de-52dd-48a2-b025-bc9081af4ac9	3BDBE78B-8F80-44DC-91F0-9763A0A36F29	TCGA-HC-8264-01	TCGA-HC-8264-01B-11D-2399-05	TCGA-HC-8264-01B-11R-2401-13	TCGA-HC-8264-01B-11D-2395-08	9adad1de-52dd-48a2-b025-bc9081af4ac9	45a0f345-3bc2-45a4-a315-8dc79eb98b11
TCGA-HC-8265-01	0	TCGA-HC-8265-01	483	0	TCGA-HC-8265	483	0	483	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-HC-8265-F48767	NO				-24382							0	483		119							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1	NO	YES				NO	8	0		N0	T3a	TCGA-HC-8265.7c2f8bb7-3fe0-459e-a885-6d7a97d753f1.pdf							0				0		0		0		80	TUMOR FREE	3	Complete Remission/Response	No	0.1	YES	R1	Primary Tumor	01	5	0.1		NO		YES	NO	HC			Prostate		A	LIVING	2011			TCGA-HC-8265-01B-04D-2298-08,TCGA-HC-8265-01A-11D-2260-08	1a1044d4-bb25-4312-a18d-0a471e7457d4,ae7f9566-e03e-4edd-8dbe-ceae61b47d10	TCGA-HC-8265-01	cefe4277-778b-42b3-8e05-5df8327f50be	TCGA-HC-8265-01A-11D-2260-08	TCGA-HC-8265-01A-11D-2260-08	TCGA-HC-8265-01A-11D-2259-01	cefe4277-778b-42b3-8e05-5df8327f50be	TCGA-HC-8265-01A-11D-2259-01	cefe4277-778b-42b3-8e05-5df8327f50be		TCGA-HC-8265-01	TCGA-HC-8265-01A-11D-2261-05,TCGA-HC-8265-01B-04D-2299-05	TCGA-HC-8265-01A-11R-2262-13,TCGA-HC-8265-01B-04R-2303-13	TCGA-HC-8265-01A-11D-2260-08,TCGA-HC-8265-01B-04D-2298-08	cefe4277-778b-42b3-8e05-5df8327f50be	1a1044d4-bb25-4312-a18d-0a471e7457d4,ae7f9566-e03e-4edd-8dbe-ceae61b47d10
TCGA-HC-8266-01	0	TCGA-HC-8266-01	35	0	TCGA-HC-8266	35	0	35	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55						-20280							0	35											2012-10-1	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES			0.5	NO	Bilateral	0.8		YES				NO	5	0		N0	T3b	TCGA-HC-8266.cb8abdbd-c61d-4ad4-bd8b-a7e9dbc20d2d.pdf							0				0		0		0		70	WITH TUMOR	4		No			R1	Primary Tumor	01	4	0.2				YES	NO	HC			Prostate		A	LIVING	2012			TCGA-HC-8266-01A-11D-2260-08	0b0f504a-8615-4917-afce-69ca18de3b87	TCGA-HC-8266-01	32798ff7-089c-46dc-afc3-1c3f3995ecf9	TCGA-HC-8266-01A-11D-2260-08	TCGA-HC-8266-01A-11D-2260-08	TCGA-HC-8266-01A-11D-2259-01	32798ff7-089c-46dc-afc3-1c3f3995ecf9	TCGA-HC-8266-01A-11D-2259-01	32798ff7-089c-46dc-afc3-1c3f3995ecf9		TCGA-HC-8266-01	TCGA-HC-8266-01A-11D-2261-05	TCGA-HC-8266-01A-11R-2262-13	TCGA-HC-8266-01A-11D-2260-08	32798ff7-089c-46dc-afc3-1c3f3995ecf9	0b0f504a-8615-4917-afce-69ca18de3b87
TCGA-HC-A48F-01	0	TCGA-HC-A48F-01	680	0	TCGA-HC-A48F	680	0	680	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			47	TCGA-HC-A48F-F64404		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-17434	29	115		30			0	680					YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		NO	YES				NO	10	1	false	N1	T2c	TCGA-HC-A48F.0886739D-01AE-43B1-9898-F1AB30BA940C.pdf			2		1		1		0		0		30		69		100	TUMOR FREE	4	Complete Remission/Response	No		YES	R1	Primary Tumor	01	4			YES		YES	NO	HC			Prostate		A	LIVING	2012	Overlapping / Multiple Zones		TCGA-HC-A48F-01A-11D-A257-08	71cf4d05-0c9e-480a-8ecc-976c07fa4997	TCGA-HC-A48F-01	bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f	TCGA-HC-A48F-01A-11D-A257-08	TCGA-HC-A48F-01A-11D-A257-08	TCGA-HC-A48F-01A-11D-A256-01	bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f	TCGA-HC-A48F-01A-11D-A256-01	bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f		TCGA-HC-A48F-01	TCGA-HC-A48F-01A-11D-A258-05	TCGA-HC-A48F-01A-11R-A25C-13	TCGA-HC-A48F-01A-11D-A257-08	bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f	71cf4d05-0c9e-480a-8ecc-976c07fa4997
TCGA-HC-A4ZV-01	0	TCGA-HC-A4ZV-01	23	0	TCGA-HC-A4ZV	23	0	23	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56					T2c	-20634		79					0	23											2013-3-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral			YES				NO	13	0	false	N0	T3b	TCGA-HC-A4ZV.424EBA82-F32C-4387-B919-F7C8F1212232.pdf			0		0		0		0		0		25		75		80	WITH TUMOR	5		No			R1	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2012	Overlapping / Multiple Zones		TCGA-HC-A4ZV-01A-11D-A26M-08	49659412-6e8e-4709-800e-33b51308a282	TCGA-HC-A4ZV-01	2728c0e3-f8fe-4da4-96ec-885334df4e0f	TCGA-HC-A4ZV-01A-11D-A26M-08	TCGA-HC-A4ZV-01A-11D-A26M-08	TCGA-HC-A4ZV-01A-11D-A26L-01	2728c0e3-f8fe-4da4-96ec-885334df4e0f	TCGA-HC-A4ZV-01A-11D-A26L-01	2728c0e3-f8fe-4da4-96ec-885334df4e0f		TCGA-HC-A4ZV-01	TCGA-HC-A4ZV-01A-11D-A26N-05	TCGA-HC-A4ZV-01A-11R-A26Y-13	TCGA-HC-A4ZV-01A-11D-A26M-08	2728c0e3-f8fe-4da4-96ec-885334df4e0f	49659412-6e8e-4709-800e-33b51308a282
TCGA-HC-A631-01	0	TCGA-HC-A631-01	54	0	TCGA-HC-A631	54	0	54	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67			Normal (no evidence of prostate cancer) [cM0]	M0	T2	-24749	25	101		21			0	54					YES	No Evidence of Extraprostatic Extension					2014-4-22	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral			YES				NO	2	0	false	N0	T2c	TCGA-HC-A631.70585F33-CB9E-4365-9CA2-E384BED102DD.pdf			0		0		0		0		0		35		65		80	WITH TUMOR	4		No			R1	Primary Tumor	01	5				3	YES	NO	HC			Prostate		A	LIVING	2012			TCGA-HC-A631-01A-11D-A29Q-08	5a885b19-c6ee-41ff-b234-a5b3ed26733f	TCGA-HC-A631-01	95086d05-3789-400a-b663-5d9d3a346325	TCGA-HC-A631-01A-11D-A29Q-08	TCGA-HC-A631-01A-11D-A29Q-08	TCGA-HC-A631-01A-11D-A323-01	95086d05-3789-400a-b663-5d9d3a346325	TCGA-HC-A631-01A-11D-A323-01	95086d05-3789-400a-b663-5d9d3a346325		TCGA-HC-A631-01	TCGA-HC-A631-01A-11D-A29T-05	TCGA-HC-A631-01A-11R-A29V-13	TCGA-HC-A631-01A-11D-A29Q-08	95086d05-3789-400a-b663-5d9d3a346325	5a885b19-c6ee-41ff-b234-a5b3ed26733f
TCGA-HC-A632-01	0	TCGA-HC-A632-01	61	0	TCGA-HC-A632	61	0	61	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68		NO		M0	T1c	-24916							0	61											2013-10-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES				NO	5	0		N0	T3a																			TUMOR FREE	4		No			R0	Primary Tumor	01	5					YES	NO	HC			Prostate			LIVING	2013			TCGA-HC-A632-01A-11D-A29Q-08	f66b6feb-e259-4eb6-93b8-081a2a0581a5	TCGA-HC-A632-01	e766089b-b399-4231-ad1a-139c4283a5bd	TCGA-HC-A632-01A-11D-A29Q-08	TCGA-HC-A632-01A-11D-A29Q-08	TCGA-HC-A632-01A-11D-A323-01	e766089b-b399-4231-ad1a-139c4283a5bd	TCGA-HC-A632-01A-11D-A323-01	e766089b-b399-4231-ad1a-139c4283a5bd		TCGA-HC-A632-01	TCGA-HC-A632-01A-11D-A29T-05	TCGA-HC-A632-01A-11R-A29V-13	TCGA-HC-A632-01A-11D-A29Q-08	e766089b-b399-4231-ad1a-139c4283a5bd	f66b6feb-e259-4eb6-93b8-081a2a0581a5
TCGA-HC-A6AL-01	0	TCGA-HC-A6AL-01	67	0	TCGA-HC-A6AL	67	0	67	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64				M0	T1c	-23618		224		21			0	67					YES	No Evidence of Extraprostatic Extension	NO				2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			YES				NO	3	0	false	N0	T2c	TCGA-HC-A6AL.2A2BA0EA-C67A-4AA6-948C-019AA6475C06.pdf			0		0		0		0		5		15		80		85	TUMOR FREE	3		No			R0	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2012			TCGA-HC-A6AL-01A-11D-A30E-08	492410b4-2f62-4cf9-a92e-8f837ee60d51	TCGA-HC-A6AL-01	97ce2468-dfb0-41c5-903c-577728feff95	TCGA-HC-A6AL-01A-11D-A30E-08	TCGA-HC-A6AL-01A-11D-A30E-08	TCGA-HC-A6AL-01A-11D-A30D-01	97ce2468-dfb0-41c5-903c-577728feff95	TCGA-HC-A6AL-01A-11D-A30D-01	97ce2468-dfb0-41c5-903c-577728feff95		TCGA-HC-A6AL-01	TCGA-HC-A6AL-01A-11D-A30F-05	TCGA-HC-A6AL-01A-11R-A30I-13	TCGA-HC-A6AL-01A-11D-A30E-08	97ce2468-dfb0-41c5-903c-577728feff95	492410b4-2f62-4cf9-a92e-8f837ee60d51
TCGA-HC-A6AN-01	0	TCGA-HC-A6AN-01	49	0	TCGA-HC-A6AN	49	0	49	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67				M0	T1c	-24697		209					0	49											2014-4-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	20		NO	Bilateral			YES				NO	1	0	false	N0	T3a	TCGA-HC-A6AN.D5C8CC7E-BADE-457C-AC31-CC138C8C794C.pdf			0		0		0		0		2		18		80		85	WITH TUMOR	4		No			R1	Primary Tumor	01	3					YES	NO	HC			Prostate		A	LIVING	2012			TCGA-HC-A6AN-01A-11D-A30E-08	b0a72ee6-b92a-4f3f-9332-f03eacaf5b98	TCGA-HC-A6AN-01	6af0bf8a-6243-493b-92f5-4ea2604d35cd	TCGA-HC-A6AN-01A-11D-A30E-08	TCGA-HC-A6AN-01A-11D-A30E-08	TCGA-HC-A6AN-01A-11D-A30D-01	6af0bf8a-6243-493b-92f5-4ea2604d35cd	TCGA-HC-A6AN-01A-11D-A30D-01	6af0bf8a-6243-493b-92f5-4ea2604d35cd		TCGA-HC-A6AN-01	TCGA-HC-A6AN-01A-11D-A30F-05	TCGA-HC-A6AN-01A-11R-A30I-13	TCGA-HC-A6AN-01A-11D-A30E-08	6af0bf8a-6243-493b-92f5-4ea2604d35cd	b0a72ee6-b92a-4f3f-9332-f03eacaf5b98
TCGA-HC-A6AO-01	0	TCGA-HC-A6AO-01	530	0	TCGA-HC-A6AO	530	0	530	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			52	TCGA-HC-A6AO-F66036			M0	T1c	-19298		301					0	530					NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	30		NO	Bilateral		NO	NO				NO			false		T2c	TCGA-HC-A6AO.37F41695-9D8D-4CA1-9728-6A04AAD76274.pdf			0		0		0		0		2		13		85		90	TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Primary Tumor	01	3			NO		YES	NO	HC			Prostate		A	LIVING	2012			TCGA-HC-A6AO-01A-11D-A30E-08	c21423aa-1ce4-43f7-a4fe-76a320c46d5f	TCGA-HC-A6AO-01	9ff2bdcd-1c48-4f81-8644-c302132b2400	TCGA-HC-A6AO-01A-11D-A30E-08	TCGA-HC-A6AO-01A-11D-A30E-08	TCGA-HC-A6AO-01A-11D-A30D-01	9ff2bdcd-1c48-4f81-8644-c302132b2400	TCGA-HC-A6AO-01A-11D-A30D-01	9ff2bdcd-1c48-4f81-8644-c302132b2400		TCGA-HC-A6AO-01	TCGA-HC-A6AO-01A-11D-A30F-05	TCGA-HC-A6AO-01A-11R-A30I-13	TCGA-HC-A6AO-01A-11D-A30E-08	9ff2bdcd-1c48-4f81-8644-c302132b2400	c21423aa-1ce4-43f7-a4fe-76a320c46d5f
TCGA-HC-A6AP-01	0	TCGA-HC-A6AP-01	71	0	TCGA-HC-A6AP	71	0	71	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61				M0	T1c	-22318		182		15			0	71					YES	No Evidence of Extraprostatic Extension	NO				2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral			NO				NO			false		T2c	TCGA-HC-A6AP.7271E139-D1C7-4FB1-B148-54DE4A1DF42B.pdf			0		0		0		0		0		40		60		70		3		No			RX	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2012	Overlapping / Multiple Zones		TCGA-HC-A6AP-01A-11D-A30E-08	d21221cc-a380-4ab5-89b9-d0f4b546a21f	TCGA-HC-A6AP-01	14b3c94a-781d-4df9-9ee6-a3236d099dc6	TCGA-HC-A6AP-01A-11D-A30E-08	TCGA-HC-A6AP-01A-11D-A30E-08	TCGA-HC-A6AP-01A-11D-A30D-01	14b3c94a-781d-4df9-9ee6-a3236d099dc6	TCGA-HC-A6AP-01A-11D-A30D-01	14b3c94a-781d-4df9-9ee6-a3236d099dc6		TCGA-HC-A6AP-01	TCGA-HC-A6AP-01A-11D-A30F-05	TCGA-HC-A6AP-01A-11R-A30I-13	TCGA-HC-A6AP-01A-11D-A30E-08	14b3c94a-781d-4df9-9ee6-a3236d099dc6	d21221cc-a380-4ab5-89b9-d0f4b546a21f
TCGA-HC-A6AQ-01	0	TCGA-HC-A6AQ-01	106	0	TCGA-HC-A6AQ	106	0	106	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60			Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22208	15						0	106					NO		NO				2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral			NO				NO					T2c																			TUMOR FREE	3		Yes, History of Prior Malignancy			R0	Primary Tumor	01	4					YES	NO	HC			Prostate			LIVING	2012			TCGA-HC-A6AQ-01A-11D-A30E-08	a2b6d9fd-3bd1-45cd-ab54-93432026d21d	TCGA-HC-A6AQ-01	deeaffd6-c733-4fc1-857e-693a49b73423	TCGA-HC-A6AQ-01A-11D-A30E-08	TCGA-HC-A6AQ-01A-11D-A30E-08	TCGA-HC-A6AQ-01A-11D-A30D-01	deeaffd6-c733-4fc1-857e-693a49b73423	TCGA-HC-A6AQ-01A-11D-A30D-01	deeaffd6-c733-4fc1-857e-693a49b73423		TCGA-HC-A6AQ-01	TCGA-HC-A6AQ-01A-11D-A30F-05	TCGA-HC-A6AQ-01A-11R-A30I-13	TCGA-HC-A6AQ-01A-11D-A30E-08	deeaffd6-c733-4fc1-857e-693a49b73423	a2b6d9fd-3bd1-45cd-ab54-93432026d21d
TCGA-HC-A6AS-01	0	TCGA-HC-A6AS-01	44	0	TCGA-HC-A6AS	44	0	44	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70			Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25661	27	127		27			0	44					YES	No Evidence of Extraprostatic Extension	NO				2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	30		NO	Right			YES				NO	5	0	false	N0	T2a	TCGA-HC-A6AS.89891821-AF8C-4105-8270-D6FCF714697F.pdf			0		0		0		0		10		30		60		70	TUMOR FREE	3		No			R0	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2012			TCGA-HC-A6AS-01A-11D-A30E-08	4afccb47-915f-4fb9-8089-a00e2f62487e	TCGA-HC-A6AS-01	9605aa9b-2739-4d98-864d-fcfdb59b9ef5	TCGA-HC-A6AS-01A-11D-A30E-08	TCGA-HC-A6AS-01A-11D-A30E-08	TCGA-HC-A6AS-01A-11D-A30D-01	9605aa9b-2739-4d98-864d-fcfdb59b9ef5	TCGA-HC-A6AS-01A-11D-A30D-01	9605aa9b-2739-4d98-864d-fcfdb59b9ef5		TCGA-HC-A6AS-01	TCGA-HC-A6AS-01A-11D-A30F-05	TCGA-HC-A6AS-01A-11R-A30I-13	TCGA-HC-A6AS-01A-11D-A30E-08	9605aa9b-2739-4d98-864d-fcfdb59b9ef5	4afccb47-915f-4fb9-8089-a00e2f62487e
TCGA-HC-A6HX-01	0	TCGA-HC-A6HX-01	38	0	TCGA-HC-A6HX	38	0	38	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55				M0	T1c	-20263		112					0	38											2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	30		NO	Bilateral			YES				NO	4	0	false	N0	T2c	TCGA-HC-A6HX.0E22E3BE-B28B-40CC-83F9-9B59593B7187.pdf			0		0		0		0		10		20		70		80	TUMOR FREE	4		No			R0	Primary Tumor	01	3				5	YES	NO	HC			Prostate		A	LIVING	2013			TCGA-HC-A6HX-01A-11D-A31L-08	5dff30a0-5584-4c3d-accd-dbf199155af0	TCGA-HC-A6HX-01	95fd9476-083d-41d5-a7dc-a605673b82d3	TCGA-HC-A6HX-01A-11D-A31L-08	TCGA-HC-A6HX-01A-11D-A31L-08	TCGA-HC-A6HX-01A-11D-A31K-01	95fd9476-083d-41d5-a7dc-a605673b82d3	TCGA-HC-A6HX-01A-11D-A31K-01	95fd9476-083d-41d5-a7dc-a605673b82d3		TCGA-HC-A6HX-01	TCGA-HC-A6HX-01A-11D-A31M-05	TCGA-HC-A6HX-01A-11R-A31R-13	TCGA-HC-A6HX-01A-11D-A31L-08	95fd9476-083d-41d5-a7dc-a605673b82d3	5dff30a0-5584-4c3d-accd-dbf199155af0
TCGA-HC-A6HY-01	0	TCGA-HC-A6HY-01	134	0	TCGA-HC-A6HY	134	0	134	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51				M0	T1c	-18779		179		92			0	134					YES	No Evidence of Extraprostatic Extension					2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			NO				NO			false		T2c	TCGA-HC-A6HY.91DC18E8-EF04-47C0-A77F-632A9DE2BA55.pdf			0		0		0		0		2		18		80		80	TUMOR FREE	3		No			R0	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2012			TCGA-HC-A6HY-01A-11D-A31L-08	cb3550d5-39b2-4864-af82-e5af37aba4a1	TCGA-HC-A6HY-01	027f330a-6206-4fd4-8790-8bb5e0207bc1	TCGA-HC-A6HY-01A-11D-A31L-08	TCGA-HC-A6HY-01A-11D-A31L-08	TCGA-HC-A6HY-01A-11D-A31K-01	027f330a-6206-4fd4-8790-8bb5e0207bc1	TCGA-HC-A6HY-01A-11D-A31K-01	027f330a-6206-4fd4-8790-8bb5e0207bc1		TCGA-HC-A6HY-01	TCGA-HC-A6HY-01A-11D-A31M-05	TCGA-HC-A6HY-01A-11R-A31R-13	TCGA-HC-A6HY-01A-11D-A31L-08	027f330a-6206-4fd4-8790-8bb5e0207bc1	cb3550d5-39b2-4864-af82-e5af37aba4a1
TCGA-HC-A76W-01	0	TCGA-HC-A76W-01	213	0	TCGA-HC-A76W	213	0	213	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			73		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-26755	62	260					0	213		213			NO		NO				2014-3-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			YES				NO	4	0	true	N0	T3b	TCGA-HC-A76W.C59C0C25-B1FC-45C5-AD7E-0FBA9574656C.pdf			0		0		0		0		40		10		50		70	WITH TUMOR	3		Yes, History of Synchronous and or Bilateral Malignancy	0.01		R1	Primary Tumor	01	4					YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2012				d68e0f6f-0ebe-4ac8-a2b3-3d5cfeb20b4f	TCGA-HC-A76W-01	94399af6-33b3-4622-a5b1-d2e446061980		TCGA-HC-A76W-01A-11D-A33T-08	TCGA-HC-A76W-01A-11D-A33S-01	94399af6-33b3-4622-a5b1-d2e446061980	TCGA-HC-A76W-01A-11D-A33S-01	94399af6-33b3-4622-a5b1-d2e446061980		TCGA-HC-A76W-01	TCGA-HC-A76W-01A-11D-A33U-05	TCGA-HC-A76W-01A-11R-A343-13		94399af6-33b3-4622-a5b1-d2e446061980	d68e0f6f-0ebe-4ac8-a2b3-3d5cfeb20b4f
TCGA-HC-A76X-01	0	TCGA-HC-A76X-01	150	0	TCGA-HC-A76X	150	0	150	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22756	10	149					0	150		150									2014-3-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral			YES				NO	1	0	true	N0	T2c	TCGA-HC-A76X.DA72A108-04AA-424B-83EE-714036869E87.pdf			0		0		0		0		40		10		50		60	TUMOR FREE	3		No	0.01		R0	Primary Tumor	01	4					YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2013				142d8246-ae41-40d3-9ba6-fe8c12a48913	TCGA-HC-A76X-01	99dd7197-d956-4e4f-aee1-e0362eef2e20		TCGA-HC-A76X-01A-11D-A33T-08	TCGA-HC-A76X-01A-11D-A33S-01	99dd7197-d956-4e4f-aee1-e0362eef2e20	TCGA-HC-A76X-01A-11D-A33S-01	99dd7197-d956-4e4f-aee1-e0362eef2e20		TCGA-HC-A76X-01	TCGA-HC-A76X-01A-11D-A33U-05	TCGA-HC-A76X-01A-11R-A343-13		99dd7197-d956-4e4f-aee1-e0362eef2e20	142d8246-ae41-40d3-9ba6-fe8c12a48913
TCGA-HC-A8CY-01	0	TCGA-HC-A8CY-01	290	0	TCGA-HC-A8CY			290	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63			Abnormal (not related to prostate cancer)	M0	T1c	-23154	41	153		41			0	290		290			YES	No Evidence of Extraprostatic Extension	NO				2014-3-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral			YES					3	1	false	N1	T3a	TCGA-HC-A8CY.4CF73411-E5F6-43E1-8207-076C5C0FE921.pdf			40		20		0		20		0		30		70		70	WITH TUMOR	5		No	0.9		R1	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2013	Overlapping / Multiple Zones			61ce6880-449e-4705-9a3b-a51ee116e5a8	TCGA-HC-A8CY-01	d6c16450-87c1-4b18-bab5-8cb782fdb99c		TCGA-HC-A8CY-01A-11D-A364-08	TCGA-HC-A8CY-01A-11D-A363-01	d6c16450-87c1-4b18-bab5-8cb782fdb99c	TCGA-HC-A8CY-01A-11D-A363-01	d6c16450-87c1-4b18-bab5-8cb782fdb99c		TCGA-HC-A8CY-01	TCGA-HC-A8CY-01A-11D-A365-05	TCGA-HC-A8CY-01A-11R-A36B-13		d6c16450-87c1-4b18-bab5-8cb782fdb99c	61ce6880-449e-4705-9a3b-a51ee116e5a8
TCGA-HC-A8D0-01	0	TCGA-HC-A8D0-01	775	0	TCGA-HC-A8D0	775	0	775	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-HC-A8D0-F68682	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22465	11	517		11	14		0	775		110			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Left		NO	YES				NO	10	0	false	N0	T2a	TCGA-HC-A8D0.E29BD9A6-B0F0-42D8-B952-85B71C3D5BC9.pdf			40		20		10		20		0		20		70		70	TUMOR FREE	3	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	4			NO		YES	NO	HC	Apex|Middle		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			4b0a637c-990a-48e6-a377-cea135ff8f52	TCGA-HC-A8D0-01	1dd9dd18-3137-4515-9346-909e772b6ca8		TCGA-HC-A8D0-01A-11D-A364-08	TCGA-HC-A8D0-01A-11D-A363-01	1dd9dd18-3137-4515-9346-909e772b6ca8	TCGA-HC-A8D0-01A-11D-A363-01	1dd9dd18-3137-4515-9346-909e772b6ca8		TCGA-HC-A8D0-01	TCGA-HC-A8D0-01A-11D-A365-05	TCGA-HC-A8D0-01A-11R-A36B-13		1dd9dd18-3137-4515-9346-909e772b6ca8	4b0a637c-990a-48e6-a377-cea135ff8f52
TCGA-HC-A8D1-01	0	TCGA-HC-A8D1-01	573	0	TCGA-HC-A8D1	573	0	573	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-HC-A8D1-F68683	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-25137	14	464					0	573		168			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-12-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		NO	YES				NO	6	0	false	N0	T2c	TCGA-HC-A8D1.6C5B3FD6-3C50-4DF3-9101-D131075F4A5B.pdf			40		20		0		20		0		30		70		70	TUMOR FREE	3	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	4			NO		YES	NO	HC			Prostate		A	LIVING	2012				4d6f1f0c-d9d7-41dc-a0ec-585ad8b711df	TCGA-HC-A8D1-01	f0c1b588-ebe6-4f6c-a013-c36091c8e29c		TCGA-HC-A8D1-01A-11D-A364-08	TCGA-HC-A8D1-01A-11D-A363-01	f0c1b588-ebe6-4f6c-a013-c36091c8e29c	TCGA-HC-A8D1-01A-11D-A363-01	f0c1b588-ebe6-4f6c-a013-c36091c8e29c		TCGA-HC-A8D1-01	TCGA-HC-A8D1-01A-11D-A365-05	TCGA-HC-A8D1-01A-11R-A36B-13		f0c1b588-ebe6-4f6c-a013-c36091c8e29c	4d6f1f0c-d9d7-41dc-a0ec-585ad8b711df
TCGA-HC-A9TE-01		TCGA-HC-A9TE-01			TCGA-HC-A9TE				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																						50		NO											false			TCGA-HC-A9TE.BC2B6EED-5BD7-407D-AFAD-47A611F3C62C.pdf			40		20		0		20		0		40		60		60								Primary Tumor	01													A						a6d04780-b130-422f-8be4-75d17ccfc892	TCGA-HC-A9TE-01	212f9e63-ba39-4765-8522-86833312f8db			TCGA-HC-A9TE-01A-11D-A41J-01	212f9e63-ba39-4765-8522-86833312f8db	TCGA-HC-A9TE-01A-11D-A41J-01	212f9e63-ba39-4765-8522-86833312f8db		TCGA-HC-A9TE-01	TCGA-HC-A9TE-01A-11D-A41L-05	TCGA-HC-A9TE-01A-11R-A41R-13		212f9e63-ba39-4765-8522-86833312f8db	a6d04780-b130-422f-8be4-75d17ccfc892
TCGA-HC-A9TH-01		TCGA-HC-A9TH-01			TCGA-HC-A9TH				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																						60		NO											false			TCGA-HC-A9TH.C2755FC2-E4BD-4997-B2F9-1F1C3A9C28AE.pdf			0		0		5		0		0		35		60		80								Primary Tumor	01													A						d23b92d4-7bfe-4c9e-8461-8011f8df5e8a	TCGA-HC-A9TH-01	3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b			TCGA-HC-A9TH-01A-11D-A41J-01	3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b	TCGA-HC-A9TH-01A-11D-A41J-01	3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b		TCGA-HC-A9TH-01	TCGA-HC-A9TH-01A-11D-A41L-05	TCGA-HC-A9TH-01A-11R-A41R-13		3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b	d23b92d4-7bfe-4c9e-8461-8011f8df5e8a
TCGA-HI-7168-01	0	TCGA-HI-7168-01	2391	0	TCGA-HI-7168			2391	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	YES	62	TCGA-HI-7168-F29017	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22881	19				19	308	0	2391		2289	1523		NO		YES	No Evidence of Extraprostatic Extension	Additional New Tumor Event	Stable Disease	2012-2-20	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.3		YES		Biochemical evidence of disease		YES	9	0		N0	T3b	TCGA-HI-7168.d29af7d7-996d-44a9-a571-878ea0f95403.pdf						0	2			0	0	60	58	40	40	55	65		4	Stable Disease	No	0.3	NO	R0	Primary Tumor	01	5	0.4		NO		NO	YES	HI		YES	Prostate	Biochemical Recurrence	A	LIVING	2005			TCGA-HI-7168-01A-11D-2114-08	6d5a7604-5ae9-4cdc-a624-3f83896228fc	TCGA-HI-7168-01	5ce29b9f-3b54-45a6-96e1-ddc3494e6141	TCGA-HI-7168-01A-11D-2114-08	TCGA-HI-7168-01A-11D-2114-08	TCGA-HI-7168-01A-11D-2112-01	5ce29b9f-3b54-45a6-96e1-ddc3494e6141	TCGA-HI-7168-01A-11D-2112-01	5ce29b9f-3b54-45a6-96e1-ddc3494e6141	3B50FC1B-3EE6-455E-A5ED-DF54202C08F6	TCGA-HI-7168-01	TCGA-HI-7168-01A-11D-2116-05	TCGA-HI-7168-01A-11R-2117-13	TCGA-HI-7168-01A-11D-2114-08	5ce29b9f-3b54-45a6-96e1-ddc3494e6141	6d5a7604-5ae9-4cdc-a624-3f83896228fc
TCGA-HI-7169-01	0	TCGA-HI-7169-01	2684	0	TCGA-HI-7169	2684	0	2684	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-HI-7169-F29015	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20133	33						0	2684		1941			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.3		YES				NO	4	0		N0	T3a	TCGA-HI-7169.ed386bc1-82a8-489e-81e0-53a93325a48e.pdf						0	0			0	0	40	35	60	65	70	70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R1	Primary Tumor	01	4	0.3		NO		NO	YES	HI	Apex		Prostate		A	LIVING	2006			TCGA-HI-7169-01A-11D-2114-08	f637dd24-e259-4124-8c3f-b0fe9f0bb336	TCGA-HI-7169-01	70a93713-e154-46c8-9360-b873c63f0f05	TCGA-HI-7169-01A-11D-2114-08	TCGA-HI-7169-01A-11D-2114-08	TCGA-HI-7169-01A-11D-2112-01	70a93713-e154-46c8-9360-b873c63f0f05	TCGA-HI-7169-01A-11D-2112-01	70a93713-e154-46c8-9360-b873c63f0f05	32D75427-C6A9-41CD-BF22-B0866C862AFB	TCGA-HI-7169-01	TCGA-HI-7169-01A-11D-2116-05	TCGA-HI-7169-01A-11R-2117-13		70a93713-e154-46c8-9360-b873c63f0f05	f637dd24-e259-4124-8c3f-b0fe9f0bb336
TCGA-HI-7170-01	0	TCGA-HI-7170-01	2522	0	TCGA-HI-7170	2522	0	2522	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-HI-7170-F29013	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21199	-96			-92	-78		0	2522		1746			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2012-2-21	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)		0.8	NO	Bilateral	1.3		YES				NO	6	0		N0	T2c	TCGA-HI-7170.96f2ece8-246a-43fe-8963-217613c84f0b.pdf						0	0			0	0	40	40	60	60	70	70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3	0.4		NO		NO	YES	HI	Apex		Prostate		A	LIVING	2006			TCGA-HI-7170-01A-11D-2114-08	01410e1a-5443-44cd-a61d-58f9be23e294	TCGA-HI-7170-01	f7ab806e-12d3-4dfc-90bf-cc49851cc34b	TCGA-HI-7170-01A-11D-2114-08	TCGA-HI-7170-01A-11D-2114-08	TCGA-HI-7170-01A-11D-2112-01	f7ab806e-12d3-4dfc-90bf-cc49851cc34b	TCGA-HI-7170-01A-11D-2112-01	f7ab806e-12d3-4dfc-90bf-cc49851cc34b	9AEB253A-A8C4-449F-979B-74FB466A931E	TCGA-HI-7170-01	TCGA-HI-7170-01A-11D-2116-05	TCGA-HI-7170-01A-11R-2117-13	TCGA-HI-7170-01A-11D-2114-08	f7ab806e-12d3-4dfc-90bf-cc49851cc34b	01410e1a-5443-44cd-a61d-58f9be23e294
TCGA-HI-7171-01	1	TCGA-HI-7171-01	1329	1	TCGA-HI-7171			1329	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	YES	56	TCGA-HI-7171-F29021	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-20776			1329			218	0			631	543	631	NO		YES	No Evidence of Extraprostatic Extension	Additional New Tumor Event	Progressive Disease	2012-2-22	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.6		YES		Biochemical evidence of disease		YES	7	0		N0	T3b	TCGA-HI-7171.0bdd67bb-5cf4-4972-9ab6-9878c351857f.pdf						0	0			0	0	20	20	80	80	75	75	WITH TUMOR	5	Stable Disease	No	0.7	NO	R1	Primary Tumor	01	4	0.3		NO		NO	YES	HI	Apex|Middle|Base		Prostate	Biochemical Recurrence	A	DECEASED	2008			TCGA-HI-7171-01A-12D-2114-08	e1a4a905-fd47-4d90-aaeb-590ea11e0cbd	TCGA-HI-7171-01	2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4	TCGA-HI-7171-01A-12D-2114-08	TCGA-HI-7171-01A-12D-2114-08	TCGA-HI-7171-01A-12D-2112-01	2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4	TCGA-HI-7171-01A-12D-2112-01	2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4	D29A9541-89D3-46EF-A1C7-C01830B931CB	TCGA-HI-7171-01	TCGA-HI-7171-01A-12D-2116-05	TCGA-HI-7171-01A-12R-2117-13	TCGA-HI-7171-01A-12D-2114-08	2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4	e1a4a905-fd47-4d90-aaeb-590ea11e0cbd
TCGA-J4-8198-01	0	TCGA-J4-8198-01	614	0	TCGA-J4-8198	614	0	614	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			49	TCGA-J4-8198-F55294	NO		M0	T1c	-17935							0	614		76							Scheduled Follow-up Submission	Complete Remission/Response	2014-1-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	0.8	NO	NO				NO					T3b	TCGA-J4-8198.c61b1da1-f0d2-48c9-ac71-5967799def29.pdf						0	0			5	5	15	10	80	85	80	85	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO		Primary Tumor	01	3	0.4		NO	5	YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2011			TCGA-J4-8198-01A-11D-2260-08	5451acf1-de17-4118-b3a0-ac145199e75f	TCGA-J4-8198-01	2cb1479d-b88e-42a6-a576-e519c98689ca	TCGA-J4-8198-01A-11D-2260-08	TCGA-J4-8198-01A-11D-2260-08	TCGA-J4-8198-01A-11D-2259-01	2cb1479d-b88e-42a6-a576-e519c98689ca	TCGA-J4-8198-01A-11D-2259-01	2cb1479d-b88e-42a6-a576-e519c98689ca	4872992E-43CD-4454-AEFE-31A3339F6687	TCGA-J4-8198-01	TCGA-J4-8198-01A-11D-2261-05	TCGA-J4-8198-01A-11R-2262-13	TCGA-J4-8198-01A-11D-2260-08	2cb1479d-b88e-42a6-a576-e519c98689ca	5451acf1-de17-4118-b3a0-ac145199e75f
TCGA-J4-8200-01	0	TCGA-J4-8200-01	374	0	TCGA-J4-8200	374	0	374	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			47	TCGA-J4-8200-F38883	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-17167	41			41			0	374		196			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-12-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.7	NO	YES				NO	4	0		N0	T2c								0				10		30		60		60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	J4			Prostate		A	LIVING	2011	Overlapping / Multiple Zones		TCGA-J4-8200-01A-11D-A29Q-08	5ccb577c-28fe-409b-9dfa-f02e169160af	TCGA-J4-8200-01	bcc096bf-c300-4e3d-b616-daee079938e6	TCGA-J4-8200-01A-11D-A29Q-08	TCGA-J4-8200-01A-11D-A29Q-08	TCGA-J4-8200-01A-11D-A323-01	bcc096bf-c300-4e3d-b616-daee079938e6	TCGA-J4-8200-01A-11D-A323-01	bcc096bf-c300-4e3d-b616-daee079938e6	1F9E72E0-4F30-43E7-9F49-71B40798BA3C	TCGA-J4-8200-01	TCGA-J4-8200-01A-11D-A29T-05	TCGA-J4-8200-01A-11R-A29V-13	TCGA-J4-8200-01A-11D-A29Q-08	bcc096bf-c300-4e3d-b616-daee079938e6	5ccb577c-28fe-409b-9dfa-f02e169160af
TCGA-J4-A67K-01	0	TCGA-J4-A67K-01	1004	0	TCGA-J4-A67K	1004	0	1004	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-J4-A67K-F63849	NO		M0	T2b	-24908		580					0	1004		557							Scheduled Follow-up Submission		2014-8-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	190		NO	Bilateral		NO	NO				NO			true		T2c	TCGA-J4-A67K.F8FF8077-8922-4CC8-95DD-4AF68CCC7EEC.pdf			1		0		0		0		40		0		60		65	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4			Prostate		A	LIVING	2011	Peripheral Zone		TCGA-J4-A67K-01A-21D-A30E-08	d6eff47d-4bc3-4a16-964c-c809f2847e40	TCGA-J4-A67K-01	631b5e57-557b-48d1-a263-5c1b456e73b2	TCGA-J4-A67K-01A-21D-A30E-08	TCGA-J4-A67K-01A-21D-A30E-08	TCGA-J4-A67K-01A-21D-A30D-01	631b5e57-557b-48d1-a263-5c1b456e73b2	TCGA-J4-A67K-01A-21D-A30D-01	631b5e57-557b-48d1-a263-5c1b456e73b2		TCGA-J4-A67K-01	TCGA-J4-A67K-01A-21D-A30F-05	TCGA-J4-A67K-01A-21R-A30I-13	TCGA-J4-A67K-01A-21D-A30E-08	631b5e57-557b-48d1-a263-5c1b456e73b2	d6eff47d-4bc3-4a16-964c-c809f2847e40
TCGA-J4-A67L-01	0	TCGA-J4-A67L-01	770	0	TCGA-J4-A67L	770	0	770	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			54	TCGA-J4-A67L-F63850	NO		M0	T2a	-20034		485					0	770		518							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Left		NO	YES				NO	1	0	true	N0	T3a	TCGA-J4-A67L.91F854F5-D488-4B25-B59A-6CB59C6357BB.pdf			1		0		0		0		0		0		100		65	TUMOR FREE	3	Complete Remission/Response	No	.01	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone		TCGA-J4-A67L-01A-11D-A30E-08	d3e8952c-d0e6-4295-9a17-5f3d59abe80f	TCGA-J4-A67L-01	1636e620-09c8-46c7-bf33-9efeceae7cd4	TCGA-J4-A67L-01A-11D-A30E-08	TCGA-J4-A67L-01A-11D-A30E-08	TCGA-J4-A67L-01A-11D-A30D-01	1636e620-09c8-46c7-bf33-9efeceae7cd4	TCGA-J4-A67L-01A-11D-A30D-01	1636e620-09c8-46c7-bf33-9efeceae7cd4		TCGA-J4-A67L-01	TCGA-J4-A67L-01A-11D-A30F-05	TCGA-J4-A67L-01A-11R-A30I-13	TCGA-J4-A67L-01A-11D-A30E-08	1636e620-09c8-46c7-bf33-9efeceae7cd4	d3e8952c-d0e6-4295-9a17-5f3d59abe80f
TCGA-J4-A67M-01	0	TCGA-J4-A67M-01	941	0	TCGA-J4-A67M	941	0	941	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-J4-A67M-F63853	NO		M0	T2a	-20211		482					0	941		482							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	320		NO	Bilateral		NO	YES				NO	6	0	true	N0	T3a	TCGA-J4-A67M.590FEE5C-E5FF-4DB2-8A7E-6502E5B9A56B.pdf			0		0		0		0		10		15		75		85	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone		TCGA-J4-A67M-01A-11D-A30E-08	2f36ff13-a4c2-4407-ba23-c3878880f27f	TCGA-J4-A67M-01	2ccc0221-155e-47b1-ace4-6c78bfc5d4a4	TCGA-J4-A67M-01A-11D-A30E-08	TCGA-J4-A67M-01A-11D-A30E-08	TCGA-J4-A67M-01A-11D-A30D-01	2ccc0221-155e-47b1-ace4-6c78bfc5d4a4	TCGA-J4-A67M-01A-11D-A30D-01	2ccc0221-155e-47b1-ace4-6c78bfc5d4a4		TCGA-J4-A67M-01	TCGA-J4-A67M-01A-11D-A30F-05	TCGA-J4-A67M-01A-11R-A30I-13	TCGA-J4-A67M-01A-11D-A30E-08	2ccc0221-155e-47b1-ace4-6c78bfc5d4a4	2f36ff13-a4c2-4407-ba23-c3878880f27f
TCGA-J4-A67N-01	0	TCGA-J4-A67N-01	503	0	TCGA-J4-A67N			503	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61		YES		M0	T2a	-22420		504				442	0	503		503									2013-8-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	420		NO	Bilateral			YES				YES	8	0	true	N0	T3a	TCGA-J4-A67N.70E5E77E-6B59-40A7-8E87-456EF28AED98.pdf			0		0		0		0		5		25		70		80	WITH TUMOR	3	Partial Remission/Response	No	0.7	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone		TCGA-J4-A67N-01A-11D-A30E-08	dc72ea3a-52eb-4722-b0aa-effa4544af8f	TCGA-J4-A67N-01	0c925aa2-8118-498b-8b5f-17740005df68	TCGA-J4-A67N-01A-11D-A30E-08	TCGA-J4-A67N-01A-11D-A30E-08	TCGA-J4-A67N-01A-11D-A30D-01	0c925aa2-8118-498b-8b5f-17740005df68	TCGA-J4-A67N-01A-11D-A30D-01	0c925aa2-8118-498b-8b5f-17740005df68		TCGA-J4-A67N-01	TCGA-J4-A67N-01A-11D-A30F-05	TCGA-J4-A67N-01A-11R-A30I-13	TCGA-J4-A67N-01A-11D-A30E-08	0c925aa2-8118-498b-8b5f-17740005df68	dc72ea3a-52eb-4722-b0aa-effa4544af8f
TCGA-J4-A67O-01	0	TCGA-J4-A67O-01	839	0	TCGA-J4-A67O	839	0	839	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-J4-A67O-F63884	NO		M0	T2a	-21714							0	839		490							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	2	0		N0	T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex		Prostate			LIVING	2012	Peripheral Zone		TCGA-J4-A67O-01A-11D-A30E-08	d77391e7-c75e-438d-b298-b026e3b5f418	TCGA-J4-A67O-01	e1fd847f-23c7-4baa-a7ff-d0954d855d1a	TCGA-J4-A67O-01A-11D-A30E-08	TCGA-J4-A67O-01A-11D-A30E-08	TCGA-J4-A67O-01A-11D-A30D-01	e1fd847f-23c7-4baa-a7ff-d0954d855d1a	TCGA-J4-A67O-01A-11D-A30D-01	e1fd847f-23c7-4baa-a7ff-d0954d855d1a		TCGA-J4-A67O-01	TCGA-J4-A67O-01A-11D-A30F-05	TCGA-J4-A67O-01A-11R-A30I-13	TCGA-J4-A67O-01A-11D-A30E-08	e1fd847f-23c7-4baa-a7ff-d0954d855d1a	d77391e7-c75e-438d-b298-b026e3b5f418
TCGA-J4-A67Q-01	0	TCGA-J4-A67Q-01	975	0	TCGA-J4-A67Q	975	0	975	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			77	TCGA-J4-A67Q-F63912	NO		M0	T2b	-28447		584					0	975		616							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	NO				NO			true		T2c	TCGA-J4-A67Q.E7702E20-7616-4A88-862B-E860045E9C81.pdf			40		20		0		20		10		30		60		60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO		Primary Tumor	01	3			NO		YES	NO	J4	Apex|Middle		Prostate		A	LIVING	2011	Peripheral Zone		TCGA-J4-A67Q-01A-21D-A30E-08	7abd09f3-0b2b-49a1-a989-59dbf2b552b1	TCGA-J4-A67Q-01	1b57a251-d1ee-4635-b3f8-8109ddbabf7d	TCGA-J4-A67Q-01A-21D-A30E-08	TCGA-J4-A67Q-01A-21D-A30E-08	TCGA-J4-A67Q-01A-21D-A30D-01	1b57a251-d1ee-4635-b3f8-8109ddbabf7d	TCGA-J4-A67Q-01A-21D-A30D-01	1b57a251-d1ee-4635-b3f8-8109ddbabf7d		TCGA-J4-A67Q-01	TCGA-J4-A67Q-01A-21D-A30F-05	TCGA-J4-A67Q-01A-21R-A30I-13	TCGA-J4-A67Q-01A-21D-A30E-08	1b57a251-d1ee-4635-b3f8-8109ddbabf7d	7abd09f3-0b2b-49a1-a989-59dbf2b552b1
TCGA-J4-A67R-01	0	TCGA-J4-A67R-01	910	0	TCGA-J4-A67R	910	0	910	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-J4-A67R-F63916	NO		M0	T1c	-23807		440					0	910		454							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		NO	YES				NO	4	0	true	N0	T2c	TCGA-J4-A67R.EAFE4CB1-BB7F-4D26-851D-49ECE5A73750.pdf			0		0		0		0		50		0		50		60	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4	Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone		TCGA-J4-A67R-01A-21D-A30E-08	70cbd166-d6b6-4da6-8073-80d1c140d845	TCGA-J4-A67R-01	5a96d821-45e8-4d06-89c3-1f951c04375d	TCGA-J4-A67R-01A-21D-A30E-08	TCGA-J4-A67R-01A-21D-A30E-08	TCGA-J4-A67R-01A-21D-A30D-01	5a96d821-45e8-4d06-89c3-1f951c04375d	TCGA-J4-A67R-01A-21D-A30D-01	5a96d821-45e8-4d06-89c3-1f951c04375d		TCGA-J4-A67R-01	TCGA-J4-A67R-01A-21D-A30F-05	TCGA-J4-A67R-01A-21R-A30I-13	TCGA-J4-A67R-01A-21D-A30E-08	5a96d821-45e8-4d06-89c3-1f951c04375d	70cbd166-d6b6-4da6-8073-80d1c140d845
TCGA-J4-A67S-01	0	TCGA-J4-A67S-01	833	0	TCGA-J4-A67S	708	1	833	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	63	TCGA-J4-A67S-F63921	NO		M0	T2b	-23332		427				708	0	833	708	522							Scheduled Follow-up Submission	Progressive Disease	2014-8-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	3	0	true	N0	T3a	TCGA-J4-A67S.D5BC3AA7-D957-4291-8A6B-D148AA7CA909.pdf			0		0		0		0		30		0		70		70	WITH TUMOR	3	Complete Remission/Response	No	0.1	NO	R1	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone		TCGA-J4-A67S-01A-11D-A30E-08	2857a770-5832-4d61-bc8f-dac6ec896a34	TCGA-J4-A67S-01	0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1	TCGA-J4-A67S-01A-11D-A30E-08	TCGA-J4-A67S-01A-11D-A30E-08	TCGA-J4-A67S-01A-11D-A30D-01	0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1	TCGA-J4-A67S-01A-11D-A30D-01	0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1		TCGA-J4-A67S-01	TCGA-J4-A67S-01A-11D-A30F-05	TCGA-J4-A67S-01A-11R-A30I-13	TCGA-J4-A67S-01A-11D-A30E-08	0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1	2857a770-5832-4d61-bc8f-dac6ec896a34
TCGA-J4-A67T-01	0	TCGA-J4-A67T-01	183	0	TCGA-J4-A67T	183	0	183	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-J4-A67T-F63922	NO		M0	T1c	-23211		409					0	183		154							Scheduled Follow-up Submission		2014-8-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	490		NO	Bilateral		YES	NO				NO			true		T2c	TCGA-J4-A67T.8E3BAF97-3B7F-4B3A-BC88-BACB5A716DFD.pdf			0		0		0		0		30		0		70		75	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle		Prostate		A	LIVING	2012	Peripheral Zone		TCGA-J4-A67T-01A-11D-A30X-08	4443f3d9-0ec2-4d5d-a174-5ff74be49098	TCGA-J4-A67T-01	d268f4e1-937a-40a8-b058-a87949bedd8b	TCGA-J4-A67T-01A-11D-A30X-08	TCGA-J4-A67T-01A-11D-A30X-08	TCGA-J4-A67T-01A-11D-A30W-01	d268f4e1-937a-40a8-b058-a87949bedd8b	TCGA-J4-A67T-01A-11D-A30W-01	d268f4e1-937a-40a8-b058-a87949bedd8b		TCGA-J4-A67T-01	TCGA-J4-A67T-01A-11D-A30Z-05	TCGA-J4-A67T-01A-11R-A310-13	TCGA-J4-A67T-01A-11D-A30X-08	d268f4e1-937a-40a8-b058-a87949bedd8b	4443f3d9-0ec2-4d5d-a174-5ff74be49098
TCGA-J4-A6G1-01	0	TCGA-J4-A6G1-01	769	0	TCGA-J4-A6G1	769	0	769	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-J4-A6G1-F63926	NO		M0	T2b	-24945		408			34		0	769		178					YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		NO	YES				NO	2	0	true	N0	T3a	TCGA-J4-A6G1.6758B6C3-61B6-4D4F-9018-CDC2E932ACC7.pdf			40		20		0		20		5		15		80		80	TUMOR FREE	4	Complete Remission/Response	No	0.1	YES	R0	Primary Tumor	01	4			NO	3	YES	NO	J4			Prostate		A	LIVING	2012	Peripheral Zone		TCGA-J4-A6G1-01A-11D-A30X-08	9e63994a-c3a5-470a-adcc-716389fa5621	TCGA-J4-A6G1-01	a9444bb5-5136-4a9a-b734-167ce00dd040	TCGA-J4-A6G1-01A-11D-A30X-08	TCGA-J4-A6G1-01A-11D-A30X-08	TCGA-J4-A6G1-01A-11D-A30W-01	a9444bb5-5136-4a9a-b734-167ce00dd040	TCGA-J4-A6G1-01A-11D-A30W-01	a9444bb5-5136-4a9a-b734-167ce00dd040		TCGA-J4-A6G1-01	TCGA-J4-A6G1-01A-11D-A30Z-05	TCGA-J4-A6G1-01A-11R-A310-13	TCGA-J4-A6G1-01A-11D-A30X-08	a9444bb5-5136-4a9a-b734-167ce00dd040	9e63994a-c3a5-470a-adcc-716389fa5621
TCGA-J4-A6G3-01	0	TCGA-J4-A6G3-01	849	0	TCGA-J4-A6G3	618	1	849	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	NO	57	TCGA-J4-A6G3-F63927	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-20836	17	479			15	618	0	849	618	528			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1]	Scheduled Follow-up Submission		2014-8-21	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	5	0	true	N0	T3b	TCGA-J4-A6G3.63F0D5A2-CCAB-48C7-9BD9-F75A699DE1AD.pdf			0		0		0		0		20		35		45		60	WITH TUMOR	4	Partial Remission/Response	No	0.4	YES	R1	Primary Tumor	01	4			NO		YES	NO	J4			Prostate		A	LIVING	2012	Peripheral Zone		TCGA-J4-A6G3-01A-11D-A30X-08	c10cb3b6-e58f-413e-917b-99f92018cd40	TCGA-J4-A6G3-01	613b606c-0d1e-49ff-bd2b-30fa17b14fb6	TCGA-J4-A6G3-01A-11D-A30X-08	TCGA-J4-A6G3-01A-11D-A30X-08	TCGA-J4-A6G3-01A-11D-A30W-01	613b606c-0d1e-49ff-bd2b-30fa17b14fb6	TCGA-J4-A6G3-01A-11D-A30W-01	613b606c-0d1e-49ff-bd2b-30fa17b14fb6		TCGA-J4-A6G3-01	TCGA-J4-A6G3-01A-11D-A30Z-05	TCGA-J4-A6G3-01A-11R-A310-13	TCGA-J4-A6G3-01A-11D-A30X-08	613b606c-0d1e-49ff-bd2b-30fa17b14fb6	c10cb3b6-e58f-413e-917b-99f92018cd40
TCGA-J4-A6M7-01	0	TCGA-J4-A6M7-01	512	0	TCGA-J4-A6M7	512	0	512	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-J4-A6M7-F63950	NO		M0	T2	-19640		309					0	512		279							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		NO	NO				NO			true		T2c	TCGA-J4-A6M7.F717DD9D-074A-4252-9125-C00A3DE587B0.pdf			0		0		0		0		5		35		60		70	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle		Prostate		A	LIVING	2012	Peripheral Zone		TCGA-J4-A6M7-01A-11D-A31L-08	0a513429-6948-4023-bdb6-b400c70d598f	TCGA-J4-A6M7-01	b6d9a928-0ecb-43c7-b88a-0179e524a7c2	TCGA-J4-A6M7-01A-11D-A31L-08	TCGA-J4-A6M7-01A-11D-A31L-08	TCGA-J4-A6M7-01A-11D-A31K-01	b6d9a928-0ecb-43c7-b88a-0179e524a7c2	TCGA-J4-A6M7-01A-11D-A31K-01	b6d9a928-0ecb-43c7-b88a-0179e524a7c2		TCGA-J4-A6M7-01	TCGA-J4-A6M7-01A-11D-A31M-05	TCGA-J4-A6M7-01A-11R-A31R-13	TCGA-J4-A6M7-01A-11D-A31L-08	b6d9a928-0ecb-43c7-b88a-0179e524a7c2	0a513429-6948-4023-bdb6-b400c70d598f
TCGA-J4-A83I-01	0	TCGA-J4-A83I-01	279	0	TCGA-J4-A83I	279	0	279	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63		NO		M0	T1c	-23240		183					0	279		257									2014-1-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	100		NO	Bilateral			YES				NO	2	0	true	N0	T3a	TCGA-J4-A83I.E3AFE230-AE22-4120-BC42-7FE78FCB06A2.pdf			0		0		0		0		5		30		65		70	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone			80e5beb3-484a-4737-9552-2918e693d59e	TCGA-J4-A83I-01	4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250		TCGA-J4-A83I-01A-11D-A364-08	TCGA-J4-A83I-01A-11D-A363-01	4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250	TCGA-J4-A83I-01A-11D-A363-01	4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250		TCGA-J4-A83I-01	TCGA-J4-A83I-01A-11D-A365-05	TCGA-J4-A83I-01A-11R-A36B-13		4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250	80e5beb3-484a-4737-9552-2918e693d59e
TCGA-J4-A83J-01	0	TCGA-J4-A83J-01	696	0	TCGA-J4-A83J	696	0	696	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-J4-A83J-F70133	NO		M0	T1c	-24960		272					0	696		235							Scheduled Follow-up Submission	Complete Remission/Response	2015-1-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	1	0	true	N0	T2c	TCGA-J4-A83J.D3FF2CCF-E6D0-4C8A-9159-F78176E7EE59.pdf			0		0		0		0		0		10		90		90	TUMOR FREE	3	Complete Remission/Response	No	0.04	NO	R1	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone			ba1ed688-eb38-4572-88d9-68c0acecb871	TCGA-J4-A83J-01	2bbec916-3c74-45b7-9eab-76022899fe7d		TCGA-J4-A83J-01A-11D-A364-08	TCGA-J4-A83J-01A-11D-A363-01	2bbec916-3c74-45b7-9eab-76022899fe7d	TCGA-J4-A83J-01A-11D-A363-01	2bbec916-3c74-45b7-9eab-76022899fe7d		TCGA-J4-A83J-01	TCGA-J4-A83J-01A-11D-A365-05	TCGA-J4-A83J-01A-11R-A36B-13		2bbec916-3c74-45b7-9eab-76022899fe7d	ba1ed688-eb38-4572-88d9-68c0acecb871
TCGA-J4-A83J-11	0	TCGA-J4-A83J-11	696	0	TCGA-J4-A83J	696	0	696	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-J4-A83J-F70133	NO		M0	T1c	-24960		272					0	696		235							Scheduled Follow-up Submission	Complete Remission/Response	2015-1-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		NO	YES				NO	1	0	true	N0	T2c				0		0		0		0		40		60		0		0	TUMOR FREE	3	Complete Remission/Response	No	0.04	NO	R1	Solid Tissue Normal	11	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone					6c5a212a-4dab-45a5-854d-296f0a6ee7c3				6c5a212a-4dab-45a5-854d-296f0a6ee7c3		6c5a212a-4dab-45a5-854d-296f0a6ee7c3				TCGA-J4-A83J-11A-11R-A36B-13		6c5a212a-4dab-45a5-854d-296f0a6ee7c3	
TCGA-J4-A83K-01	0	TCGA-J4-A83K-01	328	0	TCGA-J4-A83K	328	0	328	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			52	TCGA-J4-A83K-F63953	NO		M0	T1c	-19299							0	328		205							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO					T2c																			TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4	Apex|Middle|Base		Prostate			LIVING	2013	Peripheral Zone			eeca2478-b68f-4ff2-8a66-7ffd01f9eb0d	TCGA-J4-A83K-01	c16ddaf4-4bfe-4917-a208-aa5a89beb17e		TCGA-J4-A83K-01A-11D-A34U-08	TCGA-J4-A83K-01A-11D-A34T-01	c16ddaf4-4bfe-4917-a208-aa5a89beb17e	TCGA-J4-A83K-01A-11D-A34T-01	c16ddaf4-4bfe-4917-a208-aa5a89beb17e		TCGA-J4-A83K-01	TCGA-J4-A83K-01A-11D-A34V-05	TCGA-J4-A83K-01A-11R-A358-13		c16ddaf4-4bfe-4917-a208-aa5a89beb17e	eeca2478-b68f-4ff2-8a66-7ffd01f9eb0d
TCGA-J4-A83L-01	0	TCGA-J4-A83L-01	316	0	TCGA-J4-A83L	316	0	316	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61		NO		M0	T1c	-22338		218					0	316		316									2014-1-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			YES				NO	5	0	true	N0	T2c	TCGA-J4-A83L.837A4811-0DAF-46F6-9C84-D2BBFFC56AF0.pdf			0		0		0		0		50		0		50		60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2013	Central Zone			39f9b7f1-ab59-453f-a5cd-767ef765654b	TCGA-J4-A83L-01	2345f76d-8250-4586-a15a-633ac5abc070		TCGA-J4-A83L-01A-11D-A34U-08	TCGA-J4-A83L-01A-11D-A34T-01	2345f76d-8250-4586-a15a-633ac5abc070	TCGA-J4-A83L-01A-11D-A34T-01	2345f76d-8250-4586-a15a-633ac5abc070		TCGA-J4-A83L-01	TCGA-J4-A83L-01A-11D-A34V-05	TCGA-J4-A83L-01A-11R-A358-13		2345f76d-8250-4586-a15a-633ac5abc070	39f9b7f1-ab59-453f-a5cd-767ef765654b
TCGA-J4-A83M-01	0	TCGA-J4-A83M-01	437	0	TCGA-J4-A83M	437	0	437	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		NO		M0	T2c	-23624		412					0	437		437									2014-1-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral			YES				NO	4	0	true	N0	T2c	TCGA-J4-A83M.8AA3EBE4-49E8-4D0A-A3A4-B51E41B3AA4F.pdf			0		0		0		0		30		10		60		70		4	Complete Remission/Response	No	0.2	NO	R1	Primary Tumor	01	3			NO		YES	NO	J4	Apex|Middle		Prostate		A	LIVING	2012	Peripheral Zone			35e58745-53f0-49e4-83d1-50d7c7343787	TCGA-J4-A83M-01	8ab941c0-6e1c-403c-901d-03ac81bbb81f		TCGA-J4-A83M-01A-11D-A34U-08	TCGA-J4-A83M-01A-11D-A34T-01	8ab941c0-6e1c-403c-901d-03ac81bbb81f	TCGA-J4-A83M-01A-11D-A34T-01	8ab941c0-6e1c-403c-901d-03ac81bbb81f		TCGA-J4-A83M-01	TCGA-J4-A83M-01A-11D-A34V-05	TCGA-J4-A83M-01A-11R-A358-13		8ab941c0-6e1c-403c-901d-03ac81bbb81f	35e58745-53f0-49e4-83d1-50d7c7343787
TCGA-J4-A83N-01	0	TCGA-J4-A83N-01	617	0	TCGA-J4-A83N			617	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57		NO		M0	T1c	-20841		519					0	617		530									2014-1-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral			NO				YES			true		T2c	TCGA-J4-A83N.C40A9D7F-BFEC-4C07-A1C3-A34706E39713.pdf			0		0		0		0		0		15		85		90	WITH TUMOR	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			88930b7c-17d1-4b40-b9c5-0494a49effda	TCGA-J4-A83N-01	f01339fa-0c8b-440f-98d2-9f7365e0cc9b		TCGA-J4-A83N-01A-11D-A34U-08	TCGA-J4-A83N-01A-11D-A34T-01	f01339fa-0c8b-440f-98d2-9f7365e0cc9b	TCGA-J4-A83N-01A-11D-A34T-01	f01339fa-0c8b-440f-98d2-9f7365e0cc9b		TCGA-J4-A83N-01	TCGA-J4-A83N-01A-11D-A34V-05	TCGA-J4-A83N-01A-11R-A358-13		f01339fa-0c8b-440f-98d2-9f7365e0cc9b	88930b7c-17d1-4b40-b9c5-0494a49effda
TCGA-J4-AATV-01	0	TCGA-J4-AATV-01	358	0	TCGA-J4-AATV	358	0	358	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71		NO		M0		-25943		151					0	358		358									2014-8-13	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			YES				NO	4		true	N0	T2c	TCGA-J4-AATV.860F2174-869F-47E4-ABC1-14E4F608669A.pdf			8		1		4		1		3		63		30		80		3	Complete Remission/Response	No	0	NO	R1	Primary Tumor	01	3			NO		YES	NO	J4			Prostate		A	LIVING	2013				578514d0-3a51-4a97-915d-dc77a0ec0163	TCGA-J4-AATV-01	692c9e12-4ebc-43e2-a520-6e22b6b4e8ed			TCGA-J4-AATV-01A-11D-A41J-01	692c9e12-4ebc-43e2-a520-6e22b6b4e8ed	TCGA-J4-AATV-01A-11D-A41J-01	692c9e12-4ebc-43e2-a520-6e22b6b4e8ed		TCGA-J4-AATV-01	TCGA-J4-AATV-01A-11D-A41L-05	TCGA-J4-AATV-01A-11R-A41R-13		692c9e12-4ebc-43e2-a520-6e22b6b4e8ed	578514d0-3a51-4a97-915d-dc77a0ec0163
TCGA-J4-AATZ-01	0	TCGA-J4-AATZ-01	412	0	TCGA-J4-AATZ			412	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24226	33	170		23	23	79	0	412		386				No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2014-8-14	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral			YES				YES	4	0	true	N0	T3a	TCGA-J4-AATZ.369F71EC-186A-41DA-91F7-B0FD209BEC8F.pdf			0		0		0		0		0		40		60		70	WITH TUMOR	4	Complete Remission/Response	No	0	YES	R1	Primary Tumor	01	5			YES		YES	NO	J4	Apex		Prostate		A	LIVING	2013	Peripheral Zone			d2f92c1c-b5fc-4a2b-b2a6-215ec67b136d	TCGA-J4-AATZ-01	0f83b483-2bfe-431a-a958-cadf9a19efea			TCGA-J4-AATZ-01A-11D-A41J-01	0f83b483-2bfe-431a-a958-cadf9a19efea	TCGA-J4-AATZ-01A-11D-A41J-01	0f83b483-2bfe-431a-a958-cadf9a19efea		TCGA-J4-AATZ-01	TCGA-J4-AATZ-01A-11D-A41L-05	TCGA-J4-AATZ-01A-11R-A41R-13		0f83b483-2bfe-431a-a958-cadf9a19efea	d2f92c1c-b5fc-4a2b-b2a6-215ec67b136d
TCGA-J4-AAU2-01	0	TCGA-J4-AAU2-01	304	0	TCGA-J4-AAU2	304	0	304	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59		NO		M0		-21656		430					0	304		224									2014-8-14	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral			YES				NO	1	0	true	N0	T2c	TCGA-J4-AAU2.D4358B1C-AB27-4B36-ABF9-B4EE2E504493.pdf			0		0		0		0		0		25		75		80	TUMOR FREE	3	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4			Prostate		A	LIVING	2012				d702bbe9-db25-42f3-83b3-0d141701d004	TCGA-J4-AAU2-01	3e70c3e7-e946-46c8-b703-bc531bd1edce			TCGA-J4-AAU2-01A-11D-A41J-01	3e70c3e7-e946-46c8-b703-bc531bd1edce	TCGA-J4-AAU2-01A-11D-A41J-01	3e70c3e7-e946-46c8-b703-bc531bd1edce		TCGA-J4-AAU2-01	TCGA-J4-AAU2-01A-11D-A41L-05	TCGA-J4-AAU2-01A-11R-A41R-13		3e70c3e7-e946-46c8-b703-bc531bd1edce	d702bbe9-db25-42f3-83b3-0d141701d004
TCGA-J9-A52B-01	0	TCGA-J9-A52B-01	422	0	TCGA-J9-A52B			422	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62		NO	Normal (no evidence of prostate cancer) [cM0]		T3b	-22849	11	301		11		85	0	422		414			YES	No Evidence of Extraprostatic Extension	NO				2013-3-14	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral			YES				YES	7	0	false	N0	T3b	TCGA-J9-A52B.68F82D7A-CF0F-404F-8B39-7B2EB3DE9418.pdf			0		0		0		0		5		0		95		92		5	Complete Remission/Response	No	0.010	NO	R1	Primary Tumor	01	4			NO		NO	YES	J9	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones		TCGA-J9-A52B-01A-11D-A26M-08	4f6638d6-ca70-41a5-a3f6-8434a36385dd	TCGA-J9-A52B-01	b3c06bf7-49a3-48cb-9418-c25f8559b04c	TCGA-J9-A52B-01A-11D-A26M-08	TCGA-J9-A52B-01A-11D-A26M-08	TCGA-J9-A52B-01A-11D-A26L-01	b3c06bf7-49a3-48cb-9418-c25f8559b04c	TCGA-J9-A52B-01A-11D-A26L-01	b3c06bf7-49a3-48cb-9418-c25f8559b04c		TCGA-J9-A52B-01	TCGA-J9-A52B-01A-11D-A26N-05	TCGA-J9-A52B-01A-11R-A26Y-13	TCGA-J9-A52B-01A-11D-A26M-08	b3c06bf7-49a3-48cb-9418-c25f8559b04c	4f6638d6-ca70-41a5-a3f6-8434a36385dd
TCGA-J9-A52C-01	0	TCGA-J9-A52C-01	178	0	TCGA-J9-A52C	178	0	178	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57		NO	Normal (no evidence of prostate cancer) [cM0]		T1c	-20966	38	156		62			0	178		178			YES	No Evidence of Extraprostatic Extension	NO				2013-3-14	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral			NO				NO			false		T3b	TCGA-J9-A52C.CAAC3743-CE39-4A47-8D46-3C4917D469C1.pdf			0		0		0		0		20		0		80		75		4		No	0.03	NO	R0	Primary Tumor	01	5			NO	3	YES	NO	J9	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones		TCGA-J9-A52C-01A-11D-A26M-08	a324a0ec-2f0e-49b8-91be-ac3cf5038924	TCGA-J9-A52C-01	77d1e365-4ccc-4b1a-aa0d-cda00b246ba4	TCGA-J9-A52C-01A-11D-A26M-08	TCGA-J9-A52C-01A-11D-A26M-08	TCGA-J9-A52C-01A-11D-A26L-01	77d1e365-4ccc-4b1a-aa0d-cda00b246ba4	TCGA-J9-A52C-01A-11D-A26L-01	77d1e365-4ccc-4b1a-aa0d-cda00b246ba4	F15C57F1-CD77-4883-8DB4-26885DAF5151	TCGA-J9-A52C-01	TCGA-J9-A52C-01A-11D-A26N-05	TCGA-J9-A52C-01A-11R-A26Y-13	TCGA-J9-A52C-01A-11D-A26M-08	77d1e365-4ccc-4b1a-aa0d-cda00b246ba4	a324a0ec-2f0e-49b8-91be-ac3cf5038924
TCGA-J9-A52D-01	0	TCGA-J9-A52D-01	212	0	TCGA-J9-A52D	212	0	212	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-26023	-6	278		21			0	212		146			YES	No Evidence of Extraprostatic Extension	NO				2014-4-9	MALE	9	Prostate Adenocarcinoma  Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral			NO				NO			false		T3a	TCGA-J9-A52D.D2AF0639-286D-460B-8F66-E6401F3EE1F7.pdf			0		0		0		0		0		0		100		95	TUMOR FREE	4		No	0.059	NO	R0	Primary Tumor	01	5			NO	3	NO	YES	J9	Apex|Middle		Prostate		A	LIVING	2012	Transition Zone		TCGA-J9-A52D-01A-11D-A29Q-08			f73e06ac-aa61-45be-b666-83279a7fb908	TCGA-J9-A52D-01A-11D-A29Q-08	TCGA-J9-A52D-01A-11D-A29Q-08		f73e06ac-aa61-45be-b666-83279a7fb908		f73e06ac-aa61-45be-b666-83279a7fb908			TCGA-J9-A52D-01A-11D-A29T-05	TCGA-J9-A52D-01A-11R-A29V-13	TCGA-J9-A52D-01A-11D-A29Q-08	f73e06ac-aa61-45be-b666-83279a7fb908	
TCGA-J9-A52E-01	0	TCGA-J9-A52E-01	323	0	TCGA-J9-A52E			323	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65		NO	Normal (no evidence of prostate cancer) [cM0]		T2c	-23741	15	299		12		89	0	323		393			YES	No Evidence of Extraprostatic Extension	NO				2013-3-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	100		NO	Bilateral			YES				YES	8	0	false	N0	T3b	TCGA-J9-A52E.5154D45B-244F-45B1-BE2F-9C02716B1CB4.pdf			0		0		0		0		30		0		70		70	TUMOR FREE	4	Partial Remission/Response	No	0.01	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	J9	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones		TCGA-J9-A52E-01A-11D-A26M-08	3aead389-95a4-4cec-bbbf-d59e980a60b3	TCGA-J9-A52E-01	fc25b041-1fcb-456b-8e55-28b74a32ab91	TCGA-J9-A52E-01A-11D-A26M-08	TCGA-J9-A52E-01A-11D-A26M-08	TCGA-J9-A52E-01A-11D-A26L-01	fc25b041-1fcb-456b-8e55-28b74a32ab91	TCGA-J9-A52E-01A-11D-A26L-01	fc25b041-1fcb-456b-8e55-28b74a32ab91	5E28457A-C9A5-47D7-A83A-3797436403BF	TCGA-J9-A52E-01	TCGA-J9-A52E-01A-11D-A26N-05	TCGA-J9-A52E-01A-11R-A26Y-13	TCGA-J9-A52E-01A-11D-A26M-08	fc25b041-1fcb-456b-8e55-28b74a32ab91	3aead389-95a4-4cec-bbbf-d59e980a60b3
TCGA-J9-A8CK-01		TCGA-J9-A8CK-01			TCGA-J9-A8CK				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																																																															Primary Tumor	01																			ec5c2eba-b9ea-4f12-ac75-401049f36a1d	TCGA-J9-A8CK-01	ecb89f0a-31a4-428f-b2be-f882d55a146c		TCGA-J9-A8CK-01A-11D-A34U-08	TCGA-J9-A8CK-01A-11D-A34T-01	ecb89f0a-31a4-428f-b2be-f882d55a146c	TCGA-J9-A8CK-01A-11D-A34T-01	ecb89f0a-31a4-428f-b2be-f882d55a146c		TCGA-J9-A8CK-01	TCGA-J9-A8CK-01A-11D-A34V-05	TCGA-J9-A8CK-01A-11R-A358-13		ecb89f0a-31a4-428f-b2be-f882d55a146c	ec5c2eba-b9ea-4f12-ac75-401049f36a1d
TCGA-J9-A8CL-01	0	TCGA-J9-A8CL-01	405	0	TCGA-J9-A8CL			405	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66		YES	Equivocal	M0	T3a	-24145	6	278		11		132	0	405		405			YES	No Evidence of Extraprostatic Extension	NO				2015-1-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral			NO				YES			true		T3b	TCGA-J9-A8CL.062E0E86-B3E0-4CC0-9BE5-0EBDB81DCB5B.pdf			0		0		0		0		0		25		75		85	WITH TUMOR	4		No	12.01		R1	Primary Tumor	01	5				3	YES	NO	J9	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			181e5a0d-d640-4450-8b99-44b7ef4f64c2	TCGA-J9-A8CL-01	166b8cda-180b-4095-a991-69e79efec904		TCGA-J9-A8CL-01A-11D-A34U-08	TCGA-J9-A8CL-01A-11D-A34T-01	166b8cda-180b-4095-a991-69e79efec904	TCGA-J9-A8CL-01A-11D-A34T-01	166b8cda-180b-4095-a991-69e79efec904		TCGA-J9-A8CL-01	TCGA-J9-A8CL-01A-11D-A34V-05	TCGA-J9-A8CL-01A-11R-A358-13		166b8cda-180b-4095-a991-69e79efec904	181e5a0d-d640-4450-8b99-44b7ef4f64c2
TCGA-J9-A8CM-01		TCGA-J9-A8CM-01			TCGA-J9-A8CM				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											238																											230		NO											true			TCGA-J9-A8CM.7B7CB375-6046-437F-8513-9F713EA6407A.pdf			0		0		0		0		0		20		80		90								Primary Tumor	01													A						e574d8e9-ccd7-43c6-a48d-a63ae0347093	TCGA-J9-A8CM-01	304a95c1-2180-4a81-a85a-880427e97d67		TCGA-J9-A8CM-01A-11D-A34U-08	TCGA-J9-A8CM-01A-11D-A34T-01	304a95c1-2180-4a81-a85a-880427e97d67	TCGA-J9-A8CM-01A-11D-A34T-01	304a95c1-2180-4a81-a85a-880427e97d67		TCGA-J9-A8CM-01	TCGA-J9-A8CM-01A-11D-A34V-05	TCGA-J9-A8CM-01A-11R-A358-13		304a95c1-2180-4a81-a85a-880427e97d67	e574d8e9-ccd7-43c6-a48d-a63ae0347093
TCGA-J9-A8CN-01		TCGA-J9-A8CN-01			TCGA-J9-A8CN				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											971																											100		NO											true			TCGA-J9-A8CN.3D3F5AFD-4DA0-43EC-B6B9-D2F16B6206E8.pdf			0		0		0		0		0		15		85		90								Primary Tumor	01													A						c1ecd8c7-aeb0-4ae2-868d-da8fa16cfbf0	TCGA-J9-A8CN-01	2de65e78-be71-4f41-be55-d9ef61b277c3		TCGA-J9-A8CN-01A-11D-A34U-08	TCGA-J9-A8CN-01A-11D-A34T-01	2de65e78-be71-4f41-be55-d9ef61b277c3	TCGA-J9-A8CN-01A-11D-A34T-01	2de65e78-be71-4f41-be55-d9ef61b277c3		TCGA-J9-A8CN-01	TCGA-J9-A8CN-01A-11D-A34V-05	TCGA-J9-A8CN-01A-11R-A358-13		2de65e78-be71-4f41-be55-d9ef61b277c3	c1ecd8c7-aeb0-4ae2-868d-da8fa16cfbf0
TCGA-J9-A8CP-01		TCGA-J9-A8CP-01			TCGA-J9-A8CP				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											113																											90		NO											true			TCGA-J9-A8CP.526E96AC-D8A9-4FED-8D31-05E2427DE513.pdf			0		0		0		0		2		38		60		70								Primary Tumor	01													A						c9192f00-5ea8-484c-ac73-35ffd6fc807c	TCGA-J9-A8CP-01	4558d242-2bd6-4272-913f-59c6b8f05d64		TCGA-J9-A8CP-01A-11D-A34U-08	TCGA-J9-A8CP-01A-11D-A34T-01	4558d242-2bd6-4272-913f-59c6b8f05d64	TCGA-J9-A8CP-01A-11D-A34T-01	4558d242-2bd6-4272-913f-59c6b8f05d64		TCGA-J9-A8CP-01	TCGA-J9-A8CP-01A-11D-A34V-05	TCGA-J9-A8CP-01A-11R-A358-13		4558d242-2bd6-4272-913f-59c6b8f05d64	c9192f00-5ea8-484c-ac73-35ffd6fc807c
TCGA-KC-A4BL-01		TCGA-KC-A4BL-01			TCGA-KC-A4BL				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											2101																											160		NO											true			TCGA-KC-A4BL.EEF5303A-D63A-4D2F-A8B6-A78437A583FF.pdf			0		0		0		0		20		40		40		60								Primary Tumor	01													A					TCGA-KC-A4BL-01A-31D-A257-08	42f01c64-0a67-477a-8286-f53954c299f1	TCGA-KC-A4BL-01	71160876-7965-4899-a8b2-c549cc25260b	TCGA-KC-A4BL-01A-31D-A257-08	TCGA-KC-A4BL-01A-31D-A257-08	TCGA-KC-A4BL-01A-31D-A256-01	71160876-7965-4899-a8b2-c549cc25260b	TCGA-KC-A4BL-01A-31D-A256-01	71160876-7965-4899-a8b2-c549cc25260b	B926A73F-7CD8-4B97-8E6C-D24AE1EA5431	TCGA-KC-A4BL-01	TCGA-KC-A4BL-01A-31D-A258-05	TCGA-KC-A4BL-01A-31R-A25C-13	TCGA-KC-A4BL-01A-31D-A257-08	71160876-7965-4899-a8b2-c549cc25260b	42f01c64-0a67-477a-8286-f53954c299f1
TCGA-KC-A4BN-01	0	TCGA-KC-A4BN-01	1815	0	TCGA-KC-A4BN			1815	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55		NO		M0	T1c	-20392		1246			44		0	1815		529			NO		YES	No Evidence of Extraprostatic Extension			2014-7-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	570		NO	Right			YES					6	0	true	N0	T2a	TCGA-KC-A4BN.A929648E-54E0-4215-9148-4E1498961697.pdf			2		0		0		0		25		0		75		70		3		No	0	NO	R0	Primary Tumor	01	4			NO		NO	YES	KC	Middle		Prostate		A	LIVING	2009			TCGA-KC-A4BN-01A-61D-A257-08	e7e053f6-997f-4c8d-a0f1-d0fb65c40d90	TCGA-KC-A4BN-01	887b3624-2609-4928-9b17-d6e82cc4baa5	TCGA-KC-A4BN-01A-61D-A257-08	TCGA-KC-A4BN-01A-61D-A257-08	TCGA-KC-A4BN-01A-61D-A256-01	887b3624-2609-4928-9b17-d6e82cc4baa5	TCGA-KC-A4BN-01A-61D-A256-01	887b3624-2609-4928-9b17-d6e82cc4baa5	16E39B12-7B32-4D64-AFA8-5D55E25536DD	TCGA-KC-A4BN-01	TCGA-KC-A4BN-01A-61D-A258-05	TCGA-KC-A4BN-01A-61R-A25C-13	TCGA-KC-A4BN-01A-61D-A257-08	887b3624-2609-4928-9b17-d6e82cc4baa5	e7e053f6-997f-4c8d-a0f1-d0fb65c40d90
TCGA-KC-A4BO-01		TCGA-KC-A4BO-01			TCGA-KC-A4BO				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											742																											590		NO											true			TCGA-KC-A4BO.C601C012-0EC4-4386-9A9A-3485FD4968E1.pdf			2		0		0		0		20		0		80		70								Primary Tumor	01													A						7a6cf100-399d-42bd-a4dc-36ce3bd540a0			TCGA-KC-A4BO-01A-61D-A257-08	TCGA-KC-A4BO-01A-61D-A257-08	TCGA-KC-A4BO-01A-61D-A256-01		TCGA-KC-A4BO-01A-61D-A256-01		8DEB3822-4FED-44E2-9D11-4A43EC0C1CA0		TCGA-KC-A4BO-01A-61D-A258-05	TCGA-KC-A4BO-01A-61R-A25C-13	TCGA-KC-A4BO-01A-61D-A257-08		7a6cf100-399d-42bd-a4dc-36ce3bd540a0
TCGA-KC-A4BR-01		TCGA-KC-A4BR-01			TCGA-KC-A4BR				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											1161																											600		NO											true			TCGA-KC-A4BR.E44796E6-0446-4706-8B8F-A21D417EAB43.pdf			0		0		0		0		10		50		40		60								Primary Tumor	01													A					TCGA-KC-A4BR-01A-32D-A257-08	e620f891-cb6a-4974-bc00-4b43b116b689	TCGA-KC-A4BR-01	47c88c6e-4f26-46bc-8198-06c211f64e00	TCGA-KC-A4BR-01A-32D-A257-08	TCGA-KC-A4BR-01A-32D-A257-08	TCGA-KC-A4BR-01A-32D-A256-01	47c88c6e-4f26-46bc-8198-06c211f64e00	TCGA-KC-A4BR-01A-32D-A256-01	47c88c6e-4f26-46bc-8198-06c211f64e00	A7B9F799-6958-4860-B828-AE1F4BBB2F24	TCGA-KC-A4BR-01	TCGA-KC-A4BR-01A-32D-A258-05	TCGA-KC-A4BR-01A-32R-A25C-13	TCGA-KC-A4BR-01A-32D-A257-08	47c88c6e-4f26-46bc-8198-06c211f64e00	e620f891-cb6a-4974-bc00-4b43b116b689
TCGA-KC-A4BV-01	0	TCGA-KC-A4BV-01	1328	0	TCGA-KC-A4BV			1328	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66		YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-24138	16	943		18	81	1328	0	1328		1328			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-7-22	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	420		NO	Bilateral			YES				YES	10	0	true	N0	T3a	TCGA-KC-A4BV.CC0244A3-48CF-4448-A7F1-5DB9EC3B823A.pdf			0		0		0		0		5		35		60		80		4		No	.530	NO	R0	Primary Tumor	01	5			NO	3	NO	YES	KC	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones		TCGA-KC-A4BV-01A-31D-A26M-08	6e5bc403-becd-4484-b07f-12bff3b46d1b	TCGA-KC-A4BV-01	450b68b9-573f-4921-93b6-8a57ff9a7263	TCGA-KC-A4BV-01A-31D-A26M-08	TCGA-KC-A4BV-01A-31D-A26M-08	TCGA-KC-A4BV-01A-31D-A26L-01	450b68b9-573f-4921-93b6-8a57ff9a7263	TCGA-KC-A4BV-01A-31D-A26L-01	450b68b9-573f-4921-93b6-8a57ff9a7263	539AAD8D-FEAE-4C77-9255-512A7274E7B2	TCGA-KC-A4BV-01	TCGA-KC-A4BV-01A-31D-A26N-05	TCGA-KC-A4BV-01A-31R-A26Y-13	TCGA-KC-A4BV-01A-31D-A26M-08	450b68b9-573f-4921-93b6-8a57ff9a7263	6e5bc403-becd-4484-b07f-12bff3b46d1b
TCGA-KC-A7F3-01		TCGA-KC-A7F3-01			TCGA-KC-A7F3				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											195																											270		NO											true			TCGA-KC-A7F3.8878BDE3-634E-497C-AC4A-219E2F0B7153.pdf			2		0		0		0		20		20		60		60								Primary Tumor	01													A						5ce84d8d-9c2d-4323-aa70-cd6eea278187	TCGA-KC-A7F3-01	689a544a-c116-46f9-ae3c-769e793f21c7		TCGA-KC-A7F3-01A-21D-A33T-08	TCGA-KC-A7F3-01A-21D-A33S-01	689a544a-c116-46f9-ae3c-769e793f21c7	TCGA-KC-A7F3-01A-21D-A33S-01	689a544a-c116-46f9-ae3c-769e793f21c7		TCGA-KC-A7F3-01	TCGA-KC-A7F3-01A-21D-A33U-05	TCGA-KC-A7F3-01A-21R-A343-13		689a544a-c116-46f9-ae3c-769e793f21c7	5ce84d8d-9c2d-4323-aa70-cd6eea278187
TCGA-KC-A7F5-01		TCGA-KC-A7F5-01			TCGA-KC-A7F5				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											138																											250		NO											true			TCGA-KC-A7F5.3899F8DA-A4C2-40C3-AE27-227F7992B5EE.pdf			2		0		0		0		0		25		75		75								Primary Tumor	01													A							TCGA-KC-A7F5-01	9e0d5361-7994-48b6-a865-18d430b72239		TCGA-KC-A7F5-01A-11D-A33T-08		9e0d5361-7994-48b6-a865-18d430b72239		9e0d5361-7994-48b6-a865-18d430b72239			TCGA-KC-A7F5-01A-11D-A33U-05	TCGA-KC-A7F5-01A-11R-A343-13		9e0d5361-7994-48b6-a865-18d430b72239	
TCGA-KC-A7F6-01		TCGA-KC-A7F6-01			TCGA-KC-A7F6				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											171																											130		NO											true			TCGA-KC-A7F6.357EC50A-622F-4757-A044-7E38A12421FE.pdf			0		0		0		0		10		20		70		70								Primary Tumor	01													A						37f84795-2541-4455-98d7-4b73ab252122	TCGA-KC-A7F6-01	cea23bbc-1a4a-4498-987b-67728912ae40		TCGA-KC-A7F6-01A-11D-A33T-08	TCGA-KC-A7F6-01A-11D-A33S-01	cea23bbc-1a4a-4498-987b-67728912ae40	TCGA-KC-A7F6-01A-11D-A33S-01	cea23bbc-1a4a-4498-987b-67728912ae40		TCGA-KC-A7F6-01	TCGA-KC-A7F6-01A-11D-A33U-05	TCGA-KC-A7F6-01A-11R-A343-13		cea23bbc-1a4a-4498-987b-67728912ae40	37f84795-2541-4455-98d7-4b73ab252122
TCGA-KC-A7FA-01		TCGA-KC-A7FA-01			TCGA-KC-A7FA				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											146																											120		NO											true			TCGA-KC-A7FA.CF60F3B8-9AF5-4D51-8E17-BC7940235E96.pdf			0		0		0		0		15		0		85		75								Primary Tumor	01													A						9c292588-adaa-46a6-8d53-755a910b8005	TCGA-KC-A7FA-01	81ee8dcb-89dd-462e-b5de-2394bc6d522b		TCGA-KC-A7FA-01A-21D-A33T-08	TCGA-KC-A7FA-01A-21D-A33S-01	81ee8dcb-89dd-462e-b5de-2394bc6d522b	TCGA-KC-A7FA-01A-21D-A33S-01	81ee8dcb-89dd-462e-b5de-2394bc6d522b		TCGA-KC-A7FA-01	TCGA-KC-A7FA-01A-21D-A33U-05	TCGA-KC-A7FA-01A-21R-A343-13		81ee8dcb-89dd-462e-b5de-2394bc6d522b	9c292588-adaa-46a6-8d53-755a910b8005
TCGA-KC-A7FD-01		TCGA-KC-A7FD-01			TCGA-KC-A7FD				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											157																											130		NO											true			TCGA-KC-A7FD.15E27E53-1EF7-495A-A000-F10108E653C2.pdf			40		20		0		20		0		30		70		70								Primary Tumor	01													A						89ad7471-cd5a-4dc9-9360-8016658e7bde	TCGA-KC-A7FD-01	1d913abe-aadd-498f-9b1d-7d3746ae315c		TCGA-KC-A7FD-01A-11D-A33T-08	TCGA-KC-A7FD-01A-11D-A33S-01	1d913abe-aadd-498f-9b1d-7d3746ae315c	TCGA-KC-A7FD-01A-11D-A33S-01	1d913abe-aadd-498f-9b1d-7d3746ae315c		TCGA-KC-A7FD-01	TCGA-KC-A7FD-01A-11D-A33U-05	TCGA-KC-A7FD-01A-11R-A343-13		1d913abe-aadd-498f-9b1d-7d3746ae315c	89ad7471-cd5a-4dc9-9360-8016658e7bde
TCGA-KC-A7FE-01		TCGA-KC-A7FE-01			TCGA-KC-A7FE				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											212																											120		NO											true			TCGA-KC-A7FE.715B093C-7832-46EA-AC95-01406A90D529.pdf			40		20		0		20		0		40		60		60								Primary Tumor	01													A						7f20ebf3-0c87-4ca0-8550-4a1c5779efea	TCGA-KC-A7FE-01	17607f39-23c6-4eee-8aa4-ed705284ff4e		TCGA-KC-A7FE-01A-12D-A33T-08	TCGA-KC-A7FE-01A-12D-A33S-01	17607f39-23c6-4eee-8aa4-ed705284ff4e	TCGA-KC-A7FE-01A-12D-A33S-01	17607f39-23c6-4eee-8aa4-ed705284ff4e		TCGA-KC-A7FE-01	TCGA-KC-A7FE-01A-12D-A33U-05	TCGA-KC-A7FE-01A-12R-A343-13		17607f39-23c6-4eee-8aa4-ed705284ff4e	7f20ebf3-0c87-4ca0-8550-4a1c5779efea
TCGA-KK-A59V-01	0	TCGA-KK-A59V-01	2859	0	TCGA-KK-A59V	2859	0	2859	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		NO		M0	T3a	-23483		2742					0	2859		2500			NO		NO				2014-3-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	190		NO	Bilateral			YES				NO	9	0	true	N0	T3b	TCGA-KK-A59V.0A977EFF-C276-46CB-9187-92F504C7B535.pdf			2		0		0		0		0		0		100		75	TUMOR FREE	4		No	0.1	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2005	Peripheral Zone		TCGA-KK-A59V-01A-11D-A29Q-08	aec79c9d-7ccf-4a13-a849-0af9d6190ea7	TCGA-KK-A59V-01	d8012229-3666-4380-9d2a-2beaca772242	TCGA-KK-A59V-01A-11D-A29Q-08	TCGA-KK-A59V-01A-11D-A29Q-08	TCGA-KK-A59V-01A-11D-A323-01	d8012229-3666-4380-9d2a-2beaca772242	TCGA-KK-A59V-01A-11D-A323-01	d8012229-3666-4380-9d2a-2beaca772242	9591CEAE-DBE0-4E1F-BEB7-22EA6579225C	TCGA-KK-A59V-01	TCGA-KK-A59V-01A-11D-A29T-05	TCGA-KK-A59V-01A-11R-A29V-13	TCGA-KK-A59V-01A-11D-A29Q-08	d8012229-3666-4380-9d2a-2beaca772242	aec79c9d-7ccf-4a13-a849-0af9d6190ea7
TCGA-KK-A59X-01	0	TCGA-KK-A59X-01	1712	0	TCGA-KK-A59X	1712	0	1712	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55			Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-20416	12	1731		12			0	1712					YES	No Evidence of Extraprostatic Extension	NO				2013-5-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral			YES				NO	14	2	true	N1	T3b	TCGA-KK-A59X.64BB13A6-1071-4C2A-937C-17ACC07ADF75.pdf			0		0		0		0		2		18		80		85	TUMOR FREE	5		No		NO	R1	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2008	Peripheral Zone		TCGA-KK-A59X-01A-11D-A29Q-08	7167064c-5e06-4641-9b55-7a968f550f7c	TCGA-KK-A59X-01	efbbd41e-6911-49d5-9d54-cc95e0c81415	TCGA-KK-A59X-01A-11D-A29Q-08	TCGA-KK-A59X-01A-11D-A29Q-08	TCGA-KK-A59X-01A-11D-A323-01	efbbd41e-6911-49d5-9d54-cc95e0c81415	TCGA-KK-A59X-01A-11D-A323-01	efbbd41e-6911-49d5-9d54-cc95e0c81415	B8B5E05A-7239-4D32-A975-0409DF415833	TCGA-KK-A59X-01	TCGA-KK-A59X-01A-11D-A29T-05	TCGA-KK-A59X-01A-11R-A29V-13	TCGA-KK-A59X-01A-11D-A29Q-08	efbbd41e-6911-49d5-9d54-cc95e0c81415	7167064c-5e06-4641-9b55-7a968f550f7c
TCGA-KK-A59Y-01	0	TCGA-KK-A59Y-01	1359	0	TCGA-KK-A59Y			1359	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-20768	13	1158		13			0	1359		1359			YES	No Evidence of Extraprostatic Extension	NO				2013-5-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral			YES				YES	4	2	true	N1	T3a	TCGA-KK-A59Y.324E4C8E-1F95-4DA6-9D1F-97E6087BA2C7.pdf			0		0		0		0		0		30		70		80	TUMOR FREE	4		No	0.1	NO	RX	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone		TCGA-KK-A59Y-01A-11D-A26M-08	8a4ef113-6cc5-4247-95cd-86ab2c647653	TCGA-KK-A59Y-01	08a5e204-0002-4148-8b87-bbb9b490e825	TCGA-KK-A59Y-01A-11D-A26M-08	TCGA-KK-A59Y-01A-11D-A26M-08	TCGA-KK-A59Y-01A-11D-A26L-01	08a5e204-0002-4148-8b87-bbb9b490e825	TCGA-KK-A59Y-01A-11D-A26L-01	08a5e204-0002-4148-8b87-bbb9b490e825	70D842F6-C7CA-4E6A-BB98-0FDC991785D7	TCGA-KK-A59Y-01	TCGA-KK-A59Y-01A-11D-A26N-05	TCGA-KK-A59Y-01A-11R-A26Y-13	TCGA-KK-A59Y-01A-11D-A26M-08	08a5e204-0002-4148-8b87-bbb9b490e825	8a4ef113-6cc5-4247-95cd-86ab2c647653
TCGA-KK-A59Z-01	0	TCGA-KK-A59Z-01	1879	0	TCGA-KK-A59Z	1879	0	1879	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-24306	24	1985		20			0	1879		849			YES	No Evidence of Extraprostatic Extension	NO				2013-5-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	260		NO	Bilateral			YES				NO	2	0	true	N0	T2c	TCGA-KK-A59Z.DDF6F24F-4406-49EE-9EE0-7129D8544677.pdf			0		0		0		0		3		22		75		80	TUMOR FREE	4		No	0.1	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2007	Peripheral Zone		TCGA-KK-A59Z-01A-12D-A26M-08	7ed89165-c878-4c8e-99b7-df3ac2351d84	TCGA-KK-A59Z-01	bbc5dea9-50e1-44b7-9d43-82896b9229b5	TCGA-KK-A59Z-01A-12D-A26M-08	TCGA-KK-A59Z-01A-12D-A26M-08	TCGA-KK-A59Z-01A-12D-A26L-01	bbc5dea9-50e1-44b7-9d43-82896b9229b5	TCGA-KK-A59Z-01A-12D-A26L-01	bbc5dea9-50e1-44b7-9d43-82896b9229b5	8FA1DEF1-8C24-4B15-8875-30538F7E9E91	TCGA-KK-A59Z-01	TCGA-KK-A59Z-01A-12D-A26N-05	TCGA-KK-A59Z-01A-12R-A26Y-13	TCGA-KK-A59Z-01A-12D-A26M-08	bbc5dea9-50e1-44b7-9d43-82896b9229b5	7ed89165-c878-4c8e-99b7-df3ac2351d84
TCGA-KK-A5A1-01	0	TCGA-KK-A5A1-01	2364	0	TCGA-KK-A5A1			2364	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72		NO	Normal (no evidence of prostate cancer) [cM0]		T3a	-26415	57	3586		14			0	2364		420			YES		NO				2013-5-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral			YES				YES	3	0	true	N0	T3b	TCGA-KK-A5A1.DF56D103-963E-4C23-9DB8-1333AFF418CE.pdf			2		0		0		0		0		0		100		80		4		No	0.1	NO	R1	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2003	Overlapping / Multiple Zones		TCGA-KK-A5A1-01A-11D-A29Q-08			acd9261f-37cf-44ca-86c4-e42d88d86b6c	TCGA-KK-A5A1-01A-11D-A29Q-08	TCGA-KK-A5A1-01A-11D-A29Q-08		acd9261f-37cf-44ca-86c4-e42d88d86b6c		acd9261f-37cf-44ca-86c4-e42d88d86b6c	B87F9B41-6DAF-42E6-A00F-92DCE6D801F7		TCGA-KK-A5A1-01A-11D-A29T-05	TCGA-KK-A5A1-01A-11R-A29V-13	TCGA-KK-A5A1-01A-11D-A29Q-08	acd9261f-37cf-44ca-86c4-e42d88d86b6c	
TCGA-KK-A6DY-01	0	TCGA-KK-A6DY-01	3524	0	TCGA-KK-A6DY	3524	0	3524	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			50		NO		M0	T1c	-18420		4010					0	3524		903			NO		NO				2014-3-27	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral			YES				NO	12	0	true	N0	T2c	TCGA-KK-A6DY.3C4C5AAE-6F27-4ECE-8F72-91DC9EF477C0.pdf			40		20		0		20		0		30		70		70	TUMOR FREE	3		No	0.1	NO	R1	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2002	Peripheral Zone		TCGA-KK-A6DY-01A-12D-A30X-08	7eb168f8-7c28-4097-9350-8bee591c36a7	TCGA-KK-A6DY-01	bf46c30c-14fa-4e2a-a013-4e84f24eb63b	TCGA-KK-A6DY-01A-12D-A30X-08	TCGA-KK-A6DY-01A-12D-A30X-08	TCGA-KK-A6DY-01A-12D-A30W-01	bf46c30c-14fa-4e2a-a013-4e84f24eb63b	TCGA-KK-A6DY-01A-12D-A30W-01	bf46c30c-14fa-4e2a-a013-4e84f24eb63b		TCGA-KK-A6DY-01	TCGA-KK-A6DY-01A-12D-A30Z-05	TCGA-KK-A6DY-01A-12R-A310-13	TCGA-KK-A6DY-01A-12D-A30X-08	bf46c30c-14fa-4e2a-a013-4e84f24eb63b	7eb168f8-7c28-4097-9350-8bee591c36a7
TCGA-KK-A6E0-01	0	TCGA-KK-A6E0-01	913	0	TCGA-KK-A6E0			913	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59		YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-21700	11	859				941	0	913		913			NO		NO				2014-3-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Right			YES				YES	9	0	true	N0	T3a	TCGA-KK-A6E0.41BD5E57-29AE-41C8-96D7-2832C726E83B.pdf			40		20		0		20		0		30		70		70	WITH TUMOR	4		No	0.3	YES	R0	Primary Tumor	01	5			YES		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone		TCGA-KK-A6E0-01A-11D-A30X-08	af915427-c598-40e8-86b8-a5087214b30c	TCGA-KK-A6E0-01	12c2e11c-8ba3-4cce-8c28-c005edc4e4cc	TCGA-KK-A6E0-01A-11D-A30X-08	TCGA-KK-A6E0-01A-11D-A30X-08	TCGA-KK-A6E0-01A-11D-A30W-01	12c2e11c-8ba3-4cce-8c28-c005edc4e4cc	TCGA-KK-A6E0-01A-11D-A30W-01	12c2e11c-8ba3-4cce-8c28-c005edc4e4cc		TCGA-KK-A6E0-01	TCGA-KK-A6E0-01A-11D-A30Z-05	TCGA-KK-A6E0-01A-11R-A310-13	TCGA-KK-A6E0-01A-11D-A30X-08	12c2e11c-8ba3-4cce-8c28-c005edc4e4cc	af915427-c598-40e8-86b8-a5087214b30c
TCGA-KK-A6E1-01	0	TCGA-KK-A6E1-01	1659	0	TCGA-KK-A6E1	1659	0	1659	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-21063	-24	1598		-24			0	1659		356			YES	No Evidence of Extraprostatic Extension	NO				2014-3-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	250		NO	Bilateral			YES				NO	24	5	true	N1	T3b	TCGA-KK-A6E1.E8264E2D-E4BB-40BB-9305-18DDD777D664.pdf			0		0		10		0		0		15		75		70	TUMOR FREE	4	Complete Remission/Response	No	0.1	YES	RX	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones		TCGA-KK-A6E1-01A-11D-A30X-08	32eb09f7-c35a-4627-8120-ff4d5cc6e27e	TCGA-KK-A6E1-01	b38350db-b102-4a38-9edb-0089ca95840b	TCGA-KK-A6E1-01A-11D-A30X-08	TCGA-KK-A6E1-01A-11D-A30X-08	TCGA-KK-A6E1-01A-11D-A30W-01	b38350db-b102-4a38-9edb-0089ca95840b	TCGA-KK-A6E1-01A-11D-A30W-01	b38350db-b102-4a38-9edb-0089ca95840b		TCGA-KK-A6E1-01	TCGA-KK-A6E1-01A-11D-A30Z-05	TCGA-KK-A6E1-01A-11R-A310-13	TCGA-KK-A6E1-01A-11D-A30X-08	b38350db-b102-4a38-9edb-0089ca95840b	32eb09f7-c35a-4627-8120-ff4d5cc6e27e
TCGA-KK-A6E2-01	0	TCGA-KK-A6E2-01	4604	0	TCGA-KK-A6E2	4604	0	4604	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			54		NO		M0	T2a	-19974		4724					0	4604		438			NO		NO				2014-3-27	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	290		NO	Bilateral			YES				NO	5	0	true	N0	T2c	TCGA-KK-A6E2.84DBE486-DFA5-4FBC-BA8F-E10CC0247645.pdf			0		0		0		0		0		0		100		90	TUMOR FREE	3		No	0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2000	Transition Zone		TCGA-KK-A6E2-01A-11D-A30X-08	15543e00-d01d-4931-9153-a04a1cb4a7aa	TCGA-KK-A6E2-01	79d5f928-67b2-4db0-b018-a52889200dd3	TCGA-KK-A6E2-01A-11D-A30X-08	TCGA-KK-A6E2-01A-11D-A30X-08	TCGA-KK-A6E2-01A-11D-A30W-01	79d5f928-67b2-4db0-b018-a52889200dd3	TCGA-KK-A6E2-01A-11D-A30W-01	79d5f928-67b2-4db0-b018-a52889200dd3		TCGA-KK-A6E2-01	TCGA-KK-A6E2-01A-11D-A30Z-05	TCGA-KK-A6E2-01A-11R-A310-13	TCGA-KK-A6E2-01A-11D-A30X-08	79d5f928-67b2-4db0-b018-a52889200dd3	15543e00-d01d-4931-9153-a04a1cb4a7aa
TCGA-KK-A6E3-01	0	TCGA-KK-A6E3-01	2056	0	TCGA-KK-A6E3	2056	0	2056	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20547	10	3355					0	2056		1065			NO		NO				2014-3-27	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral			YES				NO	3	0	true	N0	T2c	TCGA-KK-A6E3.4796F9C1-49BD-411E-9D9B-D95001D76F53.pdf			0		0		0		0		7		13		80		60	TUMOR FREE	3		No	0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2004	Transition Zone		TCGA-KK-A6E3-01A-21D-A30E-08	9b3ced95-47c4-4f02-b921-998135669a63	TCGA-KK-A6E3-01	40126675-87b4-4f49-8e55-2cf42bb536eb	TCGA-KK-A6E3-01A-21D-A30E-08	TCGA-KK-A6E3-01A-21D-A30E-08	TCGA-KK-A6E3-01A-21D-A30D-01	40126675-87b4-4f49-8e55-2cf42bb536eb	TCGA-KK-A6E3-01A-21D-A30D-01	40126675-87b4-4f49-8e55-2cf42bb536eb		TCGA-KK-A6E3-01	TCGA-KK-A6E3-01A-21D-A30F-05	TCGA-KK-A6E3-01A-21R-A30I-13	TCGA-KK-A6E3-01A-21D-A30E-08	40126675-87b4-4f49-8e55-2cf42bb536eb	9b3ced95-47c4-4f02-b921-998135669a63
TCGA-KK-A6E4-01	0	TCGA-KK-A6E4-01	2753	0	TCGA-KK-A6E4	2753	0	2753	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69		NO		M0	T1c	-25338		3094					0	2753		890			NO		NO				2014-3-27	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	190		NO	Right			YES				NO	4	0	true	N0	T2b	TCGA-KK-A6E4.D4A30E0D-4829-4B4E-863A-DF2ACED85BE8.pdf			6		0		0		0		2		53		45		85	TUMOR FREE	3		No	0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2004	Peripheral Zone		TCGA-KK-A6E4-01A-11D-A30E-08	c6d03e4f-fdd1-49eb-b5a2-dff18f8dba39	TCGA-KK-A6E4-01	5793ef8d-17da-49a6-a606-9ce76c0a7a2a	TCGA-KK-A6E4-01A-11D-A30E-08	TCGA-KK-A6E4-01A-11D-A30E-08	TCGA-KK-A6E4-01A-11D-A30D-01	5793ef8d-17da-49a6-a606-9ce76c0a7a2a	TCGA-KK-A6E4-01A-11D-A30D-01	5793ef8d-17da-49a6-a606-9ce76c0a7a2a		TCGA-KK-A6E4-01	TCGA-KK-A6E4-01A-11D-A30F-05	TCGA-KK-A6E4-01A-11R-A30I-13	TCGA-KK-A6E4-01A-11D-A30E-08	5793ef8d-17da-49a6-a606-9ce76c0a7a2a	c6d03e4f-fdd1-49eb-b5a2-dff18f8dba39
TCGA-KK-A6E5-01	0	TCGA-KK-A6E5-01	1498	0	TCGA-KK-A6E5	1498	0	1498	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23144	-19			-19			0	1498		1496			YES	No Evidence of Extraprostatic Extension	NO				2014-3-27	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES				NO	27	0		N0	T3b																				4		No	0.1	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate			LIVING	2009	Peripheral Zone		TCGA-KK-A6E5-01A-11D-A30X-08	d7ebb110-2f6e-47df-a2e7-39a759d80678	TCGA-KK-A6E5-01	a9e18d77-7074-49d6-b686-fa7d3463d156	TCGA-KK-A6E5-01A-11D-A30X-08	TCGA-KK-A6E5-01A-11D-A30X-08	TCGA-KK-A6E5-01A-11D-A30W-01	a9e18d77-7074-49d6-b686-fa7d3463d156	TCGA-KK-A6E5-01A-11D-A30W-01	a9e18d77-7074-49d6-b686-fa7d3463d156		TCGA-KK-A6E5-01	TCGA-KK-A6E5-01A-11D-A30Z-05	TCGA-KK-A6E5-01A-11R-A310-13	TCGA-KK-A6E5-01A-11D-A30X-08	a9e18d77-7074-49d6-b686-fa7d3463d156	d7ebb110-2f6e-47df-a2e7-39a759d80678
TCGA-KK-A6E6-01	0	TCGA-KK-A6E6-01	3447	0	TCGA-KK-A6E6	3447	0	3447	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69		NO		M0	T2b	-25320		3813					0	3447		3447			NO		NO				2014-3-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			YES				NO	5	0	true	N0	T3a	TCGA-KK-A6E6.C67B882A-02B1-4511-B55C-87A33FC3E73E.pdf			2		0		1		0		2		57		40		80	TUMOR FREE	4		No	0.1	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2002	Peripheral Zone		TCGA-KK-A6E6-01A-11D-A30X-08	2645fbef-a99e-4474-b59c-e2c951739669	TCGA-KK-A6E6-01	79922276-6e00-4f17-851f-554f52f71520	TCGA-KK-A6E6-01A-11D-A30X-08	TCGA-KK-A6E6-01A-11D-A30X-08	TCGA-KK-A6E6-01A-11D-A30W-01	79922276-6e00-4f17-851f-554f52f71520	TCGA-KK-A6E6-01A-11D-A30W-01	79922276-6e00-4f17-851f-554f52f71520		TCGA-KK-A6E6-01	TCGA-KK-A6E6-01A-11D-A30Z-05		TCGA-KK-A6E6-01A-11D-A30X-08	79922276-6e00-4f17-851f-554f52f71520	2645fbef-a99e-4474-b59c-e2c951739669
TCGA-KK-A6E7-01	0	TCGA-KK-A6E7-01	2040	0	TCGA-KK-A6E7	2040	0	2040	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			46		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-17074	-46	2151		-45	8		0	2040		1847			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension|Equivocal			2014-3-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral			YES				NO	11	1	true	N1	T3a	TCGA-KK-A6E7.8173D1A9-5564-4824-AFD6-2097B90F4008.pdf			1		0		0		0		0		0		100		60	TUMOR FREE	5		No	0.1	NO	R1	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle		Prostate		A	LIVING	2007	Transition Zone		TCGA-KK-A6E7-01A-11D-A31L-08	b824dea6-5a68-4b37-a7e3-ea063ab4484b	TCGA-KK-A6E7-01	025caa8f-3290-488b-b7d0-aacf769a53e4	TCGA-KK-A6E7-01A-11D-A31L-08	TCGA-KK-A6E7-01A-11D-A31L-08	TCGA-KK-A6E7-01A-11D-A31K-01	025caa8f-3290-488b-b7d0-aacf769a53e4	TCGA-KK-A6E7-01A-11D-A31K-01	025caa8f-3290-488b-b7d0-aacf769a53e4		TCGA-KK-A6E7-01	TCGA-KK-A6E7-01A-11D-A31M-05	TCGA-KK-A6E7-01A-11R-A31R-13	TCGA-KK-A6E7-01A-11D-A31L-08	025caa8f-3290-488b-b7d0-aacf769a53e4	b824dea6-5a68-4b37-a7e3-ea063ab4484b
TCGA-KK-A6E8-01	0	TCGA-KK-A6E8-01	1770	0	TCGA-KK-A6E8	1770	0	1770	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25026	97	2128			104		0	1770		1769			NO		YES	No Evidence of Extraprostatic Extension			2014-3-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral			YES				NO	14	0	true	N0	T2c	TCGA-KK-A6E8.3716A52E-E0B7-4FE0-AC2B-07F2F3A0D6AD.pdf			1		0		0		0		0		0		100		80	TUMOR FREE	4		No	0.1	NO	RX	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2007	Transition Zone		TCGA-KK-A6E8-01A-11D-A31L-08	8224eed4-93b3-42b9-bfd0-a13c90b7d7b5	TCGA-KK-A6E8-01	246b4ac3-ceec-41c2-bab9-ed88baf668ae	TCGA-KK-A6E8-01A-11D-A31L-08	TCGA-KK-A6E8-01A-11D-A31L-08	TCGA-KK-A6E8-01A-11D-A31K-01	246b4ac3-ceec-41c2-bab9-ed88baf668ae	TCGA-KK-A6E8-01A-11D-A31K-01	246b4ac3-ceec-41c2-bab9-ed88baf668ae		TCGA-KK-A6E8-01	TCGA-KK-A6E8-01A-11D-A31M-05	TCGA-KK-A6E8-01A-11R-A31R-13	TCGA-KK-A6E8-01A-11D-A31L-08	246b4ac3-ceec-41c2-bab9-ed88baf668ae	8224eed4-93b3-42b9-bfd0-a13c90b7d7b5
TCGA-KK-A7AP-01	0	TCGA-KK-A7AP-01	196	0	TCGA-KK-A7AP			196	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55			Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20403	175	1130					0	196					NO		NO				2014-6-6	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	160		NO	Right			YES					15	2	true	N1	T3b	TCGA-KK-A7AP.5B2E970F-CF58-4A8E-90FD-A1AA16C95142.pdf			3		0		0		0		10		25		65		65		4		Yes, History of Prior Malignancy			R1	Primary Tumor	01	5					NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones			e9070e84-0ac9-43b1-8783-cf3c6ea40a1a	TCGA-KK-A7AP-01	9a4b7216-886c-4247-bcf3-22abc9d10835		TCGA-KK-A7AP-01A-12D-A33T-08	TCGA-KK-A7AP-01A-12D-A33S-01	9a4b7216-886c-4247-bcf3-22abc9d10835	TCGA-KK-A7AP-01A-12D-A33S-01	9a4b7216-886c-4247-bcf3-22abc9d10835		TCGA-KK-A7AP-01	TCGA-KK-A7AP-01A-12D-A33U-05	TCGA-KK-A7AP-01A-12R-A343-13		9a4b7216-886c-4247-bcf3-22abc9d10835	e9070e84-0ac9-43b1-8783-cf3c6ea40a1a
TCGA-KK-A7AQ-01	0	TCGA-KK-A7AQ-01	1386	0	TCGA-KK-A7AQ			1386	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62		NO		M0	T2a	-22731					38	1217	0	1386		1385					YES	No Evidence of Extraprostatic Extension			2014-8-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES				YES	11	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO	5	NO	YES	KK	Apex|Middle		Prostate			LIVING	2010	Peripheral Zone			d311c39f-1f08-47aa-8d6b-63b99167c953	TCGA-KK-A7AQ-01	b87af222-7056-4704-80c6-6766b8826767		TCGA-KK-A7AQ-01A-11D-A33T-08	TCGA-KK-A7AQ-01A-11D-A33S-01	b87af222-7056-4704-80c6-6766b8826767	TCGA-KK-A7AQ-01A-11D-A33S-01	b87af222-7056-4704-80c6-6766b8826767		TCGA-KK-A7AQ-01	TCGA-KK-A7AQ-01A-11D-A33U-05	TCGA-KK-A7AQ-01A-11R-A343-13		b87af222-7056-4704-80c6-6766b8826767	d311c39f-1f08-47aa-8d6b-63b99167c953
TCGA-KK-A7AU-01	0	TCGA-KK-A7AU-01	1621	0	TCGA-KK-A7AU			1621	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63		NO		M0	T2b	-23118					123	207	0	1621		1621			NO		YES	No Evidence of Extraprostatic Extension			2014-8-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES				YES	11	3		N1	T3b																			TUMOR FREE	4	Progressive Disease	No	0.0	NO	R1	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate			LIVING	2010	Peripheral Zone			a19cdc6f-f4f2-4f43-a48d-fcdf4a720faf	TCGA-KK-A7AU-01	eb344d08-f396-47b1-b832-dc0eb5d4abfb		TCGA-KK-A7AU-01A-11D-A32B-08	TCGA-KK-A7AU-01A-11D-A32A-01	eb344d08-f396-47b1-b832-dc0eb5d4abfb	TCGA-KK-A7AU-01A-11D-A32A-01	eb344d08-f396-47b1-b832-dc0eb5d4abfb		TCGA-KK-A7AU-01	TCGA-KK-A7AU-01A-11D-A32C-05	TCGA-KK-A7AU-01A-11R-A360-13		eb344d08-f396-47b1-b832-dc0eb5d4abfb	a19cdc6f-f4f2-4f43-a48d-fcdf4a720faf
TCGA-KK-A7AV-01	0	TCGA-KK-A7AV-01	822	0	TCGA-KK-A7AV	822	0	822	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58		NO		M0	T1c	-21192		587			48		0	822		822			NO		YES	No Evidence of Extraprostatic Extension			2014-8-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral			YES				NO	23	0	true	N0	T2c	TCGA-KK-A7AV.7C653DC8-83CE-42D9-A3D5-FA06CAFFF8EE.pdf			0		0		0		0		0		20		80		90	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	RX	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone			165b2bba-9c9d-4ce6-80d7-b0f292e1a920	TCGA-KK-A7AV-01	2b18be96-7a63-4bd7-b937-db23d45dd36c		TCGA-KK-A7AV-01A-11D-A32B-08	TCGA-KK-A7AV-01A-11D-A32A-01	2b18be96-7a63-4bd7-b937-db23d45dd36c	TCGA-KK-A7AV-01A-11D-A32A-01	2b18be96-7a63-4bd7-b937-db23d45dd36c		TCGA-KK-A7AV-01	TCGA-KK-A7AV-01A-11D-A32C-05	TCGA-KK-A7AV-01A-11R-A32J-13		2b18be96-7a63-4bd7-b937-db23d45dd36c	165b2bba-9c9d-4ce6-80d7-b0f292e1a920
TCGA-KK-A7AW-01	0	TCGA-KK-A7AW-01	1054	0	TCGA-KK-A7AW			1054	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57		YES		M0	T2a	-20869		983		11		204	0	1054		204			YES		NO				2014-8-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Right			YES					9	1	true	N1	T3a	TCGA-KK-A7AW.B5E8DF63-7C54-4D45-93ED-5C80075C63A5.pdf			0		0		0		0		0		20		80		90	TUMOR FREE	4		No	0.8		R0	Primary Tumor	01	3					NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2010	Peripheral Zone			a0ba64d0-7a8f-4141-9ec6-d8d561ddb4ff	TCGA-KK-A7AW-01	4f9b77fa-f087-44c3-a8f2-aeec410bfc9c		TCGA-KK-A7AW-01A-11D-A32B-08	TCGA-KK-A7AW-01A-11D-A32A-01	4f9b77fa-f087-44c3-a8f2-aeec410bfc9c	TCGA-KK-A7AW-01A-11D-A32A-01	4f9b77fa-f087-44c3-a8f2-aeec410bfc9c		TCGA-KK-A7AW-01	TCGA-KK-A7AW-01A-11D-A32C-05	TCGA-KK-A7AW-01A-11R-A360-13		4f9b77fa-f087-44c3-a8f2-aeec410bfc9c	a0ba64d0-7a8f-4141-9ec6-d8d561ddb4ff
TCGA-KK-A7AY-01	0	TCGA-KK-A7AY-01	1572	0	TCGA-KK-A7AY			1572	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60		NO		M0	T2a	-22220		1246				1390	0	1572		1572			NO		NO				2014-8-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral			YES				YES	8	0	true	N0	T2c	TCGA-KK-A7AY.BA64AA42-00AD-4DAD-ABE7-BDDC253B9B45.pdf			40		20		0		20		5		25		70		70	TUMOR FREE	4	Complete Remission/Response	No	0.2	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2010	Peripheral Zone			8cc25dbb-9a5e-4d71-bc05-60f9802090ac	TCGA-KK-A7AY-01	0fecf92d-9c02-4da8-aadd-c8105b99698b		TCGA-KK-A7AY-01A-11D-A33T-08	TCGA-KK-A7AY-01A-11D-A33S-01	0fecf92d-9c02-4da8-aadd-c8105b99698b	TCGA-KK-A7AY-01A-11D-A33S-01	0fecf92d-9c02-4da8-aadd-c8105b99698b		TCGA-KK-A7AY-01	TCGA-KK-A7AY-01A-11D-A33U-05	TCGA-KK-A7AY-01A-11R-A343-13		0fecf92d-9c02-4da8-aadd-c8105b99698b	8cc25dbb-9a5e-4d71-bc05-60f9802090ac
TCGA-KK-A7AZ-01	0	TCGA-KK-A7AZ-01	840	0	TCGA-KK-A7AZ			840	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56					T2b	-20507		1045			141		0	840					NO		YES	Equivocal			2014-8-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	200		NO	Right			YES					14	0	true	N0	T3a	TCGA-KK-A7AZ.5DEA3530-6618-4A73-94C7-F23DA06DA52C.pdf			40		20		0		20		0		30		70		70		4		No			R0	Primary Tumor	01	3					NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2010	Peripheral Zone			cc1a9739-c4ab-4308-8211-a3bfac7cfb5c	TCGA-KK-A7AZ-01	4d8fe8a9-7bf2-4c95-8aae-f43baeab5826		TCGA-KK-A7AZ-01A-12D-A32B-08	TCGA-KK-A7AZ-01A-12D-A32A-01	4d8fe8a9-7bf2-4c95-8aae-f43baeab5826	TCGA-KK-A7AZ-01A-12D-A32A-01	4d8fe8a9-7bf2-4c95-8aae-f43baeab5826		TCGA-KK-A7AZ-01	TCGA-KK-A7AZ-01A-12D-A32C-05			4d8fe8a9-7bf2-4c95-8aae-f43baeab5826	cc1a9739-c4ab-4308-8211-a3bfac7cfb5c
TCGA-KK-A7B0-01	0	TCGA-KK-A7B0-01	999	0	TCGA-KK-A7B0			999	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67		NO		M0	T2b	-24756		783				606	0	999		999			NO		NO				2014-8-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	150		NO	Bilateral			YES				YES	17	0	true	N0	T3b	TCGA-KK-A7B0.A6F717F0-66D2-4AEB-88F6-1A95D26489BC.pdf			40		20		0		20		0		20		80		80		4	Stable Disease	No	0.1	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			b892ebea-98bb-4d02-a0c0-31a8f113a0d0	TCGA-KK-A7B0-01	13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7		TCGA-KK-A7B0-01A-11D-A32B-08	TCGA-KK-A7B0-01A-11D-A32A-01	13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7	TCGA-KK-A7B0-01A-11D-A32A-01	13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7		TCGA-KK-A7B0-01	TCGA-KK-A7B0-01A-11D-A32C-05	TCGA-KK-A7B0-01A-11R-A360-13		13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7	b892ebea-98bb-4d02-a0c0-31a8f113a0d0
TCGA-KK-A7B1-01	0	TCGA-KK-A7B1-01	1063	0	TCGA-KK-A7B1	1063	0	1063	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65		NO		M0	T1c	-23803		839			52		0	1063		179			NO		YES	No Evidence of Extraprostatic Extension			2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral			YES				NO	21	0	true	N0	T3a	TCGA-KK-A7B1.F7802347-53BA-44B9-ACFE-7A10A014822B.pdf			3		0		4		2		0		51		45		80	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone			a70903c7-3a47-4069-97f0-2154ab8696cd	TCGA-KK-A7B1-01	9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6		TCGA-KK-A7B1-01A-11D-A32B-08	TCGA-KK-A7B1-01A-11D-A32A-01	9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6	TCGA-KK-A7B1-01A-11D-A32A-01	9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6		TCGA-KK-A7B1-01	TCGA-KK-A7B1-01A-11D-A32C-05	TCGA-KK-A7B1-01A-11R-A32J-13		9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6	a70903c7-3a47-4069-97f0-2154ab8696cd
TCGA-KK-A7B2-01	0	TCGA-KK-A7B2-01	692	0	TCGA-KK-A7B2	692	0	692	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24845	58	554		58			0	692		845			YES	No Evidence of Extraprostatic Extension	NO				2014-6-6	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	130		NO	Left			YES				NO	13	1	true	N1	T3a	TCGA-KK-A7B2.9A37DFF6-CDD7-40DD-A6A6-3966BC4E275A.pdf			10		2		1		2		0		55		44		80	WITH TUMOR	4	Stable Disease	No	0.3	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			0bac5667-2cf7-41f6-b070-d47ea0ec3204	TCGA-KK-A7B2-01	9d5f0b9f-ff36-4a80-8472-412d0ec803c5		TCGA-KK-A7B2-01A-12D-A32B-08	TCGA-KK-A7B2-01A-12D-A32A-01	9d5f0b9f-ff36-4a80-8472-412d0ec803c5	TCGA-KK-A7B2-01A-12D-A32A-01	9d5f0b9f-ff36-4a80-8472-412d0ec803c5		TCGA-KK-A7B2-01	TCGA-KK-A7B2-01A-12D-A32C-05	TCGA-KK-A7B2-01A-12R-A32J-13		9d5f0b9f-ff36-4a80-8472-412d0ec803c5	0bac5667-2cf7-41f6-b070-d47ea0ec3204
TCGA-KK-A7B3-01	0	TCGA-KK-A7B3-01	637	0	TCGA-KK-A7B3	637	0	637	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62		NO		M0	T3a	-22830					112		0	637		637			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-8-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES				NO	17	0		N0	T3b																			TUMOR FREE	4	Complete Remission/Response	Yes, History of Prior Malignancy	0.1	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate			LIVING	2012	Peripheral Zone			aff80d5c-8987-4959-a255-24f59ddc085d	TCGA-KK-A7B3-01	f3b04f74-8565-45f4-8a14-c0400c954ac4		TCGA-KK-A7B3-01A-11D-A33T-08	TCGA-KK-A7B3-01A-11D-A33S-01	f3b04f74-8565-45f4-8a14-c0400c954ac4	TCGA-KK-A7B3-01A-11D-A33S-01	f3b04f74-8565-45f4-8a14-c0400c954ac4		TCGA-KK-A7B3-01	TCGA-KK-A7B3-01A-11D-A33U-05	TCGA-KK-A7B3-01A-11R-A343-13		f3b04f74-8565-45f4-8a14-c0400c954ac4	aff80d5c-8987-4959-a255-24f59ddc085d
TCGA-KK-A7B4-01	0	TCGA-KK-A7B4-01	637	0	TCGA-KK-A7B4			637	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		YES	Equivocal	M0	T3b	-23644	29				29	637	0	637		637			NO		YES	Equivocal			2014-8-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES				YES	20	8		N1	T3b																			WITH TUMOR	4	Stable Disease	Yes, History of Prior Malignancy	0.6	NO	R1	Primary Tumor	01	5			YES		NO	YES	KK	Apex|Middle|Base		Prostate			LIVING	2012	Overlapping / Multiple Zones			efd024f5-173c-4b74-9a8c-8b9fb02d8d84	TCGA-KK-A7B4-01	dce52b98-298c-4980-ba8b-3791b6528d4c		TCGA-KK-A7B4-01A-11D-A32B-08	TCGA-KK-A7B4-01A-11D-A32A-01	dce52b98-298c-4980-ba8b-3791b6528d4c	TCGA-KK-A7B4-01A-11D-A32A-01	dce52b98-298c-4980-ba8b-3791b6528d4c		TCGA-KK-A7B4-01	TCGA-KK-A7B4-01A-11D-A32C-05	TCGA-KK-A7B4-01A-11R-A32J-13		dce52b98-298c-4980-ba8b-3791b6528d4c	efd024f5-173c-4b74-9a8c-8b9fb02d8d84
TCGA-KK-A8I4-01	0	TCGA-KK-A8I4-01	2068	0	TCGA-KK-A8I4			2068	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-23706	70	1798			70	1155	0	2068		1964			NO		YES	No Evidence of Extraprostatic Extension			2014-8-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	120		NO	Left			YES				YES	15	1	true	N1	T3b	TCGA-KK-A8I4.633E280A-24F4-49FF-95B8-DDA5F447480E.pdf			3		0		0		0		0		0		100		70	WITH TUMOR	4	Progressive Disease	No	0.2	NO	R0	Primary Tumor	01	3			NO	5	NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2008	Peripheral Zone			6354ebfa-6f94-4ead-8e08-e90818c1d2a9	TCGA-KK-A8I4-01	b4d87462-1fc4-4ee4-b905-c2919ebceb33		TCGA-KK-A8I4-01A-11D-A364-08	TCGA-KK-A8I4-01A-11D-A363-01	b4d87462-1fc4-4ee4-b905-c2919ebceb33	TCGA-KK-A8I4-01A-11D-A363-01	b4d87462-1fc4-4ee4-b905-c2919ebceb33		TCGA-KK-A8I4-01	TCGA-KK-A8I4-01A-11D-A365-05	TCGA-KK-A8I4-01A-11R-A36B-13		b4d87462-1fc4-4ee4-b905-c2919ebceb33	6354ebfa-6f94-4ead-8e08-e90818c1d2a9
TCGA-KK-A8I5-01	0	TCGA-KK-A8I5-01	2553	0	TCGA-KK-A8I5	2553	0	2553	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55		NO		M0	T2a	-20337		2717					0	2553		1979			NO		NO				2014-8-18	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	130		NO	Right			YES				NO	6		true	N0	T2b	TCGA-KK-A8I5.CF19D931-B8BE-4978-8C08-081744230305.pdf			2		0		0		0		15		0		85		60	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2006	Peripheral Zone			0b6b57a6-7bee-4162-84de-5d810744acdf	TCGA-KK-A8I5-01	1afe5497-bd6d-45b9-816d-52e7fb20ea4e		TCGA-KK-A8I5-01A-11D-A364-08	TCGA-KK-A8I5-01A-11D-A363-01	1afe5497-bd6d-45b9-816d-52e7fb20ea4e	TCGA-KK-A8I5-01A-11D-A363-01	1afe5497-bd6d-45b9-816d-52e7fb20ea4e		TCGA-KK-A8I5-01	TCGA-KK-A8I5-01A-11D-A365-05	TCGA-KK-A8I5-01A-11R-A36B-13		1afe5497-bd6d-45b9-816d-52e7fb20ea4e	0b6b57a6-7bee-4162-84de-5d810744acdf
TCGA-KK-A8I6-01	0	TCGA-KK-A8I6-01	668	0	TCGA-KK-A8I6	668	0	668	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-21499	-14	808		-13	17		0	668		668			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2014-8-18	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral			YES				NO	23	0	true	N0	T3a	TCGA-KK-A8I6.11107580-AAF3-4CE8-AC75-8636CE8C515E.pdf			2		0		0		0		0		0		100		70	TUMOR FREE	4	Complete Remission/Response	No	0.2	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone			4969bd48-7b88-4141-9b2d-67d2216efc26	TCGA-KK-A8I6-01	0b02de77-8d04-4be6-87db-0f0506ee5e54		TCGA-KK-A8I6-01A-11D-A364-08	TCGA-KK-A8I6-01A-11D-A363-01	0b02de77-8d04-4be6-87db-0f0506ee5e54	TCGA-KK-A8I6-01A-11D-A363-01	0b02de77-8d04-4be6-87db-0f0506ee5e54		TCGA-KK-A8I6-01	TCGA-KK-A8I6-01A-11D-A365-05	TCGA-KK-A8I6-01A-11R-A36B-13		0b02de77-8d04-4be6-87db-0f0506ee5e54	4969bd48-7b88-4141-9b2d-67d2216efc26
TCGA-KK-A8I7-01	0	TCGA-KK-A8I7-01	1891	0	TCGA-KK-A8I7			1891	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55		NO		M0	T2c	-20256		1634		24		1088	0	1891		1877			YES	No Evidence of Extraprostatic Extension	NO				2014-8-18	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	150		NO	Bilateral			YES				YES	9	0	true	N0	T3b	TCGA-KK-A8I7.70BA9BA3-05E5-4B40-9D6A-BBECCAAADD81.pdf			40		20		0		20		10		20		70		70	TUMOR FREE	4	Progressive Disease	No	0.1	NO	R1	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone			9622171a-ff77-42eb-bda8-bcf53bff3b96	TCGA-KK-A8I7-01	6086c6f1-e184-4a3e-935d-3addef5ecc2c		TCGA-KK-A8I7-01A-21D-A364-08	TCGA-KK-A8I7-01A-21D-A363-01	6086c6f1-e184-4a3e-935d-3addef5ecc2c	TCGA-KK-A8I7-01A-21D-A363-01	6086c6f1-e184-4a3e-935d-3addef5ecc2c		TCGA-KK-A8I7-01	TCGA-KK-A8I7-01A-21D-A365-05	TCGA-KK-A8I7-01A-21R-A36B-13		6086c6f1-e184-4a3e-935d-3addef5ecc2c	9622171a-ff77-42eb-bda8-bcf53bff3b96
TCGA-KK-A8I8-01	0	TCGA-KK-A8I8-01	774	0	TCGA-KK-A8I8	774	0	774	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69		NO		M0	T2a	-25546		535			31		0	774		757			NO		YES	No Evidence of Extraprostatic Extension			2014-8-18	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral			YES				NO	27		true	N0	T3b	TCGA-KK-A8I8.EA62695C-65BD-4E4A-BB9D-0D1CC5B90636.pdf			40		20		0		20		5		15		80		80	TUMOR FREE	4	Complete Remission/Response	No	0.1	YES	R1	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone			8c3b64c9-c381-4af8-a369-d5cabec18835	TCGA-KK-A8I8-01	532e3276-07d4-4e86-a955-4f474bc8ae36		TCGA-KK-A8I8-01A-11D-A364-08	TCGA-KK-A8I8-01A-11D-A363-01	532e3276-07d4-4e86-a955-4f474bc8ae36	TCGA-KK-A8I8-01A-11D-A363-01	532e3276-07d4-4e86-a955-4f474bc8ae36		TCGA-KK-A8I8-01	TCGA-KK-A8I8-01A-11D-A365-05	TCGA-KK-A8I8-01A-11R-A36B-13		532e3276-07d4-4e86-a955-4f474bc8ae36	8c3b64c9-c381-4af8-a369-d5cabec18835
TCGA-KK-A8I9-01	0	TCGA-KK-A8I9-01	721	0	TCGA-KK-A8I9	721	0	721	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-22295	0	528		-3	0		0	721		721			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2014-8-18	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			YES				NO	14		true	N0	T3a	TCGA-KK-A8I9.D086A0A1-E06A-4B7E-B158-A5D04BCE06E1.pdf			40		20		0		20		0		20		80		80	TUMOR FREE	4	Complete Remission/Response	No	0.1	YES	RX	Primary Tumor	01	4			YES		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone			4f76de2d-e07a-402b-9818-7f04d3704a43	TCGA-KK-A8I9-01	239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae		TCGA-KK-A8I9-01A-11D-A364-08	TCGA-KK-A8I9-01A-11D-A363-01	239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae	TCGA-KK-A8I9-01A-11D-A363-01	239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae		TCGA-KK-A8I9-01	TCGA-KK-A8I9-01A-11D-A365-05	TCGA-KK-A8I9-01A-11R-A36B-13		239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae	4f76de2d-e07a-402b-9818-7f04d3704a43
TCGA-KK-A8IA-01	0	TCGA-KK-A8IA-01	1439	0	TCGA-KK-A8IA	1439	0	1439	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3b	-25284	26	1665		26			0	1439		1383			YES	No Evidence of Extraprostatic Extension	NO				2014-8-18	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	230		NO	Bilateral			YES				NO	19	3	true	N1	T3b	TCGA-KK-A8IA.641BD2CD-8B57-49BB-A2E1-9EB78097B4D6.pdf			40		20		0		20		5		25		70		70		4		No	0.1	NO	RX	Primary Tumor	01	5			YES		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone			281732b6-86ab-4a17-a6b4-5f38ae598665	TCGA-KK-A8IA-01	fbf9c35e-9b03-4c5e-a065-0265ae35a409		TCGA-KK-A8IA-01A-11D-A364-08	TCGA-KK-A8IA-01A-11D-A363-01	fbf9c35e-9b03-4c5e-a065-0265ae35a409	TCGA-KK-A8IA-01A-11D-A363-01	fbf9c35e-9b03-4c5e-a065-0265ae35a409		TCGA-KK-A8IA-01	TCGA-KK-A8IA-01A-11D-A365-05	TCGA-KK-A8IA-01A-11R-A36B-13		fbf9c35e-9b03-4c5e-a065-0265ae35a409	281732b6-86ab-4a17-a6b4-5f38ae598665
TCGA-KK-A8IB-01	0	TCGA-KK-A8IB-01	83	0	TCGA-KK-A8IB			83	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65				M0	T2a	-24041		338					0	83					NO		NO				2014-8-19	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	360		NO	Bilateral			YES					21		true	N0	T3a	TCGA-KK-A8IB.B9FBCA1B-CAEB-48A1-87B8-C873AC07FD8B.pdf			0		0		0		0		50		0		50		60		4		Yes, History of Prior Malignancy			R0	Primary Tumor	01	5					NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone			29549dff-fd02-4ddf-bcdd-2f92f4471151	TCGA-KK-A8IB-01	02fea7d7-d604-41c2-9506-a62824140df4		TCGA-KK-A8IB-01A-11D-A364-08	TCGA-KK-A8IB-01A-11D-A363-01	02fea7d7-d604-41c2-9506-a62824140df4	TCGA-KK-A8IB-01A-11D-A363-01	02fea7d7-d604-41c2-9506-a62824140df4		TCGA-KK-A8IB-01	TCGA-KK-A8IB-01A-11D-A365-05	TCGA-KK-A8IB-01A-11R-A36B-13		02fea7d7-d604-41c2-9506-a62824140df4	29549dff-fd02-4ddf-bcdd-2f92f4471151
TCGA-KK-A8IC-01	0	TCGA-KK-A8IC-01	2051	0	TCGA-KK-A8IC	1060	1	2051	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	NO	54	TCGA-KK-A8IC-F64008	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-19902	7	1784		6		1060	0	2051	1060	2047	2019		YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Stable Disease	2014-8-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	38		true	N0	T3b	TCGA-KK-A8IC.D11CB264-3D9E-49ED-85AA-57E4A26A5ED1.pdf			0		0		0		0		50		0		50		60	WITH TUMOR	4	Progressive Disease	No	0.9	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2008	Peripheral Zone			8871dbe1-dca9-4369-afc9-81fb78b8094d	TCGA-KK-A8IC-01	8ae687ed-f9b2-41fc-88d7-e977fef25582		TCGA-KK-A8IC-01A-11D-A364-08	TCGA-KK-A8IC-01A-11D-A363-01	8ae687ed-f9b2-41fc-88d7-e977fef25582	TCGA-KK-A8IC-01A-11D-A363-01	8ae687ed-f9b2-41fc-88d7-e977fef25582		TCGA-KK-A8IC-01	TCGA-KK-A8IC-01A-11D-A365-05	TCGA-KK-A8IC-01A-11R-A36B-13		8ae687ed-f9b2-41fc-88d7-e977fef25582	8871dbe1-dca9-4369-afc9-81fb78b8094d
TCGA-KK-A8ID-01	0	TCGA-KK-A8ID-01	1973	0	TCGA-KK-A8ID	1973	0	1973	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-25851	43	1717		-5			0	1973		1924			YES	No Evidence of Extraprostatic Extension	NO				2014-8-18	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral			YES				NO	19	2	true	N1	T3b	TCGA-KK-A8ID.51303D5A-8963-4A4E-8A30-8EB0CA6D9437.pdf			0		0		0		0		50		0		50		60	TUMOR FREE	5	Complete Remission/Response	No	0.1	NO	R1	Primary Tumor	01	4			YES		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones			170808e1-c21e-49f2-81ba-f25946b53768	TCGA-KK-A8ID-01	dc0bcf42-993d-4119-b91e-399a639c1480		TCGA-KK-A8ID-01A-11D-A364-08	TCGA-KK-A8ID-01A-11D-A363-01	dc0bcf42-993d-4119-b91e-399a639c1480	TCGA-KK-A8ID-01A-11D-A363-01	dc0bcf42-993d-4119-b91e-399a639c1480		TCGA-KK-A8ID-01	TCGA-KK-A8ID-01A-11D-A365-05	TCGA-KK-A8ID-01A-11R-A36B-13		dc0bcf42-993d-4119-b91e-399a639c1480	170808e1-c21e-49f2-81ba-f25946b53768
TCGA-KK-A8IF-01	0	TCGA-KK-A8IF-01	804	0	TCGA-KK-A8IF			804	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57		YES		M0	T2a	-20888		2351			522	648	0	804		788			NO		YES	No Evidence of Extraprostatic Extension			2014-8-18	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral			YES				YES	33		true	N0	T3a	TCGA-KK-A8IF.BF56F683-5D52-4154-B9D4-1B6D2608C5AA.pdf			0		0		0		0		0		20		80		85	WITH TUMOR	4		No	0.7		R0	Primary Tumor	01	3					NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2007	Transition Zone			e54e5efc-a723-4958-b98c-534eba6b563b	TCGA-KK-A8IF-01	8744dea9-5e21-47b0-9327-8177526d9d31		TCGA-KK-A8IF-01A-11D-A364-08	TCGA-KK-A8IF-01A-11D-A363-01	8744dea9-5e21-47b0-9327-8177526d9d31	TCGA-KK-A8IF-01A-11D-A363-01	8744dea9-5e21-47b0-9327-8177526d9d31		TCGA-KK-A8IF-01	TCGA-KK-A8IF-01A-11D-A365-05	TCGA-KK-A8IF-01A-11R-A36B-13		8744dea9-5e21-47b0-9327-8177526d9d31	e54e5efc-a723-4958-b98c-534eba6b563b
TCGA-KK-A8IG-01	0	TCGA-KK-A8IG-01	2211	0	TCGA-KK-A8IG	2211	0	2211	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-20266	63	2057		63			0	2211		2211			YES	No Evidence of Extraprostatic Extension	NO				2014-8-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral			YES				NO	19		true	N0	T3a	TCGA-KK-A8IG.D1F786EC-03F5-458B-99AC-3B89EFFF2297.pdf			0		0		0		0		10		20		70		80	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R1	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle		Prostate		A	LIVING	2008	Transition Zone			7707b0d1-a274-43aa-976e-dbc0eba2f915	TCGA-KK-A8IG-01	95c350df-1871-430a-9c08-f3d88e2edcaf		TCGA-KK-A8IG-01A-11D-A364-08	TCGA-KK-A8IG-01A-11D-A363-01	95c350df-1871-430a-9c08-f3d88e2edcaf	TCGA-KK-A8IG-01A-11D-A363-01	95c350df-1871-430a-9c08-f3d88e2edcaf		TCGA-KK-A8IG-01	TCGA-KK-A8IG-01A-11D-A365-05	TCGA-KK-A8IG-01A-11R-A36B-13		95c350df-1871-430a-9c08-f3d88e2edcaf	7707b0d1-a274-43aa-976e-dbc0eba2f915
TCGA-KK-A8IH-01	0	TCGA-KK-A8IH-01	1635	0	TCGA-KK-A8IH	1635	0	1635	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			50		NO		M0	T2b	-18560		1631					0	1635		1634			NO		NO				2014-8-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral			YES				NO	10		true	N0	T3a	TCGA-KK-A8IH.E2FC2177-CB74-4E23-B24D-68F4ECEA57C2.pdf			0		0		0		0		30		30		40		60	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO	5	NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone			448c9c56-7da3-46b4-b6d4-c2503a954d86	TCGA-KK-A8IH-01	994566a7-664e-4b9b-9320-126940c14b6b		TCGA-KK-A8IH-01A-11D-A364-08	TCGA-KK-A8IH-01A-11D-A363-01	994566a7-664e-4b9b-9320-126940c14b6b	TCGA-KK-A8IH-01A-11D-A363-01	994566a7-664e-4b9b-9320-126940c14b6b		TCGA-KK-A8IH-01	TCGA-KK-A8IH-01A-11D-A365-05	TCGA-KK-A8IH-01A-11R-A36B-13		994566a7-664e-4b9b-9320-126940c14b6b	448c9c56-7da3-46b4-b6d4-c2503a954d86
TCGA-KK-A8II-01	1	TCGA-KK-A8II-01	3467	1	TCGA-KK-A8II	1854	1	3467	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	NO	61	TCGA-KK-A8II-F68762	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-22460	-28	3293	3467	11		626	0		1854	2891			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Progressive Disease	2014-12-16	MALE	9	Prostate Adenocarcinoma  Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral		NO	YES	Bone	Biochemical evidence of disease		YES	19		true	N0	T3a	TCGA-KK-A8II.0C940BA1-22F7-412D-AD58-84B950157601.pdf			0		0		0		0		5		30		65		80	WITH TUMOR	4	Complete Remission/Response	No	39.8	NO	R0	Primary Tumor	01	5		Medical Record	NO		NO	YES	KK	Apex|Middle|Base	YES	Prostate	Distant Metastasis	A	DECEASED	2004	Peripheral Zone			631ea376-b095-43c1-a33e-18246e3bdc5c	TCGA-KK-A8II-01	d5cb344a-fec2-4370-88ef-4837ae8573dc		TCGA-KK-A8II-01A-11D-A364-08	TCGA-KK-A8II-01A-11D-A363-01	d5cb344a-fec2-4370-88ef-4837ae8573dc	TCGA-KK-A8II-01A-11D-A363-01	d5cb344a-fec2-4370-88ef-4837ae8573dc		TCGA-KK-A8II-01	TCGA-KK-A8II-01A-11D-A365-05	TCGA-KK-A8II-01A-11R-A36B-13		d5cb344a-fec2-4370-88ef-4837ae8573dc	631ea376-b095-43c1-a33e-18246e3bdc5c
TCGA-KK-A8IJ-01	0	TCGA-KK-A8IJ-01	1559	0	TCGA-KK-A8IJ			1559	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-21793	42	1749		42			0	1559		167			YES	No Evidence of Extraprostatic Extension	NO				2014-8-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral			YES				YES	34	1	true	N1	T3b	TCGA-KK-A8IJ.F224443D-410F-4F1E-9CA0-04A652985616.pdf			3		1		0		1		2		48		50		90		4		No	0.1		R0	Primary Tumor	01	3				5	NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone			29d6f6bd-32b6-4f00-b809-5e0f67b3dea7	TCGA-KK-A8IJ-01	a8f619f1-c92e-4e7b-99f9-d25984935cde		TCGA-KK-A8IJ-01A-11D-A34U-08	TCGA-KK-A8IJ-01A-11D-A34T-01	a8f619f1-c92e-4e7b-99f9-d25984935cde	TCGA-KK-A8IJ-01A-11D-A34T-01	a8f619f1-c92e-4e7b-99f9-d25984935cde		TCGA-KK-A8IJ-01	TCGA-KK-A8IJ-01A-11D-A34V-05	TCGA-KK-A8IJ-01A-11R-A358-13		a8f619f1-c92e-4e7b-99f9-d25984935cde	29d6f6bd-32b6-4f00-b809-5e0f67b3dea7
TCGA-KK-A8IK-01	0	TCGA-KK-A8IK-01	1563	0	TCGA-KK-A8IK	1563	0	1563	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56		NO	Abnormal (not related to prostate cancer)	M0	T1c	-20594	-69	1759		-69			0	1563					YES	No Evidence of Extraprostatic Extension	NO				2014-8-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral			YES				NO	6		true	N0	T2b	TCGA-KK-A8IK.CBFE7CBE-890E-4749-9566-0CE41A93D69D.pdf			7		3		3		1		0		35		62		85	TUMOR FREE	4	Complete Remission/Response	No	0.0	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2008	Peripheral Zone			a8c4ad42-a4de-4771-a660-cb0096527643	TCGA-KK-A8IK-01	2d669bc4-fb4b-4db9-b6a3-f54dde950056		TCGA-KK-A8IK-01A-11D-A364-08	TCGA-KK-A8IK-01A-11D-A363-01	2d669bc4-fb4b-4db9-b6a3-f54dde950056	TCGA-KK-A8IK-01A-11D-A363-01	2d669bc4-fb4b-4db9-b6a3-f54dde950056		TCGA-KK-A8IK-01	TCGA-KK-A8IK-01A-11D-A365-05	TCGA-KK-A8IK-01A-11R-A36B-13		2d669bc4-fb4b-4db9-b6a3-f54dde950056	a8c4ad42-a4de-4771-a660-cb0096527643
TCGA-KK-A8IL-01	1	TCGA-KK-A8IL-01	628	1	TCGA-KK-A8IL			628	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65		NO		M0	T1c	-23849		1420	628	7	87		0			144			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2014-8-19	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral			YES					08	01	true	N1	T3b	TCGA-KK-A8IL.9F54DC02-35C0-4D0E-A1D8-63F820CF72C4.pdf			4		1		0		1		4		50		46		85		4		No	0.1		R1	Primary Tumor	01	5		Medical Record			NO	YES	KK	Apex|Middle|Base		Prostate		A	DECEASED	2009	Peripheral Zone			fa23d811-5685-43d5-ae56-dce93f0b218d	TCGA-KK-A8IL-01	0e2cfe4b-18fe-47f6-b357-a43f97a9b531		TCGA-KK-A8IL-01A-11D-A364-08	TCGA-KK-A8IL-01A-11D-A363-01	0e2cfe4b-18fe-47f6-b357-a43f97a9b531	TCGA-KK-A8IL-01A-11D-A363-01	0e2cfe4b-18fe-47f6-b357-a43f97a9b531		TCGA-KK-A8IL-01	TCGA-KK-A8IL-01A-11D-A365-05	TCGA-KK-A8IL-01A-11R-A36B-13		0e2cfe4b-18fe-47f6-b357-a43f97a9b531	fa23d811-5685-43d5-ae56-dce93f0b218d
TCGA-KK-A8IM-01	0	TCGA-KK-A8IM-01	1438	0	TCGA-KK-A8IM	1438	0	1438	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55		NO		M0	T2a	-20425		1466					0	1438		1438			NO		NO				2014-8-18	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral			YES				NO	5		true	N0	T2a	TCGA-KK-A8IM.C0D3148F-A371-4983-9E62-DA5446385173.pdf			12		2		0		2		8		50		42		75	TUMOR FREE	4	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone			7ad21b86-566f-4cfb-b090-837b8db20242	TCGA-KK-A8IM-01	6d249571-1535-4db3-9860-a56a02941200		TCGA-KK-A8IM-01A-11D-A364-08	TCGA-KK-A8IM-01A-11D-A363-01	6d249571-1535-4db3-9860-a56a02941200	TCGA-KK-A8IM-01A-11D-A363-01	6d249571-1535-4db3-9860-a56a02941200		TCGA-KK-A8IM-01	TCGA-KK-A8IM-01A-11D-A365-05	TCGA-KK-A8IM-01A-11R-A36B-13		6d249571-1535-4db3-9860-a56a02941200	7ad21b86-566f-4cfb-b090-837b8db20242
TCGA-M7-A71Y-01	0	TCGA-M7-A71Y-01	158	0	TCGA-M7-A71Y	158	0	158	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55		NO			T1c	-20357							0	158		158			NO		NO				2013-12-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral			NO				NO					T2c																			TUMOR FREE	3	Complete Remission/Response	No		NO	R0	Primary Tumor	01	4			NO		YES	NO	M7	Apex|Middle|Base		Prostate			LIVING	2013	Overlapping / Multiple Zones			bbe2319d-cb81-4c7e-beef-39731554927b	TCGA-M7-A71Y-01	a3f81069-d0a9-49af-bd22-24c6142241b6		TCGA-M7-A71Y-01A-22D-A32B-08	TCGA-M7-A71Y-01A-22D-A32A-01	a3f81069-d0a9-49af-bd22-24c6142241b6	TCGA-M7-A71Y-01A-22D-A32A-01	a3f81069-d0a9-49af-bd22-24c6142241b6		TCGA-M7-A71Y-01	TCGA-M7-A71Y-01A-22D-A32C-05			a3f81069-d0a9-49af-bd22-24c6142241b6	bbe2319d-cb81-4c7e-beef-39731554927b
TCGA-M7-A71Z-01	0	TCGA-M7-A71Z-01	643	0	TCGA-M7-A71Z	643	0	643	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-M7-A71Z-F68775	NO			T2a	-22785							0	643		209			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-12-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Right		NO	YES				NO	9	0		N0	T3a																			TUMOR FREE	4	Complete Remission/Response	No		NO	R0	Primary Tumor	01	3			NO		YES	NO	M7	Apex|Base		Prostate			LIVING	2013	Overlapping / Multiple Zones			ca3ecf9f-feca-4bce-aa45-7dccc1a8b2dd	TCGA-M7-A71Z-01	f64c8677-da87-4543-b53c-4de28d86fff1		TCGA-M7-A71Z-01A-12D-A32B-08	TCGA-M7-A71Z-01A-12D-A32A-01	f64c8677-da87-4543-b53c-4de28d86fff1	TCGA-M7-A71Z-01A-12D-A32A-01	f64c8677-da87-4543-b53c-4de28d86fff1		TCGA-M7-A71Z-01	TCGA-M7-A71Z-01A-12D-A32C-05	TCGA-M7-A71Z-01A-12R-A32J-13		f64c8677-da87-4543-b53c-4de28d86fff1	ca3ecf9f-feca-4bce-aa45-7dccc1a8b2dd
TCGA-M7-A720-01	0	TCGA-M7-A720-01	302	0	TCGA-M7-A720	302	0	302	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53		NO			T1c	-19642		190					0	302		302			NO		NO				2013-12-10	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral			NO				NO			false		T2c	TCGA-M7-A720.65D5D425-D41A-4E98-AA86-119F3BE1D3CE.pdf			40		20		0		20		10		30		60		60	TUMOR FREE	3	Complete Remission/Response	No		NO	R0	Primary Tumor	01	3			NO		YES	NO	M7	Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone			cd1a37d6-d266-4b7a-9b2a-81fbb9e945be	TCGA-M7-A720-01	0c18423b-7a7e-440d-96a7-ec3815aa411c		TCGA-M7-A720-01A-12D-A32B-08	TCGA-M7-A720-01A-12D-A32A-01	0c18423b-7a7e-440d-96a7-ec3815aa411c	TCGA-M7-A720-01A-12D-A32A-01	0c18423b-7a7e-440d-96a7-ec3815aa411c		TCGA-M7-A720-01	TCGA-M7-A720-01A-12D-A32C-05	TCGA-M7-A720-01A-12R-A360-13		0c18423b-7a7e-440d-96a7-ec3815aa411c	cd1a37d6-d266-4b7a-9b2a-81fbb9e945be
TCGA-M7-A721-01	0	TCGA-M7-A721-01	400	0	TCGA-M7-A721	400	0	400	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-M7-A721-F61812	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25585	-8				-8		0	400		162			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2014-7-7	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		YES	NO				NO					T2c																			TUMOR FREE	3	Complete Remission/Response	No		NO	R1	Primary Tumor	01	4			NO		YES	NO	M7	Apex|Middle|Base		Prostate			LIVING	2012	Overlapping / Multiple Zones			fa3b0951-6a36-468f-b541-e873be049c2a	TCGA-M7-A721-01	b490a174-95fa-4681-be76-e1690fb17131		TCGA-M7-A721-01A-12D-A32B-08	TCGA-M7-A721-01A-12D-A32A-01	b490a174-95fa-4681-be76-e1690fb17131	TCGA-M7-A721-01A-12D-A32A-01	b490a174-95fa-4681-be76-e1690fb17131		TCGA-M7-A721-01	TCGA-M7-A721-01A-12D-A32C-05	TCGA-M7-A721-01A-12R-A32J-13		b490a174-95fa-4681-be76-e1690fb17131	fa3b0951-6a36-468f-b541-e873be049c2a
TCGA-M7-A722-01	0	TCGA-M7-A722-01	822	0	TCGA-M7-A722			822	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-23880	3	577		3		559	0	822		808			YES	No Evidence of Extraprostatic Extension	NO				2014-3-27	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	190		NO	Bilateral			YES				YES	4	0	false	N0	T3a	TCGA-M7-A722.4D0EE4BC-69EC-45D2-8739-24E1FE1A526A.pdf			40		20		0		20		0		20		80		80	WITH TUMOR	4	Partial Remission/Response	No		NO	R1	Primary Tumor	01	4			NO	3	YES	NO	M7			Prostate		A	LIVING	2011	Overlapping / Multiple Zones			6a7813dc-59c9-4796-9264-b43536630523		ed257c43-c4be-42c9-8968-82bb9c0b8ce2		TCGA-M7-A722-01A-12D-A364-08	TCGA-M7-A722-01A-12D-A363-01	ed257c43-c4be-42c9-8968-82bb9c0b8ce2	TCGA-M7-A722-01A-12D-A363-01	ed257c43-c4be-42c9-8968-82bb9c0b8ce2			TCGA-M7-A722-01A-12D-A365-05	TCGA-M7-A722-01A-12R-A36B-13		ed257c43-c4be-42c9-8968-82bb9c0b8ce2	6a7813dc-59c9-4796-9264-b43536630523
TCGA-M7-A723-01	0	TCGA-M7-A723-01	763	0	TCGA-M7-A723	763	0	763	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			54	TCGA-M7-A723-F61813	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20064	8	442		11			0	763		62			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-7-7	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	150		NO	Bilateral		NO	YES				NO	17	1	false	N1	T3b	TCGA-M7-A723.8F42420C-A513-4A6A-A89F-B5C9303FBF59.pdf			40		20		0		20		5		25		70		70	TUMOR FREE	4	Complete Remission/Response	No	0.1	YES	R1	Primary Tumor	01	3			YES	5	YES	NO	M7	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			893a62e5-a0ac-4b21-b5f1-11bff1641478	TCGA-M7-A723-01	d139f13a-72aa-4bd8-bee2-c60c6bb016f2		TCGA-M7-A723-01A-12D-A32B-08	TCGA-M7-A723-01A-12D-A32A-01	d139f13a-72aa-4bd8-bee2-c60c6bb016f2	TCGA-M7-A723-01A-12D-A32A-01	d139f13a-72aa-4bd8-bee2-c60c6bb016f2		TCGA-M7-A723-01	TCGA-M7-A723-01A-12D-A32C-05	TCGA-M7-A723-01A-12R-A32J-13		d139f13a-72aa-4bd8-bee2-c60c6bb016f2	893a62e5-a0ac-4b21-b5f1-11bff1641478
TCGA-M7-A724-01	0	TCGA-M7-A724-01	483	0	TCGA-M7-A724			483	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		YES	Abnormal (not related to prostate cancer)	M0	T1c	-23595	11	351		35		161	0	483		483			YES	No Evidence of Extraprostatic Extension	NO				2013-12-10	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	160		NO	Right			YES				YES	7	0	false	N0	T3a	TCGA-M7-A724.AF3AE21A-2D5F-4769-B438-C42415A47330.pdf			40		20		2		20		0		8		90		90	WITH TUMOR	4	Progressive Disease	No		NO	R1	Primary Tumor	01	4			NO		YES	NO	M7	Apex|Base		Prostate		A	LIVING	2012	Peripheral Zone			0a86a6e2-781d-4b8e-84be-e0ee001a80a5	TCGA-M7-A724-01	8a3c4f20-3714-4dfd-9fb2-e7bae0c73432		TCGA-M7-A724-01A-12D-A32B-08	TCGA-M7-A724-01A-12D-A32A-01	8a3c4f20-3714-4dfd-9fb2-e7bae0c73432	TCGA-M7-A724-01A-12D-A32A-01	8a3c4f20-3714-4dfd-9fb2-e7bae0c73432		TCGA-M7-A724-01	TCGA-M7-A724-01A-12D-A32C-05	TCGA-M7-A724-01A-12R-A360-13		8a3c4f20-3714-4dfd-9fb2-e7bae0c73432	0a86a6e2-781d-4b8e-84be-e0ee001a80a5
TCGA-M7-A725-01	0	TCGA-M7-A725-01	573	0	TCGA-M7-A725	573	0	573	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56	TCGA-M7-A725-F61814	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-20474	16	240		16			0	573		96			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-7-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES				NO	11	0	false	N0	T3b	TCGA-M7-A725.5885079D-F3C7-44DB-9BA1-60DCA1C9919C.pdf			40		20		0		20		0		20		80		80	TUMOR FREE	4	Complete Remission/Response	No		NO	R1	Primary Tumor	01	3			NO	5	YES	NO	M7	Apex|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			fafe3e7d-585e-4745-9552-24de95353638	TCGA-M7-A725-01	2faac3f0-67e2-433a-ad56-c43e794c7fee		TCGA-M7-A725-01A-12D-A32B-08	TCGA-M7-A725-01A-12D-A32A-01	2faac3f0-67e2-433a-ad56-c43e794c7fee	TCGA-M7-A725-01A-12D-A32A-01	2faac3f0-67e2-433a-ad56-c43e794c7fee		TCGA-M7-A725-01	TCGA-M7-A725-01A-12D-A32C-05	TCGA-M7-A725-01A-12R-A32J-13		2faac3f0-67e2-433a-ad56-c43e794c7fee	fafe3e7d-585e-4745-9552-24de95353638
TCGA-MG-AAMC-01	0	TCGA-MG-AAMC-01	173	0	TCGA-MG-AAMC	173	0	173	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-MG-AAMC-F68686	NO		M0	T1c	-21846		278					0	173		54							Scheduled Follow-up Submission		2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO			YES					NO			true	N0	T3a	TCGA-MG-AAMC.CBC765C1-9191-4A40-979F-CF2434B10CAB.pdf			0		0		0		0		0		50		50		60	TUMOR FREE	4	Complete Remission/Response	No	.01	NO	R0	Primary Tumor	01	5			NO	3	NO	YES	MG			Prostate		A	LIVING	2013				52e02847-a6f5-4ed5-8a42-772ca16383fe	TCGA-MG-AAMC-01	1747f562-8e96-47e6-96ab-26f34d54b4bd			TCGA-MG-AAMC-01A-11D-A41J-01	1747f562-8e96-47e6-96ab-26f34d54b4bd	TCGA-MG-AAMC-01A-11D-A41J-01	1747f562-8e96-47e6-96ab-26f34d54b4bd		TCGA-MG-AAMC-01	TCGA-MG-AAMC-01A-11D-A41L-05	TCGA-MG-AAMC-01A-11R-A41R-13		1747f562-8e96-47e6-96ab-26f34d54b4bd	52e02847-a6f5-4ed5-8a42-772ca16383fe
TCGA-QU-A6IL-01	0	TCGA-QU-A6IL-01	97	0	TCGA-QU-A6IL	97	0	97	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-QU-A6IL-F66982	NO		M0	T2a	-23710		4048					0	97		91								Complete Remission/Response	2014-10-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy			NO	Bilateral		YES	YES				NO	4	0	true	N0	T2c	TCGA-QU-A6IL.EF13AC98-FA7C-442C-A6A4-A5E7ECB2596D.pdf			4		0		1		0		14		40		45		70	TUMOR FREE	3	Complete Remission/Response	No	0.2	NO	R0	Primary Tumor	01	4			NO		NO	YES	QU	Apex|Middle|Base		Prostate		A	LIVING	2002			TCGA-QU-A6IL-01A-11D-A31L-08	ac7f6c61-cad1-4be7-80d8-ce650618f60a	TCGA-QU-A6IL-01	788e9097-8705-44e4-a7c7-7fbb75f7f9e2	TCGA-QU-A6IL-01A-11D-A31L-08	TCGA-QU-A6IL-01A-11D-A31L-08	TCGA-QU-A6IL-01A-11D-A31K-01	788e9097-8705-44e4-a7c7-7fbb75f7f9e2	TCGA-QU-A6IL-01A-11D-A31K-01	788e9097-8705-44e4-a7c7-7fbb75f7f9e2		TCGA-QU-A6IL-01	TCGA-QU-A6IL-01A-11D-A31M-05	TCGA-QU-A6IL-01A-11R-A31R-13	TCGA-QU-A6IL-01A-11D-A31L-08	788e9097-8705-44e4-a7c7-7fbb75f7f9e2	ac7f6c61-cad1-4be7-80d8-ce650618f60a
TCGA-QU-A6IM-01	0	TCGA-QU-A6IM-01	1247	0	TCGA-QU-A6IM	1247	0	1247	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-QU-A6IM-F66983	NO	Equivocal	M0	T2b	-21792	35	3796		50	35		0	1247		896			YES	Equivocal	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Left		YES	YES				NO	2	0	true	N0	T2a	TCGA-QU-A6IM.6999B5F3-AC5C-4447-9590-548F103039C3.pdf			2		0		1		0		1		28		70		90	TUMOR FREE	3	Complete Remission/Response	Yes, History of Prior Malignancy	0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	QU	Apex|Middle		Prostate		A	LIVING	2003			TCGA-QU-A6IM-01A-11D-A31L-08	a3b5f038-d007-4ad7-bf4f-2e8299a3cd98	TCGA-QU-A6IM-01	9fe289f4-0f5f-4d72-935c-4fb3f44fa91a	TCGA-QU-A6IM-01A-11D-A31L-08	TCGA-QU-A6IM-01A-11D-A31L-08	TCGA-QU-A6IM-01A-11D-A31K-01	9fe289f4-0f5f-4d72-935c-4fb3f44fa91a	TCGA-QU-A6IM-01A-11D-A31K-01	9fe289f4-0f5f-4d72-935c-4fb3f44fa91a		TCGA-QU-A6IM-01	TCGA-QU-A6IM-01A-11D-A31M-05	TCGA-QU-A6IM-01A-11R-A31R-13	TCGA-QU-A6IM-01A-11D-A31L-08	9fe289f4-0f5f-4d72-935c-4fb3f44fa91a	a3b5f038-d007-4ad7-bf4f-2e8299a3cd98
TCGA-QU-A6IN-01	0	TCGA-QU-A6IN-01	4264	0	TCGA-QU-A6IN	4264	0	4264	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-QU-A6IN-F66984	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22286	21	3789			43		0	4264		3428			NO		YES		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES				NO	15	0	true	N0	T2c	TCGA-QU-A6IN.11063611-DCFF-427E-89A9-25961C79DF07.pdf			3		0		2		0		0		33		65		85	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	4			NO	5	NO	YES	QU	Apex|Middle|Base		Prostate		A	LIVING	2003			TCGA-QU-A6IN-01A-11D-A31L-08	79d30e38-fc4d-4dbf-b1cb-eda9ac16d82b	TCGA-QU-A6IN-01	3447e7c9-5d79-4cc0-9e00-6c8552565597	TCGA-QU-A6IN-01A-11D-A31L-08	TCGA-QU-A6IN-01A-11D-A31L-08	TCGA-QU-A6IN-01A-11D-A31K-01	3447e7c9-5d79-4cc0-9e00-6c8552565597	TCGA-QU-A6IN-01A-11D-A31K-01	3447e7c9-5d79-4cc0-9e00-6c8552565597		TCGA-QU-A6IN-01	TCGA-QU-A6IN-01A-11D-A31M-05	TCGA-QU-A6IN-01A-11R-A31R-13	TCGA-QU-A6IN-01A-11D-A31L-08	3447e7c9-5d79-4cc0-9e00-6c8552565597	79d30e38-fc4d-4dbf-b1cb-eda9ac16d82b
TCGA-QU-A6IO-01	0	TCGA-QU-A6IO-01	3716	0	TCGA-QU-A6IO	3716	0	3716	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-QU-A6IO-F66985	NO		M0	T1c	-19564		3614					0	3716		1436			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-31	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		NO	YES				NO	2	0	true	N0	T2c	TCGA-QU-A6IO.6450E3BE-55E8-4A6C-AA40-86B74F30458B.pdf			2		0		7		0		0		53		40		80	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R1	Primary Tumor	01	3			NO		NO	YES	QU	Apex|Middle|Base		Prostate		A	LIVING	2003			TCGA-QU-A6IO-01A-11D-A31L-08	680999ea-98b9-45da-9a5e-376822964d06	TCGA-QU-A6IO-01	f974f0e8-cbca-4d1f-a435-937f945ea3dc	TCGA-QU-A6IO-01A-11D-A31L-08	TCGA-QU-A6IO-01A-11D-A31L-08	TCGA-QU-A6IO-01A-11D-A31K-01	f974f0e8-cbca-4d1f-a435-937f945ea3dc	TCGA-QU-A6IO-01A-11D-A31K-01	f974f0e8-cbca-4d1f-a435-937f945ea3dc		TCGA-QU-A6IO-01	TCGA-QU-A6IO-01A-11D-A31M-05	TCGA-QU-A6IO-01A-11R-A31R-13	TCGA-QU-A6IO-01A-11D-A31L-08	f974f0e8-cbca-4d1f-a435-937f945ea3dc	680999ea-98b9-45da-9a5e-376822964d06
TCGA-QU-A6IP-01	0	TCGA-QU-A6IP-01	2620	0	TCGA-QU-A6IP	2620	0	2620	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-QU-A6IP-F66986	NO		M0	T2a	-24212		3118					0	2620		2620			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-31	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Right		YES	YES				NO	2	0	true	N0	T2a	TCGA-QU-A6IP.D1E73097-6F07-4B1E-8914-074FA037CB85.pdf			3		0		3		0		5		47		45		80	TUMOR FREE	3	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	3			NO		NO	YES	QU	Middle|Base		Prostate		A	LIVING	2004			TCGA-QU-A6IP-01A-11D-A31L-08	f39e84d9-5ac6-43e7-8ba0-364da28470e7	TCGA-QU-A6IP-01	8adec7c9-1c95-419b-9876-a3f9d068d392	TCGA-QU-A6IP-01A-11D-A31L-08	TCGA-QU-A6IP-01A-11D-A31L-08	TCGA-QU-A6IP-01A-11D-A31K-01	8adec7c9-1c95-419b-9876-a3f9d068d392	TCGA-QU-A6IP-01A-11D-A31K-01	8adec7c9-1c95-419b-9876-a3f9d068d392		TCGA-QU-A6IP-01	TCGA-QU-A6IP-01A-11D-A31M-05	TCGA-QU-A6IP-01A-11R-A31R-13	TCGA-QU-A6IP-01A-11D-A31L-08	8adec7c9-1c95-419b-9876-a3f9d068d392	f39e84d9-5ac6-43e7-8ba0-364da28470e7
TCGA-SU-A7E7-01	0	TCGA-SU-A7E7-01	551	0	TCGA-SU-A7E7	551	0	551	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	60	TCGA-SU-A7E7-F64938	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-22185	6	165		-10			0	551		426			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-16	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	300		NO	Right		NO	YES				NO	9	0	true	N0	T2b	TCGA-SU-A7E7.120AA6E7-735D-442E-99AA-4EFE93C365F6.pdf			0		0		0		0		30		20		50		60	TUMOR FREE	5	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	3			NO		YES	NO	SU	Base		Prostate		A	LIVING	2013	Peripheral Zone			52a24874-f2a9-49af-9f06-16415ea178c7	TCGA-SU-A7E7-01	041bbea8-d1fe-4f96-be85-67a95e651044		TCGA-SU-A7E7-01A-22D-A33T-08	TCGA-SU-A7E7-01A-22D-A33S-01	041bbea8-d1fe-4f96-be85-67a95e651044	TCGA-SU-A7E7-01A-22D-A33S-01	041bbea8-d1fe-4f96-be85-67a95e651044		TCGA-SU-A7E7-01	TCGA-SU-A7E7-01A-22D-A33U-05	TCGA-SU-A7E7-01A-22R-A343-13		041bbea8-d1fe-4f96-be85-67a95e651044	52a24874-f2a9-49af-9f06-16415ea178c7
TCGA-TK-A8OK-01		TCGA-TK-A8OK-01			TCGA-TK-A8OK				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											202																											620		NO											false			TCGA-TK-A8OK.887947BA-A888-40C4-8582-EE89E678EC04.pdf			3		0		0		0		25		0		75		60								Primary Tumor	01													A						139c93d9-a9d0-4aa5-ac1b-837c59d65db3	TCGA-TK-A8OK-01	244e1006-d5b9-46cb-8478-8a4591fdb6be		TCGA-TK-A8OK-01A-22D-A364-08	TCGA-TK-A8OK-01A-22D-A363-01	244e1006-d5b9-46cb-8478-8a4591fdb6be	TCGA-TK-A8OK-01A-22D-A363-01	244e1006-d5b9-46cb-8478-8a4591fdb6be		TCGA-TK-A8OK-01	TCGA-TK-A8OK-01A-22D-A365-05	TCGA-TK-A8OK-01A-22R-A36B-13		244e1006-d5b9-46cb-8478-8a4591fdb6be	139c93d9-a9d0-4aa5-ac1b-837c59d65db3
TCGA-TP-A8TT-01	0	TCGA-TP-A8TT-01	362	0	TCGA-TP-A8TT	362	0	362	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23476	23	265		15			0	362		237			YES	No Evidence of Extraprostatic Extension	NO				2014-3-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	440		NO	Left			YES				NO	11	0	true	N0	T3a	TCGA-TP-A8TT.35E5E09D-8872-4BCC-99DC-876A3CCF9761.pdf			0		0		0		0		5		40		55		70		4	Partial Remission/Response	No	0.024	YES	R0	Primary Tumor	01	3			NO		YES	NO	TP	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone			85200111-e4f4-43fe-bd83-acf2cb93e2ca	TCGA-TP-A8TT-01	f5204ae5-1d85-41ec-b9c2-c48c310c5710			TCGA-TP-A8TT-01A-12D-A41J-01	f5204ae5-1d85-41ec-b9c2-c48c310c5710	TCGA-TP-A8TT-01A-12D-A41J-01	f5204ae5-1d85-41ec-b9c2-c48c310c5710		TCGA-TP-A8TT-01	TCGA-TP-A8TT-01A-12D-A41L-05	TCGA-TP-A8TT-01A-12R-A41R-13		f5204ae5-1d85-41ec-b9c2-c48c310c5710	85200111-e4f4-43fe-bd83-acf2cb93e2ca
TCGA-TP-A8TV-01	0	TCGA-TP-A8TV-01	405	0	TCGA-TP-A8TV	405	0	405	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-TP-A8TV-F64432	NO		M0	T1c	-22872							0	405		249			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	4	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	0.019	YES	R1	Primary Tumor	01	3			NO	5	YES	NO	TP	Apex|Middle|Base		Prostate			LIVING	2013	Overlapping / Multiple Zones			d273d3a1-2be1-4ed5-8d7e-6af7114d8b30	TCGA-TP-A8TV-01	ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f			TCGA-TP-A8TV-01A-11D-A41J-01	ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f	TCGA-TP-A8TV-01A-11D-A41J-01	ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f		TCGA-TP-A8TV-01	TCGA-TP-A8TV-01A-11D-A41L-05	TCGA-TP-A8TV-01A-11R-A41R-13		ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f	d273d3a1-2be1-4ed5-8d7e-6af7114d8b30
TCGA-V1-A8MF-01	0	TCGA-V1-A8MF-01	1254	0	TCGA-V1-A8MF	1254	0	1254	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-V1-A8MF-F69431	NO		M0	T2c	-24090								1254		1218			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES				NO	8	0	true	N0	T3a	TCGA-V1-A8MF.C2A32E46-BB93-43E6-BF3A-995745161434.pdf			0		0		0		0		10		5		85		90		3	Complete Remission/Response	No	0.14	NO	R1	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			5b8f9a27-8a46-473f-b20b-62fdb8955cfa	TCGA-V1-A8MF-01	c84acacb-d7ab-481e-8462-94693fdf5980		TCGA-V1-A8MF-01A-11D-A364-08	TCGA-V1-A8MF-01A-11D-A363-01	c84acacb-d7ab-481e-8462-94693fdf5980	TCGA-V1-A8MF-01A-11D-A363-01	c84acacb-d7ab-481e-8462-94693fdf5980		TCGA-V1-A8MF-01	TCGA-V1-A8MF-01A-11D-A365-05	TCGA-V1-A8MF-01A-11R-A36B-13		c84acacb-d7ab-481e-8462-94693fdf5980	5b8f9a27-8a46-473f-b20b-62fdb8955cfa
TCGA-V1-A8MG-01	0	TCGA-V1-A8MG-01	857	0	TCGA-V1-A8MG	857	0	857	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			53	TCGA-V1-A8MG-F69432	NO		M0	T2c	-19710								857		583			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral		NO	NO				NO			true		T3b	TCGA-V1-A8MG.6E6ED2C5-9591-41BD-A910-F5E1A8637159.pdf			0		0		0		0		30		10		60		70		3	Complete Remission/Response	No	0.03	NO	R1	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			0438eeab-14dc-4974-b729-69a96ba2f838	TCGA-V1-A8MG-01	b1c64c55-b558-44b3-b617-a84d6b493d82		TCGA-V1-A8MG-01A-11D-A364-08	TCGA-V1-A8MG-01A-11D-A363-01	b1c64c55-b558-44b3-b617-a84d6b493d82	TCGA-V1-A8MG-01A-11D-A363-01	b1c64c55-b558-44b3-b617-a84d6b493d82		TCGA-V1-A8MG-01	TCGA-V1-A8MG-01A-11D-A365-05	TCGA-V1-A8MG-01A-11R-A36B-13		b1c64c55-b558-44b3-b617-a84d6b493d82	0438eeab-14dc-4974-b729-69a96ba2f838
TCGA-V1-A8MJ-01	0	TCGA-V1-A8MJ-01	1230	0	TCGA-V1-A8MJ			1230	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	YES	58	TCGA-V1-A8MJ-F69461	NO		M0	T2a	-21535						428		1230		1230			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	16	1	true	N1	T3a	TCGA-V1-A8MJ.5BF9CF4D-B724-4FFD-A336-ECE60FC80E0D.pdf			0		0		0		0		20		30		50		60		3	Progressive Disease	No	0.015	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			d466cb81-f936-45d5-b70c-d18a0cc2b15a	TCGA-V1-A8MJ-01	98662e95-24f7-41c7-a3f4-50ce203fa9a4		TCGA-V1-A8MJ-01A-11D-A364-08	TCGA-V1-A8MJ-01A-11D-A363-01	98662e95-24f7-41c7-a3f4-50ce203fa9a4	TCGA-V1-A8MJ-01A-11D-A363-01	98662e95-24f7-41c7-a3f4-50ce203fa9a4		TCGA-V1-A8MJ-01	TCGA-V1-A8MJ-01A-11D-A365-05	TCGA-V1-A8MJ-01A-11R-A36B-13		98662e95-24f7-41c7-a3f4-50ce203fa9a4	d466cb81-f936-45d5-b70c-d18a0cc2b15a
TCGA-V1-A8MK-01	0	TCGA-V1-A8MK-01	508	0	TCGA-V1-A8MK	508	0	508	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			41	TCGA-V1-A8MK-F69460	YES		M0	T2a	-15330								508		-1			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	30		NO	Bilateral		NO	NO				NO			true	N0	T2c	TCGA-V1-A8MK.B8FB60DC-69C5-421A-90B0-875AE69E27D5.pdf			0		0		0		0		20		30		50		60		3	Complete Remission/Response	No	0.83	NO	R0	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			109aa6f4-f677-4f01-9c02-bf68fad73518	TCGA-V1-A8MK-01	c7a98315-43bb-4917-90c9-93f9caf47fdc		TCGA-V1-A8MK-01A-11D-A364-08	TCGA-V1-A8MK-01A-11D-A363-01	c7a98315-43bb-4917-90c9-93f9caf47fdc	TCGA-V1-A8MK-01A-11D-A363-01	c7a98315-43bb-4917-90c9-93f9caf47fdc		TCGA-V1-A8MK-01	TCGA-V1-A8MK-01A-11D-A365-05	TCGA-V1-A8MK-01A-11R-A36B-13		c7a98315-43bb-4917-90c9-93f9caf47fdc	109aa6f4-f677-4f01-9c02-bf68fad73518
TCGA-V1-A8ML-01	0	TCGA-V1-A8ML-01	448	0	TCGA-V1-A8ML	448	0	448	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-V1-A8ML-F69415	NO		M0	T2b	-23360								448		448			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	10		NO	Bilateral		NO	YES				NO	12	0	true	N0	T2c	TCGA-V1-A8ML.4C4405A3-FC07-4155-8C5A-2693E34F347B.pdf			40		20		0		20		5		25		70		70		3	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			93a5bfe7-79b2-4a82-be18-b6b5dd3989e4	TCGA-V1-A8ML-01	4866c074-094a-4432-8d23-825fd698eeda		TCGA-V1-A8ML-01A-11D-A377-08	TCGA-V1-A8ML-01A-11D-A376-01	4866c074-094a-4432-8d23-825fd698eeda	TCGA-V1-A8ML-01A-11D-A376-01	4866c074-094a-4432-8d23-825fd698eeda		TCGA-V1-A8ML-01	TCGA-V1-A8ML-01A-11D-A378-05	TCGA-V1-A8ML-01A-11R-A37H-13		4866c074-094a-4432-8d23-825fd698eeda	93a5bfe7-79b2-4a82-be18-b6b5dd3989e4
TCGA-V1-A8MM-01	0	TCGA-V1-A8MM-01	1195	0	TCGA-V1-A8MM			1195	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	YES	60	TCGA-V1-A8MM-F69416	YES		M0	T2b	-22265						990		1195		990			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	10	0	true	N0	T3a	TCGA-V1-A8MM.2FBA596B-858D-4043-BDCF-CCE582A74D67.pdf			0		0		0		0		10		10		80		85		4	Progressive Disease	No	0.37	NO	R0	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			bca3d5af-7305-45eb-aee0-b9730f6c2cbf	TCGA-V1-A8MM-01	0386cc4d-0318-4293-a22e-869c3b34fa63		TCGA-V1-A8MM-01A-11D-A377-08	TCGA-V1-A8MM-01A-11D-A376-01	0386cc4d-0318-4293-a22e-869c3b34fa63	TCGA-V1-A8MM-01A-11D-A376-01	0386cc4d-0318-4293-a22e-869c3b34fa63		TCGA-V1-A8MM-01	TCGA-V1-A8MM-01A-11D-A378-05	TCGA-V1-A8MM-01A-11R-A37H-13		0386cc4d-0318-4293-a22e-869c3b34fa63	bca3d5af-7305-45eb-aee0-b9730f6c2cbf
TCGA-V1-A8MU-01	0	TCGA-V1-A8MU-01	1617	0	TCGA-V1-A8MU			1617	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	YES	56	TCGA-V1-A8MU-F69444	NO		M0	T2b	-20805				87		192		1617		1384			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	15	1	true	N1	T3a	TCGA-V1-A8MU.8E072738-2D8E-4254-B1DE-A8008C614B7F.pdf			0		0		0		0		30		10		60		70		3	Progressive Disease	No	0.015	NO	R1	Primary Tumor	01	4			YES		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			affba666-03ff-437b-a406-cabb633fdfd8	TCGA-V1-A8MU-01	823142ae-3165-44fd-bdd8-b54acef6897f		TCGA-V1-A8MU-01A-11D-A377-08	TCGA-V1-A8MU-01A-11D-A376-01	823142ae-3165-44fd-bdd8-b54acef6897f	TCGA-V1-A8MU-01A-11D-A376-01	823142ae-3165-44fd-bdd8-b54acef6897f		TCGA-V1-A8MU-01	TCGA-V1-A8MU-01A-11D-A378-05	TCGA-V1-A8MU-01A-11R-A37H-13		823142ae-3165-44fd-bdd8-b54acef6897f	affba666-03ff-437b-a406-cabb633fdfd8
TCGA-V1-A8WL-01	0	TCGA-V1-A8WL-01	1584	0	TCGA-V1-A8WL	1584	0	1584	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-V1-A8WL-F69417	NO		M0	T1c	-23725								1584		1175			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral		NO	YES				NO	4	0	true	N0	T3a	TCGA-V1-A8WL.6E301400-1200-40F7-8249-AD310C44A212.pdf			3		1		0		1		8		17		75		75		3	Complete Remission/Response	No	0.015	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			8f9fc812-7293-414f-a155-06ab267d3fcb	TCGA-V1-A8WL-01	bd8e46c1-5b67-407e-a6fb-67017488a923		TCGA-V1-A8WL-01A-11D-A377-08	TCGA-V1-A8WL-01A-11D-A376-01	bd8e46c1-5b67-407e-a6fb-67017488a923	TCGA-V1-A8WL-01A-11D-A376-01	bd8e46c1-5b67-407e-a6fb-67017488a923		TCGA-V1-A8WL-01	TCGA-V1-A8WL-01A-11D-A378-05	TCGA-V1-A8WL-01A-11R-A37H-13		bd8e46c1-5b67-407e-a6fb-67017488a923	8f9fc812-7293-414f-a155-06ab267d3fcb
TCGA-V1-A8WN-01	0	TCGA-V1-A8WN-01	924	0	TCGA-V1-A8WN	924	0	924	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			47	TCGA-V1-A8WN-F69450	NO		M0	T2a	-17520								924		463			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	30		NO	Bilateral		NO	NO				NO			true		T2c	TCGA-V1-A8WN.F25C1C00-CDFE-4ABD-A920-857AFEA691A5.pdf			3		1		0		1		5		20		75		75		3	Complete Remission/Response	No	0.02	NO	R0	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			4a3210e2-b0ab-4171-9d0b-646eb6a44423	TCGA-V1-A8WN-01	15b039c0-f334-4221-b438-c859bb46cc26		TCGA-V1-A8WN-01A-11D-A377-08	TCGA-V1-A8WN-01A-11D-A376-01	15b039c0-f334-4221-b438-c859bb46cc26	TCGA-V1-A8WN-01A-11D-A376-01	15b039c0-f334-4221-b438-c859bb46cc26		TCGA-V1-A8WN-01	TCGA-V1-A8WN-01A-11D-A378-05	TCGA-V1-A8WN-01A-11R-A37H-13		15b039c0-f334-4221-b438-c859bb46cc26	4a3210e2-b0ab-4171-9d0b-646eb6a44423
TCGA-V1-A8WS-01	0	TCGA-V1-A8WS-01	474	0	TCGA-V1-A8WS			474	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	YES	56	TCGA-V1-A8WS-F69434	NO		M0	T1c	-20805								474		474			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	30		NO	Bilateral		NO	NO		Biochemical evidence of disease		YES			true		T3b	TCGA-V1-A8WS.0BD9565E-DBBB-428D-BF6D-2B31F0E5DDC5.pdf			0		0		0		0		5		10		85		70		3	Progressive Disease	No	0.09	NO	R0	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			52aa572b-06c8-46d9-9994-55a12fb114a7	TCGA-V1-A8WS-01	0514988e-85d3-4ce1-a860-39bd5ac19660		TCGA-V1-A8WS-01A-11D-A377-08	TCGA-V1-A8WS-01A-11D-A376-01	0514988e-85d3-4ce1-a860-39bd5ac19660	TCGA-V1-A8WS-01A-11D-A376-01	0514988e-85d3-4ce1-a860-39bd5ac19660		TCGA-V1-A8WS-01	TCGA-V1-A8WS-01A-11D-A378-05	TCGA-V1-A8WS-01A-11R-A37H-13		0514988e-85d3-4ce1-a860-39bd5ac19660	52aa572b-06c8-46d9-9994-55a12fb114a7
TCGA-V1-A8WV-01	0	TCGA-V1-A8WV-01	686	0	TCGA-V1-A8WV	686	0	686	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			52	TCGA-V1-A8WV-F69419	NO		M0	T2a	-19345				95				686		686			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral		NO	YES				NO	10	1	true	N1	T3b	TCGA-V1-A8WV.AD602A56-B2CB-49A0-A994-7927600C952B.pdf			0		0		0		0		0		0		100		85		4	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	5			YES		NO	YES	V1	Middle		Prostate		A	LIVING		Peripheral Zone			6e81de8d-3f4d-4653-8e9e-be22f76dcf8f	TCGA-V1-A8WV-01	bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b		TCGA-V1-A8WV-01A-11D-A377-08	TCGA-V1-A8WV-01A-11D-A376-01	bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b	TCGA-V1-A8WV-01A-11D-A376-01	bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b		TCGA-V1-A8WV-01	TCGA-V1-A8WV-01A-11D-A378-05	TCGA-V1-A8WV-01A-11R-A37H-13		bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b	6e81de8d-3f4d-4653-8e9e-be22f76dcf8f
TCGA-V1-A8WW-01		TCGA-V1-A8WW-01			TCGA-V1-A8WW				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																						50		NO											true			TCGA-V1-A8WW.36FBC30B-6566-4C5F-BE51-D267B4F856B3.pdf			0		0		15		0		0		0		85		70								Primary Tumor	01													A						eab08019-c2c8-4cb5-8016-6288542841e4	TCGA-V1-A8WW-01	213f0f94-d682-462b-bbb3-bd8ce9f0ffff		TCGA-V1-A8WW-01A-11D-A377-08	TCGA-V1-A8WW-01A-11D-A376-01	213f0f94-d682-462b-bbb3-bd8ce9f0ffff	TCGA-V1-A8WW-01A-11D-A376-01	213f0f94-d682-462b-bbb3-bd8ce9f0ffff		TCGA-V1-A8WW-01	TCGA-V1-A8WW-01A-11D-A378-05	TCGA-V1-A8WW-01A-11R-A37H-13		213f0f94-d682-462b-bbb3-bd8ce9f0ffff	eab08019-c2c8-4cb5-8016-6288542841e4
TCGA-V1-A8X3-01	0	TCGA-V1-A8X3-01	202	0	TCGA-V1-A8X3	202	0	202	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51	TCGA-V1-A8X3-F69469	NO		M0	T1c	-18980								202		202			NO		NO		Scheduled Follow-up Submission		2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	18	0	true	N0	T2c	TCGA-V1-A8X3.267C0EAB-ECC4-44BC-89C9-8C54F3B22A6E.pdf			0		0		0		0		0		0		100		75		3	Complete Remission/Response	No	0.03	NO	R1	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			252551c5-8980-4183-9f38-38cbf7d5ab33	TCGA-V1-A8X3-01	560a04b3-0738-4a27-ad0f-c6a5a091c869		TCGA-V1-A8X3-01A-11D-A377-08	TCGA-V1-A8X3-01A-11D-A376-01	560a04b3-0738-4a27-ad0f-c6a5a091c869	TCGA-V1-A8X3-01A-11D-A376-01	560a04b3-0738-4a27-ad0f-c6a5a091c869		TCGA-V1-A8X3-01	TCGA-V1-A8X3-01A-11D-A378-05	TCGA-V1-A8X3-01A-11R-A37H-13		560a04b3-0738-4a27-ad0f-c6a5a091c869	252551c5-8980-4183-9f38-38cbf7d5ab33
TCGA-V1-A9O5-01	0	TCGA-V1-A9O5-01	1776	0	TCGA-V1-A9O5			1776	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		YES		M0	T2b	-23725				25		124		1776		1776			YES	No Evidence of Extraprostatic Extension	NO				2014-7-23	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	230		NO	Bilateral			YES				YES	20	6	true	N1	T4	TCGA-V1-A9O5.4C94E826-144A-4879-99A3-E3B1655D4066.pdf			0		0		0		0		0		20		80		90		5	Complete Remission/Response	No	3.26	YES	R1	Primary Tumor	01	4			YES		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			50ac91d6-8a21-41a6-a1df-f1f03aa5def6	TCGA-V1-A9O5-01	ac245ce7-dd49-4b6e-8692-6cf440e99b89			TCGA-V1-A9O5-01A-11D-A41J-01	ac245ce7-dd49-4b6e-8692-6cf440e99b89	TCGA-V1-A9O5-01A-11D-A41J-01	ac245ce7-dd49-4b6e-8692-6cf440e99b89		TCGA-V1-A9O5-01	TCGA-V1-A9O5-01A-11D-A41L-05	TCGA-V1-A9O5-01A-11R-A41R-13		ac245ce7-dd49-4b6e-8692-6cf440e99b89	50ac91d6-8a21-41a6-a1df-f1f03aa5def6
TCGA-V1-A9O5-06	0	TCGA-V1-A9O5-06	1776	0	TCGA-V1-A9O5			1776	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		YES		M0	T2b	-23725				25		124		1776		1776			YES	No Evidence of Extraprostatic Extension	NO				2014-7-23	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	100		NO	Bilateral			YES				YES	20	6	true	N1	T4	TCGA-V1-A9O5.DB538FAF-7536-4EF3-A92B-29C64C62B539.pdf			22		1		4		1		0		48		48		70		5	Complete Remission/Response	No	3.26	YES	R1	Metastatic	06	4			YES		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			cc49df19-e991-46bb-a9e8-a57a480ecdbb		b23ad2ad-d6d2-4e5a-96d7-424cd506a180				b23ad2ad-d6d2-4e5a-96d7-424cd506a180		b23ad2ad-d6d2-4e5a-96d7-424cd506a180			TCGA-V1-A9O5-06A-11D-A41L-05	TCGA-V1-A9O5-06A-11R-A41R-13		b23ad2ad-d6d2-4e5a-96d7-424cd506a180	cc49df19-e991-46bb-a9e8-a57a480ecdbb
TCGA-V1-A9O7-01	0	TCGA-V1-A9O7-01	2425	0	TCGA-V1-A9O7			2425	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60		YES		M0	T2b	-22265					45	921		2425		2425			NO		YES				2014-7-23	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	710		NO	Bilateral			YES				YES	15	0	true	N0	T3a	TCGA-V1-A9O7.0D2327CA-DE0A-4B74-BD53-6370ED222B96.pdf			5		0		1		0		3		46		50		90		5	Complete Remission/Response	No	9.69	YES	R1	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			cbf77fb5-2dd6-4cab-97aa-8c3ee6f1b364	TCGA-V1-A9O7-01	66e392a4-c4fb-43a7-bba1-6a940967158f			TCGA-V1-A9O7-01A-21D-A41J-01	66e392a4-c4fb-43a7-bba1-6a940967158f	TCGA-V1-A9O7-01A-21D-A41J-01	66e392a4-c4fb-43a7-bba1-6a940967158f		TCGA-V1-A9O7-01	TCGA-V1-A9O7-01A-21D-A41L-05	TCGA-V1-A9O7-01A-21R-A41R-13		66e392a4-c4fb-43a7-bba1-6a940967158f	cbf77fb5-2dd6-4cab-97aa-8c3ee6f1b364
TCGA-V1-A9O9-01		TCGA-V1-A9O9-01			TCGA-V1-A9O9				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																																																															Primary Tumor	01																			c96b2ecb-0d45-4a11-b51d-8b439d4488bd	TCGA-V1-A9O9-01	dda7df91-6e67-46d3-bfdc-d5bde725f44c			TCGA-V1-A9O9-01A-11D-A41J-01	dda7df91-6e67-46d3-bfdc-d5bde725f44c	TCGA-V1-A9O9-01A-11D-A41J-01	dda7df91-6e67-46d3-bfdc-d5bde725f44c		TCGA-V1-A9O9-01	TCGA-V1-A9O9-01A-11D-A41L-05	TCGA-V1-A9O9-01A-11R-A41R-13		dda7df91-6e67-46d3-bfdc-d5bde725f44c	c96b2ecb-0d45-4a11-b51d-8b439d4488bd
TCGA-V1-A9OA-01	0	TCGA-V1-A9OA-01	636	0	TCGA-V1-A9OA	636	0	636	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-V1-A9OA-F69441	NO		M0	T2c	-22630					27			636		510			NO		YES		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	10		NO	Bilateral		NO	YES				NO	8	1	true	N1	T3b	TCGA-V1-A9OA.F8BC91E0-7D98-40B2-B99E-570564C3ECD2.pdf			0		0		0		0		0		0		100		90		4	Complete Remission/Response	No	0.01	YES	R0	Primary Tumor	01	5			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			92c97e3f-8f7f-4e2f-a22a-6ac427cfb3e4	TCGA-V1-A9OA-01	434c7cb8-d131-46e0-a068-5345b5a77fff			TCGA-V1-A9OA-01A-11D-A41J-01	434c7cb8-d131-46e0-a068-5345b5a77fff	TCGA-V1-A9OA-01A-11D-A41J-01	434c7cb8-d131-46e0-a068-5345b5a77fff		TCGA-V1-A9OA-01	TCGA-V1-A9OA-01A-11D-A41L-05	TCGA-V1-A9OA-01A-11R-A41R-13		434c7cb8-d131-46e0-a068-5345b5a77fff	92c97e3f-8f7f-4e2f-a22a-6ac427cfb3e4
TCGA-V1-A9OF-01	0	TCGA-V1-A9OF-01	1184	0	TCGA-V1-A9OF	1184	0	1184	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			49	TCGA-V1-A9OF-F69400	NO		M0	T1c	-18250								1184		1184			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO					T2c																				3	Complete Remission/Response	No	0.01	NO	R1	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate			LIVING		Peripheral Zone			cf65e35f-569b-45fa-bb11-9d20a36900f2	TCGA-V1-A9OF-01	e6f9cecd-b130-441d-9073-cf1df303e2ab			TCGA-V1-A9OF-01A-11D-A41J-01	e6f9cecd-b130-441d-9073-cf1df303e2ab	TCGA-V1-A9OF-01A-11D-A41J-01	e6f9cecd-b130-441d-9073-cf1df303e2ab		TCGA-V1-A9OF-01	TCGA-V1-A9OF-01A-11D-A41L-05	TCGA-V1-A9OF-01A-11R-A41R-13		e6f9cecd-b130-441d-9073-cf1df303e2ab	cf65e35f-569b-45fa-bb11-9d20a36900f2
TCGA-V1-A9OH-01	0	TCGA-V1-A9OH-01	1253	0	TCGA-V1-A9OH	1253	0	1253	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63		NO		M0	T1c	-23360								1253		1253			NO		NO				2014-7-23	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Right			NO				NO			true		T2b	TCGA-V1-A9OH.8B30DB97-6EB7-42EF-8A12-C9B1F1B5251B.pdf			2		0		0		0		10		20		70		70		4		No	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			f8a7d381-4374-48fe-a748-55c2280a49b4	TCGA-V1-A9OH-01	4d83df74-09cf-4590-a15a-c5c583cbb639			TCGA-V1-A9OH-01A-11D-A41J-01	4d83df74-09cf-4590-a15a-c5c583cbb639	TCGA-V1-A9OH-01A-11D-A41J-01	4d83df74-09cf-4590-a15a-c5c583cbb639		TCGA-V1-A9OH-01	TCGA-V1-A9OH-01A-11D-A41L-05	TCGA-V1-A9OH-01A-11R-A41R-13		4d83df74-09cf-4590-a15a-c5c583cbb639	f8a7d381-4374-48fe-a748-55c2280a49b4
TCGA-V1-A9OL-01	0	TCGA-V1-A9OL-01	589	0	TCGA-V1-A9OL			589	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65		YES		M0	T2	-24090				19		131		589		559			YES	No Evidence of Extraprostatic Extension	NO				2014-7-11	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	190		NO	Bilateral			YES				YES	9	0	true	N0	T3b	TCGA-V1-A9OL.E63E681C-8E25-4C1E-8C37-9EAA2697088B.pdf			40		20		0		20		0		30		70		70		5	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			4b46c07b-91f4-4b82-b9ef-df62b49e0283	TCGA-V1-A9OL-01	e312e528-bed2-4067-a562-1c27dd93d540			TCGA-V1-A9OL-01A-11D-A41J-01	e312e528-bed2-4067-a562-1c27dd93d540	TCGA-V1-A9OL-01A-11D-A41J-01	e312e528-bed2-4067-a562-1c27dd93d540		TCGA-V1-A9OL-01	TCGA-V1-A9OL-01A-11D-A41L-05	TCGA-V1-A9OL-01A-11R-A41R-13		e312e528-bed2-4067-a562-1c27dd93d540	4b46c07b-91f4-4b82-b9ef-df62b49e0283
TCGA-V1-A9OQ-01	0	TCGA-V1-A9OQ-01	371	0	TCGA-V1-A9OQ	371	0	371	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-V1-A9OQ-F69411	NO		M0	T1c	-24820								371		371			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral		NO	NO				NO	0		true		T3a	TCGA-V1-A9OQ.8EA3FE2C-7C76-41F8-AEC4-A89C5DD2FF7B.pdf			40		20		0		20		0		20		80		80		3	Complete Remission/Response	No	0.01	NO	R1	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			694c6006-8326-45a2-bc7a-51e327a62a95	TCGA-V1-A9OQ-01	46993591-8ffa-4e54-ba85-d013a7c190c9			TCGA-V1-A9OQ-01A-11D-A41J-01	46993591-8ffa-4e54-ba85-d013a7c190c9	TCGA-V1-A9OQ-01A-11D-A41J-01	46993591-8ffa-4e54-ba85-d013a7c190c9		TCGA-V1-A9OQ-01	TCGA-V1-A9OQ-01A-11D-A41L-05	TCGA-V1-A9OQ-01A-11R-A41R-13		46993591-8ffa-4e54-ba85-d013a7c190c9	694c6006-8326-45a2-bc7a-51e327a62a95
TCGA-V1-A9OT-01	0	TCGA-V1-A9OT-01	476	0	TCGA-V1-A9OT			476	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	NO	61	TCGA-V1-A9OT-F69439	YES		M0	T1c	-22630						292		476		349			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		NO	NO		Biochemical evidence of disease		YES			true		T2c	TCGA-V1-A9OT.40B928AE-1977-4077-9F44-282E85273EF2.pdf			0		0		0		0		20		30		50		60		3	Progressive Disease	No	0.01	NO	R1	Primary Tumor	01	3			NO		NO	YES	V1	Middle		Prostate		A	LIVING		Peripheral Zone			9f54ab85-2e2f-4397-ac02-d7d3bfe379e7	TCGA-V1-A9OT-01	d2f9c79e-127a-4e53-869d-3ff6b2baf0aa			TCGA-V1-A9OT-01A-11D-A41J-01	d2f9c79e-127a-4e53-869d-3ff6b2baf0aa	TCGA-V1-A9OT-01A-11D-A41J-01	d2f9c79e-127a-4e53-869d-3ff6b2baf0aa		TCGA-V1-A9OT-01	TCGA-V1-A9OT-01A-11D-A41L-05	TCGA-V1-A9OT-01A-11R-A41R-13		d2f9c79e-127a-4e53-869d-3ff6b2baf0aa	9f54ab85-2e2f-4397-ac02-d7d3bfe379e7
TCGA-V1-A9OX-01	0	TCGA-V1-A9OX-01	256	0	TCGA-V1-A9OX	256	0	256	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56	TCGA-V1-A9OX-F69435	NO		M0		-20805								256		256			NO		NO		Scheduled Follow-up Submission		2015-1-9	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	8	0		N0	T2c																				3	Complete Remission/Response	No	0.04	NO	R0	Primary Tumor	01	5			NO		NO	YES	V1	Apex		Prostate			LIVING		Peripheral Zone			f7b55d2b-9c90-4cb8-8839-2615290bd861	TCGA-V1-A9OX-01	af080299-4f21-42bb-8477-8d7414cdaf9f			TCGA-V1-A9OX-01A-11D-A41J-01	af080299-4f21-42bb-8477-8d7414cdaf9f	TCGA-V1-A9OX-01A-11D-A41J-01	af080299-4f21-42bb-8477-8d7414cdaf9f		TCGA-V1-A9OX-01	TCGA-V1-A9OX-01A-11D-A41L-05	TCGA-V1-A9OX-01A-11R-A41R-13		af080299-4f21-42bb-8477-8d7414cdaf9f	f7b55d2b-9c90-4cb8-8839-2615290bd861
TCGA-V1-A9OY-01	0	TCGA-V1-A9OY-01	170	0	TCGA-V1-A9OY	170	0	170	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-V1-A9OY-F69409	NO		M0	T2	-21170								170		170			NO		NO		Scheduled Follow-up Submission		2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral		NO	YES				NO	13	1	true	N1	T3a	TCGA-V1-A9OY.93F584C1-F62C-4DA6-B2C8-755DBED9CE18.pdf			0		0		0		0		10		30		60		70		4	Complete Remission/Response	No	0.099	NO	R1	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone			6ca05946-7003-403b-a123-832c6e3d9d9c	TCGA-V1-A9OY-01	35900b9c-bc5c-49cc-acb4-410305e8ab64			TCGA-V1-A9OY-01A-11D-A41J-01	35900b9c-bc5c-49cc-acb4-410305e8ab64	TCGA-V1-A9OY-01A-11D-A41J-01	35900b9c-bc5c-49cc-acb4-410305e8ab64		TCGA-V1-A9OY-01	TCGA-V1-A9OY-01A-11D-A41L-05	TCGA-V1-A9OY-01A-11R-A41R-13		35900b9c-bc5c-49cc-acb4-410305e8ab64	6ca05946-7003-403b-a123-832c6e3d9d9c
TCGA-V1-A9Z7-01		TCGA-V1-A9Z7-01			TCGA-V1-A9Z7				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																																																															Primary Tumor	01																			ca00f265-ef84-4070-a169-1e4ddbc74a74	TCGA-V1-A9Z7-01	fa901a09-cc13-402a-aba6-f93f4242c3d1			TCGA-V1-A9Z7-01A-11D-A41J-01	fa901a09-cc13-402a-aba6-f93f4242c3d1	TCGA-V1-A9Z7-01A-11D-A41J-01	fa901a09-cc13-402a-aba6-f93f4242c3d1		TCGA-V1-A9Z7-01	TCGA-V1-A9Z7-01A-11D-A41L-05	TCGA-V1-A9Z7-01A-11R-A41R-13		fa901a09-cc13-402a-aba6-f93f4242c3d1	ca00f265-ef84-4070-a169-1e4ddbc74a74
TCGA-V1-A9Z8-01		TCGA-V1-A9Z8-01			TCGA-V1-A9Z8				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																						120		NO											true			TCGA-V1-A9Z8.3C543195-4F88-4FA4-A397-EDF375FCE61A.pdf			0		0		0		0		15		0		85		80								Primary Tumor	01													A						5273af61-5a88-4a6b-94ef-ebd8522a5f57	TCGA-V1-A9Z8-01	6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff			TCGA-V1-A9Z8-01A-11D-A41J-01	6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff	TCGA-V1-A9Z8-01A-11D-A41J-01	6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff		TCGA-V1-A9Z8-01	TCGA-V1-A9Z8-01A-11D-A41L-05	TCGA-V1-A9Z8-01A-11R-A41R-13		6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff	5273af61-5a88-4a6b-94ef-ebd8522a5f57
TCGA-V1-A9Z9-01		TCGA-V1-A9Z9-01			TCGA-V1-A9Z9				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																						140		NO											true			TCGA-V1-A9Z9.9D297084-0545-4D51-8D14-15754BAAB18B.pdf			0		0		0		0		0		20		80		80								Primary Tumor	01													A						4bea2f94-df47-487a-979c-94e1c31daea9		7c626639-ebbc-472b-8ad0-239068f6d4e8			TCGA-V1-A9Z9-01A-21D-A41J-01	7c626639-ebbc-472b-8ad0-239068f6d4e8	TCGA-V1-A9Z9-01A-21D-A41J-01	7c626639-ebbc-472b-8ad0-239068f6d4e8			TCGA-V1-A9Z9-01A-21D-A41L-05	TCGA-V1-A9Z9-01A-21R-A41R-13		7c626639-ebbc-472b-8ad0-239068f6d4e8	4bea2f94-df47-487a-979c-94e1c31daea9
TCGA-V1-A9ZG-01		TCGA-V1-A9ZG-01			TCGA-V1-A9ZG				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																						330		NO											true			TCGA-V1-A9ZG.D7B1ABAE-1A72-496C-B11F-469F65B37347.pdf			40		20		5		20		0		5		90		90								Primary Tumor	01													A						0341d7ed-3682-45ad-b446-ac589cfe6c4d	TCGA-V1-A9ZG-01	e8f34083-66fe-43d4-9860-77427c481dcd			TCGA-V1-A9ZG-01A-11D-A41J-01	e8f34083-66fe-43d4-9860-77427c481dcd	TCGA-V1-A9ZG-01A-11D-A41J-01	e8f34083-66fe-43d4-9860-77427c481dcd		TCGA-V1-A9ZG-01	TCGA-V1-A9ZG-01A-11D-A41L-05	TCGA-V1-A9ZG-01A-11R-A41R-13		e8f34083-66fe-43d4-9860-77427c481dcd	0341d7ed-3682-45ad-b446-ac589cfe6c4d
TCGA-V1-A9ZI-01		TCGA-V1-A9ZI-01			TCGA-V1-A9ZI				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																						120		NO											true			TCGA-V1-A9ZI.7C3EC6A6-C005-4877-A6C8-C3174709A3FF.pdf			3		0		2		0		3		33		62		90								Primary Tumor	01													A						d772f8ce-750a-409e-90e5-f2d536b36b62	TCGA-V1-A9ZI-01	01234d47-e213-401f-b4fe-f33b15bcec7d			TCGA-V1-A9ZI-01A-11D-A41J-01	01234d47-e213-401f-b4fe-f33b15bcec7d	TCGA-V1-A9ZI-01A-11D-A41J-01	01234d47-e213-401f-b4fe-f33b15bcec7d		TCGA-V1-A9ZI-01	TCGA-V1-A9ZI-01A-11D-A41L-05	TCGA-V1-A9ZI-01A-11R-A41R-13		01234d47-e213-401f-b4fe-f33b15bcec7d	d772f8ce-750a-409e-90e5-f2d536b36b62
TCGA-V1-A9ZK-01		TCGA-V1-A9ZK-01			TCGA-V1-A9ZK				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																						50		NO											true			TCGA-V1-A9ZK.9AD0F7C3-9DEB-427C-B8A3-007B874AB12A.pdf			8		0		1		0		10		45		44		90								Primary Tumor	01													A						b56cd120-22ef-460e-896f-fc0dd88fc45d	TCGA-V1-A9ZK-01	4c0ca123-3b83-4a25-aa0f-fe1a593ea969			TCGA-V1-A9ZK-01A-11D-A41J-01	4c0ca123-3b83-4a25-aa0f-fe1a593ea969	TCGA-V1-A9ZK-01A-11D-A41J-01	4c0ca123-3b83-4a25-aa0f-fe1a593ea969		TCGA-V1-A9ZK-01	TCGA-V1-A9ZK-01A-11D-A41L-05	TCGA-V1-A9ZK-01A-11R-A41R-13		4c0ca123-3b83-4a25-aa0f-fe1a593ea969	b56cd120-22ef-460e-896f-fc0dd88fc45d
TCGA-V1-A9ZR-01		TCGA-V1-A9ZR-01			TCGA-V1-A9ZR				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																						430		NO											true			TCGA-V1-A9ZR.DB23EC5B-D86A-4B32-8C52-E91CAD4B7695.pdf			0		0		0		0		0		20		80		90								Primary Tumor	01													A						4cf1b818-d41a-4af7-a674-ecadd3015acf	TCGA-V1-A9ZR-01	7d74ec0f-631d-463c-820e-ce796cb3b798			TCGA-V1-A9ZR-01A-11D-A41J-01	7d74ec0f-631d-463c-820e-ce796cb3b798	TCGA-V1-A9ZR-01A-11D-A41J-01	7d74ec0f-631d-463c-820e-ce796cb3b798		TCGA-V1-A9ZR-01	TCGA-V1-A9ZR-01A-11D-A41L-05	TCGA-V1-A9ZR-01A-11R-A41R-13		7d74ec0f-631d-463c-820e-ce796cb3b798	4cf1b818-d41a-4af7-a674-ecadd3015acf
TCGA-VN-A88I-01	0	TCGA-VN-A88I-01	269	0	TCGA-VN-A88I	269	0	269	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-VN-A88I-F62589	NO	Abnormal (not related to prostate cancer)	M0	T1c	-21576	9	730			-1		0	269		269			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2014-7-21	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	260		NO	Bilateral		YES	YES				NO	11	0	true	N0	T3a	TCGA-VN-A88I.571D4E0A-97DF-4B78-8F78-81DF0C040941.pdf			60		5		0		20		0		30		70		70	WITH TUMOR	4	Partial Remission/Response	No	0.16		R0	Primary Tumor	01	4				5	NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			bd4d8a9d-747c-47d3-8c5d-314dbbbb5c39	TCGA-VN-A88I-01	625d2894-bb92-450a-af72-013d81df221d		TCGA-VN-A88I-01A-11D-A34U-08	TCGA-VN-A88I-01A-11D-A34T-01	625d2894-bb92-450a-af72-013d81df221d	TCGA-VN-A88I-01A-11D-A34T-01	625d2894-bb92-450a-af72-013d81df221d		TCGA-VN-A88I-01	TCGA-VN-A88I-01A-11D-A34V-05	TCGA-VN-A88I-01A-11R-A358-13		625d2894-bb92-450a-af72-013d81df221d	bd4d8a9d-747c-47d3-8c5d-314dbbbb5c39
TCGA-VN-A88K-01	0	TCGA-VN-A88K-01	776	0	TCGA-VN-A88K	776	0	776	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-VN-A88K-F62590	NO	Equivocal	M0	T1c	-21524	24	870		24	-48		0	776		776			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-22	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	300		NO	Bilateral		YES	YES				NO	37	15	true	N1	T3a	TCGA-VN-A88K.C990DBAF-40D6-4D19-8345-62495C3959A0.pdf			60		10		0		20		0		30		70		70		4	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	4			YES	5	NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			2633fa71-27f3-4ac2-9d86-f3d058176db1	TCGA-VN-A88K-01	f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa		TCGA-VN-A88K-01A-11D-A34U-08	TCGA-VN-A88K-01A-11D-A34T-01	f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa	TCGA-VN-A88K-01A-11D-A34T-01	f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa		TCGA-VN-A88K-01	TCGA-VN-A88K-01A-11D-A34V-05	TCGA-VN-A88K-01A-11R-A358-13		f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa	2633fa71-27f3-4ac2-9d86-f3d058176db1
TCGA-VN-A88L-01	0	TCGA-VN-A88L-01	746	0	TCGA-VN-A88L	746	0	746	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			54	TCGA-VN-A88L-F65022	NO		M0	T1c	-20026		367			79		0	746		394			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES				NO	18	0	true	N0	T2c	TCGA-VN-A88L.7247904D-2E8C-49B5-8D35-A6CE0D9687DE.pdf			60		10		0		20		0		20		80		80	TUMOR FREE	3	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Middle|Base		Prostate		A	LIVING	2012				a11862ba-6d3e-441e-a5d4-418f31d55547	TCGA-VN-A88L-01	6f4d55e9-37fc-40c3-92d0-5bdabc063447		TCGA-VN-A88L-01A-11D-A34U-08	TCGA-VN-A88L-01A-11D-A34T-01	6f4d55e9-37fc-40c3-92d0-5bdabc063447	TCGA-VN-A88L-01A-11D-A34T-01	6f4d55e9-37fc-40c3-92d0-5bdabc063447		TCGA-VN-A88L-01	TCGA-VN-A88L-01A-11D-A34V-05	TCGA-VN-A88L-01A-11R-A358-13		6f4d55e9-37fc-40c3-92d0-5bdabc063447	a11862ba-6d3e-441e-a5d4-418f31d55547
TCGA-VN-A88M-01	0	TCGA-VN-A88M-01	189	0	TCGA-VN-A88M	189	0	189	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-VN-A88M-F62591			M0	T1c	-20157		288			128		0	189					NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2014-12-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral		YES	YES				NO	13	0	true	N0	T2c	TCGA-VN-A88M.787071AD-ED3D-46CA-8982-2087EE6AC0EA.pdf			60		10		0		20		0		30		70		70	TUMOR FREE	3	Complete Remission/Response	No		NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Middle		Prostate		A	LIVING	2013				6996d685-6673-4485-8754-93af033356a9	TCGA-VN-A88M-01	aa86654d-003d-4190-b2bc-f4b40f77474f		TCGA-VN-A88M-01A-11D-A34U-08	TCGA-VN-A88M-01A-11D-A34T-01	aa86654d-003d-4190-b2bc-f4b40f77474f	TCGA-VN-A88M-01A-11D-A34T-01	aa86654d-003d-4190-b2bc-f4b40f77474f		TCGA-VN-A88M-01	TCGA-VN-A88M-01A-11D-A34V-05	TCGA-VN-A88M-01A-11R-A358-13		aa86654d-003d-4190-b2bc-f4b40f77474f	6996d685-6673-4485-8754-93af033356a9
TCGA-VN-A88N-01	0	TCGA-VN-A88N-01	472	0	TCGA-VN-A88N	472	0	472	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-VN-A88N-F65020	NO	Equivocal	M0	T1c	-22695	98	156		98	-117		0	472		176			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-9-17	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		NO	YES				NO	50	0	true	N0	T2c	TCGA-VN-A88N.CB3E6129-CCCC-4EEB-88CD-63DE78D8F163.pdf			60		10		0		20		0		20		80		80	TUMOR FREE	4	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	3			NO		NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			4d2f99a6-dd49-449a-b5b2-609a191f0450	TCGA-VN-A88N-01	7dae2f3c-56cb-425a-8d7f-7113e1cfc72e		TCGA-VN-A88N-01A-11D-A364-08	TCGA-VN-A88N-01A-11D-A363-01	7dae2f3c-56cb-425a-8d7f-7113e1cfc72e	TCGA-VN-A88N-01A-11D-A363-01	7dae2f3c-56cb-425a-8d7f-7113e1cfc72e		TCGA-VN-A88N-01	TCGA-VN-A88N-01A-11D-A365-05	TCGA-VN-A88N-01A-11R-A36B-13		7dae2f3c-56cb-425a-8d7f-7113e1cfc72e	4d2f99a6-dd49-449a-b5b2-609a191f0450
TCGA-VN-A88O-01	0	TCGA-VN-A88O-01	481	0	TCGA-VN-A88O	481	0	481	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			49		NO		M0	T1c	-17945		426			70		0	481		376			NO		YES	No Evidence of Extraprostatic Extension			2014-1-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral			YES				NO	34	0	true	N0	T2c	TCGA-VN-A88O.E47DAF10-187B-4909-A0C5-D96231A5893F.pdf			60		10		0		20		0		30		70		70	TUMOR FREE	3	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	4			NO	4	NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			433e578d-ff8e-46bd-976d-203a1dbbd180	TCGA-VN-A88O-01	621b5b13-6568-41fa-9e42-3992fa05dd1f		TCGA-VN-A88O-01A-11D-A34U-08	TCGA-VN-A88O-01A-11D-A34T-01	621b5b13-6568-41fa-9e42-3992fa05dd1f	TCGA-VN-A88O-01A-11D-A34T-01	621b5b13-6568-41fa-9e42-3992fa05dd1f		TCGA-VN-A88O-01	TCGA-VN-A88O-01A-11D-A34V-05	TCGA-VN-A88O-01A-11R-A358-13		621b5b13-6568-41fa-9e42-3992fa05dd1f	433e578d-ff8e-46bd-976d-203a1dbbd180
TCGA-VN-A88P-01	0	TCGA-VN-A88P-01	1260	0	TCGA-VN-A88P	1260	0	1260	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-VN-A88P-F69078	NO	Abnormal (not related to prostate cancer)	M0	T1c	-21916	839	911		839	805		0	1260		917			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	YES				NO	65	0	true	N0	T2c	TCGA-VN-A88P.9C83DFB8-B75A-40D1-B791-BE52B52BBDA6.pdf			0		0		0		0		0		30		70		85	TUMOR FREE	3	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			8c8eba90-0186-4edb-a555-91294b2e5097	TCGA-VN-A88P-01	e6310fd5-418f-4315-8c0a-78b05a95c214		TCGA-VN-A88P-01A-11D-A34U-08	TCGA-VN-A88P-01A-11D-A34T-01	e6310fd5-418f-4315-8c0a-78b05a95c214	TCGA-VN-A88P-01A-11D-A34T-01	e6310fd5-418f-4315-8c0a-78b05a95c214		TCGA-VN-A88P-01	TCGA-VN-A88P-01A-11D-A34V-05	TCGA-VN-A88P-01A-11R-A358-13		e6310fd5-418f-4315-8c0a-78b05a95c214	8c8eba90-0186-4edb-a555-91294b2e5097
TCGA-VN-A88Q-01	0	TCGA-VN-A88Q-01	1366	0	TCGA-VN-A88Q	1366	0	1366	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-VN-A88Q-F68875	NO	Abnormal (not related to prostate cancer)	M0	T2a	-22087	929				796		0	1366		1000			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-22	MALE	8	Prostate Adenocarcinoma  Other Subtype	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	12	0		N0	T2c																			TUMOR FREE	4	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Apex		Prostate			LIVING	2010	Overlapping / Multiple Zones			dae91d6e-adde-4d99-917f-ccb972a93b41	TCGA-VN-A88Q-01	c44359a0-d7c7-45bc-80e7-5139d4a77234		TCGA-VN-A88Q-01A-11D-A34U-08	TCGA-VN-A88Q-01A-11D-A34T-01	c44359a0-d7c7-45bc-80e7-5139d4a77234	TCGA-VN-A88Q-01A-11D-A34T-01	c44359a0-d7c7-45bc-80e7-5139d4a77234		TCGA-VN-A88Q-01	TCGA-VN-A88Q-01A-11D-A34V-05	TCGA-VN-A88Q-01A-11R-A358-13		c44359a0-d7c7-45bc-80e7-5139d4a77234	dae91d6e-adde-4d99-917f-ccb972a93b41
TCGA-VN-A88R-01	0	TCGA-VN-A88R-01	784	0	TCGA-VN-A88R	512	1	784	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	NO	53	TCGA-VN-A88R-F69083	NO	Abnormal (not related to prostate cancer)	M0	T1c	-19513	316	402		316	207	512	0	784	512	459			YES	Equivocal	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2014-12-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	34	0	true	N0	T2c	TCGA-VN-A88R.6DDC4292-91C9-49A7-B34D-578ECA0A7F56.pdf			0		0		0		0		5		25		70		85		4	Partial Remission/Response	No	0.15	NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2012				a7805dfe-86cf-4190-9b2b-74b5e5ea0f8b	TCGA-VN-A88R-01	7e0203fd-e55d-4d05-9877-6b502250ffc3		TCGA-VN-A88R-01A-11D-A364-08	TCGA-VN-A88R-01A-11D-A363-01	7e0203fd-e55d-4d05-9877-6b502250ffc3	TCGA-VN-A88R-01A-11D-A363-01	7e0203fd-e55d-4d05-9877-6b502250ffc3		TCGA-VN-A88R-01	TCGA-VN-A88R-01A-11D-A365-05	TCGA-VN-A88R-01A-11R-A36B-13		7e0203fd-e55d-4d05-9877-6b502250ffc3	a7805dfe-86cf-4190-9b2b-74b5e5ea0f8b
TCGA-VN-A943-01	0	TCGA-VN-A943-01	496	0	TCGA-VN-A943	496	0	496	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71	TCGA-VN-A943-F69100	NO		M0	T1c	-26162		139			-17		0	496		132			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		NO	YES				NO	10	0	true	N0	T2c	TCGA-VN-A943.089DAFFA-4FD5-4219-9C79-17F6E5405784.pdf			0		0		0		0		5		0		95		77	TUMOR FREE	4	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			cb889857-69f8-4e9f-bc59-b2fd89bb79b1		c83c8992-5d92-4c1e-a59d-cf890ecb9bb4			TCGA-VN-A943-01A-11D-A41J-01	c83c8992-5d92-4c1e-a59d-cf890ecb9bb4	TCGA-VN-A943-01A-11D-A41J-01	c83c8992-5d92-4c1e-a59d-cf890ecb9bb4			TCGA-VN-A943-01A-11D-A41L-05	TCGA-VN-A943-01A-11R-A41R-13		c83c8992-5d92-4c1e-a59d-cf890ecb9bb4	cb889857-69f8-4e9f-bc59-b2fd89bb79b1
TCGA-VP-A872-01	0	TCGA-VP-A872-01	3388	0	TCGA-VP-A872	3388	0	3388	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-VP-A872-F64422	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-22098	8	3164					0	3388		3253			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-2	MALE	8	Prostate Adenocarcinoma  Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		NO	YES				NO	12	0	true	N0	T3a	TCGA-VP-A872.3B27B1E2-C41E-4D31-83F5-78882BDBB284.pdf			0		0		0		0		30		10		60		70	TUMOR FREE	5	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	3			NO	4	NO	YES	VP	Apex|Base		Prostate		A	LIVING	2005	Overlapping / Multiple Zones			92c27512-4fbf-49c5-b247-46971c091ff3	TCGA-VP-A872-01	f8fba04c-cd45-4f85-8b75-dcf5426b7637		TCGA-VP-A872-01A-11D-A34U-08	TCGA-VP-A872-01A-11D-A34T-01	f8fba04c-cd45-4f85-8b75-dcf5426b7637	TCGA-VP-A872-01A-11D-A34T-01	f8fba04c-cd45-4f85-8b75-dcf5426b7637		TCGA-VP-A872-01	TCGA-VP-A872-01A-11D-A34V-05	TCGA-VP-A872-01A-11R-A358-13		f8fba04c-cd45-4f85-8b75-dcf5426b7637	92c27512-4fbf-49c5-b247-46971c091ff3
TCGA-VP-A875-01	0	TCGA-VP-A875-01	2309	0	TCGA-VP-A875	2309	0	2309	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-VP-A875-F64433	NO	Abnormal (not related to prostate cancer)	M0	T2a	-24742	15			15			0	2309		867			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-2	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		YES	YES				NO	4	0		N0	T3a																			TUMOR FREE	3	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	VP	Apex|Base		Prostate			LIVING	2005	Overlapping / Multiple Zones			c6b176c9-c796-4033-9601-640bbdccab43	TCGA-VP-A875-01	c47f8609-65d3-4cca-b599-58add67672c7		TCGA-VP-A875-01A-31D-A34U-08	TCGA-VP-A875-01A-31D-A34T-01	c47f8609-65d3-4cca-b599-58add67672c7	TCGA-VP-A875-01A-31D-A34T-01	c47f8609-65d3-4cca-b599-58add67672c7		TCGA-VP-A875-01	TCGA-VP-A875-01A-31D-A34V-05	TCGA-VP-A875-01A-31R-A358-13		c47f8609-65d3-4cca-b599-58add67672c7	c6b176c9-c796-4033-9601-640bbdccab43
TCGA-VP-A876-01	0	TCGA-VP-A876-01	3333	0	TCGA-VP-A876	3333	0	3333	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			46	TCGA-VP-A876-F64436	NO	Normal (no evidence of prostate cancer) [cM0]		T1c	-16934	13	3054		13			0	3333		2576			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-2	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	20		NO	Bilateral		NO	YES				NO	12	0	true	N0	T2c	TCGA-VP-A876.A10667AF-8A71-492D-B71C-95160DE9EEE6.pdf			0		0		0		0		5		25		70		80	TUMOR FREE	3	Complete Remission/Response	No	0.1	NO	R0	Primary Tumor	01	5			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2005	Overlapping / Multiple Zones			f24dbae9-6283-4fbe-9e07-02a37c6499f1	TCGA-VP-A876-01	2099f0da-0318-4b94-a418-d6e6cf65454b		TCGA-VP-A876-01A-11D-A34U-08	TCGA-VP-A876-01A-11D-A34T-01	2099f0da-0318-4b94-a418-d6e6cf65454b	TCGA-VP-A876-01A-11D-A34T-01	2099f0da-0318-4b94-a418-d6e6cf65454b		TCGA-VP-A876-01	TCGA-VP-A876-01A-11D-A34V-05	TCGA-VP-A876-01A-11R-A358-13		2099f0da-0318-4b94-a418-d6e6cf65454b	f24dbae9-6283-4fbe-9e07-02a37c6499f1
TCGA-VP-A878-01	0	TCGA-VP-A878-01	2963	0	TCGA-VP-A878	2354	1	2963	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	NO	58	TCGA-VP-A878-F64439	NO	Normal (no evidence of prostate cancer) [cM0]		T1c	-21402	35	2725		44		1843	0	2963	2354	2879	1934	2011	YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-2	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		NO	YES	Bone	Distant Metastasis		YES	3	1	true	N1	T2c	TCGA-VP-A878.635464F3-6A6B-4574-8413-058651AB4068.pdf			0		0		0		0		10		35		55		85	WITH TUMOR	4	Partial Remission/Response	No	0.1	NO	R1	Primary Tumor	01	5			NO		NO	YES	VP	Apex|Base	NO	Prostate		A	LIVING	2006	Overlapping / Multiple Zones			7bb72e92-6c2d-4594-816c-9a90ff227bce	TCGA-VP-A878-01	2405edaf-b4cc-4292-92a3-8b890ffaa70f		TCGA-VP-A878-01A-31D-A34U-08	TCGA-VP-A878-01A-31D-A34T-01	2405edaf-b4cc-4292-92a3-8b890ffaa70f	TCGA-VP-A878-01A-31D-A34T-01	2405edaf-b4cc-4292-92a3-8b890ffaa70f		TCGA-VP-A878-01	TCGA-VP-A878-01A-31D-A34V-05	TCGA-VP-A878-01A-31R-A358-13		2405edaf-b4cc-4292-92a3-8b890ffaa70f	7bb72e92-6c2d-4594-816c-9a90ff227bce
TCGA-VP-A879-01	1	TCGA-VP-A879-01	728	1	TCGA-VP-A879	728	0	728	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-VP-A879-F64442	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25799	8	2578	728	8			0			688			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-2	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	110		NO	Right		NO	YES				NO	2	0	true	N0	T2b	TCGA-VP-A879.526F7E5C-B681-46B7-B118-10AB3F2DD30E.pdf			0		0		0		0		50		0		50		60	TUMOR FREE	4	Complete Remission/Response	No	0.01	NO	R0	Primary Tumor	01	5		Medical Record	NO		NO	YES	VP	Apex|Base		Prostate		A	DECEASED	2006	Overlapping / Multiple Zones			3aca83a8-cb6b-4925-9de7-b797ec1144a6	TCGA-VP-A879-01	1cba2729-ee83-44a3-a21a-ad5359a2bbe3		TCGA-VP-A879-01A-11D-A34U-08	TCGA-VP-A879-01A-11D-A34T-01	1cba2729-ee83-44a3-a21a-ad5359a2bbe3	TCGA-VP-A879-01A-11D-A34T-01	1cba2729-ee83-44a3-a21a-ad5359a2bbe3		TCGA-VP-A879-01	TCGA-VP-A879-01A-11D-A34V-05	TCGA-VP-A879-01A-11R-A358-13		1cba2729-ee83-44a3-a21a-ad5359a2bbe3	3aca83a8-cb6b-4925-9de7-b797ec1144a6
TCGA-VP-A87B-01	0	TCGA-VP-A87B-01	2591	0	TCGA-VP-A87B	2473	1	2591	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	NO	63	TCGA-VP-A87B-F64449	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23271		2297				2310	0	2591	2473	2309	2459		YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Right		NO	YES	Lung	New Primary Tumor		YES	2	0	true	N0	T2b	TCGA-VP-A87B.C92C198A-660D-4007-AFC2-EA9FE193C3A4.pdf			0		0		0		0		10		0		90		95	WITH TUMOR	4	Complete Remission/Response	No	3.37	NO	R0	Primary Tumor	01	4			NO	3	NO	YES	VP	Apex|Base	NO	Prostate		A	LIVING	2007	Overlapping / Multiple Zones			16b7bd32-7ff4-415e-bf28-d08bf5d91f40	TCGA-VP-A87B-01	a899dca6-deb0-49f8-8c8b-2854b108de5a		TCGA-VP-A87B-01A-11D-A34U-08	TCGA-VP-A87B-01A-11D-A34T-01	a899dca6-deb0-49f8-8c8b-2854b108de5a	TCGA-VP-A87B-01A-11D-A34T-01	a899dca6-deb0-49f8-8c8b-2854b108de5a		TCGA-VP-A87B-01	TCGA-VP-A87B-01A-11D-A34V-05	TCGA-VP-A87B-01A-11R-A358-13		a899dca6-deb0-49f8-8c8b-2854b108de5a	16b7bd32-7ff4-415e-bf28-d08bf5d91f40
TCGA-VP-A87C-01	0	TCGA-VP-A87C-01	1690	0	TCGA-VP-A87C	1690	0	1690	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-VP-A87C-F64470	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24608	14	2229		14			0	1690		1690			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	30		NO	Bilateral		YES	YES				NO	12	0	true	N0	T2c	TCGA-VP-A87C.2E0994EC-7C5F-4721-972D-5D590674D6AC.pdf			0		0		0		0		10		30		60		65	TUMOR FREE	4	Complete Remission/Response	No	0.5	NO	R0	Primary Tumor	01	3			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2007	Overlapping / Multiple Zones			0f5fe1ae-1762-4e95-841b-2f977b5b7088	TCGA-VP-A87C-01	e6e404f0-3317-496c-b4f8-555408a3dfd6		TCGA-VP-A87C-01A-11D-A34U-08	TCGA-VP-A87C-01A-11D-A34T-01	e6e404f0-3317-496c-b4f8-555408a3dfd6	TCGA-VP-A87C-01A-11D-A34T-01	e6e404f0-3317-496c-b4f8-555408a3dfd6		TCGA-VP-A87C-01	TCGA-VP-A87C-01A-11D-A34V-05	TCGA-VP-A87C-01A-11R-A358-13		e6e404f0-3317-496c-b4f8-555408a3dfd6	0f5fe1ae-1762-4e95-841b-2f977b5b7088
TCGA-VP-A87D-01	0	TCGA-VP-A87D-01	1853	0	TCGA-VP-A87D	1853	0	1853	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			54	TCGA-VP-A87D-F64469	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-19818	14	2127			12	1194	0	1853		1853			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		YES	YES				NO	12	3	true	N1	T3a	TCGA-VP-A87D.48B36158-9679-4C74-BBDA-88431481A885.pdf			0		0		0		0		10		0		90		95	TUMOR FREE	4	Complete Remission/Response	No	0.2	NO	R0	Primary Tumor	01	5			YES		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2007	Overlapping / Multiple Zones			43fe0726-6098-46c1-88ed-5a35bcd755a2	TCGA-VP-A87D-01	ca36f013-1f5d-41f4-85a5-2b8a149a5cfa		TCGA-VP-A87D-01A-11D-A34U-08	TCGA-VP-A87D-01A-11D-A34T-01	ca36f013-1f5d-41f4-85a5-2b8a149a5cfa	TCGA-VP-A87D-01A-11D-A34T-01	ca36f013-1f5d-41f4-85a5-2b8a149a5cfa		TCGA-VP-A87D-01	TCGA-VP-A87D-01A-11D-A34V-05	TCGA-VP-A87D-01A-11R-A358-13		ca36f013-1f5d-41f4-85a5-2b8a149a5cfa	43fe0726-6098-46c1-88ed-5a35bcd755a2
TCGA-VP-A87E-01	0	TCGA-VP-A87E-01	2037	0	TCGA-VP-A87E	2037	0	2037	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-VP-A87E-F64474	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21811	15	2059		15			0	2037		2037			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		YES	YES				NO	12	0	true	N0	T2c	TCGA-VP-A87E.6B46F895-B5CD-40B8-8962-AA8DF2505446.pdf			0		0		0		0		25		30		45		60	TUMOR FREE	3	Complete Remission/Response	No	0.11	NO	R0	Primary Tumor	01	3			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones			49de02ad-b9c3-4bb9-a2a8-8a6555840c9c	TCGA-VP-A87E-01	ecbb33ff-c485-485f-a169-6bb7c1c84baf		TCGA-VP-A87E-01A-31D-A34U-08	TCGA-VP-A87E-01A-31D-A34T-01	ecbb33ff-c485-485f-a169-6bb7c1c84baf	TCGA-VP-A87E-01A-31D-A34T-01	ecbb33ff-c485-485f-a169-6bb7c1c84baf		TCGA-VP-A87E-01	TCGA-VP-A87E-01A-31D-A34V-05	TCGA-VP-A87E-01A-31R-A358-13		ecbb33ff-c485-485f-a169-6bb7c1c84baf	49de02ad-b9c3-4bb9-a2a8-8a6555840c9c
TCGA-VP-A87H-01	0	TCGA-VP-A87H-01	663	0	TCGA-VP-A87H	663	0	663	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			76	TCGA-VP-A87H-F64478	NO		M0	T2	-28060		1714		24			0	663		663			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		YES	YES				NO	16	0	true	N0	T3b	TCGA-VP-A87H.B2B58670-AE26-43A0-8D3C-AAF354958727.pdf			0		0		0		0		40		0		60		70	TUMOR FREE	4	Complete Remission/Response	No	0.01	NO	R2	Primary Tumor	01	5			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones			1b3d88ef-f9e2-446d-b50d-7195cc160141	TCGA-VP-A87H-01	3aba16f9-47fe-419a-92d3-c73049adce2b		TCGA-VP-A87H-01A-11D-A34U-08	TCGA-VP-A87H-01A-11D-A34T-01	3aba16f9-47fe-419a-92d3-c73049adce2b	TCGA-VP-A87H-01A-11D-A34T-01	3aba16f9-47fe-419a-92d3-c73049adce2b		TCGA-VP-A87H-01	TCGA-VP-A87H-01A-11D-A34V-05	TCGA-VP-A87H-01A-11R-A358-13		3aba16f9-47fe-419a-92d3-c73049adce2b	1b3d88ef-f9e2-446d-b50d-7195cc160141
TCGA-VP-A87J-01	0	TCGA-VP-A87J-01	1623	0	TCGA-VP-A87J	1623	0	1623	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56	TCGA-VP-A87J-F64485	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-20792	11	1379		13			0	1623		1506			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES				NO	11	1	true	N1	T3a	TCGA-VP-A87J.03F4F8F1-ACE1-4391-85AC-A10B2F56CDD0.pdf			0		0		0		0		30		20		50		60	TUMOR FREE	3	Complete Remission/Response	No	0.2	NO	R2	Primary Tumor	01	4			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones			56efc1cd-21b2-4737-aefa-c83c2031ec6f	TCGA-VP-A87J-01	eecb9837-09fc-4e99-93d3-d3686c9783da		TCGA-VP-A87J-01A-11D-A34U-08	TCGA-VP-A87J-01A-11D-A34T-01	eecb9837-09fc-4e99-93d3-d3686c9783da	TCGA-VP-A87J-01A-11D-A34T-01	eecb9837-09fc-4e99-93d3-d3686c9783da		TCGA-VP-A87J-01	TCGA-VP-A87J-01A-11D-A34V-05	TCGA-VP-A87J-01A-11R-A358-13		eecb9837-09fc-4e99-93d3-d3686c9783da	56efc1cd-21b2-4737-aefa-c83c2031ec6f
TCGA-VP-A87K-01	0	TCGA-VP-A87K-01	1306	0	TCGA-VP-A87K	697	1	1306	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	YES	63	TCGA-VP-A87K-F64502	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23030	13	1112		13		467	0	1306	697	655	533	655	YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	8	Prostate Adenocarcinoma  Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	12	0	true	N0	T3b	TCGA-VP-A87K.6B2C5B8F-61B5-4D8B-A091-B28066A1629A.pdf			0		0		0		0		10		20		70		80	TUMOR FREE	4	Complete Remission/Response	No	0.3	NO	R1	Primary Tumor	01	4			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones			35e97546-39cb-459b-a19e-dd85c2f27b2d	TCGA-VP-A87K-01	1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca		TCGA-VP-A87K-01A-11D-A34U-08	TCGA-VP-A87K-01A-11D-A34T-01	1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca	TCGA-VP-A87K-01A-11D-A34T-01	1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca		TCGA-VP-A87K-01	TCGA-VP-A87K-01A-11D-A34V-05	TCGA-VP-A87K-01A-11R-A358-13		1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca	35e97546-39cb-459b-a19e-dd85c2f27b2d
TCGA-VP-AA1N-01	0	TCGA-VP-AA1N-01	1365	0	TCGA-VP-AA1N	1365	0	1365	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-VP-AA1N-F64506	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25781	17	2112		17			0	1365		542			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	250		NO	Bilateral		YES	YES				NO	5	0	true	N0	T3a	TCGA-VP-AA1N.B76B30C1-F87D-494B-A95A-3F9E511ED3B1.pdf			0		0		0		0		10		30		60		75	TUMOR FREE	5	Complete Remission/Response	No	0.01	YES	R1	Primary Tumor	01	4			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones			e18bc3f3-bbdb-4abc-88e4-5a169031448a	TCGA-VP-AA1N-01	81f85c7b-5262-466b-b4fb-a4fe9febfe0a			TCGA-VP-AA1N-01A-31D-A41J-01	81f85c7b-5262-466b-b4fb-a4fe9febfe0a	TCGA-VP-AA1N-01A-31D-A41J-01	81f85c7b-5262-466b-b4fb-a4fe9febfe0a		TCGA-VP-AA1N-01	TCGA-VP-AA1N-01A-31D-A41L-05	TCGA-VP-AA1N-01A-31R-A41R-13		81f85c7b-5262-466b-b4fb-a4fe9febfe0a	e18bc3f3-bbdb-4abc-88e4-5a169031448a
TCGA-WW-A8ZI-01	0	TCGA-WW-A8ZI-01	449	0	TCGA-WW-A8ZI	449	0	449	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70	TCGA-WW-A8ZI-F67645	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-25593	13	135		20			0	449		176			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-7	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	4	0	true	N0	T2c	TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf			0		0		0		0		5		10		85		95	TUMOR FREE	4	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	4			NO		YES	NO	WW	Apex		Prostate		A	LIVING	2013				85561406-2a9d-493b-a39a-384a2441ac2a	TCGA-WW-A8ZI-01	effc8583-559f-4e01-bd93-11b39d95a290		TCGA-WW-A8ZI-01A-11D-A377-08	TCGA-WW-A8ZI-01A-11D-A376-01	effc8583-559f-4e01-bd93-11b39d95a290	TCGA-WW-A8ZI-01A-11D-A376-01	effc8583-559f-4e01-bd93-11b39d95a290		TCGA-WW-A8ZI-01	TCGA-WW-A8ZI-01A-11D-A378-05	TCGA-WW-A8ZI-01A-11R-A37H-13		effc8583-559f-4e01-bd93-11b39d95a290	85561406-2a9d-493b-a39a-384a2441ac2a
TCGA-X4-A8KQ-01	0	TCGA-X4-A8KQ-01	1383	0	TCGA-X4-A8KQ			1383	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-X4-A8KQ-F67716	NO		M0	T1c	-23999						883	0	1383		963			NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-11-10	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Right		NO	YES		Biochemical evidence of disease		YES	3	0		N0	T3b																			WITH TUMOR	4	Progressive Disease	No	.25	YES	RX	Primary Tumor	01	5			YES		NO	YES	X4			Prostate			LIVING	2010	Peripheral Zone			c81ad42d-9469-44f7-9d21-7278ae653654	TCGA-X4-A8KQ-01	cff667cc-724f-4f8a-96c0-cdd6512805a2		TCGA-X4-A8KQ-01A-12D-A364-08	TCGA-X4-A8KQ-01A-12D-A363-01	cff667cc-724f-4f8a-96c0-cdd6512805a2	TCGA-X4-A8KQ-01A-12D-A363-01	cff667cc-724f-4f8a-96c0-cdd6512805a2		TCGA-X4-A8KQ-01	TCGA-X4-A8KQ-01A-12D-A365-05	TCGA-X4-A8KQ-01A-12R-A36B-13		cff667cc-724f-4f8a-96c0-cdd6512805a2	c81ad42d-9469-44f7-9d21-7278ae653654
TCGA-X4-A8KS-01	0	TCGA-X4-A8KS-01	979	0	TCGA-X4-A8KS	979	0	979	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-X4-A8KS-F67714	NO		M0	T2c	-22571		735					0	979		797			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2014-11-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	NO				NO			true		T2c	TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf			0		0		0		0		15		50		35		60	TUMOR FREE	3	Partial Remission/Response	No	.01	NO	RX	Primary Tumor	01	4			NO		NO	YES	X4			Prostate		A	LIVING	2011	Peripheral Zone			aa832875-9dec-4383-a2ff-9933771aafe8		984a3498-4b0b-4242-9fd3-640175da22ec		TCGA-X4-A8KS-01A-12D-A364-08	TCGA-X4-A8KS-01A-12D-A363-01	984a3498-4b0b-4242-9fd3-640175da22ec	TCGA-X4-A8KS-01A-12D-A363-01	984a3498-4b0b-4242-9fd3-640175da22ec			TCGA-X4-A8KS-01A-12D-A365-05	TCGA-X4-A8KS-01A-12R-A36B-13		984a3498-4b0b-4242-9fd3-640175da22ec	aa832875-9dec-4383-a2ff-9933771aafe8
TCGA-XA-A8JR-01	0	TCGA-XA-A8JR-01	119	0	TCGA-XA-A8JR	119	0	119	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68		NO		M0		-25090		223					0	119		69									2013-10-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral			YES				NO	7	0	true	N0	T2c	TCGA-XA-A8JR.587379B6-9AF9-471D-834C-668555ABC32A.pdf			0		0		0		0		50		0		50		60	WITH TUMOR	4	Stable Disease	No	0	NO	R2	Primary Tumor	01	3			NO	5	YES	NO	XA			Prostate		A	LIVING	2013				067ce4e2-41e6-413a-8f2b-86c0b41890a7	TCGA-XA-A8JR-01	419e456e-40fc-4bc7-8b9f-c54d9935b7e2		TCGA-XA-A8JR-01A-11D-A364-08	TCGA-XA-A8JR-01A-11D-A363-01	419e456e-40fc-4bc7-8b9f-c54d9935b7e2	TCGA-XA-A8JR-01A-11D-A363-01	419e456e-40fc-4bc7-8b9f-c54d9935b7e2		TCGA-XA-A8JR-01	TCGA-XA-A8JR-01A-11D-A365-05	TCGA-XA-A8JR-01A-11R-A36B-13		419e456e-40fc-4bc7-8b9f-c54d9935b7e2	067ce4e2-41e6-413a-8f2b-86c0b41890a7
TCGA-XJ-A83F-01	0	TCGA-XJ-A83F-01	1127	0	TCGA-XJ-A83F	1127	0	1127	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-XJ-A83F-F57164	NO						872					0	1127		762			NO		NO		Scheduled Follow-up Submission		2014-10-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Transurethral resection (TURBT)	20		NO	Right		NO	YES				NO	7	0	false	N0	T3a	TCGA-XJ-A83F.FAFE6F58-BE44-442F-B0E6-F3D7BD60EFBD.pdf			3		0		0		0		0		0		100		60	TUMOR FREE	3	Complete Remission/Response	No	0.01	NO	RX	Primary Tumor	01	4			NO		NO	YES	XJ	Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone			5f4264d3-d9a9-4068-9f91-11ae28e11c92	TCGA-XJ-A83F-01	ef59f19f-f7c0-4cf3-b686-a0cd09a996b3		TCGA-XJ-A83F-01A-11D-A34U-08	TCGA-XJ-A83F-01A-11D-A34T-01	ef59f19f-f7c0-4cf3-b686-a0cd09a996b3	TCGA-XJ-A83F-01A-11D-A34T-01	ef59f19f-f7c0-4cf3-b686-a0cd09a996b3		TCGA-XJ-A83F-01	TCGA-XJ-A83F-01A-11D-A34V-05	TCGA-XJ-A83F-01A-11R-A358-13		ef59f19f-f7c0-4cf3-b686-a0cd09a996b3	5f4264d3-d9a9-4068-9f91-11ae28e11c92
TCGA-XJ-A83G-01	0	TCGA-XJ-A83G-01	1157	0	TCGA-XJ-A83G	1157	0	1157	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			51		NO			T1c			1114					0	1157		1126			NO						2014-3-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral			YES				NO	4	0	false	N0	T3b	TCGA-XJ-A83G.F5DB0EA7-336E-4A5E-9BFD-3291A5DB4D3D.pdf			0		0		0		0		10		20		70		80	TUMOR FREE	4	Complete Remission/Response	No	0.01	NO		Primary Tumor	01	3			NO	5	NO	YES	XJ	Apex|Middle		Prostate		A	LIVING	2010	Peripheral Zone			74ef9a7f-de64-4de5-924c-ecb5b0ff5f6a	TCGA-XJ-A83G-01	585bed4d-5d57-4308-ab8e-7a0f97e48153		TCGA-XJ-A83G-01A-11D-A34U-08	TCGA-XJ-A83G-01A-11D-A34T-01	585bed4d-5d57-4308-ab8e-7a0f97e48153	TCGA-XJ-A83G-01A-11D-A34T-01	585bed4d-5d57-4308-ab8e-7a0f97e48153		TCGA-XJ-A83G-01	TCGA-XJ-A83G-01A-11D-A34V-05	TCGA-XJ-A83G-01A-11R-A358-13		585bed4d-5d57-4308-ab8e-7a0f97e48153	74ef9a7f-de64-4de5-924c-ecb5b0ff5f6a
TCGA-XJ-A83H-01		TCGA-XJ-A83H-01			TCGA-XJ-A83H				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-XJ-A83H-F66192	NO		M0	T2a			2241					0	0		1280			NO		NO		Scheduled Follow-up Submission		2014-10-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		YES	NO				NO			false		T2c	TCGA-XJ-A83H.B4E981CF-B54B-422D-9FD4-E867FAB1FAA8.pdf			0		0		0		0		10		20		70		75		3	Partial Remission/Response	No	0.03	NO	R0	Primary Tumor	01	4			NO		NO	YES	XJ	Middle|Base		Prostate		A	LIVING	2007	Peripheral Zone			75bbbfdb-cb7d-4d44-808d-acec09023c71	TCGA-XJ-A83H-01	617f26fb-18d8-44dc-8ced-bf3a32428fc9		TCGA-XJ-A83H-01A-11D-A34U-08	TCGA-XJ-A83H-01A-11D-A34T-01	617f26fb-18d8-44dc-8ced-bf3a32428fc9	TCGA-XJ-A83H-01A-11D-A34T-01	617f26fb-18d8-44dc-8ced-bf3a32428fc9		TCGA-XJ-A83H-01	TCGA-XJ-A83H-01A-11D-A34V-05	TCGA-XJ-A83H-01A-11R-A358-13		617f26fb-18d8-44dc-8ced-bf3a32428fc9	75bbbfdb-cb7d-4d44-808d-acec09023c71
TCGA-XJ-A9DI-01	0	TCGA-XJ-A9DI-01	1461	0	TCGA-XJ-A9DI	1461	0	1461	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-XJ-A9DI-F66555	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b		-61	1443					0	1461		1461			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-20	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	20		NO			NO	YES				NO	5	0	false	N0	T3b	TCGA-XJ-A9DI.8D5547ED-4864-4CE1-87D0-2FE7621B9B7C.pdf			15		2		1		2		15		40		44		60	TUMOR FREE	5	Complete Remission/Response	No	0.10	YES	R0	Primary Tumor	01	4			YES		NO	YES	XJ	Base		Prostate		A	LIVING	2009	Peripheral Zone			9d9b36bf-4c98-4190-8cf2-a8f339c9ecb2	TCGA-XJ-A9DI-01	4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b		TCGA-XJ-A9DI-01A-11D-A377-08	TCGA-XJ-A9DI-01A-11D-A376-01	4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b	TCGA-XJ-A9DI-01A-11D-A376-01	4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b		TCGA-XJ-A9DI-01	TCGA-XJ-A9DI-01A-11D-A378-05	TCGA-XJ-A9DI-01A-11R-A37H-13		4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b	9d9b36bf-4c98-4190-8cf2-a8f339c9ecb2
TCGA-XJ-A9DK-01	0	TCGA-XJ-A9DK-01	275	0	TCGA-XJ-A9DK	275	0	275	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-XJ-A9DK-F66561	NO		M0	T1c			2327					0	275		275			NO		NO		Scheduled Follow-up Submission		2014-10-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Right		YES	NO				NO			false		T2c	TCGA-XJ-A9DK.67B87CD1-3C76-47DD-93B9-BB9ADCF64404.pdf			0		0		0		0		50		0		50		60	TUMOR FREE	4	Complete Remission/Response	No	0.10	NO	R0	Primary Tumor	01	4			NO		NO	YES	XJ	Apex		Prostate		A	LIVING	2007	Peripheral Zone			0d1c2ae5-4823-42c3-a1fc-a730050f8952	TCGA-XJ-A9DK-01	f4024393-b3f0-43b4-916e-4e92cb95c084		TCGA-XJ-A9DK-01A-11D-A377-08	TCGA-XJ-A9DK-01A-11D-A376-01	f4024393-b3f0-43b4-916e-4e92cb95c084	TCGA-XJ-A9DK-01A-11D-A376-01	f4024393-b3f0-43b4-916e-4e92cb95c084		TCGA-XJ-A9DK-01	TCGA-XJ-A9DK-01A-11D-A378-05	TCGA-XJ-A9DK-01A-11R-A37H-13		f4024393-b3f0-43b4-916e-4e92cb95c084	0d1c2ae5-4823-42c3-a1fc-a730050f8952
TCGA-XJ-A9DQ-01	0	TCGA-XJ-A9DQ-01	91	0	TCGA-XJ-A9DQ	91	0	91	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			48	TCGA-XJ-A9DQ-F66562	NO		M0	T1c			2265					0	91					NO		NO		Scheduled Follow-up Submission		2014-10-20	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	20		NO	Right		YES	NO				NO			false		T2a	TCGA-XJ-A9DQ.CAD1C3A1-9EF6-4253-AEEB-C6D80A07C8E7.pdf			4		0		0		0		18		52		30		75		3		No		NO	R0	Primary Tumor	01	3			NO		NO	YES	XJ	Apex|Base		Prostate		A	LIVING	2007	Peripheral Zone			86347ea4-7535-43d0-85b5-dbedc5ae0be7	TCGA-XJ-A9DQ-01	8a7c238f-3e35-4156-b84d-44a95f8653bc		TCGA-XJ-A9DQ-01A-11D-A377-08	TCGA-XJ-A9DQ-01A-11D-A376-01	8a7c238f-3e35-4156-b84d-44a95f8653bc	TCGA-XJ-A9DQ-01A-11D-A376-01	8a7c238f-3e35-4156-b84d-44a95f8653bc		TCGA-XJ-A9DQ-01	TCGA-XJ-A9DQ-01A-11D-A378-05	TCGA-XJ-A9DQ-01A-11R-A37H-13		8a7c238f-3e35-4156-b84d-44a95f8653bc	86347ea4-7535-43d0-85b5-dbedc5ae0be7
TCGA-XJ-A9DX-01	0	TCGA-XJ-A9DX-01	973	0	TCGA-XJ-A9DX			973	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	YES	51	TCGA-XJ-A9DX-F66568	NO		M1c	T1c			651				151	0	973		790			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2014-10-20	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	22	2	false	N1	T3b	TCGA-XJ-A9DX.FB120749-2C3B-4760-82F2-73C630BF0346.pdf			0		0		0		0		20		0		80		90	TUMOR FREE	5	Partial Remission/Response	No	0.05		R1	Primary Tumor	01	4					NO	YES	XJ	Base		Prostate		A	LIVING	2012	Peripheral Zone			c6dc4750-6cb1-4fdf-83fa-c7f24801d653	TCGA-XJ-A9DX-01	66635f8c-2731-4231-9b71-f68f7d5f8072		TCGA-XJ-A9DX-01A-11D-A377-08	TCGA-XJ-A9DX-01A-11D-A376-01	66635f8c-2731-4231-9b71-f68f7d5f8072	TCGA-XJ-A9DX-01A-11D-A376-01	66635f8c-2731-4231-9b71-f68f7d5f8072		TCGA-XJ-A9DX-01	TCGA-XJ-A9DX-01A-11D-A378-05	TCGA-XJ-A9DX-01A-11R-A37H-13		66635f8c-2731-4231-9b71-f68f7d5f8072	c6dc4750-6cb1-4fdf-83fa-c7f24801d653
TCGA-XK-AAIR-01	0	TCGA-XK-AAIR-01	972	0	TCGA-XK-AAIR	972	0	972	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			75	TCGA-XK-AAIR-F68320	NO		M0	T1c	-27703		897					0	972		953			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-14	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	10		NO	Bilateral		NO	YES				NO	10	0	true	N0	T2c	TCGA-XK-AAIR.72784D06-D1DA-4E0C-B378-771030D57046.pdf			0		0		0		0		15		25		60		70	TUMOR FREE	4	Complete Remission/Response	No	0.09	NO	R0	Primary Tumor	01	4			NO		NO	YES	XK	Apex|Middle		Prostate		A	LIVING	2011				c7c18e4f-93d3-4b37-ba06-fe5af260f10d		daca8915-ce62-4c6b-a268-c23de4aed85e			TCGA-XK-AAIR-01A-11D-A41J-01	daca8915-ce62-4c6b-a268-c23de4aed85e	TCGA-XK-AAIR-01A-11D-A41J-01	daca8915-ce62-4c6b-a268-c23de4aed85e			TCGA-XK-AAIR-01A-11D-A41L-05	TCGA-XK-AAIR-01A-11R-A41R-13		daca8915-ce62-4c6b-a268-c23de4aed85e	c7c18e4f-93d3-4b37-ba06-fe5af260f10d
TCGA-XK-AAIV-01	0	TCGA-XK-AAIV-01	1133	0	TCGA-XK-AAIV	1133	0	1133	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-XK-AAIV-F66999	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23325	16	898		20	42		0	1133		85			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-29	MALE	10	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral		NO	YES				NO	18	2	true	N1	T3b	TCGA-XK-AAIV.84F5F45E-FE71-407C-A892-996B8A6CC0B6.pdf			90		10		0		0		10		40		50		60	TUMOR FREE	5	Complete Remission/Response	No	0.32	YES	R1	Primary Tumor	01	5			YES		NO	YES	XK	Apex|Middle|Base		Prostate		A	LIVING	2011				9a9c0fe0-c68b-44b2-a4f1-5963240d62c1	TCGA-XK-AAIV-01	822773fd-5a37-49ea-8064-c20738ecc24a			TCGA-XK-AAIV-01A-11D-A41J-01	822773fd-5a37-49ea-8064-c20738ecc24a	TCGA-XK-AAIV-01A-11D-A41J-01	822773fd-5a37-49ea-8064-c20738ecc24a		TCGA-XK-AAIV-01	TCGA-XK-AAIV-01A-11D-A41L-05	TCGA-XK-AAIV-01A-11R-A41R-13		822773fd-5a37-49ea-8064-c20738ecc24a	9a9c0fe0-c68b-44b2-a4f1-5963240d62c1
TCGA-XK-AAIW-01	0	TCGA-XK-AAIW-01	1218	0	TCGA-XK-AAIW	1218	0	1218	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			78	TCGA-XK-AAIW-F67892	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-28721	7	884		7			0	1218		769			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral		NO	YES				NO	7	0	true	N0	T3b	TCGA-XK-AAIW.A6E4263E-CFAA-4704-B143-095BA0E8DABF.pdf			0		0		0		0		0		25		75		80	TUMOR FREE	5	Complete Remission/Response	No	0.09	NO	R1	Primary Tumor	01	4			NO		NO	YES	XK	Middle|Base		Prostate		A	LIVING	2011				7f2247a5-a03b-4b5d-b841-00f831855819	TCGA-XK-AAIW-01	7f94c422-c322-46d8-be7a-eab05ea534af			TCGA-XK-AAIW-01A-11D-A41J-01	7f94c422-c322-46d8-be7a-eab05ea534af	TCGA-XK-AAIW-01A-11D-A41J-01	7f94c422-c322-46d8-be7a-eab05ea534af		TCGA-XK-AAIW-01	TCGA-XK-AAIW-01A-11D-A41L-05	TCGA-XK-AAIW-01A-11R-A41R-13		7f94c422-c322-46d8-be7a-eab05ea534af	7f2247a5-a03b-4b5d-b841-00f831855819
TCGA-XK-AAJ3-01	0	TCGA-XK-AAJ3-01	1262	0	TCGA-XK-AAJ3	1262	0	1262	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56	TCGA-XK-AAJ3-F66870	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20604	13	1185		6			0	1262		863			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-10-24	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	20		NO	Bilateral		NO	YES				NO	6	0	true	N0	T3a	TCGA-XK-AAJ3.6DAD48EB-0C26-4417-A2C1-57332165EEF2.pdf			0		0		0		0		0		30		70		80	TUMOR FREE	4	Complete Remission/Response	Yes, History of Prior Malignancy	0.09	NO	R0	Primary Tumor	01	4			NO		NO	YES	XK	Apex|Middle|Base		Prostate		A	LIVING	2010				74e3c5da-e60a-4f14-8d4a-1c68561e23bb	TCGA-XK-AAJ3-01	81674433-89de-4024-aadc-fd8fede17699			TCGA-XK-AAJ3-01A-11D-A41J-01	81674433-89de-4024-aadc-fd8fede17699	TCGA-XK-AAJ3-01A-11D-A41J-01	81674433-89de-4024-aadc-fd8fede17699		TCGA-XK-AAJ3-01	TCGA-XK-AAJ3-01A-11D-A41L-05	TCGA-XK-AAJ3-01A-11R-A41R-13		81674433-89de-4024-aadc-fd8fede17699	74e3c5da-e60a-4f14-8d4a-1c68561e23bb
TCGA-XK-AAJA-01	0	TCGA-XK-AAJA-01	930	0	TCGA-XK-AAJA	930	0	930	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-22771	15						0	930		712			NO		NO				2014-5-12	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES				NO	7	0		N0	T3a																				4	Complete Remission/Response	No	0.09	NO	R0	Primary Tumor	01	3			NO		NO	YES	XK	Apex|Middle|Base		Prostate			LIVING	2010				a899328a-df34-4ee5-9a1b-fde273ba16dc	TCGA-XK-AAJA-01	ec7657a0-88da-482a-90d1-1fd03578e11b			TCGA-XK-AAJA-01A-11D-A41J-01	ec7657a0-88da-482a-90d1-1fd03578e11b	TCGA-XK-AAJA-01A-11D-A41J-01	ec7657a0-88da-482a-90d1-1fd03578e11b		TCGA-XK-AAJA-01	TCGA-XK-AAJA-01A-11D-A41L-05	TCGA-XK-AAJA-01A-11R-A41R-13		ec7657a0-88da-482a-90d1-1fd03578e11b	a899328a-df34-4ee5-9a1b-fde273ba16dc
TCGA-XK-AAJP-01	0	TCGA-XK-AAJP-01	1259	0	TCGA-XK-AAJP	1259	0	1259	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-XK-AAJP-F66882	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24320	18	1008			18		0	1259		889			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	10		NO	Left		NO	YES				NO	6	0	true	N0	T3a	TCGA-XK-AAJP.53A095AB-0819-49D5-BC41-7D4F761BFAE0.pdf			3		0		0		0		5		25		70		90	TUMOR FREE	4	Complete Remission/Response	No	0.09	NO	R0	Primary Tumor	01	3			NO		NO	YES	XK	Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone			1deee350-b77c-48d1-858f-cdec5e1e47c1	TCGA-XK-AAJP-01	b426dd0e-446d-4738-a608-beaa368920bf			TCGA-XK-AAJP-01A-11D-A41J-01	b426dd0e-446d-4738-a608-beaa368920bf	TCGA-XK-AAJP-01A-11D-A41J-01	b426dd0e-446d-4738-a608-beaa368920bf		TCGA-XK-AAJP-01	TCGA-XK-AAJP-01A-11D-A41L-05	TCGA-XK-AAJP-01A-11R-A41R-13		b426dd0e-446d-4738-a608-beaa368920bf	1deee350-b77c-48d1-858f-cdec5e1e47c1
TCGA-XK-AAJR-01	0	TCGA-XK-AAJR-01	1124	0	TCGA-XK-AAJR	1124	0	1124	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-XK-AAJR-F67901	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22643	12	776		10		131	0	1124		753			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-12	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	10		NO	Bilateral		NO	YES				NO	8	0	true	N0	T3a	TCGA-XK-AAJR.2FB129E0-B651-4F2F-96DA-B2CCECD4F432.pdf			3		0		2		0		18		55		25		75	TUMOR FREE	4	Complete Remission/Response	No	0.09	NO	R0	Primary Tumor	01	3			NO	5	NO	YES	XK	Apex|Middle|Base		Prostate		A	LIVING	2011				1ebadd7d-f9b5-4593-9759-81f0541db272	TCGA-XK-AAJR-01	15850809-45e4-400d-89c0-20d313f699cb			TCGA-XK-AAJR-01A-11D-A41J-01	15850809-45e4-400d-89c0-20d313f699cb	TCGA-XK-AAJR-01A-11D-A41J-01	15850809-45e4-400d-89c0-20d313f699cb		TCGA-XK-AAJR-01	TCGA-XK-AAJR-01A-11D-A41L-05	TCGA-XK-AAJR-01A-11R-A41R-13		15850809-45e4-400d-89c0-20d313f699cb	1ebadd7d-f9b5-4593-9759-81f0541db272
TCGA-XK-AAJT-01	0	TCGA-XK-AAJT-01	1434	0	TCGA-XK-AAJT	1434	0	1434	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			75	TCGA-XK-AAJT-F66883	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-27428	19	1135		14			0	1434		566			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	10		NO	Bilateral		NO	YES				NO	4	0	true	N0	T3a	TCGA-XK-AAJT.7596C336-6BF6-4188-9C8B-90C0EC840911.pdf			3		0		1		0		4		35		60		90	TUMOR FREE	4	Partial Remission/Response	No	0.09	NO	R1	Primary Tumor	01	3			NO	5	NO	YES	XK	Base		Prostate		A	LIVING	2010	Peripheral Zone			286df95d-9c43-4702-a809-2a9dabc7e420	TCGA-XK-AAJT-01	4caa2b59-1435-4e64-9cf5-1658b3e9c147			TCGA-XK-AAJT-01A-11D-A41J-01	4caa2b59-1435-4e64-9cf5-1658b3e9c147	TCGA-XK-AAJT-01A-11D-A41J-01	4caa2b59-1435-4e64-9cf5-1658b3e9c147		TCGA-XK-AAJT-01	TCGA-XK-AAJT-01A-11D-A41L-05	TCGA-XK-AAJT-01A-11R-A41R-13		4caa2b59-1435-4e64-9cf5-1658b3e9c147	286df95d-9c43-4702-a809-2a9dabc7e420
TCGA-XK-AAJU-01	0	TCGA-XK-AAJU-01	1576	0	TCGA-XK-AAJU	1576	0	1576	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-XK-AAJU-F66884	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23958	9	1276					0	1576		1206			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES				NO	5	0	true	N0	T2c	TCGA-XK-AAJU.08C5834B-E57D-4182-86DE-4B83314D6799.pdf			0		0		0		0		10		40		50		60	TUMOR FREE	4	Complete Remission/Response	No	0.09	NO	R0	Primary Tumor	01	3			NO		NO	YES	XK	Apex|Middle|Base		Prostate		A	LIVING	2010				e7d1f18c-31e5-44cb-be70-1b76a3bbed36	TCGA-XK-AAJU-01	45f7bba9-5bf4-4b9c-b749-996e4b8d5582			TCGA-XK-AAJU-01A-11D-A41J-01	45f7bba9-5bf4-4b9c-b749-996e4b8d5582	TCGA-XK-AAJU-01A-11D-A41J-01	45f7bba9-5bf4-4b9c-b749-996e4b8d5582		TCGA-XK-AAJU-01	TCGA-XK-AAJU-01A-11D-A41L-05	TCGA-XK-AAJU-01A-11R-A41R-13		45f7bba9-5bf4-4b9c-b749-996e4b8d5582	e7d1f18c-31e5-44cb-be70-1b76a3bbed36
TCGA-XK-AAK1-01		TCGA-XK-AAK1-01			TCGA-XK-AAK1				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											575																											10		NO											true			TCGA-XK-AAK1.55565AD3-723E-4899-BBEA-D6FDF557E4C6.pdf			3		0		1		0		2		40		57		90								Primary Tumor	01													A						94b2fe48-1571-43b6-a1a2-31fcb80e962a	TCGA-XK-AAK1-01	ec4f5770-275f-494f-af91-b82e62f19f1a			TCGA-XK-AAK1-01A-11D-A41J-01	ec4f5770-275f-494f-af91-b82e62f19f1a	TCGA-XK-AAK1-01A-11D-A41J-01	ec4f5770-275f-494f-af91-b82e62f19f1a		TCGA-XK-AAK1-01	TCGA-XK-AAK1-01A-11D-A41L-05	TCGA-XK-AAK1-01A-11R-A41R-13		ec4f5770-275f-494f-af91-b82e62f19f1a	94b2fe48-1571-43b6-a1a2-31fcb80e962a
TCGA-XQ-A8TA-01		TCGA-XQ-A8TA-01			TCGA-XQ-A8TA				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma																																																																															Primary Tumor	01																			a3924d65-0b06-45f9-b367-564c3c7e6d6f	TCGA-XQ-A8TA-01	ae50d91a-35e2-4b18-8089-b18844a63b5e		TCGA-XQ-A8TA-01A-11D-A364-08	TCGA-XQ-A8TA-01A-11D-A363-01	ae50d91a-35e2-4b18-8089-b18844a63b5e	TCGA-XQ-A8TA-01A-11D-A363-01	ae50d91a-35e2-4b18-8089-b18844a63b5e		TCGA-XQ-A8TA-01	TCGA-XQ-A8TA-01A-11D-A365-05	TCGA-XQ-A8TA-01A-11R-A36B-13		ae50d91a-35e2-4b18-8089-b18844a63b5e	a3924d65-0b06-45f9-b367-564c3c7e6d6f
TCGA-XQ-A8TB-01		TCGA-XQ-A8TB-01			TCGA-XQ-A8TB				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											420																											90		NO											true			TCGA-XQ-A8TB.EDF35290-BD43-4527-A8BF-ED6F3CC1F0AB.pdf			0		0		0		0		0		50		50		60								Primary Tumor	01													A						4eef35af-93f0-4ea9-b8c6-65b0445cd602	TCGA-XQ-A8TB-01	ad733fd8-9c1f-4552-88de-3bc50ec1a9ac		TCGA-XQ-A8TB-01A-11D-A364-08	TCGA-XQ-A8TB-01A-11D-A363-01	ad733fd8-9c1f-4552-88de-3bc50ec1a9ac	TCGA-XQ-A8TB-01A-11D-A363-01	ad733fd8-9c1f-4552-88de-3bc50ec1a9ac		TCGA-XQ-A8TB-01	TCGA-XQ-A8TB-01A-11D-A365-05	TCGA-XQ-A8TB-01A-11R-A36B-13		ad733fd8-9c1f-4552-88de-3bc50ec1a9ac	4eef35af-93f0-4ea9-b8c6-65b0445cd602
TCGA-Y6-A8TL-01	0	TCGA-Y6-A8TL-01	775	0	TCGA-Y6-A8TL	775	0	775	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65		NO			T2a	-23776		677		328			0	775		775			YES	No Evidence of Extraprostatic Extension	NO				2014-4-17	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	370		NO	Right			YES				NO	5	0	true	N0	T3a	TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf			0		0		0		0		15		30		55		70	TUMOR FREE	3		No	0	NO	R0	Primary Tumor	01	3			NO		NO	YES	Y6	Apex		Prostate		A	LIVING	2012	Peripheral Zone			51c70f41-518b-4a37-b2d2-788cc107d61a	TCGA-Y6-A8TL-01	baeaec83-29cf-4fcd-b6b4-6054510d9d86		TCGA-Y6-A8TL-01A-21D-A377-08	TCGA-Y6-A8TL-01A-21D-A376-01	baeaec83-29cf-4fcd-b6b4-6054510d9d86	TCGA-Y6-A8TL-01A-21D-A376-01	baeaec83-29cf-4fcd-b6b4-6054510d9d86		TCGA-Y6-A8TL-01	TCGA-Y6-A8TL-01A-21D-A378-05	TCGA-Y6-A8TL-01A-21R-A37H-13		baeaec83-29cf-4fcd-b6b4-6054510d9d86	51c70f41-518b-4a37-b2d2-788cc107d61a
TCGA-Y6-A9XI-01		TCGA-Y6-A9XI-01			TCGA-Y6-A9XI				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											413																											210		NO											true			TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf			0		0		0		0		0		15		85		90								Primary Tumor	01													A						c3209e2a-b97c-46de-862d-3305c688944b	TCGA-Y6-A9XI-01	20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf			TCGA-Y6-A9XI-01A-11D-A41J-01	20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf	TCGA-Y6-A9XI-01A-11D-A41J-01	20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf		TCGA-Y6-A9XI-01	TCGA-Y6-A9XI-01A-11D-A41L-05	TCGA-Y6-A9XI-01A-11R-A41R-13		20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf	c3209e2a-b97c-46de-862d-3305c688944b
TCGA-YJ-A8SW-01	0	TCGA-YJ-A8SW-01	148	0	TCGA-YJ-A8SW			148	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67		YES			T1c			2051				148	0	148		148									2014-5-13	MALE	9	Prostate Adenocarcinoma  Other Subtype	No		8480/3	C61.9	YES	Core needle biopsy	1000		NO	Right			YES					2	0	true	N0	T3b	TCGA-YJ-A8SW.33D6587B-0289-49B5-9D16-497B6C17EFD9.pdf			5		0		5		0		5		25		65		70		5		No	0.38		R1	Primary Tumor	01	4					NO	YES	YJ			Prostate		A	LIVING	2008				1013996a-5544-46d7-8d5f-baba022aa9bf	TCGA-YJ-A8SW-01	6fc325bf-9627-45d7-9081-28df74e79bdb		TCGA-YJ-A8SW-01A-11D-A377-08	TCGA-YJ-A8SW-01A-11D-A376-01	6fc325bf-9627-45d7-9081-28df74e79bdb	TCGA-YJ-A8SW-01A-11D-A376-01	6fc325bf-9627-45d7-9081-28df74e79bdb		TCGA-YJ-A8SW-01	TCGA-YJ-A8SW-01A-11D-A378-05	TCGA-YJ-A8SW-01A-11R-A37H-13		6fc325bf-9627-45d7-9081-28df74e79bdb	1013996a-5544-46d7-8d5f-baba022aa9bf
TCGA-YL-A8HJ-01	0	TCGA-YL-A8HJ-01	1611	0	TCGA-YL-A8HJ	1611	0	1611	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-YL-A8HJ-F67253	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-21416	54	1653		-34			0	1611		1589			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-3	MALE	9	Prostate Adenocarcinoma  Other Subtype	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	370		NO	Bilateral		NO	NO				NO			true		T3b	TCGA-YL-A8HJ.A4B8AFC5-774E-4FB2-8191-735949EC3E42.pdf			0		0		0		0		0		45		55		70	TUMOR FREE	4	Complete Remission/Response	No	0.03	YES	R0	Primary Tumor	01	5			YES	3	NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones			71387db5-74cb-4843-a36f-c33fa14ee4a5	TCGA-YL-A8HJ-01	de7d6e8a-7408-4011-be1a-52e3cc9fa61b		TCGA-YL-A8HJ-01A-11D-A364-08	TCGA-YL-A8HJ-01A-11D-A363-01	de7d6e8a-7408-4011-be1a-52e3cc9fa61b	TCGA-YL-A8HJ-01A-11D-A363-01	de7d6e8a-7408-4011-be1a-52e3cc9fa61b		TCGA-YL-A8HJ-01	TCGA-YL-A8HJ-01A-11D-A365-05	TCGA-YL-A8HJ-01A-11R-A36B-13		de7d6e8a-7408-4011-be1a-52e3cc9fa61b	71387db5-74cb-4843-a36f-c33fa14ee4a5
TCGA-YL-A8HK-01	0	TCGA-YL-A8HK-01	1491	0	TCGA-YL-A8HK	1376	1	1491	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-YL-A8HK-F56601	YES	Normal (no evidence of prostate cancer) [cM0]	M0		-21850	27	1477		195		1376	0	1491	1376	1491			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event		2014-3-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	1	0	true	N0	T3b	TCGA-YL-A8HK.AB7217AC-ABF7-4704-9413-9298DDE688EE.pdf			3		2		0		1		2		28		70		70	WITH TUMOR	4	Complete Remission/Response	No	1.0	YES	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones			05bcfb9a-4e0f-4a0d-b294-294c2814190b	TCGA-YL-A8HK-01	8697017a-b4d9-4f19-8887-168e80124ebd		TCGA-YL-A8HK-01A-11D-A364-08	TCGA-YL-A8HK-01A-11D-A363-01	8697017a-b4d9-4f19-8887-168e80124ebd	TCGA-YL-A8HK-01A-11D-A363-01	8697017a-b4d9-4f19-8887-168e80124ebd		TCGA-YL-A8HK-01	TCGA-YL-A8HK-01A-11D-A365-05	TCGA-YL-A8HK-01A-11R-A36B-13		8697017a-b4d9-4f19-8887-168e80124ebd	05bcfb9a-4e0f-4a0d-b294-294c2814190b
TCGA-YL-A8HL-01	0	TCGA-YL-A8HL-01	1565	0	TCGA-YL-A8HL	1565	0	1565	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-YL-A8HL-F67258	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-21249	25	1387		27			0	1565		1173			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	8	2	true	N1	T3b	TCGA-YL-A8HL.0C91388C-CCC6-4BBD-B13A-E543A8FC2E5F.pdf			2		1		0		1		0		20		80		80		4	Stable Disease	No	0.03	YES	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones			7861b5c2-46b3-4887-a56b-5301da489f7a	TCGA-YL-A8HL-01	c291389a-1dfd-4eef-9542-7269a8bd797a		TCGA-YL-A8HL-01A-11D-A364-08	TCGA-YL-A8HL-01A-11D-A363-01	c291389a-1dfd-4eef-9542-7269a8bd797a	TCGA-YL-A8HL-01A-11D-A363-01	c291389a-1dfd-4eef-9542-7269a8bd797a		TCGA-YL-A8HL-01	TCGA-YL-A8HL-01A-11D-A365-05	TCGA-YL-A8HL-01A-11R-A36B-13		c291389a-1dfd-4eef-9542-7269a8bd797a	7861b5c2-46b3-4887-a56b-5301da489f7a
TCGA-YL-A8HM-01	0	TCGA-YL-A8HM-01	1482	0	TCGA-YL-A8HM	1473	1	1482	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-YL-A8HM-F67260	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24121	26	1323				1473	0	1482	1473	1124			NO		NO		Additional New Tumor Event		2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	10	0	true	N0	T3b	TCGA-YL-A8HM.4CDB8D1D-D1F1-4A78-A0C0-CA56CBC0689C.pdf			2		1		0		1		0		20		80		80	WITH TUMOR	4	Complete Remission/Response	No	0.03	YES	R0	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base	YES	Prostate	Biochemical Recurrence	A	LIVING	2010	Overlapping / Multiple Zones			367e8df6-4851-4dc7-9436-3e580b1bb71a	TCGA-YL-A8HM-01	49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45		TCGA-YL-A8HM-01A-11D-A364-08	TCGA-YL-A8HM-01A-11D-A363-01	49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45	TCGA-YL-A8HM-01A-11D-A363-01	49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45		TCGA-YL-A8HM-01	TCGA-YL-A8HM-01A-11D-A365-05	TCGA-YL-A8HM-01A-11R-A36B-13		49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45	367e8df6-4851-4dc7-9436-3e580b1bb71a
TCGA-YL-A8HO-01	0	TCGA-YL-A8HO-01	2183	0	TCGA-YL-A8HO	1068	1	2183	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	YES	67	TCGA-YL-A8HO-F57520	NO	Abnormal (not related to prostate cancer)	M0		-24509	62	2100		117		1068	0	2183	1068	2168			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Complete Remission/Response	2014-3-13	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	330		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	18	0	true	N0	T3a	TCGA-YL-A8HO.3C690B20-F9EC-456D-B397-928E39B3FFE2.pdf			3		1		0		1		15		25		60		60		4	Stable Disease	No	0.01	NO	R1	Primary Tumor	01	3			NO	5	NO	YES	YL	Middle|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones			625fe7dd-a0fe-48cf-aabd-54560205a122	TCGA-YL-A8HO-01	35e62a79-9fa0-4ff9-a8c3-d163817d7f08		TCGA-YL-A8HO-01A-11D-A364-08	TCGA-YL-A8HO-01A-11D-A363-01	35e62a79-9fa0-4ff9-a8c3-d163817d7f08	TCGA-YL-A8HO-01A-11D-A363-01	35e62a79-9fa0-4ff9-a8c3-d163817d7f08		TCGA-YL-A8HO-01	TCGA-YL-A8HO-01A-11D-A365-05	TCGA-YL-A8HO-01A-11R-A36B-13		35e62a79-9fa0-4ff9-a8c3-d163817d7f08	625fe7dd-a0fe-48cf-aabd-54560205a122
TCGA-YL-A8S8-01	0	TCGA-YL-A8S8-01	1890	0	TCGA-YL-A8S8	679	1	1890	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	YES	68	TCGA-YL-A8S8-F58862	YES	Normal (no evidence of prostate cancer) [cM0]	M0		-25119	18	2146		28		679	0	1890	679	1890			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Progressive Disease	2014-4-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	10	0	true	N0	T3a	TCGA-YL-A8S8.6D4A3078-4C6B-4E94-B859-CCA473B09CF9.pdf			0		0		0		0		0		30		70		80	WITH TUMOR	4	Stable Disease	No	1.36	NO	R1	Primary Tumor	01	5			NO		NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones			a4741b59-022f-464f-b233-2ed1f736ba01	TCGA-YL-A8S8-01	8a1e40cc-f9be-4df4-9958-53c97d7fd794		TCGA-YL-A8S8-01A-11D-A377-08	TCGA-YL-A8S8-01A-11D-A376-01	8a1e40cc-f9be-4df4-9958-53c97d7fd794	TCGA-YL-A8S8-01A-11D-A376-01	8a1e40cc-f9be-4df4-9958-53c97d7fd794		TCGA-YL-A8S8-01	TCGA-YL-A8S8-01A-11D-A378-05	TCGA-YL-A8S8-01A-11R-A37H-13		8a1e40cc-f9be-4df4-9958-53c97d7fd794	a4741b59-022f-464f-b233-2ed1f736ba01
TCGA-YL-A8S9-01	0	TCGA-YL-A8S9-01	1842	0	TCGA-YL-A8S9	1006	1	1842	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	YES	63	TCGA-YL-A8S9-F58868	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23204	20						0	1842	1006	1839			NO		NO		Additional New Tumor Event	Complete Remission/Response	2014-4-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES		Locoregional Recurrence		YES	5	0		N0	T3a																				4	Stable Disease	No	0.03	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	YL	Apex|Middle		Prostate			LIVING	2008	Overlapping / Multiple Zones			a76269f1-dda8-489e-9a1b-44c146a3bbc7	TCGA-YL-A8S9-01	ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea		TCGA-YL-A8S9-01A-11D-A377-08	TCGA-YL-A8S9-01A-11D-A376-01	ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea	TCGA-YL-A8S9-01A-11D-A376-01	ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea		TCGA-YL-A8S9-01	TCGA-YL-A8S9-01A-11D-A378-05	TCGA-YL-A8S9-01A-11R-A37H-13		ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea	a76269f1-dda8-489e-9a1b-44c146a3bbc7
TCGA-YL-A8SA-01	0	TCGA-YL-A8SA-01	512	0	TCGA-YL-A8SA	512	0	512	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69	TCGA-YL-A8SA-F67565	NO		M0	T2b	-25340		1465					0	512		467			NO		NO		Scheduled Follow-up Submission		2014-11-6	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	200		NO	Bilateral		YES	YES				NO	9	0	true	N0	T3b	TCGA-YL-A8SA.F837EF53-FF44-4F51-8764-27B00168B113.pdf			0		0		0		0		0		30		70		80		4	Stable Disease	No	0.06	YES	R1	Primary Tumor	01	4			NO	5	NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones			be2975bb-ccc9-487c-9c2b-5fba604e8333	TCGA-YL-A8SA-01	42b3e255-38df-41f7-a4b8-77510d467dd2		TCGA-YL-A8SA-01A-21D-A377-08	TCGA-YL-A8SA-01A-21D-A376-01	42b3e255-38df-41f7-a4b8-77510d467dd2	TCGA-YL-A8SA-01A-21D-A376-01	42b3e255-38df-41f7-a4b8-77510d467dd2		TCGA-YL-A8SA-01	TCGA-YL-A8SA-01A-21D-A378-05	TCGA-YL-A8SA-01A-21R-A37H-13		42b3e255-38df-41f7-a4b8-77510d467dd2	be2975bb-ccc9-487c-9c2b-5fba604e8333
TCGA-YL-A8SB-01	0	TCGA-YL-A8SB-01	1719	0	TCGA-YL-A8SB	1384	1	1719	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	NO	62	TCGA-YL-A8SB-F67264	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22991	27			52		1384	0	1719	1384	1384			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES		Biochemical evidence of disease		YES	3	0		N0	T3a																			WITH TUMOR	4	Stable Disease	No	0.23	YES	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base	YES	Prostate	Biochemical Recurrence		LIVING	2010	Overlapping / Multiple Zones			e26a92b6-bb88-4e60-b26c-d4ca9c33e413	TCGA-YL-A8SB-01	d593d47e-581a-4da3-bb3a-648b2bfb4cae		TCGA-YL-A8SB-01A-31D-A377-08	TCGA-YL-A8SB-01A-31D-A376-01	d593d47e-581a-4da3-bb3a-648b2bfb4cae	TCGA-YL-A8SB-01A-31D-A376-01	d593d47e-581a-4da3-bb3a-648b2bfb4cae		TCGA-YL-A8SB-01	TCGA-YL-A8SB-01A-31D-A378-05	TCGA-YL-A8SB-01A-31R-A37H-13		d593d47e-581a-4da3-bb3a-648b2bfb4cae	e26a92b6-bb88-4e60-b26c-d4ca9c33e413
TCGA-YL-A8SC-01	0	TCGA-YL-A8SC-01	1261	0	TCGA-YL-A8SC	152	1	1261	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-YL-A8SC-F58906	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24206	40	1387		47		152	0	1261	152	1261			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Partial Remission/Response	2014-4-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	100		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	6	0	true	N0	T3a	TCGA-YL-A8SC.557F4A89-87FC-44FA-9460-F8D1BCA759AE.pdf			0		0		0		0		0		35		65		85	WITH TUMOR	4	Partial Remission/Response	No	0.65	NO	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base	YES	Prostate	Biochemical Recurrence	A	LIVING	2010	Overlapping / Multiple Zones			340ed0e1-02c7-4c87-a73f-c3652a956b18	TCGA-YL-A8SC-01	cc9dfa83-d316-4455-bd08-967fb33a54ff		TCGA-YL-A8SC-01A-11D-A377-08	TCGA-YL-A8SC-01A-11D-A376-01	cc9dfa83-d316-4455-bd08-967fb33a54ff	TCGA-YL-A8SC-01A-11D-A376-01	cc9dfa83-d316-4455-bd08-967fb33a54ff		TCGA-YL-A8SC-01	TCGA-YL-A8SC-01A-11D-A378-05	TCGA-YL-A8SC-01A-11R-A37H-13		cc9dfa83-d316-4455-bd08-967fb33a54ff	340ed0e1-02c7-4c87-a73f-c3652a956b18
TCGA-YL-A8SF-01	0	TCGA-YL-A8SF-01	1373	0	TCGA-YL-A8SF	1373	0	1373	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			62	TCGA-YL-A8SF-F67270	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22844	29			22			0	1373		1247			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-3	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	2	0		N0	T3b																				4	Stable Disease	No	0.01	NO	R1	Primary Tumor	01	4			NO	5	NO	YES	YL	Apex|Middle|Base		Prostate			LIVING	2010	Overlapping / Multiple Zones			f138ac7a-9881-4a60-b828-6b12c74c7ed4	TCGA-YL-A8SF-01	bac074d2-4e5b-4450-baee-749fc4a93c7a		TCGA-YL-A8SF-01A-11D-A377-08	TCGA-YL-A8SF-01A-11D-A376-01	bac074d2-4e5b-4450-baee-749fc4a93c7a	TCGA-YL-A8SF-01A-11D-A376-01	bac074d2-4e5b-4450-baee-749fc4a93c7a		TCGA-YL-A8SF-01	TCGA-YL-A8SF-01A-11D-A378-05	TCGA-YL-A8SF-01A-11R-A37H-13		bac074d2-4e5b-4450-baee-749fc4a93c7a	f138ac7a-9881-4a60-b828-6b12c74c7ed4
TCGA-YL-A8SH-01	1	TCGA-YL-A8SH-01	875	1	TCGA-YL-A8SH	875	0	875	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69		NO		M0		-25395		1481	875				0			617			NO		NO				2014-4-25	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	510		NO	Bilateral			YES				NO	21	0	true	N0	T3a		Other Non-Malignant Disease		0		0		0		0		10		20		70		80	TUMOR FREE	4	Complete Remission/Response	No	0.06	NO	R0	Primary Tumor	01	3		Death Certificate	NO		NO	YES	YL	Apex|Middle|Base		Prostate		B	DECEASED	2009	Overlapping / Multiple Zones			ec6b4cf0-43a8-49bc-9b96-7c20b05301a3	TCGA-YL-A8SH-01	905e6c11-d8d7-40a3-a933-f450c544714e		TCGA-YL-A8SH-01B-11D-A377-08	TCGA-YL-A8SH-01B-11D-A376-01	905e6c11-d8d7-40a3-a933-f450c544714e	TCGA-YL-A8SH-01B-11D-A376-01	905e6c11-d8d7-40a3-a933-f450c544714e		TCGA-YL-A8SH-01	TCGA-YL-A8SH-01B-11D-A378-05	TCGA-YL-A8SH-01B-11R-A37H-13		905e6c11-d8d7-40a3-a933-f450c544714e	ec6b4cf0-43a8-49bc-9b96-7c20b05301a3
TCGA-YL-A8SI-01	0	TCGA-YL-A8SI-01	1614	0	TCGA-YL-A8SI	1423	1	1614	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	YES	69	TCGA-YL-A8SI-F67703	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-25292	47	1345		62		1423	0	1614	1423	1441			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-10	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	390		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	15	0	true	N0	T3a	TCGA-YL-A8SI.30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE.pdf			3		1		0		2		2		18		80		80	TUMOR FREE	4	Complete Remission/Response	No	0.48	NO	R0	Primary Tumor	01	5			NO		NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones			0f3be0c2-2e98-4bb8-acaa-c81b4b99053a	TCGA-YL-A8SI-01	968c1021-d6c1-4e0e-8417-43b78a6bdf6d			TCGA-YL-A8SI-01A-11D-A41J-01	968c1021-d6c1-4e0e-8417-43b78a6bdf6d	TCGA-YL-A8SI-01A-11D-A41J-01	968c1021-d6c1-4e0e-8417-43b78a6bdf6d		TCGA-YL-A8SI-01	TCGA-YL-A8SI-01A-11D-A41L-05	TCGA-YL-A8SI-01A-11R-A41R-13		968c1021-d6c1-4e0e-8417-43b78a6bdf6d	0f3be0c2-2e98-4bb8-acaa-c81b4b99053a
TCGA-YL-A8SJ-01	0	TCGA-YL-A8SJ-01	1395	0	TCGA-YL-A8SJ	752	1	1395	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	NO	YES	60	TCGA-YL-A8SJ-F58899	YES		M0		-21916		1306				752	0	1395	752	1426			NO		NO		Additional New Tumor Event	Partial Remission/Response	2014-4-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	460		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	29	0	true	N0	T3b				0		0		0		0		0		30		70		80	WITH TUMOR	4	Complete Remission/Response	No	0.24	NO	R0	Primary Tumor	01	5			NO		NO	YES	YL	Middle|Base		Prostate		B	LIVING	2010	Overlapping / Multiple Zones			51a6c00f-3dc6-4da5-b8c6-836b9dd6b509	TCGA-YL-A8SJ-01	146b24ab-44b3-4b64-80c2-7ced0f829501		TCGA-YL-A8SJ-01B-11D-A377-08	TCGA-YL-A8SJ-01B-11D-A376-01	146b24ab-44b3-4b64-80c2-7ced0f829501	TCGA-YL-A8SJ-01B-11D-A376-01	146b24ab-44b3-4b64-80c2-7ced0f829501		TCGA-YL-A8SJ-01	TCGA-YL-A8SJ-01B-11D-A378-05	TCGA-YL-A8SJ-01B-11R-A37H-13		146b24ab-44b3-4b64-80c2-7ced0f829501	51a6c00f-3dc6-4da5-b8c6-836b9dd6b509
TCGA-YL-A8SK-01	0	TCGA-YL-A8SK-01	1408	0	TCGA-YL-A8SK	1408	0	1408	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-YL-A8SK-F67551	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24759	38	1208					0	1408		924			NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-11-6	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	410		NO	Bilateral		NO	YES				NO	20	4	true	N1	T3b				0		0		0		0		40		10		50		60		4	Stable Disease	No	0.03	YES	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base		Prostate		B	LIVING	2010	Overlapping / Multiple Zones			3ca776b9-4020-47b4-a3c1-bd31fb4a7138	TCGA-YL-A8SK-01	530578d1-044b-4423-bd9c-ae80a2d7fda1		TCGA-YL-A8SK-01B-21D-A377-08	TCGA-YL-A8SK-01B-21D-A376-01	530578d1-044b-4423-bd9c-ae80a2d7fda1	TCGA-YL-A8SK-01B-21D-A376-01	530578d1-044b-4423-bd9c-ae80a2d7fda1		TCGA-YL-A8SK-01	TCGA-YL-A8SK-01B-21D-A378-05	TCGA-YL-A8SK-01B-21R-A37H-13		530578d1-044b-4423-bd9c-ae80a2d7fda1	3ca776b9-4020-47b4-a3c1-bd31fb4a7138
TCGA-YL-A8SL-01	0	TCGA-YL-A8SL-01	987	0	TCGA-YL-A8SL	987	0	987	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			74	TCGA-YL-A8SL-F67548	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-27033	41	835		43			0	987		623			YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-6	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	760		NO	Bilateral		NO	YES				NO	19	3	true	N1	T3b				0		0		0		0		30		20		50		60	TUMOR FREE	4	Complete Remission/Response	No	0	NO	R0	Primary Tumor	01	4			YES	3	NO	YES	YL	Apex|Middle|Base		Prostate		B	LIVING	2011	Overlapping / Multiple Zones			c0bb7dd0-3492-4081-9ca8-a3e74ebc7e4c	TCGA-YL-A8SL-01	20f7a673-eb82-4bfc-a757-096b2fc3f98b		TCGA-YL-A8SL-01B-21D-A377-08	TCGA-YL-A8SL-01B-21D-A376-01	20f7a673-eb82-4bfc-a757-096b2fc3f98b	TCGA-YL-A8SL-01B-21D-A376-01	20f7a673-eb82-4bfc-a757-096b2fc3f98b		TCGA-YL-A8SL-01	TCGA-YL-A8SL-01B-21D-A378-05	TCGA-YL-A8SL-01B-21R-A37H-13		20f7a673-eb82-4bfc-a757-096b2fc3f98b	c0bb7dd0-3492-4081-9ca8-a3e74ebc7e4c
TCGA-YL-A8SO-01	0	TCGA-YL-A8SO-01	3479	0	TCGA-YL-A8SO	3479	0	3479	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-YL-A8SO-F67275	NO		M0	T1a	-23584		3329					0	3479		3247							Scheduled Follow-up Submission	Stable Disease	2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Transurethral resection (TURBT)	1270		NO	Bilateral		NO	NO				NO			true		T3a				0		0		0		0		10		60		30		60		4	Stable Disease	No	0	NO	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle		Prostate		B	LIVING	2004	Overlapping / Multiple Zones			e5d7a947-32e5-4be5-ba82-b0077531b7c3	TCGA-YL-A8SO-01	7471bd76-b32f-41a3-bf95-8752745a7e70		TCGA-YL-A8SO-01B-31D-A377-08	TCGA-YL-A8SO-01B-31D-A376-01	7471bd76-b32f-41a3-bf95-8752745a7e70	TCGA-YL-A8SO-01B-31D-A376-01	7471bd76-b32f-41a3-bf95-8752745a7e70		TCGA-YL-A8SO-01	TCGA-YL-A8SO-01B-31D-A378-05	TCGA-YL-A8SO-01B-31R-A37H-13		7471bd76-b32f-41a3-bf95-8752745a7e70	e5d7a947-32e5-4be5-ba82-b0077531b7c3
TCGA-YL-A8SP-01	0	TCGA-YL-A8SP-01	2170	0	TCGA-YL-A8SP	2036	1	2170	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58	TCGA-YL-A8SP-F59002	NO		M0	T2a	-21455		2125				2036	0	2170	2036	2155							Additional New Tumor Event		2014-4-30	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	1680		NO	Bilateral		NO	NO		Biochemical evidence of disease		YES			true		T3b				0		0		0		0		0		30		70		75	WITH TUMOR	4	Complete Remission/Response	No	0.38	NO	R1	Primary Tumor	01	5			YES	3	NO	YES	YL	Apex|Middle|Base		Prostate		B	LIVING	2008	Overlapping / Multiple Zones			c359a565-421b-450b-b214-2d21e84e1daa	TCGA-YL-A8SP-01	2974a881-8198-4c55-89b9-822b8f8c94b0		TCGA-YL-A8SP-01B-11D-A377-08	TCGA-YL-A8SP-01B-11D-A376-01	2974a881-8198-4c55-89b9-822b8f8c94b0	TCGA-YL-A8SP-01B-11D-A376-01	2974a881-8198-4c55-89b9-822b8f8c94b0		TCGA-YL-A8SP-01	TCGA-YL-A8SP-01B-11D-A378-05	TCGA-YL-A8SP-01B-11R-A37H-13		2974a881-8198-4c55-89b9-822b8f8c94b0	c359a565-421b-450b-b214-2d21e84e1daa
TCGA-YL-A8SQ-01	0	TCGA-YL-A8SQ-01	1910	0	TCGA-YL-A8SQ	1445	1	1910	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61	TCGA-YL-A8SQ-F59021	YES	Normal (no evidence of prostate cancer) [cM0]	M0		-22482	19	1898				1445	0	1910	1445	1943			NO		NO		Additional New Tumor Event		2014-4-30	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	2630		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	05	0	true	N0	T3b				0		0		0		0		0		40		60		70	WITH TUMOR	4	Complete Remission/Response	No	1.1	YES	R1	Primary Tumor	01	5			YES	3	NO	YES	YL	Apex|Middle|Base	YES	Prostate	Biochemical Recurrence	B	LIVING	2008	Overlapping / Multiple Zones			25733085-428b-44c9-b858-2290abe68f73	TCGA-YL-A8SQ-01	8da55b3d-99f9-4ab4-8ee3-35bafb8d624f		TCGA-YL-A8SQ-01B-11D-A377-08	TCGA-YL-A8SQ-01B-11D-A376-01	8da55b3d-99f9-4ab4-8ee3-35bafb8d624f	TCGA-YL-A8SQ-01B-11D-A376-01	8da55b3d-99f9-4ab4-8ee3-35bafb8d624f		TCGA-YL-A8SQ-01	TCGA-YL-A8SQ-01B-11D-A378-05	TCGA-YL-A8SQ-01B-11R-A37H-13		8da55b3d-99f9-4ab4-8ee3-35bafb8d624f	25733085-428b-44c9-b858-2290abe68f73
TCGA-YL-A8SR-01	0	TCGA-YL-A8SR-01	273	0	TCGA-YL-A8SR	273	0	273	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-YL-A8SR-F67281	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23488	-1060			-1062			0	273		222			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-11-7	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		YES	YES				NO	6	0		N0	T3a																				4	Stable Disease	No	0.06	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	YL	Apex|Middle|Base		Prostate			LIVING	2011	Overlapping / Multiple Zones			a0093504-0c0f-4c09-81e0-0828928cbf7e	TCGA-YL-A8SR-01	c3d6c3bb-8882-4033-855e-f164c03799cd		TCGA-YL-A8SR-01B-11D-A377-08	TCGA-YL-A8SR-01B-11D-A376-01	c3d6c3bb-8882-4033-855e-f164c03799cd	TCGA-YL-A8SR-01B-11D-A376-01	c3d6c3bb-8882-4033-855e-f164c03799cd		TCGA-YL-A8SR-01	TCGA-YL-A8SR-01B-11D-A378-05	TCGA-YL-A8SR-01B-11R-A37H-13		c3d6c3bb-8882-4033-855e-f164c03799cd	a0093504-0c0f-4c09-81e0-0828928cbf7e
TCGA-YL-A9WH-01	0	TCGA-YL-A9WH-01	427	0	TCGA-YL-A9WH	427	0	427	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-YL-A9WH-F67282	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24755	55						0	427		349			NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy				Bilateral		YES	YES				NO	2	1		N1	T3b																				4	Stable Disease	No	0.03	YES	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base		Prostate			LIVING	2011	Overlapping / Multiple Zones			f396fb5a-ea56-45de-8277-43d9f858264b	TCGA-YL-A9WH-01	abef0f85-b339-476f-bc5b-faded3ad6cf7		TCGA-YL-A9WH-01A-11D-A377-08	TCGA-YL-A9WH-01A-11D-A376-01	abef0f85-b339-476f-bc5b-faded3ad6cf7	TCGA-YL-A9WH-01A-11D-A376-01	abef0f85-b339-476f-bc5b-faded3ad6cf7		TCGA-YL-A9WH-01	TCGA-YL-A9WH-01A-11D-A378-05	TCGA-YL-A9WH-01A-11R-A37H-13		abef0f85-b339-476f-bc5b-faded3ad6cf7	f396fb5a-ea56-45de-8277-43d9f858264b
TCGA-YL-A9WI-01	0	TCGA-YL-A9WI-01	1623	0	TCGA-YL-A9WI	1623	0	1623	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			63	TCGA-YL-A9WI-F67552	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23184	93	1325		99			0	1623		1259			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-6	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	680		NO	Bilateral		NO	YES				NO	15	1	true	N1	T3a	TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf			40		20		0		20		0		30		70		70	TUMOR FREE	4	Stable Disease	No	0.03	NO	R0	Primary Tumor	01	5			NO		NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones			221c55a6-dbf4-4dd0-9000-addd29d67f35	TCGA-YL-A9WI-01	2bb8de70-7555-4409-b667-c11b1fb716b5		TCGA-YL-A9WI-01A-11D-A377-08	TCGA-YL-A9WI-01A-11D-A376-01	2bb8de70-7555-4409-b667-c11b1fb716b5	TCGA-YL-A9WI-01A-11D-A376-01	2bb8de70-7555-4409-b667-c11b1fb716b5		TCGA-YL-A9WI-01	TCGA-YL-A9WI-01A-11D-A378-05	TCGA-YL-A9WI-01A-11R-A37H-13		2bb8de70-7555-4409-b667-c11b1fb716b5	221c55a6-dbf4-4dd0-9000-addd29d67f35
TCGA-YL-A9WJ-01	1	TCGA-YL-A9WJ-01	1855	1	TCGA-YL-A9WJ	1476	1	1855	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			47	TCGA-YL-A9WJ-F58534	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T4	-17322	19	2017	1855	21	51	76	0		1476	838			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-4-14	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	360		NO	Bilateral		NO	YES	Other, specify	Distant Metastasis	Neck	YES	10	1	true	N1	T3b	TCGA-YL-A9WJ.EC025153-CB9C-4683-82B4-985AAA9E80AC.pdf	Prostate Cancer		0		0		0		0		30		20		50		60	WITH TUMOR	4	Partial Remission/Response	No	3.1	YES	R1	Primary Tumor	01	4		Medical Record		3	NO	YES	YL	Apex|Middle		Prostate		A	DECEASED	2008	Overlapping / Multiple Zones			ac034f65-6270-462d-a946-0366de1c0eeb	TCGA-YL-A9WJ-01	79169be4-6386-4c36-9330-c56b6c9e6ebd		TCGA-YL-A9WJ-01A-11D-A377-08	TCGA-YL-A9WJ-01A-11D-A376-01	79169be4-6386-4c36-9330-c56b6c9e6ebd	TCGA-YL-A9WJ-01A-11D-A376-01	79169be4-6386-4c36-9330-c56b6c9e6ebd		TCGA-YL-A9WJ-01	TCGA-YL-A9WJ-01A-11D-A378-05	TCGA-YL-A9WJ-01A-11R-A37H-13		79169be4-6386-4c36-9330-c56b6c9e6ebd	ac034f65-6270-462d-a946-0366de1c0eeb
TCGA-YL-A9WK-01	0	TCGA-YL-A9WK-01	1897	0	TCGA-YL-A9WK	1009	1	1897	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma	YES	NO	63	TCGA-YL-A9WK-F58524	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-23272	329	1865				1009	0	1897	1009	1871	1687		NO		NO		Additional New Tumor Event		2014-4-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	2085		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	1	0	true	N0	T3b	TCGA-YL-A9WK.B963A02D-0AE8-494C-A522-376AFABA374A.pdf			40		20		0		20		0		10		90		90	WITH TUMOR	4	Complete Remission/Response	No	15.6	NO	R1	Primary Tumor	01	5			YES		NO	YES	YL	Middle	YES	Prostate	Biochemical Recurrence	A	LIVING	2008	Overlapping / Multiple Zones			4397fb23-cb98-4b3b-bc8d-b49f1c419f29		0da1e08f-d489-4579-a1ac-5cd79072ce9a		TCGA-YL-A9WK-01A-11D-A377-08	TCGA-YL-A9WK-01A-11D-A376-01	0da1e08f-d489-4579-a1ac-5cd79072ce9a	TCGA-YL-A9WK-01A-11D-A376-01	0da1e08f-d489-4579-a1ac-5cd79072ce9a			TCGA-YL-A9WK-01A-11D-A378-05	TCGA-YL-A9WK-01A-11R-A37H-13		0da1e08f-d489-4579-a1ac-5cd79072ce9a	4397fb23-cb98-4b3b-bc8d-b49f1c419f29
TCGA-YL-A9WL-01	0	TCGA-YL-A9WL-01	740	0	TCGA-YL-A9WL	740	1	740	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			59	TCGA-YL-A9WL-F58511	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-21626	28	755		39		740	0	740	740	740			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event		2014-4-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	1300		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	15	0	true	N0	T3a	TCGA-YL-A9WL.F309E64F-E31C-478A-9F2B-B33AAD6BE37A.pdf			40		20		0		20		0		20		80		80	WITH TUMOR	4	Complete Remission/Response	No	6.4	YES	R0	Primary Tumor	01	5			YES	3	NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			2f187600-487a-4bf0-ab89-2b7adc4b0c04	TCGA-YL-A9WL-01	a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b			TCGA-YL-A9WL-01A-11D-A41J-01	a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b	TCGA-YL-A9WL-01A-11D-A41J-01	a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b		TCGA-YL-A9WL-01	TCGA-YL-A9WL-01A-11D-A41L-05	TCGA-YL-A9WL-01A-11R-A41R-13		a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b	2f187600-487a-4bf0-ab89-2b7adc4b0c04
TCGA-YL-A9WX-01	0	TCGA-YL-A9WX-01	1518	0	TCGA-YL-A9WX	1506	1	1518	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			68	TCGA-YL-A9WX-F58515	YES	Abnormal (not related to prostate cancer)	M0	T3a	-25008	34	1520		37	41	1506	0	1518	1506	1610			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Additional New Tumor Event		2014-4-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	960		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	11	1	true	N1	T3b	TCGA-YL-A9WX.F7A04AAE-D1E0-4842-82AD-64F2813454F2.pdf			0		0		0		0		35		5		60		75	WITH TUMOR	4	Complete Remission/Response	No	0.76	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	YL	Middle		Prostate		A	LIVING	2009	Overlapping / Multiple Zones			3b922775-6bb2-46c0-9cdb-dcf35554a31e	TCGA-YL-A9WX-01	31f4a718-276b-4bf1-a61b-b6d946a91c32			TCGA-YL-A9WX-01A-21D-A41J-01	31f4a718-276b-4bf1-a61b-b6d946a91c32	TCGA-YL-A9WX-01A-21D-A41J-01	31f4a718-276b-4bf1-a61b-b6d946a91c32		TCGA-YL-A9WX-01	TCGA-YL-A9WX-01A-21D-A41L-05	TCGA-YL-A9WX-01A-21R-A41R-13		31f4a718-276b-4bf1-a61b-b6d946a91c32	3b922775-6bb2-46c0-9cdb-dcf35554a31e
TCGA-YL-A9WY-01	0	TCGA-YL-A9WY-01	862	0	TCGA-YL-A9WY	765	1	862	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-YL-A9WY-F58520	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-21164	50	785			62	765	0	862	765	765			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1]	Additional New Tumor Event		2014-4-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	970		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	19	11	true	N1	T3b	TCGA-YL-A9WY.50396173-9B31-42A1-81BC-9D2B5905E54A.pdf			0		0		0		0		10		0		90		60	WITH TUMOR	5	Complete Remission/Response	No	1.8	NO	R1	Primary Tumor	01	4			YES		NO	YES	YL	Apex|Middle|Base	YES	Prostate	Biochemical Recurrence	A	LIVING	2011	Overlapping / Multiple Zones			ef86f189-4581-438e-a5f6-dc6bf13af20b	TCGA-YL-A9WY-01	93dcc430-967c-4410-97ec-c3c814d9b826			TCGA-YL-A9WY-01A-11D-A41J-01	93dcc430-967c-4410-97ec-c3c814d9b826	TCGA-YL-A9WY-01A-11D-A41J-01	93dcc430-967c-4410-97ec-c3c814d9b826		TCGA-YL-A9WY-01	TCGA-YL-A9WY-01A-11D-A41L-05	TCGA-YL-A9WY-01A-11R-A41R-13		93dcc430-967c-4410-97ec-c3c814d9b826	ef86f189-4581-438e-a5f6-dc6bf13af20b
TCGA-ZG-A8QW-01	0	TCGA-ZG-A8QW-01	94	0	TCGA-ZG-A8QW	94	0	94	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-ZG-A8QW-F67802		Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-26632	8	156			43		0	94					NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	270		NO	Bilateral		NO	YES				NO	13	1	true	N1	T3b	TCGA-ZG-A8QW.6883BDF0-68B9-4D35-8A55-025C98AD2FCA.pdf			0		0		2		0		0		18		80		90	TUMOR FREE	4	Stable Disease	No		NO	R0	Primary Tumor	01	5			NO		NO	YES	ZG	Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			944f9440-9036-4aee-9d33-a97d56591669	TCGA-ZG-A8QW-01	b3079945-f405-4810-b7cc-efa81b3b46ad		TCGA-ZG-A8QW-01A-11D-A377-08	TCGA-ZG-A8QW-01A-11D-A376-01	b3079945-f405-4810-b7cc-efa81b3b46ad	TCGA-ZG-A8QW-01A-11D-A376-01	b3079945-f405-4810-b7cc-efa81b3b46ad		TCGA-ZG-A8QW-01	TCGA-ZG-A8QW-01A-11D-A378-05	TCGA-ZG-A8QW-01A-11R-A37H-13		b3079945-f405-4810-b7cc-efa81b3b46ad	944f9440-9036-4aee-9d33-a97d56591669
TCGA-ZG-A8QX-01	0	TCGA-ZG-A8QX-01	442	0	TCGA-ZG-A8QX	442	0	442	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			56	TCGA-ZG-A8QX-F67804			M0	T1c	-20683		167					0	442					NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	18	0	true	N0	T2c	TCGA-ZG-A8QX.153CAD0D-4566-4BC2-B33D-FF1B44BA8E2B.pdf			0		0		0		0		0		20		80		90	TUMOR FREE	3	Stable Disease	No		NO	R0	Primary Tumor	01	3			NO		NO	YES	ZG	Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			3bc3b8cd-b2c6-455c-a336-704756b026e9	TCGA-ZG-A8QX-01	1727eb06-107a-4b21-97d7-20cabf1826ac		TCGA-ZG-A8QX-01A-11D-A377-08	TCGA-ZG-A8QX-01A-11D-A376-01	1727eb06-107a-4b21-97d7-20cabf1826ac	TCGA-ZG-A8QX-01A-11D-A376-01	1727eb06-107a-4b21-97d7-20cabf1826ac		TCGA-ZG-A8QX-01	TCGA-ZG-A8QX-01A-11D-A378-05	TCGA-ZG-A8QX-01A-11R-A37H-13		1727eb06-107a-4b21-97d7-20cabf1826ac	3bc3b8cd-b2c6-455c-a336-704756b026e9
TCGA-ZG-A8QY-01	0	TCGA-ZG-A8QY-01	404	0	TCGA-ZG-A8QY	404	0	404	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-ZG-A8QY-F67806		Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-24731	5	250			5		0	404					NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	YES				NO	14	1	true	N1	T3b	TCGA-ZG-A8QY.4A09ACD5-F433-4F49-A47A-8DC4D5807E7A.pdf			0		0		0		0		10		30		60		80	WITH TUMOR	5	Stable Disease	No		NO	RX	Primary Tumor	01	4			NO	3	NO	YES	ZG	Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			2c5d7d19-0868-4f01-87ed-cca5556a2995	TCGA-ZG-A8QY-01	bd991045-7c0f-404b-b9e6-63086f9c816f		TCGA-ZG-A8QY-01A-11D-A377-08	TCGA-ZG-A8QY-01A-11D-A376-01	bd991045-7c0f-404b-b9e6-63086f9c816f	TCGA-ZG-A8QY-01A-11D-A376-01	bd991045-7c0f-404b-b9e6-63086f9c816f		TCGA-ZG-A8QY-01	TCGA-ZG-A8QY-01A-11D-A378-05	TCGA-ZG-A8QY-01A-11R-A37H-13		bd991045-7c0f-404b-b9e6-63086f9c816f	2c5d7d19-0868-4f01-87ed-cca5556a2995
TCGA-ZG-A8QZ-01	0	TCGA-ZG-A8QZ-01	308	0	TCGA-ZG-A8QZ	308	0	308	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-23980	12	322		42			0	308		239			YES	No Evidence of Extraprostatic Extension	NO				2014-5-21	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral			YES				NO	8	1	true	N1	T3b	TCGA-ZG-A8QZ.930A234B-9B7E-4F2C-905C-AF4CCB5570CB.pdf			0		0		0		0		20		20		60		80	TUMOR FREE	4		No	0.01	YES	R1	Primary Tumor	01	5			YES	3	NO	YES	ZG	Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			091d0d34-72e8-4842-bba9-bff4a89b58f9	TCGA-ZG-A8QZ-01	8d4a6058-e687-4bb7-afdc-e9936fdc49b1		TCGA-ZG-A8QZ-01A-11D-A377-08	TCGA-ZG-A8QZ-01A-11D-A376-01	8d4a6058-e687-4bb7-afdc-e9936fdc49b1	TCGA-ZG-A8QZ-01A-11D-A376-01	8d4a6058-e687-4bb7-afdc-e9936fdc49b1		TCGA-ZG-A8QZ-01	TCGA-ZG-A8QZ-01A-11D-A378-05	TCGA-ZG-A8QZ-01A-11R-A37H-13		8d4a6058-e687-4bb7-afdc-e9936fdc49b1	091d0d34-72e8-4842-bba9-bff4a89b58f9
TCGA-ZG-A9KY-01	0	TCGA-ZG-A9KY-01	130	0	TCGA-ZG-A9KY	130	0	130	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			73	TCGA-ZG-A9KY-F67809		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-27000	14	112		14			0	130					YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral		NO	YES				NO	16	2	true	N1	T4	TCGA-ZG-A9KY.2E48E905-FCAF-4A5F-A2E0-600276051562.pdf			0		0		0		0		10		20		70		80		5	Stable Disease	No		NO	R1	Primary Tumor	01	4			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			e7805163-e116-4f32-bead-1db31ccac6d7	TCGA-ZG-A9KY-01	8083711c-418c-49d4-9717-0e494b50103e			TCGA-ZG-A9KY-01A-11D-A41J-01	8083711c-418c-49d4-9717-0e494b50103e	TCGA-ZG-A9KY-01A-11D-A41J-01	8083711c-418c-49d4-9717-0e494b50103e		TCGA-ZG-A9KY-01	TCGA-ZG-A9KY-01A-11D-A41L-05	TCGA-ZG-A9KY-01A-11R-A41R-13		8083711c-418c-49d4-9717-0e494b50103e	e7805163-e116-4f32-bead-1db31ccac6d7
TCGA-ZG-A9L0-01	0	TCGA-ZG-A9L0-01	68	0	TCGA-ZG-A9L0			68	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			71			Normal (no evidence of prostate cancer) [cM0]	M0		-26055	-16	152		-119			0	68					YES	No Evidence of Extraprostatic Extension	NO				2014-7-17	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	420		NO	Bilateral			YES					20	7	true	N1	T3b	TCGA-ZG-A9L0.F5D6CACB-458D-4C16-972E-EF6848DEC4D8.pdf			0		0		0		0		0		20		80		90	WITH TUMOR	5		No			R1	Primary Tumor	01	4				3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			7ab9c42f-4b36-4064-9d56-384194c3f934		02fc78ec-68ae-4326-8df1-4f69850b5edd			TCGA-ZG-A9L0-01A-11D-A41J-01	02fc78ec-68ae-4326-8df1-4f69850b5edd	TCGA-ZG-A9L0-01A-11D-A41J-01	02fc78ec-68ae-4326-8df1-4f69850b5edd			TCGA-ZG-A9L0-01A-11D-A41L-05	TCGA-ZG-A9L0-01A-11R-A41R-13		02fc78ec-68ae-4326-8df1-4f69850b5edd	7ab9c42f-4b36-4064-9d56-384194c3f934
TCGA-ZG-A9L1-01		TCGA-ZG-A9L1-01			TCGA-ZG-A9L1				Prostate	TCGA Prostate Cancer	prostate adenocarcinoma											1246																											750		NO											true			TCGA-ZG-A9L1.1F620B81-F034-4F28-8DE0-6B19D181D24F.pdf			0		0		0		0		0		50		50		60								Primary Tumor	01													A						54515dea-d0bd-48dd-a4d8-02e382931c5e	TCGA-ZG-A9L1-01	adda35fc-181d-4a0c-9afe-f2bdd83ab087			TCGA-ZG-A9L1-01A-11D-A41J-01	adda35fc-181d-4a0c-9afe-f2bdd83ab087	TCGA-ZG-A9L1-01A-11D-A41J-01	adda35fc-181d-4a0c-9afe-f2bdd83ab087		TCGA-ZG-A9L1-01	TCGA-ZG-A9L1-01A-11D-A41L-05	TCGA-ZG-A9L1-01A-11R-A41R-13		adda35fc-181d-4a0c-9afe-f2bdd83ab087	54515dea-d0bd-48dd-a4d8-02e382931c5e
TCGA-ZG-A9L2-01	0	TCGA-ZG-A9L2-01	986	0	TCGA-ZG-A9L2			986	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			70		YES	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-25573	6	1056				180	0	986		1137			NO		NO				2014-7-17	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	390		NO				YES				YES	14	0	true	N0	T3b	TCGA-ZG-A9L2.CA9BA514-709C-48BA-B620-48BFBBA35493.pdf			40		20		0		20		0		40		60		60	WITH TUMOR	4	Stable Disease	No	0.01	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	ZG			Prostate		A	LIVING	2011	Peripheral Zone			fd65e856-a8be-4758-a656-3128295ef8c7	TCGA-ZG-A9L2-01	08fc16b8-f635-4e11-9ee7-afc7e3ea084c			TCGA-ZG-A9L2-01A-31D-A41J-01	08fc16b8-f635-4e11-9ee7-afc7e3ea084c	TCGA-ZG-A9L2-01A-31D-A41J-01	08fc16b8-f635-4e11-9ee7-afc7e3ea084c		TCGA-ZG-A9L2-01	TCGA-ZG-A9L2-01A-31D-A41L-05	TCGA-ZG-A9L2-01A-31R-A41R-13		08fc16b8-f635-4e11-9ee7-afc7e3ea084c	fd65e856-a8be-4758-a656-3128295ef8c7
TCGA-ZG-A9L4-01	0	TCGA-ZG-A9L4-01	1108	0	TCGA-ZG-A9L4	1108	0	1108	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			61		NO		M0	T1c	-22388		986					0	1108		1108									2014-7-17	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral			YES				NO	10	0	true	N0	T3b	TCGA-ZG-A9L4.BC344956-732B-4A0A-9493-299442B05CD1.pdf			0		0		0		0		0		50		50		60		5	Progressive Disease	No	0.03	NO	R1	Primary Tumor	01	4			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			875f8fd2-effc-4b1f-b340-65102d4fe67e	TCGA-ZG-A9L4-01	52371577-673b-43b9-ae0b-5dd12bd2dc32			TCGA-ZG-A9L4-01A-11D-A41J-01	52371577-673b-43b9-ae0b-5dd12bd2dc32	TCGA-ZG-A9L4-01A-11D-A41J-01	52371577-673b-43b9-ae0b-5dd12bd2dc32		TCGA-ZG-A9L4-01	TCGA-ZG-A9L4-01A-11D-A41L-05	TCGA-ZG-A9L4-01A-11R-A41R-13		52371577-673b-43b9-ae0b-5dd12bd2dc32	875f8fd2-effc-4b1f-b340-65102d4fe67e
TCGA-ZG-A9L5-01	0	TCGA-ZG-A9L5-01	854	0	TCGA-ZG-A9L5			854	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			58		NO		M0	T2a	-21293		953		11			0	854					YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO				2014-7-17	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	460		NO	Bilateral			YES					3	1	true	N1	T4	TCGA-ZG-A9L5.FE097411-281D-4804-BAB4-D732A95EC689.pdf			0		0		0		0		0		30		70		80	WITH TUMOR	5	Progressive Disease	No			R1	Primary Tumor	01	4			YES	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			f180744f-d5c2-4f22-b6ba-0759ac043ac3	TCGA-ZG-A9L5-01	8778e5a4-d61f-4fe0-a917-1f8036f85907			TCGA-ZG-A9L5-01A-12D-A41J-01	8778e5a4-d61f-4fe0-a917-1f8036f85907	TCGA-ZG-A9L5-01A-12D-A41J-01	8778e5a4-d61f-4fe0-a917-1f8036f85907		TCGA-ZG-A9L5-01	TCGA-ZG-A9L5-01A-12D-A41L-05	TCGA-ZG-A9L5-01A-12R-A41R-13		8778e5a4-d61f-4fe0-a917-1f8036f85907	f180744f-d5c2-4f22-b6ba-0759ac043ac3
TCGA-ZG-A9L6-01	0	TCGA-ZG-A9L6-01	664	0	TCGA-ZG-A9L6			664	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64		YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23681	13	733		13		664	0	664		664			YES	No Evidence of Extraprostatic Extension	NO				2014-7-17	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	520		NO	Bilateral			YES				YES	25	0	true	N0	T3b	TCGA-ZG-A9L6.1EAD6485-88D7-467C-8E00-335B3D7056B7.pdf			0		0		0		0		10		20		70		80	WITH TUMOR	5	Partial Remission/Response	No	0.36		R1	Primary Tumor	01	4				3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			8405cbd6-8572-4048-97c7-931b856120b1	TCGA-ZG-A9L6-01	6cd409f7-0933-4fa5-a998-735eadfb30ab			TCGA-ZG-A9L6-01A-11D-A41J-01	6cd409f7-0933-4fa5-a998-735eadfb30ab	TCGA-ZG-A9L6-01A-11D-A41J-01	6cd409f7-0933-4fa5-a998-735eadfb30ab		TCGA-ZG-A9L6-01	TCGA-ZG-A9L6-01A-11D-A41L-05	TCGA-ZG-A9L6-01A-11R-A41R-13		6cd409f7-0933-4fa5-a998-735eadfb30ab	8405cbd6-8572-4048-97c7-931b856120b1
TCGA-ZG-A9L9-01	0	TCGA-ZG-A9L9-01	617	0	TCGA-ZG-A9L9	617	0	617	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-ZG-A9L9-F67816	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-22108	-4	665			0	51	0	617					NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	270		NO	Bilateral		NO	YES				NO	15	3	true	N1	T3b	TCGA-ZG-A9L9.89DB264B-7026-4A51-BF05-A0629F25CFF6.pdf			2		1		0		1		3		22		75		75	WITH TUMOR	4	Progressive Disease	No		YES	R1	Primary Tumor	01	5			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			482b5a05-5689-421a-8ef6-4e83c190fbc8	TCGA-ZG-A9L9-01	2718ed2d-63b0-4699-b23d-dacb86e6c926			TCGA-ZG-A9L9-01A-11D-A41J-01	2718ed2d-63b0-4699-b23d-dacb86e6c926	TCGA-ZG-A9L9-01A-11D-A41J-01	2718ed2d-63b0-4699-b23d-dacb86e6c926		TCGA-ZG-A9L9-01	TCGA-ZG-A9L9-01A-11D-A41L-05	TCGA-ZG-A9L9-01A-11R-A41R-13		2718ed2d-63b0-4699-b23d-dacb86e6c926	482b5a05-5689-421a-8ef6-4e83c190fbc8
TCGA-ZG-A9LB-01	0	TCGA-ZG-A9LB-01	583	0	TCGA-ZG-A9LB	583	0	583	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-ZG-A9LB-F67821	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-26447	21	629		31			0	583		485			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	380		NO	Right		NO	YES				NO	9	0	true	N0	T3b	TCGA-ZG-A9LB.224AC4AB-11CC-4832-90FD-937C3C7B4C8E.pdf			2		1		0		1		2		18		80		80	WITH TUMOR	5	Partial Remission/Response	No	0.02	NO	R1	Primary Tumor	01	4			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			92e38059-d0c0-4604-935b-af4410305028	TCGA-ZG-A9LB-01	5eef1fb4-f7a7-4e33-bb83-5f589f9a4642			TCGA-ZG-A9LB-01A-11D-A41J-01	5eef1fb4-f7a7-4e33-bb83-5f589f9a4642	TCGA-ZG-A9LB-01A-11D-A41J-01	5eef1fb4-f7a7-4e33-bb83-5f589f9a4642		TCGA-ZG-A9LB-01	TCGA-ZG-A9LB-01A-11D-A41L-05	TCGA-ZG-A9LB-01A-11R-A41R-13		5eef1fb4-f7a7-4e33-bb83-5f589f9a4642	92e38059-d0c0-4604-935b-af4410305028
TCGA-ZG-A9LM-01	0	TCGA-ZG-A9LM-01	378	0	TCGA-ZG-A9LM	378	0	378	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			72	TCGA-ZG-A9LM-F67938	NO		M0	T2b	-26377		251		14			0	378		121			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	170		NO	Right		NO	YES				NO	11	2	true	N1	T3a	TCGA-ZG-A9LM.C66F9B46-7652-4BB9-B554-B9AB372EC7BC.pdf			0		0		0		0		0		30		70		70	TUMOR FREE	4	Complete Remission/Response	No	0.0	NO	R0	Primary Tumor	01	5			NO	3	NO	YES	ZG	Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone			383aa34e-bde9-4afd-9d90-cb33b9dc6e22	TCGA-ZG-A9LM-01	a79de49e-9b1c-4512-b6ed-df4a858c4875			TCGA-ZG-A9LM-01A-11D-A41J-01	a79de49e-9b1c-4512-b6ed-df4a858c4875	TCGA-ZG-A9LM-01A-11D-A41J-01	a79de49e-9b1c-4512-b6ed-df4a858c4875		TCGA-ZG-A9LM-01	TCGA-ZG-A9LM-01A-11D-A41L-05	TCGA-ZG-A9LM-01A-11R-A41R-13		a79de49e-9b1c-4512-b6ed-df4a858c4875	383aa34e-bde9-4afd-9d90-cb33b9dc6e22
TCGA-ZG-A9LN-01	0	TCGA-ZG-A9LN-01	115	0	TCGA-ZG-A9LN	115	0	115	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			57	TCGA-ZG-A9LN-F67937	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21050	3	76		9	7		0	115		90			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Stable Disease	2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral		NO	YES				NO	10	6	true	N1	T3b	TCGA-ZG-A9LN.3B5E5429-7D1E-4AD2-8329-DC784D412393.pdf			5		0		0		0		0		30		70		70	WITH TUMOR	5	Partial Remission/Response	No	7.42	NO	R1	Primary Tumor	01	4			YES		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			3e60191b-918a-40d7-8f5a-506457a27413		60e9a97e-8cf7-465c-9a31-7c0b714fbf95			TCGA-ZG-A9LN-01A-11D-A41J-01	60e9a97e-8cf7-465c-9a31-7c0b714fbf95	TCGA-ZG-A9LN-01A-11D-A41J-01	60e9a97e-8cf7-465c-9a31-7c0b714fbf95			TCGA-ZG-A9LN-01A-11D-A41L-05	TCGA-ZG-A9LN-01A-11R-A41R-13		60e9a97e-8cf7-465c-9a31-7c0b714fbf95	3e60191b-918a-40d7-8f5a-506457a27413
TCGA-ZG-A9LS-01	0	TCGA-ZG-A9LS-01	516	0	TCGA-ZG-A9LS	516	0	516	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			64	TCGA-ZG-A9LS-F67932	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-23540	16	215		16			0	516		147			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	190		NO	Bilateral		NO	YES				NO	47	3	true	N1	T3b	TCGA-ZG-A9LS.C08F26E6-5CC1-42FC-9533-D4199A5CE8B4.pdf			1		0		0		0		0		0		100		65	TUMOR FREE	5	Complete Remission/Response	No	0.03	YES	R1	Primary Tumor	01	4			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Central Zone			e46f93c9-418e-4f56-adc0-6b28f116a6f7	TCGA-ZG-A9LS-01	580772bc-57d8-4be2-ad7f-e4d0a8d754a4			TCGA-ZG-A9LS-01A-12D-A41J-01	580772bc-57d8-4be2-ad7f-e4d0a8d754a4	TCGA-ZG-A9LS-01A-12D-A41J-01	580772bc-57d8-4be2-ad7f-e4d0a8d754a4		TCGA-ZG-A9LS-01	TCGA-ZG-A9LS-01A-12D-A41L-05	TCGA-ZG-A9LS-01A-12R-A41R-13		580772bc-57d8-4be2-ad7f-e4d0a8d754a4	e46f93c9-418e-4f56-adc0-6b28f116a6f7
TCGA-ZG-A9LU-01	0	TCGA-ZG-A9LU-01	579	0	TCGA-ZG-A9LU	579	0	579	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			67	TCGA-ZG-A9LU-F67851	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-24742	37	617			40		0	579		549			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	380		NO	Bilateral		NO	YES				NO	7	0	true	N0	T3a	TCGA-ZG-A9LU.DC8CC307-723F-4E7F-AD59-4936BFA55789.pdf			1		0		0		0		0		0		100		70	WITH TUMOR	5	Partial Remission/Response	No	0.70	YES	R1	Primary Tumor	01	4			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			8d99c7e2-a1b2-4fdf-a6cd-e1404e485eac	TCGA-ZG-A9LU-01	39c01e87-6cb4-47f5-9ecd-be16781ef1f2			TCGA-ZG-A9LU-01A-11D-A41J-01	39c01e87-6cb4-47f5-9ecd-be16781ef1f2	TCGA-ZG-A9LU-01A-11D-A41J-01	39c01e87-6cb4-47f5-9ecd-be16781ef1f2		TCGA-ZG-A9LU-01	TCGA-ZG-A9LU-01A-11D-A41L-05	TCGA-ZG-A9LU-01A-11R-A41R-13		39c01e87-6cb4-47f5-9ecd-be16781ef1f2	8d99c7e2-a1b2-4fdf-a6cd-e1404e485eac
TCGA-ZG-A9LY-01	0	TCGA-ZG-A9LY-01	370	0	TCGA-ZG-A9LY	370	0	370	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			60	TCGA-ZG-A9LY-F67845	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-21942	20	404		12			0	370		288			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	100		NO	Bilateral		NO	YES				NO	11	1	true	N1	T3b	TCGA-ZG-A9LY.E4B3E97A-9587-47C2-BE35-C67B268CA133.pdf			0		0		0		0		5		25		70		80	TUMOR FREE	4	Complete Remission/Response	No	0.01	YES	R1	Primary Tumor	01	5			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			52ddbf44-b9bc-476f-9d5a-3f6071c32f48	TCGA-ZG-A9LY-01	c672c2b4-da56-4584-9126-4d59b5cecc1b			TCGA-ZG-A9LY-01A-11D-A41J-01	c672c2b4-da56-4584-9126-4d59b5cecc1b	TCGA-ZG-A9LY-01A-11D-A41J-01	c672c2b4-da56-4584-9126-4d59b5cecc1b		TCGA-ZG-A9LY-01	TCGA-ZG-A9LY-01A-11D-A41L-05	TCGA-ZG-A9LY-01A-11R-A41R-13		c672c2b4-da56-4584-9126-4d59b5cecc1b	52ddbf44-b9bc-476f-9d5a-3f6071c32f48
TCGA-ZG-A9LZ-01	0	TCGA-ZG-A9LZ-01	692	0	TCGA-ZG-A9LZ	692	0	692	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			66	TCGA-ZG-A9LZ-F67847	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-24132	-15	817		-9		310	0	692		692			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	5	0	true	N0	T3b	TCGA-ZG-A9LZ.D8F34923-C864-4CCC-9012-E74DE7A483CE.pdf			0		0		0		0		0		30		70		80	WITH TUMOR	4	Partial Remission/Response	No	2.19	YES	R1	Primary Tumor	01	5			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones			6a4b8c52-9cd6-42fd-a566-f49fcaa5815e	TCGA-ZG-A9LZ-01	0e33492b-b79a-42cc-8820-f077875a9384			TCGA-ZG-A9LZ-01A-11D-A41J-01	0e33492b-b79a-42cc-8820-f077875a9384	TCGA-ZG-A9LZ-01A-11D-A41J-01	0e33492b-b79a-42cc-8820-f077875a9384		TCGA-ZG-A9LZ-01	TCGA-ZG-A9LZ-01A-11D-A41L-05	TCGA-ZG-A9LZ-01A-11R-A41R-13		0e33492b-b79a-42cc-8820-f077875a9384	6a4b8c52-9cd6-42fd-a566-f49fcaa5815e
TCGA-ZG-A9M4-01	0	TCGA-ZG-A9M4-01	547	0	TCGA-ZG-A9M4	547	0	547	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			65	TCGA-ZG-A9M4-F67945	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-24030	21	509		22			0	547		218			YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	150		NO	Bilateral		NO	YES				NO	18	1	true	N1	T3b	TCGA-ZG-A9M4.86764ADF-5B8B-4989-99AA-595616A115A4.pdf			0		0		0		0		0		40		60		70	WITH TUMOR	5	Partial Remission/Response	No	0.95	NO	R1	Primary Tumor	01	4			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones			68e8a0c6-769a-4209-8208-bab351dd9297	TCGA-ZG-A9M4-01	9c1dbf62-a42a-4a60-84bb-98715d9a4b60			TCGA-ZG-A9M4-01A-11D-A41J-01	9c1dbf62-a42a-4a60-84bb-98715d9a4b60	TCGA-ZG-A9M4-01A-11D-A41J-01	9c1dbf62-a42a-4a60-84bb-98715d9a4b60		TCGA-ZG-A9M4-01	TCGA-ZG-A9M4-01A-11D-A41L-05	TCGA-ZG-A9M4-01A-11R-A41R-13		9c1dbf62-a42a-4a60-84bb-98715d9a4b60	68e8a0c6-769a-4209-8208-bab351dd9297
TCGA-ZG-A9MC-01	0	TCGA-ZG-A9MC-01	455	0	TCGA-ZG-A9MC	455	0	455	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			69	TCGA-ZG-A9MC-F67960	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-25477	3	434			0		0	455		427			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Stable Disease	2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	230		NO	Bilateral		NO	YES				NO	14	2	true	N1	T3b	TCGA-ZG-A9MC.1B48B5AE-27A9-4D79-923C-14AF6DE4B4E0.pdf			40		20		0		20		0		40		60		60	WITH TUMOR	5	Partial Remission/Response	No	31.85	YES	R1	Primary Tumor	01	4			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone			24177a07-4087-4699-bcc0-ed30eb85ecb6	TCGA-ZG-A9MC-01	d992a3c1-fe30-4d15-a4e6-4e250e834da2			TCGA-ZG-A9MC-01A-31D-A41J-01	d992a3c1-fe30-4d15-a4e6-4e250e834da2	TCGA-ZG-A9MC-01A-31D-A41J-01	d992a3c1-fe30-4d15-a4e6-4e250e834da2		TCGA-ZG-A9MC-01	TCGA-ZG-A9MC-01A-31D-A41L-05	TCGA-ZG-A9MC-01A-31R-A41R-13		d992a3c1-fe30-4d15-a4e6-4e250e834da2	24177a07-4087-4699-bcc0-ed30eb85ecb6
TCGA-ZG-A9N3-01	0	TCGA-ZG-A9N3-01	349	0	TCGA-ZG-A9N3	349	0	349	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			73	TCGA-ZG-A9N3-F68209	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-26902	7	69			7		0	349		244			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Stable Disease	2014-11-14	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	30	1	true	N1	T3b	TCGA-ZG-A9N3.C97CA9D4-71F2-4068-9959-BF8F7829189C.pdf			3		1		1		1		0		19		80		80	WITH TUMOR	5	Partial Remission/Response	No	0.1	NO	R1	Primary Tumor	01	4			YES	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			a793c4a6-8339-411f-bea9-b04cb243e27d		2ee45f38-cb92-4e91-acea-e454a13f59d9			TCGA-ZG-A9N3-01A-11D-A41J-01	2ee45f38-cb92-4e91-acea-e454a13f59d9	TCGA-ZG-A9N3-01A-11D-A41J-01	2ee45f38-cb92-4e91-acea-e454a13f59d9			TCGA-ZG-A9N3-01A-11D-A41L-05	TCGA-ZG-A9N3-01A-11R-A41R-13		2ee45f38-cb92-4e91-acea-e454a13f59d9	a793c4a6-8339-411f-bea9-b04cb243e27d
TCGA-ZG-A9ND-01	0	TCGA-ZG-A9ND-01	410	0	TCGA-ZG-A9ND	410	0	410	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			55	TCGA-ZG-A9ND-F68219	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20428	7	283		10			0	410		184			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-14	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		NO	YES				NO	8	0	true	N0	T3a	TCGA-ZG-A9ND.89122E71-1246-44A5-9D44-4F95284EB02E.pdf			3		1		0		1		0		15		85		85	TUMOR FREE	5	Complete Remission/Response	No	0.08	NO	R0	Primary Tumor	01	4			NO	3	NO	YES	ZG	Apex|Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			a33e9f09-6247-418f-aa46-56e8f6deabde	TCGA-ZG-A9ND-01	35a82435-e313-4206-b328-b2b1db736aef			TCGA-ZG-A9ND-01A-11D-A41J-01	35a82435-e313-4206-b328-b2b1db736aef	TCGA-ZG-A9ND-01A-11D-A41J-01	35a82435-e313-4206-b328-b2b1db736aef		TCGA-ZG-A9ND-01	TCGA-ZG-A9ND-01A-11D-A41L-05	TCGA-ZG-A9ND-01A-11R-A41R-13		35a82435-e313-4206-b328-b2b1db736aef	a33e9f09-6247-418f-aa46-56e8f6deabde
TCGA-ZG-A9NI-01	0	TCGA-ZG-A9NI-01	132	0	TCGA-ZG-A9NI	132	0	132	Prostate	TCGA Prostate Cancer	prostate adenocarcinoma			73		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-26697	22	139		22			0	132		99			YES	No Evidence of Extraprostatic Extension	NO				2014-7-18	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61.9	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral			YES				NO	21	0	true	N0	T3b	TCGA-ZG-A9NI.70DD94DF-13D1-40FC-A52B-43E2229563E3.pdf			3		1		0		1		3		17		80		80	WITH TUMOR	5	Complete Remission/Response	No	0.03	NO	R1	Primary Tumor	01	4			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones			482b5252-2960-47ae-9b90-d86c5b5b1ea8	TCGA-ZG-A9NI-01	ed5fb1bc-ffb9-4946-89e0-73635d84f448			TCGA-ZG-A9NI-01A-11D-A41J-01	ed5fb1bc-ffb9-4946-89e0-73635d84f448	TCGA-ZG-A9NI-01A-11D-A41J-01	ed5fb1bc-ffb9-4946-89e0-73635d84f448		TCGA-ZG-A9NI-01	TCGA-ZG-A9NI-01A-11D-A41L-05	TCGA-ZG-A9NI-01A-11R-A41R-13		ed5fb1bc-ffb9-4946-89e0-73635d84f448	482b5252-2960-47ae-9b90-d86c5b5b1ea8
